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SUMMARY 
The pharmaceutical and chemical industry is interested to replace as much as possible 
in vivo experiments with alternative in vitro models which have improved capability to 
assess and predict the safety profile of their products. This is influenced by the 3R 
principles of reducing the number of tests, the refinement of existing experiments and 
the replacement of animal experiments with new and alternative methods (Russell & 
Burch, 1959). The latter is also supported by EU-programms, which ultimately will be 
reflected in new regulatory guidelines. 
One major target in the safety testing of new chemical products is the liver. This is not 
surprising as the liver is the major organ for xenobiotic metabolism. Several different 
culture systems for primary hepatocytes are actually in use for the study of acute 
toxicity, the basic mechanisms of action, metabolism or enzyme induction. Yet, there is 
no established and standardized culture method maintaining hepatocyte specific 
functionality for longer term experiments. This PhD work has the aim of developing a 
longer-term sandwich culture model which maintains hepatocytes in their differentiated 
and metabolically active state. To elucidate advantages and disadvantages of this 
culture, it was compared to several currently used culture models. Functional tests 
revealed an improved metabolic activity and viability over time in culture. Global gene 
expression analysis showed common effects caused by the liver perfusion as well as 
individual differences in the different culture systems. 
The improved sandwich culture was applied to a toxicologically relevant study in which 
the cells were dosed with fifteen well known model compounds (hepatotoxins and 
negative controls) and the global gene expression data was used to build a predictive 
discrimination model for hepatotoxicity based on a defined gene set of 724 genes. This 
model was successfully applied on a blinded compound and on acetaminophen, which 
both were correctly classified to be hepatotoxic. 
The use of the new Illumina global gene expression platform enabled a detailed 
comparison with the current state of the art technologies from Affymetrix and TaqMan 
real time PCR. Several technical parameters were checked for concordance and 
sensitivity between both platforms and the biological interpretation of an in vivo and in 
vitro toxicogenomics study was compared. The results of these studies revealed a high 
concordance between both platforms making both of them equally applicable for 
toxicogenomics studies. 
In conclusion, the field of toxicogenomics, applied to an in vitro test system proved to 
deliver reliable and promising results allowing new insights into the mechanism of 
compound toxicity. Additionally, the prediction of toxicity of new compounds, with the 
help of a classification model, based on a large dataset of model compounds, seems to 
be applicable for early screening in drug development. 
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ZUSAMMENFASSUNG 
Die pharmazeutische und chemische Industrie ist daran interessiert, in vivo 
Experimente so weit wie möglich durch alternative in vitro Methoden mit Möglichkeiten 
zu ersetzen, die das Sicherheitsprofil ihrer Produkte besser erfassen. Dies wird 
beeinflusst durch die 3R-Prinzipien, das Reduzieren der Anzahl von Tierversuchen, die 
Verbesserung existierender Experimente und dem Ersetzen von Tierversuchen durch 
alternative Methoden Russell & Burch, 1959). Letzteres wird ebenfalls durch EU 
geförderte Programme unterstützt und it das Ziel verschiedener regulatorischer 
Richtlinien. 
Ein zentrales Ziel der Sicherheitstestung neuer chemikalischer Produkte ist die Leber. 
Dies ist nicht überraschend, da die Leber das Hauptorgan des 
Fremdstoffmetabolismus ist. 
Momentan werden viele verschiedene Primärhepatozyten-Kultursysteme die 
Untersuchung von akuter Toxizität, den zugrunde liegenden Mechanismen, dem 
Metabolismus oder der Enzym-Induktion eingesetzt. Zurzeit gibt es jedoch keine 
etablierte und standardisierte Kulturmethode, welche die hepatozytenspezifischen 
Funktionen erhält und somit Langzeitversuche ermöglichen würde. Die vorliegende 
Doktorarbeit hatte das Ziel solch eine Methode in Form der Sandwich-Kultur zu 
entwickeln und dadurch den Differenzierungsgrad der Zellen sowie deren metabolische 
Aktivität zu erhalten. Um Vor- und Nachteile dieser Kulturmethode zu beleuchten 
wurde sie mit anderen, momentan verwendeten Methoden verglichen. Die globale 
Genexpressionsanalyse zeigte gemeinsame, durch die Leber-Perfusion verursachte 
Effekte sowie individuelle Unterschiede der verschiedenen Zellkulturen. 
Basierend auf diesem Wissen wurden toxikologisch relevante Studien mit dem 
Sandwich-Kultur-System durchgeführt. Dafür wurden die Zellen mit fünfzehn 
Modellsubstanzen behandelt, anhand ihrer globalen Genexpressionsprofile ein 
diskriminatives Prädikitonsmodel für Hepatotoxizität erstellt und ein Gen-Set von 724 
prädiktiven Genen definiert. Dieses Model wurde danach erfolgreich mit einer 
verblindeten Substanz und mit Acetaminophen getestet. 
Die Nutzung einer neuen Plattform zur globalen Genexpressionsanalyse von Illumina 
ermöglichte den detaillierten Vergleich mit der zurzeit meistverwendeten Plattform 
(Affymetrix) sowie mit der TaqMan PCR. Hierbei wurden verschiedenste technische 
Parameter auf Übereinstimmung und Sensitivität überprüft und die biologische 
Interpretation von mit beiden Plattformen gemessenen in vivo und in vitro Studien 
verglichen. Die Ergebnisse dieser Studien zeigten die hohe Übereinstimmung 
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zwischen beiden Mess-Plattformen, die eine Anwendung beider in toxikogenomischen 
Studien erlaubt. 
Zusammenfassend lässt sich sagen dass toxikogenomische Studien in Verbindung mit 
einem in vitro Test System verlässliche und viel versprechende Ergebnisse liefert, 
welche neue Einblicke in den Wirkmechanismus von Substanzen ermöglicht. 
Zusätzlich ermöglicht die Klassifizierung von Substanzen mit Hilfe des erstellten 
Prädiktionsmodells ein frühes Screening in der Medikamentenentwicklung. 
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1 INTRODUCTION 
 
1.1 Endeavors of modern toxicology 
Toxicology is the study of adverse effects of chemical and physical agents on living 
organisms and the environment. The basic assumption of toxicology is that there is a 
relationship between the dose, the concentration at the affected site, and the resulting 
adverse effects. The physician Theophrast von Hohenheim (Paracelsus, 1493-1541) 
said: “Alle Ding sind Gift, und nichts ohn Gift; allein die Dosis macht, daß ein Ding kein 
Gift ist”1. As he was the first one to discover the relationship between dose and effect 
of substances he is often called the “father of toxicology”. 
The purpose of modern toxicology is to understand the character and dimension of 
toxic effects and to regulate the use of potentially toxic substances. Up to now, there is 
a general lack of knowledge regarding 99% of chemicals manufactured around the 
world. The distinction between so-called "existing" and "new" chemicals is based on 
the cut-off date of 1981. All chemicals that were on the European Community market 
between 1 January 1971 and 18 September 1981 are called "existing"2. Prior to that 
date, no stringent health and safety tests were needed to market chemicals, it was up 
to the authorities to prove that a substance posed a threat before it could be withdrawn. 
Since then, 3,800 so-called “new” chemicals have gone through a more stringent safety 
screening process. New perceptions have now introduced the possibility that the 
incidence of diseases, such as cancer, could be linked to this multitude of chemicals 
already on the market (Irigaray et al., 2007) Therefore, in June 2007, the European 
Parliament introduced a new system of Registration, Evaluation and Authorisation of 
CHemicals (REACH). Central to the system is a requirement for producers and 
importers of chemicals to prove that their substances are safe before put on the market 
(reversal of burden of proof). "Existing" chemicals will have to be screened for health 
and safety reasons over a period of 11 years. Therefore, defined, standardized and 
validated assays have to be conducted and the results regulated by national and 
international commissions3.  
                                                
1 "All things are poisonous and nothing is without poison, only the dose permits something not to 
be poisonous." 
2 Around 100,000, listed in the European Inventory of Existing Commercial Chemical 
Substances (EINECS). 
3 Umweltbundesamt, Dessau-Rosslau, Germany; European Chemicals Agency, Helsinki, Finland 
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Up to now, only few of these mandatory tests can be accomplished with animal-free 
alternative methods leading to the problem that a marked increase of animal testing will 
be of animals are required (Figure 1). This contradicts the simultaneous effort of 
reducing the number of animals used in experiments for ethical and cost reasons.  
In 1959, Russel and Burch suggested the principle of the 3Rs in order to reduce animal 
experiments (Russell & Burch, 1959). It refers to the improvement of the animal welfare 
by reducing the number of tests realised, the refinement of existing experiments to 
reduce the suffering of the animals and to a replacement of animal experiments with 
new and alternative methods. Considering this, it is believed that in vitro toxicity testing 
methods can be a useful, time and cost-effective supplement or in some case even a 
replacement of toxicology studies in living animals. Certain endpoints of toxicity can be 
depicted quite well, although currently available in vitro tests are not adequate to 
entirely replace animals in toxicology testing. In 1991, the European Centre for the 
Validation of Alternative Methods (ECVAM) was founded to assist and coordinate the 
development and validation of alternative test methods under the guidance of the 
European Union. 
 
 
Figure 1: Increasing number of animals needed in toxicological testing procedure for one 
compound beginning with an acute toxicity study and ending with a 2-year carcinogenicity 
study. 
 
1.2 The liver morphology and its cell types 
The liver is the largest and most complex gland of the body. It is the main detoxifying 
organ in mammals, with large amounts of phase 1 and phase 2 metabolic enzymes 
and it is responsible for large parts of lipid and cholesterol metabolism, the production 
of hormones, phagocytosis of debris and bacteria as well as participating in iron 
metabolism. Additionally, it has an important role in many vital functions of the body, 
like the production of bile, the processing and storage of nutrients and Vitamin A and 
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the synthesis of blood proteins including albumin, lipoproteins, transferrin, growth 
factors and coagulation factors (LaBrecque, 1994; Kevresan et al., 2006).  
In vertebrates, the liver is divided into four lobes, with each containing thousands of 
equally built lobules, and is served by two distinct blood supplies. The hepatic artery 
supplies oxygenated blood and the hepatic portal vein feeds blood from the intestinal 
system (including the pancreas and the spleen) and is rich in nutrients but is low in 
oxygen. The blood flows out of the liver via the hepatic vein in the direction of the 
inferior vena cava. Thereby, xenobiotics absorbed by ingestion have to pass the 
hepatocytes, the predominant cell type in liver, and can be taken up, metabolised 
and/or detoxified (first pass effect). The metabolites are excreted partly, depending on 
their chemical properties, into the bile canaliculi or via the venous blood into the urine. 
Hepatocytes, the liver parenchymal cells, account for about 80-90% of liver mass and 
65% of cell number of a normal liver, Non-parenchymal cells like Kupffer cells (15%), 
endothelial cells, hepatic stellate cells or pit cells make up the remaining mass (Blouin, 
Bolender & Weibel, 1977; Widmann, Cotran & Fahimi, 1972; Wisse, 1977a, 1977b).  
 
 
 
 
 
 
Figure 2: Schematic diagram 
of a normal liver lobule 
showing sheets of 
hepatocytes and the sinusoids 
which contain a variety of 
specialized cells like Ito-cells, 
Kupffer cells and endothelial 
cells. (Figure taken from 
www.ener-chi.com/ d_liv.htm) 
 
In a hexagonal shaped liver lobule, the central vein is surrounded by 4-6 portal areas 
(Matsumoto & Kawakami, 1982) and hepatocytes are arranged in cords radiating from 
the central vein (Figure 2). Hepatic endothelial cells form the walls of the sinusoidal, the 
capillaries between the cords of hepatocytes. Unlike other endothelial cells, they lack a 
basement membrane and the endothelial structures possess pores called fenestrae, 
allowing the blood to flow directly around the hepatocytes. They express several 
adhesion molecules facilitating inflammatory cell migration, usually as response to 
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activation by Kupffer cell signalling following liver damage (Ohira et al., 2003; Scoazec 
& Feldmann, 1994).  
The Kupffer cells, resident macrophages in the liver, represent the second largest cell 
population of the liver. They are located in the hepatic sinusoids, in between or on top 
of endothelial cells, but they also make contact to the hepatocytes through their 
extensions. They exhibit several important functions, such as endocytosis of foreign 
material and bacteria, antigen presentation and secretion of biologically active products 
(e.g. nitric oxide and cytokines) and play an important role in immune and inflammatory 
responses involving cytokine-signalling (Winwood & Arthur, 1993).  
Stellate cells are the fat-storing cells of the liver where they reside in the space of Disse 
between hepatocytes and endothelial cells. They store Vitamin A in lipid droplets, 
synthesize extracellular matrix proteins and it has been suggested that they contribute 
to liver fibrosis and immune response (Ogata et al., 1991; Friedman, 1997) 
 
1.3 Hepatocytes and xenobiotic metabolism 
As mentioned above, the liver is the main organ for endogenous and exogenous 
metabolism and detoxification of foreign compounds. The fenestrated endothelial 
allows the blood plasma to leak through the endothelial cell layer and come into close 
contact with the microvilli of the underlying hepatocytes in the space of Disse, providing 
optimal conditions for an extensive metabolic exchange (Enomoto et al., 2004). 
Hepatocytes are polygonally-shaped, polarized and highly differentiated cells with a 
turnover time in vivo of 300-400 days (Imai et al., 2001). There is an abundance of 
mitochondria and they often contain a second nucleus to manage their extensive roles 
in energy production, protein synthesis and metabolism/detoxification. Polyploidy is a 
general physiological process indicative of terminal differentiation (Sigal et al., 1999).  
Each hepatocyte has a basolateral surface facing the lymph in the space of Disse and 
canalicular surfaces facing the bile duct. The basolateral membrane is rich in 
microvillus and expresses many transporters for uptake of organic anions, cations 
(OATPs and Oct1-3 respectively) and bile salts (NTCP, OST α and β).  The canalicular 
membrane of neighbouring hepatocytes is sealed by tight junctions generating fine 
channels that run around the cells (Figure 3). 
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Figure 3: Ultrastructure of hepatocytes as polarized, secretory active cells with basolateral and 
apical surrounding (Figure adapted from Siegenthaler & Blum, 2006). 
 
The hepatocyte membranes accommodate transporters which have overlapping 
substrate specify (MDR 1-3, OATP) and are responsible for the export of bile salts or 
products of metabolic pathways (Figure 4). Hepatic export into the bile is an important 
function for the detoxification of foreign compounds entering the body and is therefore 
often referred to as phase 3 of xenobiotic metabolism (Makowski & Pikuła, 1997; 
Yamazaki, Suzuki & Sugiyama, 1996). MRPs 1, 3 & 4 and OST α, β are basolaterally 
located, ATP-dependent, transporters. The shading of these transporters in Figure 4, 
and the white arrows in the pathways leading to and through them, symbolize their low 
activity in the normal hepatocyte. With hepatocellular disease or cholestasis, they are 
greatly up regulated, increasing the export of organic anions, thus limiting accumulation 
of toxic organic anions (e.g. bilirubin, bile salts) within the hepatocyte. 
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Figure 4: Schematic diagram of transport processes in hepatocytes. Shown are influx 
transporters, such as OATPs, OATs, NTCP and OCTs at the sinusoidal membrane, and efflux 
transporters, such as MDR1, MDR3, MRP2 and BSEP at the canalicular membrane. Additional 
efflux transporters such as MRP3, MRP4, and MRP6 at the basolateral membrane are not 
shown. (Figure taken from www.uwgi.org/ gut/liver_05.asp) 
 
There are different requirements, which the hepatocytes, as xenobiotic metabolizing 
cells, have to accomplish. The cells have to transform non-polar, lipophilic xenobiotics 
to more hydrophilic metabolites to facilitate their excretion into the bile or the urine 
(Figure 5). The resulting metabolites should be less biologically active (detoxificated) 
and the metabolizing enzymes must have a broad, overlapping specificity so new and 
unknown compounds can be metabolized (Marquardt et al.,1999). For this reason, 
hepatocytes express a variety of metabolic enzymes, which are responsible for 
different types of reactions.  
 
Figure 5: Phase model of 
xenobiotic metabolism. 
Lipophilic compounds are 
sequentially metabolized 
over electrophilic or 
nucleophilic intermediates 
to hydrophilic products that 
can afterwards be excreted 
renally or biliary. (Figure 
adapted from Marquardt & 
Schäfer, 2004). 
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Two main processes usually occur sequentially called phase 1 and phase 2. The 
former leads to an activation of the compound by introducing functional groups into the 
compound by oxidation, reduction or hydrolysis reactions. This is followed by phase 2 
reactions, the conjugation of the active metabolite with a highly polar ligand like 
glucuronic acid or glutathione, leading to more hydrophilic products. As mentioned 
above, the directed transport of metabolites out of the cells by specialized transporters 
is often referred to as phase 3 of xenobiotic metabolism. 
Typical phase 1 enzymes are listed in Table 1. The CYP enzymes, the predominant 
group of phase 1 enzymes in mammals, consist of at least 17 gene families with 50-60 
individual isoforms (Guengerich, 2003; Waxman, 1999). The major human CYP 
enzymes involved in metabolism of drugs or exogenous toxins are Cyp3A4, Cyp1A1, 
Cyp1A2, Cyp2D6 and Cyp2C (Figure 6). The amount of each of these enzymes 
present in the liver reflects their importance in drug metabolism (Goodman et al., 
1996). 
 
 
 
 
 
 
 
Figure 6: Proportion of drugs 
metabolized by cytochrome 
P450 isoenzymes (upper 
figure) and phase 2 enzymes 
(lower figure). Figures adapted 
from (Evans & Relling, 
1999) and (Wrighton & 
Stevens, 1992). 
 
Depending on the chemical properties of the introduced functional groups, phase 1 
products can be classified as electrophilic or nucleophilic metabolites. Strong 
electrophilic metabolites are able to covalently bind to biological molecules like DNA, 
RNA or proteins and therefore have inherent cytotoxic or mutagenic potential 
(Besaratinia & Pfeifer, 2005). In contrast to this, nucleophiles can show biological 
activity by binding to cellular receptors and activating downstream reactions. Thus, the 
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metabolic activity of cells can lead not only to a detoxification but also, in certain cases, 
to a toxification of compounds.  
The activation reaction is in most cases followed by a detoxifying phase 2 conjugation 
reaction. Thereby, the water solubility is increased allowing the cells to excrete the 
conjugates into the bile canaliculi and/or the blood plasma. Enzymes catalyzing phase 
2 reactions are e.g. sulfotransferases (SULT), acetyltransferases (AT), 
glucoronyltransferases and Glutathione-S-Transferases (GST) (Figure 6).  
 
Phase-1-Enzymes  Phase-2-Enzymes 
Cytochrom-P450-dependent 
monooxygenases (CYP) 
 Transferases 
 
Oxidoreduktases  Glutathiontransferases (GST) 
Flavin-dependent monooxygenases (FMO)  UDP-glucuronosyltransferases (UGT) 
Monoaminoxidases (MAO)  Sulfotransferases (SULT) 
Cyclooxygenases (COX)  Acetyltransferases (NAT) 
Dihydrodioldehydrogenases  Methyltransferases 
Alcohol- and aldehyddehydrogenases (ADH, 
ALDH) 
 Aminoacyltransferases 
Esterases    
Amidases  Phase-3-Enzymes 
Glucuronidases  OATCs 
Epoxidhydrolases (EH)  MDRs 
DT-Diaphorase (NQOR)  MRPs 
Hydrolases  
Table 1: Examplse of enzyme classes involved in the three phases of xenobiotic metabolism. 
 
Several factors can influence the efficiency of xenobiotic metabolism. The activation 
and inhibition of enzyme activity and the induction and repression of gene expression 
are the main elements of regulation. Inducers usually affect multiple enzymes from 
different steps of xenobiotic metabolism. Thereby, an entire metabolism cascade can 
be activated leading to the detoxification of the compound (Elias & Mills, 2007; Xu, Li & 
Kong, 2005). Responsible for this coordinated gene expressions are several forms of 
nuclear receptors which act in concert with other regulatory proteins (Figure 7). In their 
inactive form, they are present in the cytoplasm and, after binding of a substrate, are 
translocated into the nucleus in their active form as homo- or heterodimers. By binding 
to the DNA at different hormone response elements (HRE´s) and recruiting other 
proteins, so called co-regulators, their effect can be modulated in various ways. 
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Figure 7: interaction of cellular transcription factors and their influence on several biological 
processes (Taken from Ulrich 2003). 
 
Some receptors, so-called orphan receptors, do not have any known endogenous 
ligands but can bind metabolic intermediates with low affinity (Benoit et al., 2006). They 
are therefore thought to function as metabolic (Peroxisome Proliverator activated 
receptors (PPAR)) or xenobiotic (pregnane X receptor (PXR), constitutively active 
receptor (CAR)) sensors. Ligands for these kinds of receptors include lipophilic 
substances like hormones or xenobiotic compounds. They often build heterodimers 
with the Retinoic X receptor (RXR) or the AHR-nuclear translocator (Arnt) to activate 
the transcription of a wide range of metabolizing enzymes which in turn are often 
needed for further metabolisation of the initial substrate. This whole mechanism builds 
up an autoregulatory metabolic feedback-loop.  
The expression of most metabolic enzymes, especially the CYP enzymes, is regulated 
in this way with the exception being CYP2E1, which is regulated in an even more 
complex manner. It is regulated on not only transcriptional but also pre-translational, 
translational, and posttranslational level with the stabilization of mRNA and protein as 
the most important steps (Ingelman-Sundberg et al., 1994)  
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1.4 Hepatotoxicity 
Because of the central role the liver plays in the metabolism of xenobiotic compounds, 
hepatotoxicity is a major issue in pharmaceutical drug development (Ballet, 1997). 
Drug-induced liver injury is the major reason for attrition in clinical studies (Wysowski & 
Swartz, 2005) and hepatotoxic side effects are the main reason for drug withdrawals 
from the market (31%). A broad variety of liver pathophysiologies have been reported, 
including steatosis (fatty liver), cholestasis (obstruction of bile secretion), fibrosis 
(increased production and deposition of extracellular matrix components), hepatitis 
(inflammation), necrosis (cell death) or the formation of liver tumours. These 
pathological findings may arise from diseases affecting the liver, but also from 
xenobiotics, alcohol abuse or undesired drug-drug interactions. The pathological 
symptoms of certain liver diseases allow conclusions about the affected intracellular 
organelles. Although different histological changes can appear, a compound-class 
often displays a typical clinical or pathological appearance.  
Xenobiotics administered orally first pass through the liver before entering the general 
blood circulation (first pass effect). Because the liver has multiple functions for the 
homeostasis of the whole body, drug induced liver toxicity can have severe 
consequences. Thirty to fifty percent of acute liver failures and fifteen percent of liver 
transplantations are related to chemical-induced hepatotoxicity (Andrade et al., 2004; 
Kaplowitz, 2001; Lewis, 2002).There is often a lack of reasonable understanding of the 
general molecular mechanisms of most drug-induced hepatoxicities (Boelsterli, 2003; 
Jaeschke et al., 2002; Lee, 2003). The inhibition of mitochondrial function, disruption of 
intracellular calcium homeostasis, activation of apoptosis, oxidative stress, inhibition of 
specific enzymes or transporters and the formation of reactive metabolites that cause 
direct toxicity or immunogenic responses are some mechanisms that have to be 
considered.  
The drug development process comprises a variety of steps to assess whether a test 
compound has adequate efficacy, appropriate physicochemical properties, metabolic 
stability, safety and bioreactivity in humans. Hepatotoxicity in humans has a poor 
correlation with regulatory animal toxicity tests (Olson et al., 1998; Olson et al., 2000). 
However, if assays identified a compound as a human liver-toxicant, there is more than 
80% correlation to the corresponding findings in animals (Xu, Diaz & O'Brien, 2004). 
While in vivo models, limited by animal welfare/ethical concerns, are used to 
investigate systemic influences, cell culture models provide systems that can 
investigate specific mechanisms in a precisely controlled environment (Ulrich et al., 
1995). 
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Although there are ways to analyse the many toxicological parameters individually in 
vitro, most have low predictive value for the detection of human hepatotoxicity. The 
poor predictivity and sensitivity of standard in vitro cytotoxicity assays is due to several 
reasons, including strong inter-species variation, the lack of a true physiological 
environment of in vitro experiments or the insufficient culturing conditions, resulting in a 
loss of e.g. metabolic capabilities (Olson et al., 1998). The in vitro assays usually 
measure lethal events in late stages of toxicity, but toxicity may not always be lethal per 
se. Cytotoxicity may take several days to appear (Olson et al., 1998; Slaughter, 
Thakkar & O'Brien 2002; Schoonen et al., 2005), demanding repeated drug 
administration. In contrast to directly active compounds (primary toxins), some 
compounds elicit their toxic potential only as a metabolite (secondary toxins) and 
usually cause damage in the organ where they are produced. 
This of course raises the need for metabolically active long-term in vitro models that 
facilitate extended exposure times. Several models have been used for the detection of 
acute toxicity, but sub-chronic and chronic toxicities have not been addressed so far. 
Furthermore, standard tests generally investigate only one parameter whereas 
hepatotoxicity can develop via many different mechanisms and is considered a multi-
factorial process. In order to improve sensitivity it will be necessary to analyse several 
morphological, biochemical and functional endpoints in parallel. Finally, tests should be 
performed not only with high concentrations, causing acute toxicity, but also with in vivo 
pharmacological concentrations. 
 
1.5 In vitro liver models 
In vitro tests have the advantage of allowing multiple testing of different compounds, 
doses and/or time points simultaneously under well-defined conditions. The simplicity 
of some in vitro systems, besides saving time, money and animals used for 
experimentation, provides the ability to specifically manipulate and analyze a small 
number of well-defined parameters. The most commonly used test systems include, 
the isolated perfused liver, liver slices, primary hepatocytes in suspension or culture, 
cell lines, transgenic cells and sub-cellular fractions such as S9 mix, microsomes, 
supersomes or cytosol (Table 2). The reduction in the complexity of the system and the 
increase in throughput offer the ability to study specific parameters more closely but 
create inherent constraints for each model (Figure 8). However, this limits their 
widespread use and acceptance by the regulatory authorities as an alternative for in 
vivo testing (Brandon et al., 2003). Although studies have shown that in vitro 
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cytotoxicity data can be used to identify appropriate doses for in vivo studies (Scholz et 
al., 1999)  
 
 
Figure 8: Models and genomic tools used for drug development, ordered by the correlation of 
the complexity of experiments conducted, the expressiveness, and the complexity of an in vitro 
model. (Adapted and modified from Brandon et al., 2003) 
 
One major obstacle for some in vitro models is their limited metabolic competence, 
mainly due to the down regulation of CYP enzymes over time (Ching et al., 1996; De 
Smet et al., 1998). This is especially important since phase 1 and phase 2 metabolic 
conversions of chemicals can greatly influence their toxicity (Holme, 1985). To 
overcome these problems, new and innovative strategies are being developed in order 
to find reliable markers that are involved not only in early toxic responses but also in 
chronic toxicities, also occurring at sub-lethal doses of a test compound. Furthermore, 
there is a strong need for a robust long-term in vitro screening system that allows the 
characterisation of drug/chemical induced toxicities and helps to reduce the use of 
animals in toxicity testing. 
Isolated perfused liver 
Ideally, an in vitro test system should adequately represent the in vivo situation as 
closely as possible. Most liver specific features are preserved in whole isolated and 
perfused livers, first developed in 1972 by Gordon and colleagues (Gordon et al., 
1972). Especially, the three-dimensional architecture of the liver, the cell-cell, cell-
matrix interactions and functional bile canaliculi are maintained. Additionally, all liver 
cell types are present and the communication between them can play an important role 
in mediating toxicity. Despite all these advantages, the isolated perfused liver model is 
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difficult to handle and retains its functional integrity for only a few hours. Moreover, 
reproducibility is low, the use of animals is not significantly reduced and human organs 
are rarely available. 
Precision-cut liver slices 
First used in 1923 by Otto Warburg and improved over the following decades 
(Warburg, 1923; Krumdieck, dos Santos & Ho, 1980), precision-cut liver slices have the 
advantage of partially conserved liver cyto-architecture, cell-cell, cell-matrix contacts 
and the presence of different cell types (Lerche-Langr & Toutain, 2000). The 
preparation of slices from different parts of the liver facilitates lobe and zone specific 
analysis of metabolism and toxicity. In addition, since many slices can be prepared 
from the same human or animal donor, reproducibility and throughput can be increased 
significantly. Another major advantage is the possibility to conduct histopathological 
examinations, as well as biochemical and molecular biological studies from the same 
tissue. Due to the thickness of liver slices, 200-250 µm resembling 10-20 cell layers, 
the adequate supply of nutrients and oxygen from the incubation medium is only 
maintained for the outer cell layers. Therefore, liver slices are only useful for short-term 
toxicity studies due to their limited viability and the rapid decline of liver specific 
functions. The metabolic activity of tissue slices are reported to be preserved for 1-2 
days in culture (Ekins et al., 1995).  
Cell lines and sub-cellular fractions 
Cell lines, isolated hepatocytes or whole liver cell suspensions are used as the starting 
material for a variety of in vitro models of different complexity and throughput. The 
simplest liver in vitro models are sub-cellular fractions, such as organ homogenates, 
microsomes, mitochondria or nuclei. Most sub-cellular fractions can be prepared and 
separated relatively easily by homogenisation of the tissue and sequential 
centrifugation. They are commercially available for a large number of species, including 
human. Nevertheless, they are only suitable for short-term studies with specific 
questions, such as enzyme inhibition, covalent binding or clearance studies. For 
example, liver supernatants (“S9”) are used as an activation system for xenobiotics in 
in vitro genotoxicity assays (e.g., Ames-assay (Ames, Lee & Durston, 1973)). 
Mitochondria are added for the analysis of drug effects on respiration, ATP-synthesis 
and fatty acid oxidation. To acquire increased metabolic activity, animals are often 
induced by treatment with Arochlor 1254 or a Phenobarbital/beta-naphthoflavone 
(PB/BNF) mixture prior to S9 preparation (Callander et al., 1995), leading to elevated 
and unphysiological expression levels of metabolic enzymes. Most systems are 
supplemented with cofactors to preserve enzymatic activity. Other disadvantages 
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include the absence of complete enzyme systems like for phase 2 enzymes in 
microsomes. 
The usage of different cell lines is one step forward in complexity. They are used for a 
variety of toxicological applications, but since most hepatic cell lines originate from 
tumours, they have lost the high degree of differentiation seen in hepatocytes and their 
gene expression pattern is distinctively different from normal liver cells. In addition, 
many cell lines display genetic instability. For example, the frequently used human 
hepatoma cell line HepG2 lacks expression of several CYP isoforms and phase 2 
enzymes, making them insensitive to secondary toxic compounds (Knasmüller et al., 
2004). To complicate matters, different sources of HepG2 cells can have very different 
enzyme profiles (Hewitt & Hewitt, 2004). Several transfected variants of HepG2 have 
been constructed which express increased levels of drug metabolising enzymes, 
including CYP1A1, CYP1A2, CYP2E1 and glutathione-S-transferases (Knasmüller et 
al., 2004), but in vivo relevance may not always be assumed because expression of 
the cloned enzymes is not at physiological levels and only single enzyme functions can 
be analyzed. Recently, the human hepatoma cell line HepaRG has been described. It 
is a naturally immortalized cell line from human liver with liver progenitor properties 
(Parent et al., 2004). After application of a differentiation protocol (Chapter 2.2.1.9, 
Page 51), HepaRG cells display hepatocyte like morphology and expression of drug 
metabolising enzymes at near in vivo levels (Gripon et al., 2002; Parent & Beretta, 
2008). However, these novel cell lines still have to be confirmed and validated as a 
reasonable alternative cell-based assay for use in toxicological studies. 
Cultures of isolated primary liver cells 
To overcome the dilemma of non physiological gene expression and genomic 
instability, freshly isolated hepatocytes are often used for toxicological research. 
Although these are mostly mono-factorial systems which do not take into account the 
interactions between cell types or even whole organs in the body, cultures of primary 
rat and human hepatocytes are used in a variety of pharmacological and toxicological 
experiments, for example the evaluation of hepatic drug uptake and metabolism, drug-
drug interactions and hepatotoxicity (Brandon et al., 2003; Gebhardt et al., 2003; Cross 
& Bayliss, 2000).  
Fresh liver cells can be obtained by different procedures, all of which involve perfusion 
of the liver with Ca2+-free buffers combined with enzymes/proteases which disintegrate 
the extracellular matrix, leading to the separation of the cells from each other (Seglen, 
1976; Howard et al., 1967). The isolation of liver cells is routinely performed for many 
species used in toxicity testing, but also with tissue from partial liver resections and 
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non-transplantable whole livers from human donors (LeCluyse et al., 2005; Richert et 
al., 2004).  
In suspension, the survival of cells is short lived, normally not longer than 6 hours. 
Although the system is relatively high throughput, easy to use and preserves most of 
the metabolising enzymes at in vivo levels for a short time, it is only useable for acute 
toxicology or metabolism studies because the loss of contact to surrounding cells and 
the ECM environment has severe influence on the defined cell polarization and shape 
(Gebhardt et al., 2003). By capturing the cells into beads of alginate, the survival time 
can be prolonged to 24 hours. However, the lack of functional bile canaliculi, cell 
polarity and cell-cell contacts limits the use of alginate-embedded cells for drug 
transporter studies (Rialland et al., 2000). 
The survival time in culture can be increased if hepatocytes are cultured on adhesive 
surfaces, for example, tissue culture dishes coated with ECM components. The most 
commonly used models are the monolayer culture (ML) where hepatocytes are usually 
attached to dried films of collagen I or Matrigel, a laminin-rich preparation from the 
Engelbreth-Holm-Swarm mouse sarcoma (Berthiaume et al., 1996).  
During the perfusion procedure the cells are already primed for proliferation and can 
easily be forced to proliferate by the addition of mitogenic compounds, for example 
epidermal growth factor (EGF), allowing longer culturing (Etienne et al., 1988). 
However, this causes a down regulation of metabolic enzymes and thereby induces 
dedifferentiation associated with a loss of many liver specific functions and defined cell 
polarity (Luttringer et al., 2002; Skett & Bayliss, 1996; Paine & Andreakos, 2004; 
LeCluyse et al., 2000). Additionally, it is known that the typical phenotypic change of 
hepatocytes in monolayer culture, the “spreading” of the cells, has a negative effect on 
liver specific gene expression (Miranti, 2002). Intracellular signalling is closely 
connected to the interaction between ECM, cell-adhesion molecules and the 
cytoskeleton and therefore has a major impact on gene expression and the metabolic 
capacity of the cells. Altogether, this processes lead to a loss of up to 80-90% of phase 
1 and about 50% of phase 2 metabolic activity during the first 24h in culture 
(Rodríguez-Antona et al., 2002; Wilkening, Stahl & Bader, 2003). 
Culturing hepatocytes in a sandwich configuration (SW), embedded between two 
layers of gelled ECM proteins (e.g., collagen I or Matrigel), has prolonged the time in 
culture displaying hepatocyte-specific functions dramatically (LeCluyse et al., 2000; 
Dunn, Tompkins & Yarmush, 1991; Richert et al., 2002; Dunn et al., 1989). Cells 
adapted and maintained their physiologically occurring polygonal shape and bile 
canalicular-like structures could be observed for up to 14 days in culture (Tuschl & 
Müller, 2006). The same study showed less alterations of known stress-markers like 
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Gadd45α in serum free sandwich culture compared to others and the expression of 
some marker genes involved in hepatocyte function were more stable. Additionally, SW 
cultured hepatocytes were successfully used for metabolism and induction studies 
(Kern et al., 1997; LeCluyse et al., 1999) indicating that the collagen overlay does not 
interfere with the test compounds. The development of long-term primary hepatocyte 
cultures is an essential step towards the study of chronic effects in vitro.  
Another factor greatly influencing the morphological development and cell survival of 
hepatocytes in culture is the medium formulation and the addition/omission of serum, 
specified hormone mixtures or other supplements (Sidhu, Liu & Omiecinski, 2004; 
Pascussi et al., 2000; Turncliff, Meier & Brouwer, 2004). Among the most frequently 
used basal media, Dulbecco's modified Eagle medium (DMEM), modified Chee's 
medium (MCM) and Williams' medium E (WME), the DMEM/F12 mix seems most 
appropriate to maintain liver-specific functions and to help rebuild bile canaliculi 
(Turncliff, Tian & Brouwer, 2006). In culture, the addition of the glucocorticoid 
dexamethasone (DEX), at nanomolar concentrations, is essential for the long-term 
preservation of hepatocyte specific functions like polygonal hepatocyte morphology, 
structural integrity of cytoplasmic membranes, bile canaliculi-like structures and by 
maintaining the expression of liver specific transcription factors. Insulin enhances the 
glucose uptake of cells and contributes to maintaining liver specific gene expression. 
Selenium, a structural component of the enzyme glutathione peroxidase, which plays 
an essential role in the neutralization of metabolically generated peroxides, has also 
been shown to be beneficial when added to the medium (Yamada et al., 1980; Laishes 
& Williams, 1976; Müller & Pallauf, 2003). Since it is well known that serum enhances 
the surface attachment ability of hepatocytes (Williams, Bermudez & Scaramuzzino, 
1977), cells are generally seeded in medium containing fetal calf serum, regardless of 
the subsequent culture conditions. 
Co-cultures, spheroid cultures and 3 d bioreactor cultures 
Hepatocytes make up about 60-70% of the cells in the intact liver. However, liver 
toxicity may not always originate from these cells. Therefore, co-cultures of 
hepatocytes with other non-parenchymal liver cells, such as endothelial, Kupffer, or 
stellate cells and also stable cell lines or fibroblasts can be applied to reflect a more 
physiological situation. For example, the excretion of TNFα or nitric oxide by Kupffer 
cells can lead to inflammatory reactions or apoptosis (El-Bahay et al., 1999; Kmieć, 
2001).  
Spheroids (spherical multicellular aggregates) will form if a crude liver cell suspension 
is prevented from adherence to the surface by continuous shaking. Cell-cell contacts 
are re-established, hepatocytes are located on the inside, non-parenchymal cells on 
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the outside and the deposition of ECM is seen throughout the spheroids. Alginate or 
other materials can be added to make up the internal structure of the spheres. Several 
studies showed the positive effect of this culture method on the expression of 
hepatotypic genes and the maintenance of metabolic capacity (Guigoz et al., 1987; 
Landry et al., 1985). The maintenance of prolonged functional activity has been related 
to the restoration and stability of cell polarity and close cell-to-cell contacts (Lu et al., 
2005). However, the formation of these spheroids leads to hypoxic and necrotic cells 
dying at their centre. Additional problems arise from the accumulation of bile in the 
centre of spheroids.  
Another skilful attempt to mimic a liver-like environment in vitro is the bioartificial liver 
system (3 d-bioreactors). Their major advantage is the re-establishment of the 3 d liver 
cyto-architecture with cell-cell contacts and a three-dimensional ECM environment, 
combined with continuous medium perfusion, providing a constant supply of oxygen 
and nutrients. Today a variety of culture systems are being used for bioreactor setups 
(Bader et al., 1998; Powers et al., 2002). Different studies have shown an improvement 
in some hepatocyte-specific functions in co-culture with other cell types, in spheroids 
and in 3D-bioreactors (Sivaraman et al., 2005). A very new and promising attempt to 
transfer and rebuild liver specific properties was developed by Linke et al (Linke et al., 
2007). They co-cultured primary hepatocytes and microvascular endothelial cells by 
seeding them into a decellularized porcine jejunal segment with preserved vascular 
structures. The supply with nutrients was accomplished by perfusion of the blood 
vessels with culture medium. Biochemical testing showed metabolic and morphological 
stability for up to three weeks. However, the preparation of these cultures is quite 
elaborate, therefore their use as a high throughput tool for toxicological screening tests 
is unlikely. 
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Model  Advantages  Disadvantages 
 Isolated 
Perfused Liver 
- liver specific functions close to in vivo 
- three dimensional cytoarchitecture 
- functional bile canaliculi 
- lobular structure preserved 
- collection of bile possible 
- short-term kinetic studies 
- not a high throughput system 
- hepatic function only preserved for a few  
  hours 
- complicated to use 
- study of human liver difficult/impossible 
- best suited for liver of small animals 
- no significant reduction in the number of  
  animals used 
Liver Tissue
Slices 
- in vivo cytoarchitecture preserved 
- reasonably high throughput 
- functional drug metabolising enzymes, transporters    
  and bile canaliculi 
- zone specific metabolism and toxicity may be studied
- lobular structure preserved, selective effects  
  detectable 
- human tissue slices more easily available than whole  
  organs 
- hepatic function preserved for no more  
  than 24 h 
- bile cannot be collected and analysed 
- necrotic cells / scar tissue at edges of 
  the slice 
- presence of necrotic cells might affect    
  the performance of the culture 
3 d-Bioreactors
(Bioartificial 
Liver Systems) 
- long-term use possible 
- re-establishment of 3 d cytoarchitecture 
- continuous perfusion with medium 
- specific gene expression closer to in vivo than  
  in hepatocyte cultures 
- very low throughput 
- difficult to standardize 
Spheroids 
- re-establishment of 3 d cytoarchitecture 
- presence of non-parenchymal cells on outer layer of  
  and extra-cellular matrix throughout the spheroids 
- necrotic and hypoxic cells in centre  
  of spheroids 
- accumulation of bile in centre  
  of spheroids possible 
- not usable for long-term investigations  
  (disaggregation  and dedifferentiation) 
Primary 
Hepatocyte 
Cultures 
- reasonably high throughput 
- viability and differentiation preserved for up to 2  
  weeks 
- potential for use of long-term cultures in chronic  
  toxicity  
- analysis of human samples possible 
- functional drug metabolising enzymes, transporters   
  and bile canaliculi,    
- co-culture with other liver cells possible 
- culture may need special supplements  
  in media 
- survival, differentiation status and function   
  depends on culture conditions 
- no culture system is able to preserve all the  
  different liver specific functions in vitro 
- difficult to regain cells for FACS analysis 
Hepatocytes 
in Suspension 
- reasonably high throughput 
- most drug metabolising enzymes well-preserved at  
  in vivo  levels 
- zone specific metabolism and toxicity may be studied
- cryopreservation possible 
- analysis of human samples possible 
- limited use for drug transporter studies 
- lack of functional bile canaliculi 
- short-term viability (2-4 h.) 
- lack of cell-cell and cell-matrix contacts 
- variations in samples from different human  
  donors 
Cell Lines 
- unlimited availability 
- some liver specific functions have been shown to 
  be maintained 
- easy to use 
- reasonably high throughput 
- lacks in vivo phenotype 
- only a small set of hepatic functions  
  expressed at levels different from liver 
- genotypic instability 
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Model  Advantages  Disadvantages 
S9-Mix 
- contains microsomal and cytosolic fractions 
- phase 1 and phase 2 activity 
- cofactors required for activity 
- lower enzyme activity compared to  
  microsomes or cytosol 
Microsomes, 
Supersomes, 
Baculosomes,  
- high throughput system 
- maintain expression of phase 1 enzymes 
- can be recovered from frozen tissue 
- production of metabolites for structural analysis   
  possible 
- use for drug inhibition, covalent binding and  
  clearance studies 
- available from several species (including human)  
- one or more human enzymes (CYPs, UGTs) can be  
  specifically expressed 
- lacks phase 2 and other cytosolic enzymes 
- short-term studies 
- cofactors required for activity 
- inadequate representation of the diversity of   
  hepatic functions  
- UGT-reaction partly impaired 
Mitochondria 
- high throughput 
- analysis of the effect of drugs on respiration and 
  ATP synthesis 
  and fatty acid oxidation 
- only very short-term studies 
Cytosol 
- soluble phase 2 enzymes (GST, ST, NAT) can  
  be studied 
  separately depending on added cofactors 
- cofactors required for activity 
- no CYPs, UGTs 
Cloned 
Expression 
Systems  
- high throughput 
- one or more human enzymes can be specifically    
  expressed 
- unlimited cell number 
- studies may lack in vivo relevance 
- no physiologic levels of expressed enzymes 
- only single (some) enzymes can be analyzed
The Virtual
Hepatocyte 
- mathematical modelling of cellular events 
- prediction of unknown interactions may be possible 
- limited computational power 
- still in experimental stage 
Table 2: Overview of in vitro methods used for toxicology (adapted and expanded from Sahu, 
2008)  
 
1.6 Endpoints for the analysis of hepatocyte cultures 
The list of tests used to gain insight into the effect of a test-substance on cells and to 
assess functional and biochemical parameters of cultured cells is extensive. These 
range from standardised tests, e.g. cell viability measurements or morphology-based 
approaches, to hepatocyte specific activity tests such as bile production, CYP activity 
or drug transport. In addition, the analysis of gene or protein expression with 
established molecular methods like real-time PCR, microarray technologies, mass 
spectrometry or immune detection is commonly applied.  
Some chemically induced changes in cellular functions may be irreversible, ultimately 
leading to cell death, whereas others may be transient. Irreversible endpoints include 
the induction of apoptosis, measured by increased caspase activity, or the loss of 
plasma membrane integrity. Plasma membrane damage can be analysed by the 
detection of cytoplasmic enzyme release (e.g., lactate dehydrogenase, LDH) or the 
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uptake of specific dyes such as neutral red and trypan blue into the cytoplasm. In 
addition, alterations in general hepatocyte functions like albumin synthesis and urea or 
bile secretion provide information on the impairment of cellular processes. The energy 
status of the cell is often used to determine cytotoxicity by studying the ATP content of 
cells or the mitochondrial or enzymatic capacity to reduce tetrazolium salts (XTT, MTT, 
WST) (Berridge, Herst & Tan, 2005). Compound induced oxidative stress can lead to 
glutathione (GSH) depletion. GSH is considered one of the primary antioxidant 
molecules for sustaining the intracellular redox status by scavenging peroxides and the 
reduction of oxidized molecules. Additionally, it is used in phase 2 reactions for 
neutralizing strong oxidants, by the formation of glutathinyl adducts which is catalyzed 
by various glutathione S-transferases (GSTs) and plays a vital role in rescuing cells 
from apoptosis. The cytosolic GSH content can be measured with specific glutathione 
detection kits. Drug transport is studied by fluorescent dyes or with the analysis of the 
bile acid transport by HPLC (High Performance Liquid Chromatography) (Kostrubsky et 
al., 2003; Liu et al., 1999). 
 
1.7 Toxicogenomics  
Traditional toxicological studies, e.g. the 2-year carcinogenicity rodent study, are time 
consuming and expensive together with a high requirement for laboratory animals. 
They focus on evaluating classical endpoints like gain of body- or organ-weight, death 
rate, tumour incidence, serum markers or histological changes, making safety 
assessment one of the bottlenecks in the pharmaceutical drug developmental process. 
New methods and processes like genomics, proteomics, lipidomics or metabonomics 
are being used to improve the drug development process (Ballet, 1997; Brandon et al., 
2003) and the “-omics” field is rapidly growing. Toxicogenomics is defined as a 
scientific sub-discipline that combines toxicology (the study of the nature and effects of 
poisons) with genomics (the investigation of the way that our genetic make-up, the 
genome, translates into biological functions). It is the study of the structure and output 
of the genome as it responds to adverse xenobiotic exposure and the identification of 
their putative mechanisms of action. The analysis of changes in gene expression 
caused by exposure to a test-compound together with strong bioinformatics and 
toxicological knowledge form the basis of toxicogenomics (Khor, Ibrahim & Kong, 2006; 
Nuwaysir et al., 1999; Chin & Kong, 2002). Central to genomic studies in toxicology is 
the assumption that compounds with a common endpoint can be classified based on 
related changes in gene expression. This allows extrapolation of toxic effects from 
known model compounds to unknown compounds by comparison of their expression 
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profiles (Hamadeh et al., 2002a; 2002b; Zidek et al., 2007; Ellinger-Ziegelbauer et al., 
2004). Several open source or commercial attempts (e.g., GENELOGIC (USA), 
ICONIX Biosciences Inc. (USA)) have been made to develop databases based on 
expression profiles of reference compounds in order to classify chemicals. It should not 
be forgotten that many internal databases in the pharmaceutical industry are only used 
for in house purposes and are not made accessible to the public (Mattes et al., 2004). 
There are several statistical methods to discriminate compounds on the basis of their 
gene expression profiles, some of which are discussed later (Page 33). In principle, 
they try to find single genes or gene sets that can discriminate between different 
treatment groups. These highly informative gene clusters can then be used to predict 
the class membership of a new unknown sample (Hamadeh et al., 2002a; Simon et al., 
2003). The reported results are very encouraging but also show the need for large 
gene expression databases and effective analysis models to allow their future 
implementation into the drug development process. 
Mechanistic studies are performed to increase the understanding of the function and 
regulation of genes that lead to compound specific toxicity. In most cases, the changes 
in gene and protein expression precede the physiological effects. This means that 
there is a great potential to extrapolate from changes in gene expression to long term 
toxicological endpoints such as liver necrosis, inflammation, steatosis or tumour 
neogenesis (Pennie, 2000; Burchiel et al., 2001; Fielden & Zacharewski, 2001). The 
detection of both the underlying mechanism of toxicity and the molecular basis of the 
response to exposure in an early stage of drug development will have a great impact 
on safety evaluation. Recent studies showed the possibility to define different toxic 
mechanisms, including tumour formation, inflammatory effects, oxidative stress, 
impairment of cellular signalling and induction of apoptosis (Bulera et al., 2001; Lettieri, 
2006). Warring and his coworkers have shown a correlation between a physiological 
response to a toxicant and changes in the genomic profile, allowing the interpretation of 
gene expression data with respect to specific organotypic endpoints. This concept is 
referred to as “phenotypic anchoring” (Waring et al., 2001; Orphanides, 2003). 
There have been numerous attempts to find new biomarkers for the early identification 
of hepatocarcinogenesis with the use of toxicogenomics and proteomics methods 
(Ellinger-Ziegelbauer et al., 2004; Fella et al., 2005). There is hope that these new 
methods will make it possible to detect intrinsic changes in the molecular pattern 
(“genetic fingerprint”) that are indicative of the pathological endpoint before he 
becomes histopathologically detectable (Aardema & MacGregor, 2002). Besides the 
improvement of the drug development process, this could also facilitate a considerable 
reduction in the time needed to obtain results and the number of animals used in 
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toxicity testing (Kroeger, 2006). Although most data is generated from in vivo liver 
samples, there are efforts to build databases for the screening of hepatotoxicity based 
on primary hepatocyte cell culture experiments by genomic and proteomic approaches. 
Therefore, it is necessary to carefully characterise the cell culture model used.  
In order to understand the mechanisms behind any compound induced change of gene 
expression, it is essential to know the basal gene expression in the test system. In the 
case of primary hepatocytes, it is not only the individual differences but also the effects 
of time and the conditions of culturing which have to be taken into account. Therefore, 
a comprehensive analysis of gene expression changes in rat and human hepatocytes 
and different cell culture systems (liver slices, suspension culture, primary hepatocytes 
cultured on plastic surface, on collagen I ML and in SW culture as well as different cell 
lines) has been carried out as part of this thesis. 
Not every cell culture system is appropriate for every toxicological endpoint, as liver 
specific functions gradually decrease over time. In vivo, they are supported by liver 
architecture, cell-cell and cell-matrix interactions and the complex hormonal signalling 
of the body. It is impossible to mimic these conditions in culture and great endeavours 
are being made to maintain liver specific functions and attributes for as long as 
possible (LeCluyse et al., 2005; Richert et al., 2004; Turncliff et al., 2006; Vinken et al., 
2006). Evaluating the basal gene expression pattern will help to understand the 
processes of dedifferentiation and will allow the interpretation of gene expression 
changes caused by xenobiotics and to extrapolate to mechanisms in vivo. 
However, one has to be aware of the limitations of these techniques. Some compounds 
directly effect cellular macromolecules causing damage without changing gene 
expression. Often expression changes may reflect secondary effects following after the 
primary direct toxicity of the compound. The dimension of changes in gene expression 
is also dependent on dose, duration of exposure to the toxicant and on time from 
dosing to sampling (Gatzidou, Zira & Theocharis, 2007). Not all changes in gene 
expression have a direct impact on the corresponding protein content of a cell. Due to 
the variety of epigenetic control mechanisms there can be significant differences in 
gene and protein expression. Additionally, changes in protein activity, caused for 
example by phosphorylation or ubiquitinylation, can not be addressed and other , 
proteomic techniques have to be considered (Pennie et al., 2000; Merrick & 
Madenspacher, 2005). With this in mind, toxicogenomics can be a powerful tool. The 
extrapolation from data generated from animals to potential human activity could be 
enhanced by finding species-overlapping biomarkers (Aardema & MacGregor, 2002). 
Even the generation of human data is achievable and relatively straight forward.  
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1.8 Techniques for global gene expression analysis 
The new and developing field of microarray technology evolved from E.M. Southerns 
realization that labelled nucleic acid molecules can be hybridized to their counterparts 
and therefore be used to detect their existence and amount in the original sample 
(Southern, 1975). The sequencing of whole genomes from human, as well as of many 
“laboratory” animal species, quickened the development of new technologies for the 
measurement of several thousand genes in a single experiment (Brown & Botstein, 
1999; Schena, 1996). Meanwhile, these microarray technologies are used for a wide 
spectrum of issues, like drug discovery, basic research and target discovery, biomarker 
determination, pharmacology, toxicology, target selectivity, development of prognostic 
tests and disease-subclass determination (Butte, 2002). A wide range of different 
platforms for global gene expression are currently available. Although they all are either 
cDNA or oligonucleotide based, they differ in distinct properties such as the type of 
probes (short/long oligonucleotides, cDNA), the number of genes, probe selection and 
design, competitive versus non-competitive hybridization, labeling methods or the 
methods of production (in situ polymerization, spotting, microbeads). In the following 
paragraphs, the bead chip technology of Illumina Inc. and the Affymetrix Gene Chip, 
used during this work, are introduced. 
 
Illumina BeadChip arrays 
Illumina Inc. developed in 2003 a bead based technology for global gene expression 
analysis (Gunderson et al., 2004). The chips are based on a silicon wafer with 3 µm 
sized beads on their surface and covalently bound 50mer oligonucleotide probes. One 
single probe-type representing one gene is bound to each bead type with more than 
100,000 copies per bead. All the bead types are pooled and put onto the surface of a 
silicon wafer (Figure 9). This wafer was previously prepared by plasma etching to 
provide wells at a regular distance of 5 µm. Each array contains about 900,000 beads 
so statistically on a whole genome array, each bead-type is represented ~30 times on 
average. This redundancy allows up to 30,000 genes to be detected simultaneously 
per array. Because of the random arrangement of the beads and their high 
redundancy, local area effects (scratches, impurity and intensity variation) are of minor 
consequence, but this feature also raises the need for an initial decoding step. 
Therefore, the probes consist not only of the gene specific part (50 nt) but also a 23 nt-
long address sequence. Decoding is performed by Illumina Inc. by sequential 
hybridizations with differently coloured probes and is at the same time an important 
quality control step (Gunderson et al., 2004). 
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Figure 9: The production process of an Illumina BeadChip array. A) Depicts the 
structure of a single bead, the generation of a bead pool and the combination with a 
previously etched silicon wafer to a complete BeadChip. B) Shows a histogram of the 
average abundance of bead types per chip. 
Affymetrix gene expression arrays 
Affymetrix arrays are based on in situ synthesis of oligonucleotides directly on to the 
array surface. The probes are 25 nt long and are directly synthesized onto a silicon 
wafer via a combination of photolithography and combinational chemistry (McGall & 
Fidanza, 2001). For each gene, Affymetrix uses 11 to 20 probe sets, a probe set 
consisting of a 25 nt perfect match and a 25 nt mismatch oligonucleotide, to guarantee 
statistical relevance and certainty. After scanning, the intensity differences between 
perfect match and mismatch probes are calculated to give both quantitative (signal 
intensity) and qualitative (statistical significance) measurements (Figure 10). 
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Figure 10: Scheme of the process and the architecture of an Affymetrix gene expression array 
(Taken from the Affymetrix homepage, www.affymetrix.com).  
 
The RNA samples have to be isolated from the sample and reverse transcribed in 
order to produce biotinylated cRNA before hybridizing them to arrays of both suppliers, 
Illumina and Affymetrix. This procedure allows detection and quantification which 
otherwise wouldn’t be possible. After scanning, raw data must be preprocessed before 
statistical analysis and the relative expression level of each gene can be determined by 
comparing the intensities of the genes to each other or to a control. With respect to the 
technical aspects and the experiment layout, each set of microarray data has to be 
normalized in an appropriate way. Further details of both techniques used will be 
discussed in detail in chapter 3.1. 
 
Methods of data analysis 
DNA microarray technology has made it possible to generate millions of data-points in 
a relatively short time. The analytical steps needed to convert the noisy data into 
reliable and interpretable biological information are challenging and error prone. Due to 
their great number, only an overview of the most common and important methods and 
algorithms used during these studies are presented. In principle, there are two main 
statistical approaches to identify genes or patterns of interest from microarray data. 
Supervised methods are used to identify patterns of gene expression, e.g. for the 
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identification of marker genes or the classification of compounds. Unsupervised 
methods identify signatures in the data set without input of data specific knowledge and 
can be used to summarize and to reduce the complexity of the multidimensional data. 
Important unsupervised tools include Principal Components Analysis (PCA), 
Hierarchical Clustering, Correlation and Self Organizing Maps (SOM) (Butte, 2002).  
PCAs are an attempt to reduce the multi-dimensional data of microarrays. Therefore, 
vectors (so called “Eigenvektoren”) are calculated, each representing the greatest 
amount of variance of the data cloud within one certain experiment (Figure 11). The 
largest, and therefore statistically most relevant, Eigenvektoren are plotted resulting in 
one single point per sample in two- or three-dimensional space and is therefore a good 
tool for data reduction and display (Yeung & Ruzzo, 2001).  
 
 
Figure 11: Graphical representation of a PCA transformation in two dimensions (x and y). The 
variance of the data in the original space (x, y) is best captured by the basis vectors v1 and v2, 
which in turn are used as basis for the localization of the experiment in the appertaining PCA. 
 
Several different algorithms can be applied depending on the structure of the dataset 
and the aim of the analysis. Hierarchical clustering calculates the distance of the 
sample or gene profiles from each other and visualizes this in form of a dendrogram-
tree. Experiments closer to each other are more similar to each other than those further 
away. During a correlation analysis, the correlation of samples or genes to each other 
are calculated and then visualized in a heat map with a defined colour code. A two 
dimensional output is also produced by SOM Clustering, also termed as Kohonen-
Maps after its inventor (Kohonen, 1997). This statistical method is a type of artificial 
neural network that is trained using unsupervised learning. During the presented work 
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SOM was used to group genes according to their expression profile (Nikkilä et al., 
2002). 
Supervised methods include t-test and the Analysis of Variance (ANOVA). T-test was 
applied to detect differences between empirical mean values of two datasets giving 
statistical confidence to the detected values. ANOVA was used to identify genes in a 
multivariate model whose expression is significantly altered between different biological 
samples. First described by R.A. Fisher in the 1920s, an ANOVA partitions the 
observed variance into components due to different explanatory variables and allows 
the effects of two or more treatment variables to be studied simultaneously. Other 
supervised methods include classification methods, such as Support Vector Machine or 
K-nearest-neighbour analysis. These algorithms “learn” to classify the data into preset 
categories from a training set and are able to match new data to the existing classifier 
(Raudys, 2000). Additionally, the minimum amount of genes needed for this 
discrimination can be calculated by ranking. 
 
1.9 Toxicoproteomics 
Marc Wilkins first used the term “proteome” in 1994. He defined it as the totality of all 
proteins produced at a certain moment by a cell and encoded by a genome. Like the 
transcriptome it depends on broadly diverse factors and is highly dynamic. The 
analysis of proteins, of the total proteome especially, is very challenging because of its 
extreme heterogeneity. Proteins range from relatively small peptides to large multi-
enzyme complexes and are built up out of amino acids, which can, due to their side 
chains, develop multiple interactions and carry different charges. Several mechanisms 
of post-translational modification are known which enhance and increase this 
complexity of the proteome. It is believed that about 30,000 genes are encoded by the 
human genome. These genes result, via alternative splicing, in about 100,000 different 
transcripts. Further modifications are achieved by mechanisms such as nuclear 
transport, posttranscriptional modifications, gene silencing, changes in mRNA stability 
and in post-translational modifications like glycosylations, phosphorylations, 
methylations, enzymatic cleaving, changes in protein stability or intracellular transport 
mechanisms. 
The abundance of proteins in the cell can be very heterogeneous. Some proteins are 
present only in a low copy number (e.g. some cellular receptors) whereas others are 
highly abundant (e.g. structural proteins) (Smith, 2000). The dynamic range of protein 
expression encompasses more then seven orders of magnitude (Anderson & 
Anderson, 2002). It is obvious then that the analysis of the proteome has high 
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demands on the techniques applied for their exploration. To date none of the 
techniques can acquire the analysis of the whole proteome. Each method has certain 
advantages and drawbacks and depicts only a small part of the whole picture. 
Similar to genomic studies, proteomic methods can be used to examine early changes 
due to treatment with xenobiotics on a molecular level. Occurring prior to changes on 
histopathological level or classical toxicological endpoints, these changes can help in 
candidate selection, mechanistic studies, finding new biomarkers or the classification of 
compounds (Bandara & Kennedy, 2002). The classification of compounds is possible 
even without further mechanistic knowledge on the basis of “molecular signatures” 
(Wetmore & Merrick, 2004). One technique to collect such signatures of protein 
expression is the Surface Enhanced Laser Desorption and Ionisation (SELDI) Chip 
Technology (Bio-Rad, Hercules, CA, USA). This method was invented in 1993 by 
Hutchens and Yip and is a mixture of chromatographic surfaces and mass 
spectrometry (Hutchens & Yip, 1993). Samples of proteins are bound to a 
chromatographic surface (e.g. anionic, cationic, hydrophobic, hydrophilic or metal-
binding) due to their physical properties and are afterwards analyzed via time of flight 
mass spectrometry. The resulting spectrum of masses resembles a so called 
“proteomic fingerprint” (Veenstra & Conrads, 2003).  
A drawback of this method is the lack of fragmentation of the proteins. Therefore, an 
identification of the proteins detected with SELDI is complicated and needs additional 
efforts. Complex mixtures of proteins, like cell lysates, have to be intensely cleaned up 
as far as possible and enzymaticaly digested. Afterwards, they can be used for 
downstream analysis with “normal” MS or MS/MS techniques. 
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1.10 Aim of this work 
 
The aim of this work was the development and characterization of the sandwich culture 
of primary rat and human hepatocytes as a tool for in in vitro toxicology studies. 
Moreover, the gene expression changes in response of compound treatment of the 
cells in culture were addressed and used to build a predictive classification model. 
Primarily, a thorough optimization of the culture conditions was performed with the 
main goal to enhance the differentiation status of cells and to prolong their time in 
culture. Besides the insurance of cells displaying liver-typical functionality over a long 
period of time, a clear definition of changes over time on different levels, the cell 
morphology and viability, gene and protein expression, metabolic activity and 
inducibility, were part of this project.  
The main part of this work was concerned with the extensive characterization of the 
global gene expression changes over time in culture. Therefore, several culture 
systems were analyzed and compared with regard to their similarities and differences 
in gene expression over time. 
The ability to establish a predictive hepatotoxicity model was examined by conducting 
toxicological studies with the new sandwich in vitro culture system. Cells were dosed 
with reference compounds (Chapter 3.4.2, Figure 58), changes in gene expression were 
analyzed and used to calculate a novel predictive model based on the global 
expression profile. Additionally, a predictive subset of discriminative genes should be 
found. The gene expression profile of two blinded compounds should be conducted as 
a preliminary verification of this model. 
As the new platform from Illumina was used for these experiments, it was important to 
compare the results gained from these experiments to a well established platform 
(Affymetrix) and to TaqMan PCR, as the quality standard, in terms of reliability, 
sensitivity and concordance. 
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2 MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Chemicals and reagents 
Chemical/ Reagent Provider 
Secondary antibodies (Rabbit, Sheep) 
GE Healthcare Europe GmbH, Freiburg, 
Germany 
ECL Detection-Reagents and Hyperfilm  
GE Healthcare Europe GmbH, Freiburg, 
Germany 
Neutral Red Sigma-Aldrich, Taufkirchen, Germany 
Carboxi-DCFDA Invitrogen, Karlsruhe, Germany 
Acetic Acid (CH3CO2 h) Invitrogen, Karlsruhe, Germany 
Ammonium bicarbonate (NH4HCO3) Merck KGaA, Darmstadt, Germany 
Ammonium persulfate ((NH4)2S2O8) Merck KGaA, Darmstadt, Germany 
Anti-Streptavidin Antibody (goat), 
biotinylated 
Vector Laboratories, Burlingame, USA 
Benzyloxy-Resorufin Sigma-Aldrich, Taufkirchen, Germany 
Biotin-16-UTP, 10 mm 
PerkinElmer Life and Analytical Sciences, 
Waltham, USA 
Bovine serum albumin (BSA), acetylated, 20 
mg/ml 
Ambion - An Applied Biosystems Business, 
Austin, USA 
Calcium chloride hexahydrate (CaCl2 • 6 
H2O) 
Sigma-Aldrich, Taufkirchen, Germany 
CHAPS (C32 h58N2O7S) Merck KGaA, Darmstadt, Germany 
Chloroform LiChrosolv® (CHCl3) Merck KGaA, Darmstadt, Germany 
Coomassie Brilliant Blue G250 Serva, Heidelberg, Germany 
E1BC Buffer Buffer Illumina, San Diego, USA 
ECL-Detection Kit Amersham, Buckinghamshire, UK 
EDTA-Solution (0.5M) 
Ambion - An Applied Biosystems Business, 
Austin, USA 
Ethanol LiChrosolv® (CH3CH2OH) Merck KGaA, Darmstadt, Germany 
Ethoxy-Resorufin Sigma-Aldrich, Taufkirchen, Germany 
Cy3TM labelled streptavidin (1 mg/ml) 
Amersham Biosciences, Buckinghamshire, UK 
(GE Healthcare) 
Formamide, deionised (HCONH2) 
Ambion - An Applied Biosystems Business, 
Austin, USA 
HEPES (C8H18N2O4S) Merck KGaA, Darmstadt, Germany 
Hering sperm DNA (10 mg/ml) Promega Corporation, Madison, USA 
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HybE1 Buffer Buffer Illumina, San Diego, USA 
NuPage 4-12% Bis-Tris Gel Invitrogen - Molecular Probes, Eugene, USA 
Isopropanol, LiChrosolv® ((CH3)2CHOH) Merck KGaA, Darmstadt, Germany 
Calcium chloride (CaCl2) Sigma-Aldrich, Taufkirchen, Germany 
Potassium sulfate (KH2SO4) Sigma-Aldrich, Taufkirchen, Germany 
Potassium chloride (KCl) Merck KGaA, Darmstadt, Germany 
Potassium phosphate monobasic (KH2PO4) Merck KGaA, Darmstadt, Germany 
Liberase Blendzyme 2 Roche Applied Biosciences, Basel, Suisse 
Magnesium sulfate (MgSO4) Sigma-Aldrich, Taufkirchen, Germany 
MES (2-[N-Morpholino]ethanesulfonic acid, 
C6 h13NO4S) 
Sigma-Aldrich, Taufkirchen, Germany 
Magnesium sulfate monohydrate (MgSO4 • 
7 H2O) 
Sigma-Aldrich, Taufkirchen, Germany 
Sodium phosphate dibasic (Na2 hPO4) Sigma-Aldrich, Taufkirchen, Germany 
Sodium chloride (NaCl) Sigma-Aldrich, Taufkirchen, Germany 
Sodium acetate (CH3COONa) Merck KGaA, Darmstadt, Germany 
Sodium hydrogen carbonate (NaHCO3) Merck KGaA, Darmstadt, Germany 
Sodium hydroxide (NaOH) Merck KGaA, Darmstadt, Germany 
Trypan Blue 0.5% (w/v) in PBS Biochrome AG, Berlin, Germany 
Nuclease free water 
Ambion - An Applied Biosystems Business, 
Austin, USA 
Pentoxy-Resorufin Sigma-Aldrich, Taufkirchen, Germany 
RNA 6000 Ladder 
Ambion - An Applied Biosystems Business, 
Austin, USA 
Hydrochloric acid (HCl) Merck KGaA, Darmstadt, Germany 
ß-Mercaptoethanol Sigma-Aldrich, Taufkirchen, Germany 
SSPE (3 M NaCl, 0.2 M NaH2PO4, 0.02 M 
EDTA) 
BioWhittaker Molecular Applications, Rockland, 
USA 
Streptavidin Phycoerythrin (SAPE) Invitrogen - Molecular Probes, Eugene, USA 
Trichloroacetic acid (TCA, Cl3CCOOH) Merck KGaA, Darmstadt, Germany 
Triton X-100 Serva, Heidelberg, Germany 
TRI ReagentTM Sigma-Aldrich, Taufkirchen, Germany 
Tween20 (10%) Merck KGaA, Darmstadt, Germany 
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2.1.2 Technical equipment and auxiliary material 
Equipment Provider 
PBSII ProteinChip Reader  Ciphergen 
ABI Prism 7000 Applied Biosystems, Foster City, USA 
Agilent 2100 Bioanalyzer Agilent Technologies, Waldbronn, Germany 
Autoclave H&P Labortechnik, Oberschleißheim, Germany 
Axon GenePix® 4000B Microarray Scanner Molecular Devices (Axon Technologies), Union 
City, USA 
Bead Station 500 Illumina, San Diego, USA 
BeadChip® Hyb Cartridge Illumina, San Diego, USA 
BeadChip® Hyb Wheel Illumina, San Diego, USA 
BeadChip® Staining Dish Illumina, San Diego, USA 
BeadChip® Wash Trays Illumina, San Diego, USA 
Bottle-top filter, 0.2μm Nalge Nunc International, Rochester, USA 
Syringes MT Braun, Melsungen, Germany 
Cell scraper (25 cm, sterile) Greiner-Bio One, Frickenhausen, Germany 
Centrifuge 5415R Eppendorf, Hamburg, Germany 
Fluidic Station 450 Affymetrix, Santa Clara, USA 
Digital camera CC 12 Olympus, Hamburg, Germany 
iBlot™ Dry Blotting System Invitrogen, Karlsruhe, Germany 
Fluorescent-Spectralphotometer (RF-1502) Shimadzu Europa, Duisburg, Germany 
Fuchs-Rosenthal-Chamber (Neubauer 
improved) 
Paul Marienfeld GmbH & Co., Lauda-
Königshofen, Germany 
Gene Chip® Fluidic Station 450 Affymetrix, Santa Clara, USA 
Gene Chip® Human Genome U133 Plus 2.0 
Array 
Affymetrix, Santa Clara, USA 
Gene Chip® Rat Expression Array (RAE) 
230 2.0 
Affymetrix, Santa Clara, USA 
Gene Chip® Scanner 3000 Affymetrix, Santa Clara, USA 
Glassware Schott Glas, Mainz, Germany 
Heat block Thermo Stat Plus Eppendorf, Hamburg 
HP GeneArrayTM Scanner Affymetrix, Santa Clara, USA 
HumanRef-8 v2 Expression BeadChip Illumina, San Diego, USA 
NuPAGE® MES Running Buffer Invitrogen, Karlsruhe, Germany 
NuPAGE® Novex Bis-Tris-Gele Invitrogen, Karlsruhe, Germany 
NuPAGE® Reducing Agent Invitrogen, Karlsruhe, Germany 
Hybridization Oven 650 Affymetrix, Santa Clara, USA 
Incubator Kendro Laboratory, Hanau, Germany 
Krumdieck-Tissue-Slicer Alabama R&D Corp., Munford, USA 
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Microscope Zeiss, Jena, Germany 
Microtiterplates (96 well, 24 well and 6 well) Nalge Nunc, Rochester, USA 
Molecular Imager BIORAD, München, Germany 
NanoDrop ND-1000 NanoDrop Technologies, Wilmington, USA 
Nitrocellulose membrane Schleicher & Schuell, Dassel, Germany 
Microscope Olympus IX70 Olympus, Hamburg, Germany 
Peristaltic Pump 313S Watson-Marlow, Birmingham, UK 
Petri-dishes TC (100 mm, 60 mm) Greiner-Bio One, Frickenhausen, Germany 
pH-Meter Knick, Berlin, Germany 
Pipettboy Hirschmann Laborgeräte, Eberstadt, 
Plastic ware Nalge Nunc, Rochester, USA 
Plastic tubes 15/50 ml Greiner-Bio One, Frickenhausen, 
Germany 
RatRef-12 Expression BeadChip Illumina, San Diego, USA 
Reaction-cups (0.2 / 1.5 / 2 ml), Nuclease 
free 
Eppendorf, Hamburg, Germany 
Scale Sartorius, Göttingen, Germany 
Sentrix BeadChip custom array Illumina, San Diego, USA 
Speed-Vac Concentrator 5301 Eppendorf, Hamburg 
Spectrophotometer TM3000 Bio-Rad, Hercules, USA 
Steel beads Qiagen, Hilden, Germany 
Sterile Workbench Kendro Laboratory, Hanau, Germany 
Sterile filters (0.2 μM) Nalge Nunc, Rochester, USA 
Surgical instruments Braun, Melsungen, Germany 
Thermocycler Eppendorf, Hamburg, Germany 
TissueLyser Qiagen, Hilden, Germany 
Multifuge® 3 S-R Thermo Fisher Scientific (Heraeus), Waltham, 
USA 
U-RFL-T Power Supply Unit Olympus, Hamburg, Germany 
Vortex Scientific Industries, Bohemia, USA 
Varioclav Steam Sterilyzer ThermoFisher Scientific, Schwerte, Germany 
Water bath Lauda GmbH & Co. KG, Lauda, Germany 
Water bath SW 21 Julabo Labortechnik, Seelbach, Germany 
Centrifuge Kendro Laboratory, Hanau, Germany 
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2.1.3 Kits 
Chemical/ Reagent Provider 
Apo-ONE® Homogeneous Caspase-3/7 
assay 
Promega Corporation, Madison, USA 
BeadChip Buffer Kit Illumina, San Diego, USA 
CellTiter-Glo® Luminescent Cell Viability 
Assay 
Promega Corporation, Madison, USA 
CytoTox-ONE™ Homogeneous Membrane 
Integrity Assay 
Promega Corporation, Madison, USA 
Gene Chip® Hybridization Control Kit Affymetrix, Santa Clara, USA 
Gene Chip® IVT Labeling Kit Affymetrix, Santa Clara, USA 
Gene Chip® One-Cycle cDNA Synthesis Kit Affymetrix, Santa Clara, USA 
Gene Chip® Poly-A RNA Control Kit Affymetrix, Santa Clara, USA 
Gene Chip® Sample Cleanup Module  Affymetrix, Santa Clara, USA 
Glutathione (GSH) Detection Kit Chemicon International, Tamecula, CA 
MessageAmpTM II aRNA Amplification Kit 
 
Ambion- An Applied Biosystems Business, 
Austin, USA 
P450Glo® (3A4 and 2C9) Assay Kit Promega Corporation, Madison, USA 
Primer and Probes for TaqMan®-RT-PCR Applied Biosystems, Foster City, USA 
QIAquick PCR Purification Kit Qiagen, Hilden, Germany 
RNA 6000 Nano LabChip® Kit Agilent Technologies, Waldbronn, Germany 
RNeasy Mini Kit Qiagen, Hilden, Germany 
WST-1-Assay Roche, Mannheim, Germany 
 
2.1.4 Software 
Software Provider 
GECOS Affymetrix, Santa Clara, USA 
AnalySIS cell imaging Soft Imaging System, Münster, Germany 
2100 Expert Software Agilent Technologies, Waldbronn, Germany 
ABI Prism 7000 SDS Applied Biosystems, Foster City, USA 
BeadScan Illumina, San Diego, USA 
BeadStudio Illumina, San Diego, USA 
Expressionist®Pro Genedata, Basel, Swisse 
Gene Chip® Operating Software (GCOS) Affymetrix, Santa Clara, USA 
GenePixTM Pro  Molecular Devices, UnionCity, USA 
KC4 Bio-Tek Instruments, Vermont, USA 
MetaCoreTM GeneGO, St. Joseph, USA 
OriginLab OriginLab, Northampton, USA 
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2.1.5 Culture media and supplements  
Media/ Supplement Provider 
After-shipment media for HepaRG-cells Biopredic international, Rennes, France 
Albumin Solution 35% Sigma-Aldrich, Taufkirchen, Germany 
Bovine serum albumin (BSA) Merck KGaA, Darmstadt, Germany 
Collagen I (Rat Tail) Roche, Mannheim, Germany 
D-MEM/F-12 (1:1) (1X), liquid - with 
GlutaMAX™ I 
Invitrogen, Karlsruhe, Germany 
D-MEM/F-12 (1:1) (1X), liquid - with L-
Glutamine, without Phenol Red 
Invitrogen, Karlsruhe, Germany 
D-MEM/F-12, powder, 1:1 Invitrogen, Karlsruhe, Germany 
DMSO ((CH3)2SO) Sigma-Aldrich, Taufkirchen, Germany 
Fetal Bovine Serum (Research Grade) HyClone, South Logan, USA 
HEPARG culture medium  Biopredic international, Rennes, France 
Insulin Novo Nordisk Pharma, Mainz, Germany 
ITS Invitrogen, Karlsruhe, Germany 
L-Glutamine Ferak, Berlin, Germany 
PBS Invitrogen, Karlsruhe, Germany 
Penicillin [10000 U/ ml] Sigma-Aldrich, Taufkirchen, Germany 
Streptomycin [10 mg/ml] Sigma-Aldrich, Taufkirchen, Germany 
 
2.1.6 Buffers and solutions 
2.1.6.1 Perfusion buffers for rat liver perfusion 
Stock solution  For Perfusion Buffer 1, add 
6.30 g NaCl  0.038 g EGTA 
0.32 g KCl  Calibrate to pH 7.2 
0.27 g MgSO4 • 7 H20  
0.15 g KH2PO4 
 
For Perfusion Buffer 2, add 
1.81 g NaHCO3 0.58 g CaCl2•2 H2O 
3.58 g HEPES 
1.50 g D-Glucose 
 
Calibrate to pH 7.2 and add Liberase 
Blendzyme to 300 ml 
Add H2O to 1 l 
 
Washing buffer 
0.58 g CaCl2•2 H2O 
20.00 g BSA 
Add H2O to 1 l and calibrate to pH 7.2 
Trypan-blue solution 
500 μl Trypanblue-Solution (0.5 %) 
500 μl Wash buffer 
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modified Williams’ Medium E  Krebs-Henseleit-Buffer 
1 mg Ampicillin  60 mm NaCl 
125 mg Gentamicin  2.4 mm KCl 
29.2 mg L-Glutamin  0.6 mm KH2PO4 
345 mg Insulin  0.6 mm MgSO4 × 7 H2O 
10 mg Tylosin  12.5 mm NaHCO3 
Add 100 ml Williams’ Medium E and 
calibrate to pH 7.4 
 
0.625 mm CaCl2 × 6 H2O 
   12.6 mm HEPES 
  50 mg/l Gentamycin 
   Add H2O to 1 l and calibrate to pH 7.4 
 
 
2.1.6.2 Buffers for SELDI-TOF-MS 
Pre-activation buffer WCX  Binding buffer WCX 
10 mM HCl (1 M)  0.1 M Natriumacetat pH 4.5 
Add H2O to 1 l  0.05% (v/v) Triton X-100 
 
 
2.1.6.3 Buffers for protein-preparation adn immunodetection 
Lysis buffer for resuspending of 
Proteins 
 PBS-Tween-Buffer 
6.3 g Urea  10% (v/v) PBS (10x) 
2.3 g Thio-urea  0,1-5% (v/v) Tween 20 
0.48 g CHAPS  85-89,9%  Aqua purificata 
600 μl DTT (1 M)   
300 μl Spermin (1 M)  Coating-Solution 
Add H2O to 12 ml  5% (m/v) Magermilchpulver 
   PBS-Tween-Buffer 
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2.1.6.4 Buffers and solutions for Illumina BeadChip arrays 
First strand synthesis mastermix (8 
samples) 
 IVT-Reaction 
2.2 μl T7(dT)Primer, 10 pmol/μL  8.8 μl 10X reaction buffer 
4.4 μl 10X 1st-strand buffer  8.8 μl ATP, 75 mM 
8.8 μl dNTP mix  8.8 μl CTP, 75 mM 
2.2 μl RNase Inhibitor  8.8 μl GTP, 75 mM 
2.2 μl Reverse Transcriptase  4.4 μl UTP, 75 mM 
24.2 μl Nuclease free water  33 μl Biotin-16-UTP, 10 mM 
   8.8 μl T7 Enzyme Mix 
Second strand synthesis mastermix  6.6 μl nuclease free water 
(8 samples) 
 
  
22 μl 10X 2nd-strand buffer    
8.8 μl dNTP mix  Wash buffer E1BC 
4.4 μl DNA polymerase  1.5 ml E1BC Buffer 
2.2 μl RNaseH, 2U/μL  500 ml Nuclease free water 
140 μl nuclease free water  Heat to 55°C over night 
     
Heat Wash buffer  Cy3 staining solution 
50 ml Heat wash buffer 
 
2 ml 
BlockerTM Casein in PBS 
(1% m/v) 
450 ml Nuclease free water 
 
2 μl 
FluoroLinkTM CyTM3 
labelled streptavidin (1 
mg/ml) 
 
 
2.1.6.5 Buffers and solutions for Affymetrix Gene Chips® 
first strand mastermix  Second strand Mastermix 
4 µl 
5x First Strand Reaction Mix 
Buffer 
 30 µl 
5x Second Strand Reaction 
Mix Buffer 
2 µl DTT [0.1M]  3 µl dNTP Mix [10 mM] 
1 µl dNTP Mix [10 mM]  1 µl E. coli DNA Ligase (10 U/µl) 
   4 µl 
E. coli DNA Polymerase I (10 
U/µl) 
IVT Mastermix  1 µl RNase H (2 U/µl) 
4 µl 10x IVT Labeling Buffer  91 µl nuclease free water 
12 µl IVT Labeling NTP Mix    
4 µl IVT Labeling Enzyme Mix    
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Hybridization mix  Non-stringent washing buffer 
20 μl fragmentede cRNA (15 μg)  300 ml 20x SSPE 
5 μl 
Control-Oligonucleotide B2 (5 
nm) 
 1 ml Tween20 (10 %) 
Add H2O to 1 l 
3 μl Herring-sperm DNA [10 mg/ml]  
  
15 μl 100x Control-cRNA-Cocktail  Stringent washing buffer 
3 μl acetylated BSA [50 mg/ml]  83.3 ml 20x SSPE 
150 μl MES-Hybridising buffer  5.2 ml 5 M NaCl 
104 μl DEPC-H2O  1.0 ml Tween20 (10 %) 
Add H2O to 12 ml  Add H2O to 1 l 
     
MES-buffer for chip staining  Antibody detection solution 
41.7 ml 12x MES  300 µl 2x MES-buffer 
92.5 ml 5 M NaCl  60 µl acetylated BSA (20 mg/ml) 
2.5 ml Tween20 (10 %)  6.0 µl 
Goat IgG (10 mg/ml in 150 
mM NaCl) 
Add H2O to 1 l  3.6 µl 
Anti-Streptavidin Antibody, 
biotinylated (0.5 mg/ml) 
   230.4 μl nuclease free water 
SAPE- buffer    
600 μl 2x MES-buffer    
120 μl acetylated BSA (20 mg/ml)    
12 μl SAPE (1 mg/ml)    
468 μl Nuclease free Water    
Centrifuge 5 min at 9,000 x g    
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2.2 Methods 
2.2.1 Cell culture 
2.2.1.1 Isolation of primary rat hepatocytes 
Male Wistar-rats with a weight between 200 to 300 g were used for the isolation of 
hepatocytes. The animals were kept according to animal welfare regulations4 and the 
perfusion was done with authorization from the local authorities5. The rats had free 
access to food and water and were kept at a constant temperature of 20°C and a light 
dark circle of 12 h each.  
The perfusion was carried out using a modification of the two-step perfusion method 
described by Seglen (Seglen, 1976). Before that, the rats were weighed, and 
anesthetised by a mixture of Ketanest S and Rampun 2% at a concentration of 100 
mg/kg bodyweight and 15 mg/kg bodyweight, respectively. The anesthesized rats were 
mounted facing backwards and the abdominal wall was opened. A syringe was 
inserted into the portal vein and fixed with a ligature. The syringe was connected to a 
pumping system and the perfusion buffers by a flexible tube.  
During the first step of perfusion the liver was flushed with perfusion buffer 1 (PB1) with 
a flow rate of 50 ml/min for 2 min and afterwards with a flow rate of 40 ml/min for 
another 3 min. To guaranty the complete removal of blood and to allow the perfusion 
buffers to flow trough the liver, the inferior vena cava, which is located behind the liver, 
was opened. PB1 is Ca2+ free and contains EGTA, which complexes the remaining 
Ca2+-ions which are important for cellular adhesion. During this procedure, the colour of 
the liver changes from red to pink.  
Secondly, perfusion buffer 2 (PB2) was used at a flow rate of 45 ml/min for 5-7 min. 
PB2 contains Liberase Blendzyme 2, a mixture of Thermolysin (a neutral protease) and 
a collagenase. The dissociation of the tissue and thereby the separation of the cells 
was indicated by the appearance of a fine network on the surface of the liver. The liver 
was transferred into an ice cold washing buffer (WB), the liver capsule was opened and 
the separated cells were released. The cell suspension was filtered through a coarse 
gaze to remove bigger cell clumps. To remove non-parenchymal cells, the cell 
suspension was three times centrifuged (500rpm, 4°C for 2 min) to pellet the 
hepatocytes, the supernatant containing the other cell types of the liver was aspirated 
and the pellet was resuspended with cold WB. 
                                                
4 Deutsches Tierschutzgesetz 
5 Approval-Nr. v54-19c20/15 [DA4/Anz271E] 
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2.2.1.2 Trypan Blue exclusion test  
Cell viability and cell number of freshly isolated hepatocytes was assessed by the 
trypan blue exclusion test. It is based on the principle that live cells possess intact cell 
membranes that exclude trypan blue, whereas dead cells do not.  
50 µl Cell suspension was incubated with 1 ml trypan blue solution (500 µl Trypan blue, 
0.5% + 500 µl WB1) for 1 min at RT. Afterwards, viable and dead cells were counted in 
a Fuchs-Rosenthal-Chamber by counting 3 fields with 16 squares each. The 
determined numbers of living and dead cells were used to calculate the viability, as well 
as the total number of cells. 
 
         5000/ ••= DCellsmlCells Viable                 100% )( •=
Dead
Viable
Viability Cells
Cells
 
D= Dilution Factor 
 
The outcome per perfusion usually was in between 5x108 and 1x109 hepatocytes and 
the viability had to be greater than 85% for the cells to be used for further studies. 
 
2.2.1.3 Preparation of culture dishes 
Cells were plated onto either uncoated or collagen I coated culture plates for the 
plastic- and monolayer cultures and on a collagen-gel for sandwich cultures. This 
required different pre-processing of the culture dishes, except for the plastic cultures, 
were the culture-dishes were used as delivered. 
The dishes for the monolayer cultures (ML) were coated by adding an acidic collagen I 
solution [10µg/ml] and letting it dry either over night (ON) or for two days (Table 3).  
 
Cell culture plate Area/well Volume Concentration Time to dry 
96 well plate 0.32 cm2 110 µl 20 µg/ml 2 d 
24 well plate 2 cm2 125 µl 100 µg/ml ON 
6 well plate 9.6 cm2 600 µl 100 µg/ml ON 
60 mm dish 28 cm2 1.8 ml 100 µg/ml ON 
Table 3: Scheme of pipetting for coating of culture dishes for monolayer culture 
 
For the sandwich cultures (SW) a layer of gelled collagen had to be prepared prior to 
the seeding of the cells. An ice-cold acidic solution of collagen I [83 µg/ml] was mixed 
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with 1/10th volume 10x DMEM-F12 media resulting in a final collagen-concentration of 
75 µg/ml. This was then neutralized to a pH of 7.2 to 7.4, with a 1M sodium hydroxide 
solution and directly transferred to the culture dishes/plates (Table 4). By incubation in 
an incubator at 37°C for at least 30 min, the collagen was allowed to gelatinize. 
 
 
Table 4: Volume of collagen I 
solution used for each layer of 
sandwich culture.  
 
2.2.1.4 Plating of cells 
After isolation, hepatocytes were plated as fast as possible. Cells were mixed with 
plating media (DMEM/F12 medium (Gibco)) supplemented with 10% (v/v) FBS, sodium 
pyruvate, antibiotics and insulin and dispensed uniformly onto the dishes (Table 5).  
 
Cell culture plate Cells/ ml Volume Total number of cells 
96 well plates 500 *103 100 µl 50 *103 
24 well plates 500 *103 0.5 ml 250 *103 
6 well plates 1 *106 1.5 ml 1.5 *106 
60 mm dishes 1.5 *106 3 ml 4.5 *106 
Table 5: The media volumes and the amount of cells used for seeding. 
 
Cells were allowed to attach to the culture surfaces at 37°C and 5% CO2 in a 
humidified atmosphere for 4 h. Cultures were subsequently washed with cooled PBS to 
remove dead and damaged cells. Specific media, according to the experiment type, 
was added (medium with FBS (above) or serum-free medium supplemented with 0.1% 
BSA, dexamethasone and ITS) and cells were cultured in an incubator as described 
above. 
After attachment (3-6 h) SW cultures were overlaid with a second layer of collagen I in 
the same manner as the first layer and incubated at 37°C for additional 30 min to allow 
the second layer to gelatinize. Medium was added afterwards and either changed daily 
for the time course experiments or every second day for the experiments with 
compound treatment.  
 
Cell culture plate Volume 
24 well plate 75 µl 
6 well plate 200 µl 
60 mm dish 500 µl 
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2.2.1.5 Culture of FaO and HepG2-cells 
The human hepatoma cell line HepG2 and the rat hepatoma cell line FaO were grown 
in DMEM/F12 medium (Gibco) supplemented with 10% (v/v) FBS, sodium pyruvate, 
antibiotics and insulin at 37°C and 5% CO2 in a humidified atmosphere to 90% 
confluency, washed with PBS and lysed with Trizol for subsequent RNA isolation. 
 
2.2.1.6 Suspension culture 
The preparation and cultivation of rat and human suspension cultures was performed 
by Biopredic International. After perfusion, rat and human hepatocytes were purified, 
suspended in DMEM supplemented with fetal calf serum (5%), insulin (4 mg/l), 
hydrocortisone (10–6 mM), and gentamycin (50 mg/l) and incubated at 37 °C, 5% CO2 
on a mixer at 300 rpm. At each time point used for later analysis, cells were collected, 
shock frozen in liquid nitrogen and stored for subsequent RNA isolation with Trizol. 
 
2.2.1.7 Precision cut liver slices 
The preparation and cultivation of rat liver slices was performed in the laboratory of 
Prof. Müller6. 33-40 Day old male Wistar-rats from the institutes own breeding facility 
were kept according to the actual rules of animal welfare7 at a light dark rhythm of 12 h, 
22°C and free access to water and food (Altromin 1316, Altromin GmbH, Lage, 
Germany). Animals were sacrificed by decapitation after being anaesthetized with ether 
and liver slices were cut according to the method of Müller (Müller et al., 1998). 
Briefly after dissection, the liver was flushed with and then transferred into ice-cold 
Krebs-Henseleit-Buffer. Cylinders of 8 mm diameter were cut out and a Krumdieck-
Tissue-Slicer was used to cut liver slices with a thickness of about 200-250µm. Four 
slices per 25 ml Erlenmeyer flask were incubated in 5 ml modified Williams´E Medium 
for 2 h, 6 h, 1 d and 2 d at 37°C, gassed with carbogen (95% O2 and 5% CO2) and 
bidirectionally shaken (100 hz). Change of media was made after 2 h and 24 h. At the 
mentioned time points, liver slices were transferred into 1.5 ml reaction tubes, shock-
frozen in liquid nitrogen and stored at -80°C until RNA isolation. 
 
 
                                                
6 Institute of Pharmacology and Toxicology of the Friedrich-Schiller-University of Jena 
7 Deutsches Tierschutzgesetz 
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2.2.1.8 Isolation of primary human hepatocytes 
Primary human hepatocytes were prepared from lobectomy segments resected from 
adult patients for medically required purposes by KaLy Cell8. Cells were checked for 
viability and seeded in culture wells in either ML culture or on a collagen gel as 
preparation for SW configuration. After incubation over night to ensure attachment of 
the cells, they were sent to Merck KGaA and used for further analyses. Cells 
designated for SW cultures were overlaid with a second layer of collagen gel as 
described in 2.2.1.4 and cells were incubated for another night at 37°C to allow the 
cells to recover from the transport procedure. 
 
2.2.1.9 HepaRG cells 
Cells were seeded and pre-incubated by Biopredic International9 and delivered as 
confluent ML cultures. After receipt, the media was changed to “after-shipment” media 
and cells were incubated at 37°C and 5% CO2 in a humidified atmosphere for three 
days to allow regeneration. Following this incubation, media was changed to either 
basal media or to basal media supplemented with 2% DMSO and incubated for another 
two days. During this time, cells differentiated to their “hepatocyte-like” phenotype and 
were then used for time course experiments.  
 
2.2.2 Rat in vivo study 
Liver samples from rats treated with tetracycline (Tet) or vehicle control were taken 
from a short term toxicity study performed by phase-1 Molecular Toxicology Inc.10 The 
study was run according to the official guideline of animal welfare11 and “Good 
laboratory Practices” (GLP)12 compliance.  
Male Sprague Dawley (Crl:CD®) rats with a body weight between 300 g and 400 g 
were kept under regular light-dark cycle of 12:12 hours with food (PMI Feeds Inc., 
Purina Milla, Richmond, USA) and water ad libitum. The rats were separated in groups 
of three animals per time point. Each group was treated once with vehicle control 
                                                
8 KaLy Cell, 2500 Besançon, France 
9 Biopredic International, 35000 RENNES, FRANCE 
10 PHASE 1 MOLECULAR TOXICOLOGY INC., Santa Fe, USA 
11 United States Department of Agriculture (USDA) Animal Welfare Act (9 CRF Parts 1, 2, 3) 
12 Good Laboratory Practice refers to a system of management controls for laboratories and 
research organisations to ensure the consistency and reliability of results as outlined in the 
OECD Principles of GLP and national regulations. The FDA has rules for GLP in 21CFR58 
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(sodium chloride solution), low or high doses of tetracycline by i.p. injection. The high 
dose was 150 mg/kg and as low dose, one third of it was chosen (50 mg/kg). Dose 
finding was done by phase-1 Molecular Toxicology Inc. and was based on both 
published and unpublished data. 
Treatment groups of three rats were sacrificed at 6 h, 1 d or 3 d by exposure to CO2. 
After bleeding of the rats, the livers were withdrawn and divided into two pieces and cut 
into small pieces, shock-frozen in liquid nitrogen and stored at -80°C for later RNA 
extraction.  
 
2.2.3 Biochemical methods and cell viability assays 
There are a variety of assays to test for the number of dead cells (cytotoxicity assays), 
the number of living cells (viability assays), the total number of cells or the mechanism 
of cell death (e.g., apoptosis). Here, a number of different tests were used to address 
several of these different parameters. These tests were used to assess hepatocyte 
viability after perfusion (Trypan blue Test) or to characterize the different cell-cultures 
and their change over incubation time and to determine the kinetics of cell death 
caused by compound treatment. Results of the latter experiments were used to 
calculate the final concentrations used in the gene expression experiments.  
 
2.2.3.1 CellTiter-Glo® Luminescent cell viability assay 
For the detection of cell viability, the CellTiter-Glo® Luminescent Cell Viability Assay 
was used. This test is based on a luciferase reaction (Figure 12 
Figure 12) to measure the amount of ATP in cells. This correlates directly with the 
number of cells and their viability because cells lose the ability to synthesize ATP 
directly after e.g. loss of membrane integrity or a cytotoxic event. The protocol was 
adapted to 24 well plates and to the different culture conditions resulting in a 
standardized protocol which is described below. Cell lysis, inhibition of endogenous 
ATPases and detection of ATP was performed by adding the CellTiter-Glo® Reagent to 
the culture wells. Per well, 100 µl reagent were mixed with the same volume of DMEM-
F12 Medium. Lysing of the cells took place by 10 min incubation at RT and moderate 
shaking. Three times 50 µl cell lysate was transferred into a white 96 well plate to 
eliminate stray light, and the bioluminescence was measured. 
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Figure 12: Chemical reaction of 
the CellTiter-Glo® Luminescent 
Cell Viability Assay. The reagent 
contains recombinant luciferase 
that uses the likewise contained 
luciferin as a substrate and 
reacts under the consumption of 
cellular ATP with the release of 
luminescence (Adapted from 
Assay Manual). 
 
2.2.3.2 WST-1-assay 
This test is based on the reduction of a tetrazolium salt that can be used for cell 
proliferation or cell viability assays. The rate of WST-1 cleavage by mitochondrial 
dehydrogenases correlates with the number of viable cells in the culture (Figure 13).  
 
Figure 13: Assay mechanism of 
WST-1 conversion by 
dehydrogenases in viable cells. 
The water-soluble tetrazolium salt 
WST-1 is reduced to the coloured 
dye formazan by mitochondrial 
dehydrogenase enzymes with the 
intermediate electron acceptor 
PMS (Adapted from Assay 
Manual). 
 
After aspiration of the culture wells, 350 µl of a mixture of DMEM F-12 media and WST-
1 reagent (1/10th volume) was added to the cells and, following 4 hours incubation at 
37°C, absorbance at 450 nm was measured. 
 
2.2.3.3 LDH release 
If cells get damaged or die, they loose their membrane integrity, releasing, among 
others, cytoplasmic proteins like lactate dehydrogenase (LDH) into the surrounding 
media. Based on the CytoTox-ONE™ Homogeneous Membrane Integrity Assay, a 
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standardized protocol was developed to measure the release of LDH from damaged 
hepatocytes as an indicator of cytotoxicity.  
LDH catalyzes the conversion of lactate to pyruvate with the simultaneous production 
of NADH. The CytoTox-ONE™ Reagent contains substrates as well as cofactors for 
this reaction and for the conversion of resazurin to resorufin using NADH as an energy 
source. The emerging fluorescence is relative to the amount of LDH released into the 
media and was optically measured at 544 nm excitation and 595 nm emission 
wavelengths (Figure 14).  
 
 
Figure 14: Principal behind the 
CytoTox-ONE™- Homogeneous 
Membrane Integrity Assay. 
Released LDH of damaged cells 
catalyzes the conversion of 
Lactate to Pyruvate under 
production of NADH in the 
culture media. This NADH is 
used to drive the diaphorase-
catalyzed production of the 
resorufin product from resazurin. 
 
Three times 50 µl culture media per well were transferred to a black 96 well plate, 
mixed with the same volume of CytoTox-ONE™ Reagent and incubated for 10 min at 
RT. The reaction was stopped by adding 25 µl Stop Solution and the fluorescence 
intensity was measured. Meanwhile, the remaining reaction media was aspirated and 
cells were lysed with 200 µl 0.1%TritonX100 in PBS (v/v) for 10 min at RT. Again, three 
times 50 µl were transferred to a black 96 well plate, the reaction was carried out and 
the fluorescence was measured as described above.  
The LDH content of treated cells relative to the controls (time matched or fresh cells), 
which is an indication for the membrane integrity and cell viability, was calculated as 
follows: 
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2.2.3.4 Cytochrome P450 isoform induction and activity 
2.2.3.4.1 Induction of Cyp isoforms 
Hepatocytes in ML and SW culture were induced with known inducers for the 
expression of CYP 1A, 2B, 2C and 3A isoforms. Cells were cultured as previously 
described and dosed at 0 h, 3 d and 9 d with the appropriate inducer for 48 h. CYP 1A1 
was induced with β-naphthoflavone (BNF; 10µM), CYP 2B and 2C with phenobarbital 
(PB; 500µM) and CYP 3A with dexamethasone (Dex; 50µM). The concentrations of the 
inducers used in this experiment were selected based on preliminary experiments to 
obtain the largest enzyme induction without causing toxicity (data not shown). 
 
2.2.3.4.2 Detection of Cytochromes P4503A7 and 2C9 isoform activity 
The activity and induction of cytochrome P450s 3A7 and 2C9 were measured with the 
P450-GloTM Assays (Promega). These tests are based on the CYP450-isoenzyme 
specific conversion of derivatives of beetle luciferin to a luciferin product that can be 
detected in a second reaction with a Luciferin Detection Reagent via the generation of 
luminescence. The amount of light produced is proportional to the activity of the 
CYP450-isoform (Figure 15). 
 
Figure 15: Conversion of P450-Glo™ substrate by cytochrome P450. Cytochrome P450 
isoenzymes act specifically on a substrate to produce a luciferin product that generates light 
with the Luciferin Detection Reagent (modified from assay-manual). 
 
The luciferin substrate (5 mM) was diluted in an appropriate Media (1:50) and culture 
media was replaced by 100 µl of this mixture. Cells were incubated for 4 h at 37°C and 
5% CO2 for the progress of the biochemical reaction. Afterwards 2x 40 µl were 
transferred into a white 96 well plate and the same volume of the P450-Glo™ Luciferin 
Detection Reagent was added. The reagent simultaneously stops the CYP450 reaction 
and initiates a luminescent signal, which was measured after 20min incubation at RT 
with a luminescence plate reader. 
 
 
 
Luciferin-R          P450          Luciferin      luciferase
(inactive)                               (active)
R
Light
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2.2.3.4.3 Detection of Cytochromes P450 1A1 and 2B6 isoform activity 
Cytochrome P450 1A1 and Cytochrome P450 2B6 isoform activities and induction 
were characterized with either 7-ethoxyresorufin-O-deethylase (EROD) or 
benzyloxyresorufin-O-debenzylase (BROD). The reaction product was measurable with 
an excitation wavelength of 544 nm and an emission wavelength of 595 nm (Burke et 
al., 1985). 
The cell culture media of cells cultured in a 24 well plate was aspirated and replaced by 
150 µl salicylamide solution (0.3M). Cells were incubated for 10 min at 37°C and 5% 
CO2 and subsequently 150 µl substrate solution was added (concentration of EROD 
was 5 µM, BROD was 10 µM). After 20 min incubation at 37°C, 3x 75 µl were 
transferred into a black 96well plate and fluorescence was measured in a fluorescence 
plate reader. 
 
2.2.3.5 Canalicular transporter activity 
The functional activity of the canalicular transporter multidrug resistance associated 
protein (Mrp2) was studied with carboxy-DCFDA. This diacetate exhibits only weak 
fluorescence but is, after penetrating through the plasma membrane, rapidly 
metabolized to the fluorescent product carboxydichlorofluorescein. This fluorescent bile 
acid is known to be a substrate for this hepatocellular transporter (Heredi-Szabo et al., 
2008) and therefore the dye efflux from hepatocytes cultured in either ML or SW culture 
could be determined over time.  
Per well of a 24 well plate, the culture media was replaced by 500 µl carboxy-DCFDA 
(diluted in PBS to a concentration of 5 µM). The cells were incubated for 20min at 37°C 
and 5% CO2, subsequently washed three times with warm PBS and observed with a 
fluorescence microscope at an excitation wavelength of 480 nm and a 530 nm filter for 
detection of the emitted light. 
 
2.2.4 Molecular biological methods 
2.2.4.1 Isolation of RNA and proteins 
The isolation of RNA and proteins was conducted with TRI Reagent. TRI Reagent 
contains phenol and guanidine thiocyanate to maintain nucleotide and protein integrity 
during cell/tissue homogenization while at the same time disrupting and breaking down 
cells and cell components. All steps of the procedure were conducted according to the 
manufacturers’ manual (Sigma).  
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Cells in culture were lysed by replacing the culture media with the appropriate volume 
of TRI reagent and the lysate was transferred into a 15 ml reaction tube. Tissue slices 
were homogenized by the addition of a nuclease free steel bead and the appropriate 
volume of TRI reagent with the Tissue Lyzer for 1 min with a frequency of 25 Hz. All 
samples were incubated for 10 min at RT, afterwards 200 µl chloroform per 1 ml TRI 
reagent were added, mixed by shaking and incubated for another 10 min. For the 
separation of the phases, this mixture was centrifuged for 15 min at 12,000 x g and 
4°C. The upper aqueous phase containing the RNA was transferred into new reaction 
tube containing 500 µl ice cold isopropanol per ml TRI reagent, mixed by vortexing and 
incubated for 10 min at RT. Another centrifugation step precipitated the RNA. The 
pellet was washed with 1.5 ml ethanol (75%), the supernatant discarded, the pellet 
dried for 5-10 min and finally resolved in nuclease free water. 
The proteins, which are contained in the organic lower phase, were isolated by 
discarding the white interphase containing the genomic DNA, precipitated by adding 
1.5 ml isopropanol per 1 ml of TRI reagent used for initial homogenization and 
incubation for 10 min at room temperature. The proteins were sedimented by 
centrifugation at 12000 x g for 10 min at 4°C. The protein pellet was washed 3 times for 
20 min at RT in 0.3 M guanidine hydrochloride in 95% ethanol (2 ml per ml TRI 
reagent) and once in 100% ethanol with centrifugation steps of 7500 x g for 5 min at 
4°C to re-acquire the pellet. After this final wash step, the protein pellet was air dried for 
5-10 min at RT and resuspended in 200-300 µl lysis buffer by using the tissue lyzer. 
After complete solubilization, the protein solution was stored at -20°C. 
 
2.2.4.2 Quantification and quality check of nucleic acids 
The quantification of isolated nucleic acids and the check for absence of protein was 
done by measuring the absorbance at 260 nm and 280 nm with a UV-
spectrophotometer (NanoDrop ND-1000). The ratio between the two resulting values 
must be 1.8 or higher to guarantee a protein-free solution. With the help of the 
Lambert-Beer-Law and the molar extinction-coefficient, the concentration of the RNA in 
solution was calculated as follows: 
 
d
I
I
c •= ε
0
10log
 
c= Concentration, I0 = Intensity of the initial light beam, I = Intensity of the transmitted 
light, log10 I0/I = Absorption, ε = Extinction coefficient, d = Thickness of the cell 
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The quality of the nucleic acids was checked with the RNA 6000 Nano LabChip Kit II 
on the Agilent 2100 bioanalyzer according to the manufacturers’ recommendations. 
This assay is based on capillary electrophoresis so the RNA was separated according 
to their length and detected by fluorescent labeling. The resulting electropherograms 
(Figure 16) were checked for signs of RNA degradation. 
 
 
 
2.2.4.3 TaqMan® Low Density Arrays (TLDA) 
2.2.4.3.1 Quantification of mRNA with TaqMan® Low Density Arrays 
(TLDA)  
TaqMan real time PCR is based on the principle of a linear amplification and the 5’ 
exonuclease activity of DNA polymerase during the PCR (Lawyer et al., 1993). 
TaqMan® probes contain a reporter dye (6-FAM™) linked to the 5’ end of the probe 
and a non-fluorescent quencher (NFQ) at the 3’ end of the probe. When the probe is 
intact, the proximity of the reporter dye to the quencher results in suppression of the 
reporter fluorescence, primarily due to Förster energy transfer (Förster, 1948).  
Figure 16: Electropherograms depicting the 
RNA-ladder, total RNA, cRNA and fragmented 
cRNA analyzed with the Agilent RNA 6000 
Nano Chip kit. cDNA was checked for quality 
and quantified with the Agilent RNA 6000 Pico 
Chip kit. 
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During PCR, the TaqMan® probe anneals specifically to the middle of the amplified 
sequence. These probes are cleaved by the 5’ exonuclease activity of the DNA 
polymerase during amplification whereby the reporter dye is separated from the 
quencher, resulting in an increase in fluorescence (Figure 17). The amount of 
fluorescence produced is measured at each amplification cycle, providing a real-time 
estimation of the amount of mRNA. This increase in fluorescent signal occurs only if 
the probe was bound to the target sequence which is amplified during PCR. The 
assays are designed to span exon junctions to eliminate the possibility of detecting 
genomic DNA, which may still be present in the cDNA sample. 
 
 
Figure 17: Principle of TaqMan-PCR. Additionally to the two amplification primers, a third gene 
specific primer, carrying a reporter and a quencher, hybridizes to the amplified gene. During 
amplification, this primer is degraded by the exonuclease activity of the Taq-polymerase, the 
reporter separates from the quencher and a fluorescent signal can be measured (modified from 
assay-manual). 
 
TLDA´s are a high throughput application of TaqMan PCR. A 384 well micro fluidic card 
enables 384 simultaneous real-time PCR reactions to be run in parallel across 12 to 
384 targets. They are pre-loaded with optimized primers and probes and can be 
customized. A list of genes measured for the verification of microarray experiments can 
be found in the Appendix (Appendix 5 and Appendix 6). 
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2.2.4.3.2 cDNA synthesis for TaqMan® Low Density Arrays (TLDA) 
For cDNA synthesis, the Transcriptor First Strand cDNA Synthesis Kit for RT-PCR 
(AMV) was used with random hexamers. 1 µg Total RNA in a volume of 11 µl was 
mixed with 9 µl reverse transcription mastermix and transcribed as follows: 
 
Incubation 10 min 25°C 
Reverse transcription 60 min 50°C 
RT-Inactivation 5 min 85°C 
Table 6: cDNA synthesis reaction for TaqMan® by RT-PCR 
 
The success of the reverse transcription was reviewed and cDNA was quantified with 
the Agilent 2100 Bioanalyzer using the RNA 6000 Pico LabChip Kit according to the 
manufacturers manual (Figure 16). 
The area under the curve (AUC) from the ladder and samples was used to calculate 
the concentrations of cDNA. One µl Ladder represents an AUC of 100 and a cDNA 
concentration of 1 ng/µl.  
 
Sample
Ladder AUCAUCµlpgcDNA ••=
100
/10][  
 
2.2.4.3.3 Conduction of TaqMan® Low Density Arrays (TLDA) 
10 ng cDNA of each sample were made up to 50 µl with nuclease free water, mixed 
with the same volume qPCRTM Mastermix Plus (Eurogentec) and transferred into the 
sample reservoirs of the TLDA card. By centrifugation (2 min at 331 g), the samples 
were distributed into the sample wells and finally, the card was sealed to avoid mixing 
of the samples and reagents.  
The cards were measured using the ABI Prism 790 hT Sequence Detection System 
controlled by the AB Prism 7900 h SDS Software 2.1 according to the manufacturers’ 
recommendations (Applied Biosystems). Following time scale was used with 45 cycles:  
 
Initial phase 2 min 50°C 
Activation of Taq-Polymerase 10 min 94.5°C 
Denature cDNA 30 sec 97°C 
Annealing and Elongation 1 min 59.7°C 
Table 7: Cycle-scheme of TLDA-cards, step 2-4 were repeated 45 times. 
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2.2.4.3.4 Evaluation of TaqMan® Low Density Arrays (TLDA) 
Changes in gene expression were calculated relative to a constitutively expressed 
housekeeping gene such as 18s ribosomal RNA, and additionally compared to a 
control sample of fresh liver or a time matched vehicle control. Under optimal 
conditions, the amplification is exponential corresponding to a doubling of the amplified 
sequence during each cycle. Because this is not always the case, the efficiency 
corrected ∆CT method of Pfaffl was used (Pfaffl, 2001). The CT value is defined as the 
number of cycles in the exponential phase of amplification 
.  
)arg(CT
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E = Efficiency of reverse transcription 
∆CT = Change in the number of cycles between sample and control 
 
To calculate the efficiency of reverse transcription, a titration series of a standard cDNA 
over four orders of magnitude (0.1 ng - 100 ng) was prepared and amplified. The 
resulting CT values for each gene were plotted against the amount of cDNA inserted 
and a standard curve for each gene was calculated. The slope of this curve (m) was 
used to calculate the transcription efficiency as follows: 
 
)
1
(
10 mE
−=  
  
2.2.4.4 Processing of RNA for Illumina and Affymetrix Chips 
To enable signal detection and quantification after hybridization to the microchips, the 
sample RNA has to be labelled. In this case, this was done for both techniques used 
(Affymetrix and Illumina) by incorporation of biotin-labelled nucleotides during an in 
vitro transcription reaction after an initial cDNA generation from total RNA. The labeling 
kits were purchased and enzymatic reactions were carried out as recommended by the 
suppliers. 
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2.2.4.4.1 cRNA Synthesis from total RNA for Illumina BeadChips 
For the cRNA synthesis, the MessageAmp II aRNA Amplification Kit (Ambion Inc.), the 
RNeasy® MiniKit and the QIAquick® PCR Purification Kit (both Qiagen) were used. Per 
sample, 500ng total RNA were dried in a 0.2 ml PCR tube in a vacuum centrifuge 
concentrator at RT prior to the first strand synthesis. 
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Figure 18: Workflow for the conduction of Illumina BeadChip arrays 
 
During the first strand synthesis step, a single stranded cDNA from the mRNA-
containing total RNA sample was synthesized with oligo-dT-primers and a reverse 
transcriptase. 5μl 1st strand synthesis master mix were dispensed into each sample 
tube, mixed to dissolve the dried RNA and incubated at 42°C for two hours.  
In the 2nd strand synthesis step, the single stranded cDNA from the previous step was 
converted to double-stranded cDNA; the second strand master mix was prepared 
directly prior to use. 20 μl of this solution were dispensed into each sample tube and 
samples were incubated at 16°C for a further two hours. 
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For the clean up of the sample, the QIAquick PCR Purification Kit was used according 
to the manufacturers’ instructions up to the point of elution which was done with 50 µl 
nuclease free water. The double stranded cDNA was dried down in a vacuum 
centrifuge concentrator at RT prior to in vitro transcription (IVT). 
During IVT, multiple copies of cRNA were created from every cDNA molecule and 
additionally, biotinylated UTP-nucleotides were incorporated into the cRNA. 10 µl IVT 
mastermix were dispensed into each sample and the reaction was incubated at 37°C 
for 20 hours. 
Following the IVT, samples were cleaned using the RNeasy Mini Kit (QIAGEN) 
according to the provided manual up to the point of elution. The cRNA was eluted from 
the columns by washing twice with 50 µl nuclease free water and quantified and 
checked for quality as described under 2.2.4.2.  
 
2.2.4.4.2 Hybridizing, staining and detection on Illumina BeadChips 
For hybridization, 750ng of the biotin labelled cRNA of each sample was made up to a 
volume of 5 µl with Nuclease free water and mixed with 10 µl GEX-HYB buffer 
(provided by Illumina). Each mixture was then preheated at 65°C for 5 minutes, allowed 
to cool down to RT again and dispensed into a separate sample port on the chip 
(Figure 19). The RatRef-12_v1 chip allows 12 samples to be hybridized 
simultaneously, Human_RefSeq-8_v2 arrays can be loaded with 8 samples. Each 
BeadChip simultaneously assays 22,523 probes per sample, targeting genes and 
known alternative splice variants derived from the National Center for Biotechnology 
Information Reference Sequence (NCBI RefSeq) database (Build 36.2, Release 22 for 
human and Release 16 for rat) 
Each BeadChip was placed into a BeadChip hybridization chamber, prepared with 
200μl GEX HCB in each of the two humidifying buffer reservoirs. Hybridization 
chambers were sealed and incubated for 20 hours at 58°C with a rocker speed of 5. 
 
Figure 19: The RatRef-12 Expression 
BeadChip with IntelliHyb Seal contains 12 rat 
specific whole genome gene expression 
arrays, allowing 12 samples to be hybridized 
to a single chip. Each array probes 21,910 
genes and contains 22,523 probes. 
 
To guarantee a consistent quality and fluorescence intensity, several washing steps 
were performed after hybridization. A high stringency washing step with high 
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temperature wash buffer to remove unbound and mismatched cRNA, low stringency 
washing steps with Wash E1BC solution and ethanol, a blocking step with Block E1 
buffer, the detection with Prepare Block E1 buffer containing streptavidin-Cy3 [1 mg/ml] 
and final wash steps with Wash E1BC solution were performed according to the 
manufacturers protocol. Finally, the BeadChips were dried by centrifugation at 275g at 
RT for 4 minutes. Scanning was done directly afterwards with the Illumina 
BeadStation500x at 532 nm and a resolution of 3µm. Three BeadChips could be 
scanned at once, data extraction was performed simultaneously during the scanning 
process by the BeadScan control software and the intensity data was exported. 
 
2.2.4.4.3 cRNA synthesis from total-RNA for Affymetrix microarrays 
During the whole process of generating cRNA the Gene Chip® One-Cycle cDNA 
Synthesis Kit, the Gene Chip® Sample Cleanup Module and the Gene Chip® IVT 
Labeling Kit supplied by Affymetrix were used. All enzymes and buffers used were 
included in these kits and all steps were accomplished according to the manufacturers’ 
recommendations.  
For the reverse transcription, 5µg of total RNA were used in 8 µl nuclease free water. 2 
µl Poly-A RNA spike in controls and 2 µl T7 Oligo(dT) Primer [50 mM] were added to 
make a final volume of 12 µl and incubated for 10 min at 70°C.  
7 µl First strand mastermix was added and the mixture was heated up to 42°C for 2 
min. Finally, 1 µl enzyme (Superscript IITM [200µM]) was added and the reaction was 
incubated for 1 h at 42°C. 
The single stranded cDNA resulting from the first strand synthesis reaction was used 
completely for the second strand synthesis. Therefore, 130 µl second strand synthesis 
mastermix was added and the reaction was incubated for 2 h at 16°C. The reaction 
was started by adding 2 µl T4-DNA-polymerase (5U/ µl), incubation for another 5 min 
at 16°C and stopped by the addition of 10 µl EDTA-solution (0.5 M). The clean up was 
done with the Gene Chip® Sample Cleanup Module and the cDNA was eluted from the 
columns with 14 µl nuclease free water. 
Based on the double stranded cDNA, the biotinylated cRNA was synthesized with the 
Gene Chip® IVT Labeling Kit. 12 µl cDNA were made up to 20 µl with nuclease free 
water, mixed with 20 µl IVT-mastermix and incubated for 16 h at 37°C. The cleanup 
was again performed with the Gene Chip® Sample Cleanup Module and the elution 
was done in two steps with 11 µl and 10 µl nuclease free water. Quantification and 
quality control of the synthesized cRNA was performed as described in 2.2.4.2.  
Prior to hybridization, the cRNA was fragmented to 200–300mers by metal-induced 
hydrolysis in fragmentation buffer (supplied with Sample Cleanup Module). 15µg cRNA 
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was made up to 32 µl with nuclease free water, mixed with 8 µl 5x Fragmentation 
Buffer and heated up to 94°C for 35 min. The fragmentation was checked on the 
Agilent Bioanalyzer 2100. 
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Figure 20: Scheme of the whole workflow for the conduction of Affymetrix Gene Chips®. 
2.2.4.4.4 Hybridizing, staining and detection on Affymetrix microarrays 
15µg fragmented cRNA (40 µl) were mixed with 260 µl hybridization mastermix, 
incubated for 5 min first at 99°C followed by 5min at 45°C and afterwards centrifuged at 
maximum speed for 5 min. The Affymetrix Chips used (either Gene Chip® Rat 
Expression Array(RAE) 230 2.0 or Gene Chip® Human Genome U133Plus 2.0Array) 
were pre-hybridized with 200 µl 1x MES-Hybridization Buffer for 10 min at 45°C and at 
a rotation speed of 60rpm. The 1 x MES-Hybridization Buffer was replaced by 200 µl of 
the cRNA-hybridization-mastermix (10 µg) and the Chips were hybridized for 16 h at 
the same rotation speed. 
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The washing and staining steps were performed automatically by the Affymetrix 
Fluidics Station 400. Therefore, the precast washing program EukGE WS5, including 
the initial low and high stringency wash steps with wash buffers A and B, staining with 
SAPE-staining solution, antibody solution and a final wash step again with wash buffer 
A (Figure 20), was used. 
The scanning took place in a Gene Chip® Scanner 3000 at 570 nm wavelength and a 
resolution of 3 µm controlled by the GCOS-Software which was used for data 
extraction and quality control afterwards, too. 
 
2.2.5 Microarray data analysis 
The data extraction for Illumina BeadChips and for Affymetrix Genome arrays was 
performed with specific vendor software. 
 
2.2.5.1 Data extraction and quality control from Illumina BeadChip 
arrays 
Data extraction for Illumina BeadChips was performed by the supplied BeadScan 
software during the process of scanning and data was exported. The intensity values 
for every bead were aligned with the decoding data, which was delivered together with 
each chip (Gunderson et al., 2004, Chapter 1.8). The data from all beads with the 
same probe bound to their surface were condensed to one value. Simultaneously, for 
each bead type, a p-Value was calculated indicating the probability to be able to 
discriminate between negative controls and the samples. Each array on the BeadChips 
contained also various controls which could be analyzed and used to confirm the 
quality of the data. Three different hybridization controls with low, medium and high 
concentration, contained in the hybridization buffer, were used to identify the over all 
quality of the hybridization, independent from the sample cRNA. Perfect match and 
mismatch controls were used to detect unspecific hybridizations and, together with a 
GC-rich probe, to ensure the stringency of the hybridization. Also contained in the 
hybridization buffer were two biotin-labelled oligonucleotides to control the fluorescence 
intensity and negative controls with random sequences to identify the background 
intensity level. Arrays which did not fulfil defined quality parameters were removed and 
sample hybridization was repeated. In some cases the BeadStudio software was used 
to normalize the data. Further statistical analyses were conducted in the software 
Expressionist®Analyzer of Genedata and will be discussed in later chapters. 
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Figure 21: Overview of the hybridization controls for Illumina BeadChips. Mean values for all 
arrays analyzed are shown together with the standard deviation for low, medium and high 
abundant controls, a perfect and a mismatch control, a biotin control, the background intensity 
and the overall intensity for housekeepers and all genes. Together, these controls ensure the 
high quality of the data used for later analyses. 
 
2.2.5.2 Data extraction and quality control from Affymetrix arrays 
For each probe cell on the array, a single value was generated by the GCOS software. 
Because of the layout with eleven perfect match and eleven mismatch probe-cells per 
gene, a condensing step was included in the data extraction process, so only a single 
value per probe set was computed. The overall intensity and the intensity of the spike-
in controls were visualized and checked for quality. The created .cel-files were 
uploaded into and processed with the Expressionist®Refiner software from Genedata. 
Therein, an automated workflow, including several quality controls and a RMA-
normalization, was performed (Irizarry et al., 2003). This normalization method uses 
2 MATERIALS AND METHODS 
 68
only the perfect match data to perform background correction, normalization and 
expression value estimation. This results in lower variation coefficients and enhances 
the comparability between experiments (Irizarry et al., 2003). 
At the end of each workflow and as a result of the controls, each Array was classified 
by the software in the quality parameters as either good, medium or bad (Figure 22). 
Chips classified as good were used in the analysis, chips classified as bad were 
repeated. The medium classification was checked manually and the decision if the data 
was used was made on a case-by-case basis. 
 
Classification
Distortion severity
Masked Area (%)
Defective Area (%)
Corner Noise
3´/5´Mean
A B
 
Figure 22: A) Overview of the Refiner workflow including chip statistics, quality controls, 
classification and RMA-normalization. B) Detail of the result report of a refiner analysis. The 
classification indicates the overall quality with a colour code; additional details for each Chip are 
shown on the right side. 
 
2.2.6 Protein separation by SDS polyacrylamide gel 
electrophoresis (SDS-PAGE) 
Isolated proteins and cell lysates were separated by SDS-PAGE. 5-50 µg Protein with 
a volume of 20-25 µl were mixed with 5 µl LDS sample buffer and 2 µl of reducing 
agent and heated for 10 min at 70°C. Each sample was transferred into a pocket of a 
NuPAGE® Novex 4-12% Bis-Tris-gel in an incubation tray assembled in accordance 
with the manufacturers’ recommendations (Invitrogen). The separation was performed 
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at 200 V and 125 mA per gel for 60 min. 10 µl Molecular marker were always run in 
one slot of the gel to allow an estimation of protein size. 
 
2.2.7 Protein detection by western blot analysis and immune 
detection  
Blotting of proteins from polyacrylamide gels to nitrocellulose membranes (0.2 μm) was 
performed with the iBlot™ Dry Blotting System (Invitrogen) according to the 
manufacturers´ recommendations. This system enables rapid protein transfers by the 
use of a shortened distance between electrodes, high field strength and high currents. 
The ion reservoirs are incorporated into the gel matrix instead of the buffer tanks or 
soaked papers. Transfer membranes and the copper electrodes (anode and cathode) 
are included into the iBlot™ Gel Transfer Stacks (Figure 23). 
 
 
 
Figure 23: Principle of the iBlot™ Dry Blotting System (taken from the system manual). 
 
 
 
 
 
 
2 MATERIALS AND METHODS 
 70
Membranes were blocked by incubation with coating solution (5% milk solution in PBS-
Tween buffer) for 1 h. The primary antibodies were diluted and incubated together with 
the membranes as follows: 
 
Antibody Organism Provider 
Time of 
incubation 
Dilution 
Primary antibodies 
Cytochrome P450 3A1 Mouse abcam 1h 1:3,000 
Cytochrome P450 2B1/2 Mouse abcam 1h 1:3,000 
Cytochrome P450 1A1 Rabbit abcam 1.5h 1:3,000 
Secondary antibodies 
Peroxidase conjugated 
(HRP) anti-rabbit IgG Sheep GE Healthcare (#329616) 1:5,000 
Peroxidase conjugated 
(HRP) anti-mouse IgG Rabbit GE Healthcare (#328634) 1:5,000 
Table 8: Antibodies used for immunodetection. 
 
The membrane was washed with PBS-Tween buffer 3x 10 min, incubated with the 
adequate secondary antibody, also diluted in PBS-Tween buffer, for another hour and 
finally washed again as previously mentioned. 
The detection was performed with ECL solution which was freshly prepared directly 
before use according to the manufacturers´ recommendations (ECL-Kit, Amersham 
Biosciences). A chemoluminescent signal is produced by an enzymatic reaction 
between the secondary antibody-coupled horseradish peroxidase and the reagent 
which can be used to detect and quantify the specific protein. 
The ECL solution was spread out on the membrane and incubated for 1min. The 
membrane was put into a film cassette together with a detection Film (Hyperfilm ECL, 
Amersham Biosciences), the time of exposure ranged from 2 min to 5 h. The 
processing of the films was performed automatically with a Hyper processor 
(Amersham Biosciences).  
 
2.2.8 SELDI-TOF analysis 
SELDI-TOF (Surface-enhanced laser desorption/ionization - time of flight) retains the 
target proteins on a solid-phase chromatographic surface array, were they are 
vaporized by ionization using a laser and fly through a "time-of-flight" tube where they 
separate based on mass and charge (Figure 24). To allow ionization, sinapinic acid 
was applied to each array. As the solvent evaporates, the proteins co-crystallize with 
the sinapinic acid. By absorbing the laser energy these crystals raise ionized proteins 
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which can then be detected. In these experiments cation exchange ProteinChip CM10 
arrays were used to bind positively charged proteins, containing for example lysine, 
arginine or histidine, with weak anionic carboxylate groups. 
The chip surface was pre-activated for 10 min with 50 µl pre-activation binding buffer, 
afterwards 50 to 500 µg isolated protein sample were applied onto the chip surface in 
150 µl citrate binding buffer and centrifuged in a special chip processor for 1 h at 270 
rpm and RT. The chip surface was washed three times with 300 µl binding buffer for 7 
min at 270 rpm to remove unbound proteins. Washing was finalized by incubation with 
300 µl H2O for 1 min and drying for 15 – 20 min. Two times 0.5 µl sinapinic acid, freshly 
diluted in a 1:1 mix of acetonitrile and TFA [1%] were applied onto the chip surface and 
allowed to dry.  
After drying, chips were placed into the PBSII ProteinChip Reader (Ciphergen) and 
measured in the linear mode. The ionisation of the sample was achieved with a N2-
laser beam at (337 nm) with one warming shot with energy of 2,100 nJ and 10 data 
shots with 2,000 nJ. The mass range accomplished was 2 to 30 kDa, with a focus 
mass of 10 kDa. These settings were kept constant across all chips in an experiment. 
The ProteinChip Reader is directly linked to the ProteinChip Software for data analysis. 
The generated protein profiles were analysed by a multiple comparison of all spectra’s. 
The Biomarker Wizard. A software tool allows clustering of the detected mass to 
charge (m/z) signals for all spectra. Similar m/z signals were matched to a cluster and 
afterwards relatively quantified. Significant intensity changes of single mass-ion-peaks 
were detected using non-parametric Mann–Whitney statistical analysis (p-Value ≤ 
0.01). Signals with a deregulation of more than two fold were accepted as differentially 
expressed. The visualisation of the differences between different groups was 
accomplished by plotting the signal intensities against the m/z-values of the clusters. 
 
 
 
 
 
 
 
 
 
 
Figure 24: Scheme of the 
SELDI-workflow. 
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3 RESULTS AND DISCUSSIONS 
 
3.1 Comparison of different global gene expression 
platforms 
 
Microarray technology is one of the fastest evolving and most promising fields in 
molecular biology. Over the last decade, this technology has basically changed the way 
of addressing biological interrogations and opens new perspectives in monitoring 
cellular mechanisms and processes on a global level. There are applications in almost 
every field of biology and medicine and the number is still growing. The analysis of 
genomic data has become more and more important in modern toxicology and drug 
development, enabling researchers to identify changes in global gene expression as 
well as specifically affected pathways. Also the computing power was no longer a 
limitation, allowing the implementation of larger and more realistic models The FDA 
and the EPA (US Environmental Protection Agency) have defined pharmaco- and 
toxicogenomics as key opportunities to personalized medicine and risk assessment 
(Dix et al., 2006; Lesko & Woodcock, 2004). 
The use of microarrays to obtain insight into cellular processes and to monitor 
molecular interactions is a well-established method and has enabled scientists to 
understand cellular mechanisms in extreme detail and complexity. As illustrated in 
Figure 25, the amount of data in public databases, together with the molecular 
knowledge has tremendously increased over the last years. In the past, there were no 
official guidelines for conducting these types of experiments and so, the vast majority 
were performed without internal controls or accepted standards. The comparison of 
data within each platform and of results gained with other platforms gave quite 
conflicting results, showing either agreement (Li, Pankratz & Johnson, 2002; Parrish et 
al., 2004) or disagreement (Kuo et al., 2006; Mah et al., 2004) between the outcomes. 
This fact has driven the development of more rigid quality standards and guidelines not 
only in the manufacturing process but also on the handling and processing of the 
resulting data. The Implementation of MIAME (Minimal Information About a Microarray 
Experiment) was the first step towards a common standard. The FDA initiated a 
comprehensive project to look at microarray quality control and cross-platform 
comparisons (MAQC). The aim of this study was to learn how to handle existing 
microarray data in respect to reliability, comparability, repeatability and how the various 
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sources of variance, like intra- and interplatform and interlaboratory differences, affect 
the resulting data (Shi et al., 2006). 
 
 
 
 
 
Figure 25: Growth of public gene 
bank databases. Shown are the 
number of nucleotides and entries 
submitted to the Genbank 
database from 1982 to 2006 (Data 
courtesy of NCBI). 
 
Several providers have developed diverse variants of this technique and although the 
basic principle, measuring the amount of transcripts, is elementary, there are various 
differences in commercially available microarray platforms. Variability can be caused 
by multiple factors like the type of probes (in situ polymerization, spotting, microbeads), 
the probe selection and design, the number of probes (short/long oligonucleotides, 
cDNA), different labeling methods or competitive versus non-competitive hybridization. 
Affymetrix and Illumina both provide platforms allowing one sample to be hybridized 
per array. Array-to-array variability is minimized by highly standardized manufacturing 
and hybridization procedures. The degree of variation between replicates is an 
important issue for the experimental design and the interpretation of the results. 
Results of gene expression experiments are often used for the development of large 
databases. Right now, great efforts are taking place to test the ability of integrating data 
generated with different types of platforms (Roter, 2005). An important aspect is the 
understanding of the influence that the technology has on the data itself, data handling 
and processing and of course the overlap of genes common to these technologies. 
Therefore, the reliability and accuracy of gene expression measurements are a quality 
attribute and an elementary requirement. 
With this study, we wanted to investigate the comparability of a new global rat gene 
expression platform provided by Illumina Inc. with the well-established and accepted 
technique provided by Affymetrix. We therefore analyzed data generated from samples 
simultaneous on Illumina RatRef-12 Expression BeadChips (Illumina) and the 
Affymetrix Gene Chip® Rat Genome 230 2.0 Arrays. 
The study comprised two sets of samples to elucidate the technical and biological 
differences/similarities. A titration series with RNA extracted from control liver and 
N
uc
le
ot
id
es
(*
10
9 )
 &
 E
nt
rie
s
(1
0*
6 )
Year
N
uc
le
ot
id
es
(*
10
9 )
 &
 E
nt
rie
s
(1
0*
6 )
3 RESULTS AND DISCUSSION 
 75
kidney was generated for the more technically based comparison to test the linearity 
and the detection sensitivity of both platforms. Additionally, we investigated liver 
samples from rats treated with the model compound tetracycline as well as primary rat 
hepatocytes treated with tetracycline hydrochloride (both will be called Tet in the 
following to simplify reading). This setup enabled not only the direct comparison of 
results of both platforms but also to compare the changes in gene expression in vivo 
with the reaction of the hepatocytes cultured in vitro.  
Our study design gave us the option to analyze the comparability of both platforms by 
means of technical concordance but also on the level of the biological interpretation of 
the data. The evaluation of intra-laboratory variation is important for future experimental 
design as are the number of replicates (biological and technical) needed. Additionally, 
by comparing in vivo and in vitro data, we gained deeper insights into the compound-
specific mechanism of action and the possibility to mimic these effects in vitro. 
The key questions of this study were:  
 
1) Do we find a high concordance in the results of both platforms and if not, to 
what extent do they vary? 
2) Is the biological interpretation of the data nevertheless the same? 
3) Are both types of gene expression platforms equally qualified to measure 
samples with such a variety of origins? 
 
Tet is an antibiotic that is produced by streptomycetes in nature. It inhibits bacterial 
growth by reversibly binding to the 16S subunit of the bacterial ribosome, inhibiting the 
binding of amino-acyl-tRNA to the ribosomal A site and thereby translation. In higher 
doses, this effect has been proven to take place in mammalian cells (McKee et al., 
2006). In addition, Tet and its derivates exert anti-inflammatory and immunomodulatory 
effects that are completely separate from its antimicrobial action (Gabler & Creamer, 
1991). A toxic side effect of Tet is the causing of microvesicular steatosis in the liver, 
which occurs dose dependent through inhibition of mitochondrial ß-oxidation of fatty 
acids and cholesterol biosynthesis (Fréneaux et al., 1988). Hepatic microvesicular 
steatosis can have severe consequences in some people (Westphal, Vetter & Brogard, 
1994). Known molecular mechanisms include the inhibition of mitochondrial β-oxidation 
and peroxisome proliferator receptors (PPARs), and, in high doses, protein synthesis. 
Other genes affected play roles in cell proliferation, nucleoside metabolism and signal 
transduction. Additionally, Tet inhibits the induction of IL-1-converting enzyme and 
reduces cyclooxygenase-2 expression and prostaglandin E2 production. Also the 
Poly(ADP-ribose) polymerase-1 (PARP-1), which promotes both cell death and 
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inflammation when activated by DNA damage, is inhibited (Yin et al., 2006). The clear 
dose and time dependent mode of action enables us to examine if the same biological 
interpretations following Tet treatment can be inferred from different platforms. 
 
3.1.1 Results of the platform comparison study 
 
3.1.1.1 Experimental layout 
Technical comparison (Figure 26A) 
RNA was isolated from a male Wistar rat and the titration series was performed with 
dilution steps of initially 10% and for the later steps 20% resulting in 7 samples, ranging 
from pure liver to pure kidney RNA (100%:0%, 90%:10%, 70%:30%, 50%:50%, 
30%:70%, 10%:90%, 0%:100%; Liver:Kidney). Each sample was hybridized in 
technical triplicates on both platforms. The combination of biological differences in 
gene expression and the known inverse titration of both organs allow the assessment 
of the relative accuracy of each platform based on differentially detected genes and 
dilution effects. 
 
Biological comparison (Figure 26B) 
Liver samples from rats treated with low (50 mg/kg) or high (150 mg/kg) doses of Tet or 
a vehicle control were taken 6 h; 1 d or 3 d after treatment. RNA extraction was 
conducted as already described (see chapter 2 for details).  
To obtain the in vitro samples, livers of male Wistar rats were perfused, primary 
hepatocytes isolated and cultured in SW format. Cells were treated with either vehicle 
control (0.5% DMSO) or Tet (low dose 40 µM or high dose 200 µM) twice, 72 h and 
120 h after seeding. Cells were collected 6 h, 24 h and 72 h after the initial treatment. 
All samples were split, labelled according to the manufacturers’ manuals and 
hybridized to either the Illumina RatRef-12 array or the Affymetrix Rat Genome 230 
v2.0 array. 
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Figure 26: Experimental layouts of the studies conducted for comparing Affymetrix and Illumina 
global gene expression platforms. A) Technical comparison, a titration series between total 
RNA isolated from liver and kidney (100%:0%, 90%:10%, 70%:30%, 50%:50%, 30%:70%, 
10%:90%, 0%:100%; liver:kidney). B) Biological comparison, an in vivo and an in vitro 
toxicogenomics studies were compared. Three biological replicates of either animals or 
hepatocytes in SW culture were treated with Tet at two doses. 
 
Data extraction and probe mapping 
Affymetrix data was extracted by the GCOS-Software, normalized with the RMA 
method and checked for quality parameters within the Expressionist®- Refiner software. 
Illumina data was processed and checked for quality in BeadStudio (Illumina). Data 
was imported into separate sessions of Expressionist®Analyst (Genedata), Illumina 
data was normalized with the LOESS-method, and both datasets were analyses in an 
analogous manner. 
Because of their differences in probe design and the fact that they are based on 
different versions of sequence databases, it is necessary to map the probe sequences 
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contained on both chips to a common database version. This step was required 
because gene identifiers can change between different versions of the database due to 
new knowledge about specific genes or splice variants. There is a need to assure the 
identifiers of both platforms to characterize the same gene. Therefore, probe 
sequences from each platform were mapped to transcript sequences from RefSeq 
Release 19 (downloaded from ftp://ftp.ncbi.nih.gov/refseq/R_norvegicus/mRNA_Prot). 
A probe was defined as valid if it perfectly matched a transcript sequence and did not 
perfectly match any other transcript sequence with a different gene symbol. For 
Affymetrix probe sets, individual probes were determined to be valid by applying the 
definition above. Then probe sets were defined as valid if at least 80% of the probes 
within the set were valid. This procedure resulted in a gene list of 7,271 valid probes 
common on both platforms which was used in subsequent studies.  
 
3.1.1.2 Intraplatform comparability 
Due to technical differences the data produced by Illumina and Affymetrix contrast 
strongly in their intensity values. Therefore, the intraplatform comparability was 
examined by comparing the coefficients of variance (CV). The CV was used instead of 
the standard deviation because it is a dimensionless number and independent from the 
mean. CVs were calculated for each of the 7,271 valid genes using the 3 technical 
replicates for all samples of the titration series as well as the 3 biological replicates of 
the toxicogenomic dataset. The distribution of the replicate CV values of both platforms 
is shown as a series of box plots in Figure 27. The technical variance is directly 
compared to the biological variance arising from the individual differences of the 
animals used. 
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Figure 27: Box plots showing the distribution of the coefficients of variance (CV) for the 7,271 
identically detected genes for the technical and biological replicates. The constriction of the bars 
denotes the median CV, the bars themselves include 50% of all CV values and the whiskers an 
additional 10%. The x-axis indicates the samples, the amount of liver RNA in the titration 
sample (L100 to L0) for the technical comparison and the time points of control, low and high 
dose for the biological comparison. 
 
The median value of the technical variance for three replicates demonstrated 
analogous rates for both platforms. For Illumina, the CV was, with 7.3%, slightly higher 
than for Affymetrix (6.3%). The distribution of the CV values was also comparable and 
showed an asymmetrical shape. Thereby, the nature of the sample (Liver or Kidney) 
seems to have no effect on the result. 
The median value for the biological variance ranged from 6.7% to 13.6%. For the in 
vitro samples measured with Illumina, it was only slightly higher than the median of the 
technical variance (7.8%). In contrast to this, the distribution of the CV values per gene 
was broader. Although the median of CV values is higher for in vivo samples measured 
with Affymetrix (9.8 %), their distribution is in the same range as for Illumina. The in 
vitro samples showed slightly, but not significantly, increased median CV values 
compared with the in vivo samples for both platforms (12.1% for Affymetrix and 12.7% 
for Illumina). The Isolation of hepatocytes and the time of incubation seem to be an 
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additional factor that introduces variability into the gene expression data, although it is 
still within acceptable limits.  
These findings correlate well with the results of the MAQC consortium (Shi et al., 2006; 
Klebanov & Yakovlev, 2007), where 5% to 15% of variance was reported for different 
global gene expression platforms (Affymetrix and Illumina were both below 10%). 
Several reasons are responsible for these differences in the signal detection. Affymetrix 
and Illumina have fundamental differences in probe design and number of probes. 
Whereas Affymetrix uses a set of eleven 25mer oligonucleotides probes with perfect 
match and mismatch controls, Illumina instead uses 50mer oligonucleotides as probes 
in 30-fold redundancy. Sequence variations in the probe sets that target the same gene 
at different locations, the GC content, sequence length, intraplatform cross-match 
opportunities and the location of the probe sequence in relation to the 3'-end of the 
target gene might additionally cause different strengths of binding and therefore 
contribute to different levels of signal intensity. It has been shown that probes with 
complete sequence matches yield concordant results across platforms. There is a 
direct correlation between probe sequences and signal intensities for probes that target 
the same gene on different platforms (Pusztai, 2006). 
 
3.1.1.3 Interplatform comparability 
The interplatform comparison could only be performed indirectly. Due to their 
differences in probe sequences, labeling and hybridizing techniques, the resulting 
intensity values are fundamentally different. To overcome this problem, relative 
expression values between the titration samples and the 100% liver sample were 
calculated and compared. The relative expression values from the 7,271 commonly 
detected were collectively imported into Expressionist®Analyst and analyzed for 
common changes. Genes which had a more than 2-fold expression difference between 
liver and kidney samples and a pValue lower than 0.05 (ANOVA) were grouped 
according to their profile over the titration series with the help of SOM clustering (see 
chapter 2.2.5).  
Six groups of genes were identified by SOM clustering (Figure 28). Groups E and F 
showed genes with a medium level expression in both tissues and a rising or falling 
expression profile with each dilution step and a close to linear slope in both platforms 
Groups A and B were similar but showed higher expressed genes reaching the 
saturation of intensity measurement. This results in a nonlinear increase of intensity. 
A subset of genes, contained in groups C and D, had showed no correlated or 
contradicting expression between both platforms. The intensity values of many (but not 
all) of those genes were close to the background level. Small variations in intensity 
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therefore result in large fold change values and no clear concentration dependency can 
be detected. 
 
 
 
 
 
 
 
 
Figure 28: HeatMap generated by SOM-
clustering of genes according to their fold 
change profile relative to the liver. The 7,271 
commonly detected genes were filtered by a 
fold change ≥ 2 and a pValue of ≤0.05 between 
liver and kidney samples to retain only genes 
with a linear dependency. Clusters A, B, E and 
F contain genes shown to have equal 
tendencies across both Platforms, clusters C 
and D are a subset of genes with either no 
clear or contradictory tendency between both 
platforms. 
 
The histogram shown in Figure 29 depicts the distribution of CVs of the titration 
experiment for both platforms. The value 1 indicates a perfect correlation and that the 
intensity values of the genes demonstrated the same behavior in the samples 
measured, -1 resembles negative correlation which means an inverse behavior. For 
Affymetrix, about 75% of the genes have a correlation of 1 to 0.9 and -1 to -0.9, for 
Illumina this value is 69%. The genes in between have lower linear dependency to the 
titration samples. 
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To further explore and validate these findings, the rat Tet toxicogenomics dataset was 
analyzed. Fold change values and pValues of this dataset were calculated for both 
platforms and each dose, time point and experiment type (in vivo or in vitro) relative to 
the time matched vehicle controls. The resulting gene lists were ranked either by the 
pValue (Figure 30A) or by the fold change (Figure 30B). The comparability between the 
gene lists was quantified using the “OrderedList” functionality of the Bioconductor R 
software (Lottaz et al., 2006).  
 
A B
0             500          1000         1500         2000       2500
Figure 30: Gene list comparison (example shown for the in vitro experiment, high dose, 24 h). 
Genes have been ranked according to the p-Value (A) and to the extent of the fold change (B). 
The size of overlap of the top 500, 1000, 1500 etc. (labeling of the axis) genes of these lists 
were computed and compared to an overlap expected just by chance (orange line) and to the 
result obtained by reversing one of the two lists (green line). 
 
 
Figure 29: Histogram of 
the correlation 
coefficients of genes to 
the titration curve. The 
number of genes, found 
to have a more than 2 
fold different expression 
levels in both tissues was 
plotted against their 
correlation values.  
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Ranked gene lists were searched from the top (pValue ranked lists) or from both sides 
simultaneously (fold change ranked lists) for commonly occurring genes. The 
background of genes overlapping just by chance was calculated by comparing 
randomly perturbed gene lists 1,000 times. The negative control was obtained by 
inverting one of the two gene lists and comparing the top of one list with the bottom of 
the other. 
The p-Values for the possibility to derive the obtained results just by chance were 
calculated (Appendix 2 and Appendix 13). The results show that the lists of top-ranked 
genes are highly saturated with genes detected by both platforms. Differences in the 
score indicating the overlap between the gene lists were detected and are plotted in 
Figure 31. The degree of overlap is strongly influenced by the nature of the samples. 
Gene lists of samples treated with low doses of Tet generally showed a lower analogy 
than others treated with high doses. In addition, time effects were seen in vivo and in 
vitro. The overlap of gene lists from both platforms is small 72 h after dosing compared 
to earlier time points. This can be explained by time dependent effects of Tet. The 
differences in scores between high and low doses of Tet in vivo or in vitro generally 
showed the same trend.  
The highest overlap between the platforms for lists of genes was detected in vivo 6 h 
and in vivo and in vitro 24 h after high dose treatment. These are exactly the time 
points were the highest effect of the treatment was expected and are therefore best 
suited to analyze the effect of the compound on gene expression. Initial changes (6 h 
after dosing) leading to a high gene list overlap might be due to acute inflammatory 
effects. This would explain the discrepancy between vivo and in vitro. The latter is 
missing non parenchymal liver cell types, e.g. Kupffer cells, which are important for the 
induction and maintenance of inflammatory mechanisms.  
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Figure 31: The difference of the scores calculated by the gene list overlap and the negative 
control were plotted for all the experiments. Scores were computed on the basis on the number 
of overlapping genes and reflect in principle a weighted sum of these values. A) Genes have 
been ranked by pValue; B) Genes have been ranked by fold change 
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These results were confirmed by a correlation analysis (Figure 32). Both platforms 
showed a high concordance, with high correlation coefficients, between each other. 
There were only minor differences in the correlation coefficients compared to the 
vehicle control for the 72 h time point and the 24 h time point (low dose). Significantly 
lower correlation coefficients were detected 6 h after treatment for both doses and 24 h 
after treatment with the high dose. 
 
 
 
Figure 32: Correlation 
map of in vivo samples of 
tetracycline treated cells. 
Each square resembles 
one experiment; red is 
positive correlation, green 
represents a negative 
correlation. 
 
Genes found to be changed in expression after treatment with Tet in vivo and in vitro 
(≥2-fold, pV≤0.05) were common within both platforms. Lowering the fold change value 
to 1.5 lowered the platform concordance to 88.2%. In most cases not only the direction 
but also the extent of deregulations was very analogous between both platforms. 
These results show that the variance across technical replicates is in a satisfactory 
range and even the individual differences of biological replicates caused only a slight 
increase. Conducting biological replicates instead of technical replicates helps to 
increase the statistical significance and therefore the match between the results of 
Illumina and Affymetrix. 
 
3.1.1.4 Biological interpretation 
Whereas the histopathological analysis of the in vivo samples showed no abnormality 
(data not shown, see Zidek et al., 2007, the morphological analysis of Tet treated 
primary rat hepatocytes showed a clear accumulation of lipid droplets over time (Figure 
33) Cells treated with high doses of Tet were more affected and showed additional 
signs of cellular damage. This proved that the mechanisms leading to microvesicular 
steatosis in vivo are also present in vitro and that the sandwich culture model therefore 
is a qualified tool to analyze the mechanistic basis of the toxic effects of Tet. 
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The effect of treatment on gene expression can largely be seen 6 h after dosing in vivo 
and 24 h after dosing in vivo and in vitro. Whereas the effects endure in vitro, a 
recovery of the animals can be seen in vivo. Further analyses were accomplished 
within the Expressionist®Analyst software from Genedata and the biological 
interpretation was supported with MetaCore™ pathway analysis tools from GeneGo. 
 
 
Figure 33: Primary rat hepatocytes treated with either DMSO (vehicle control) or low and high 
doses of Tet for 6/24/72 h. Cells were pre-cultured in sandwich culture for two days to 
acclimatise to the culture conditions and subsequently dosed with either 40µM or 200µM Tet. 
Both doses caused an accumulation of lipid droplets inside the cells and this effect was more 
pronounced in the high dose (See red arrows). 
 
Figure 34 shows a PCA which separated samples from both platforms of the in vivo (A 
and B) and in vitro (C and D) experiments. The PCA analysis shows the basic 
tendencies within the data, which resembles the biological effects of treatment. 
The time and dose dependent effects were observed in vivo and in vitro. Vehicle 
controls, low dose treatment groups 24 h and 72 h after treatment and high dose group 
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72 h after treatment clustered closely together in vivo. Two separate clouds, one 
containing both dosing groups 6 h after treatment and the other with the high dose 
experiments 24 h after treatment, indicate a change in gene expression in these 
animals. Whereas both treatment groups caused similar gene expression changes 
after 6 h the gene expression of the low dose animals returned to the control level after 
24 h. The high dose group after 24 h separated from all groups indicating more severe 
effects. After 72 h even high dose animals appeared to have returned to normal animal 
gene expression levels. This can be explained with the single dose treatment of the 
animals and the reversible effect of Tet. 
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Figure 34: Principal components analysis (PCA) of the same datasets measured with Affymetrix 
Rat Genome 230 2.0 Array (A and C) and Illumina RatRef-12 Expression BeadChip arrays (B 
and D). Each point resembles the principal expression characteristics of all 7,271 common 
genes. The Tet in vivo study shows a clear separation of the experiments from the control group 
for both doses after 6 h and the high dose 24 h after treatment. In vitro, the separation is less 
clear after 6 h but high doses also separate at later time points.  
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In vitro (Figure 34 C and D) experiments showed related, but not identical, results to 
the in vivo samples. Due to the study design, where hepatocytes were dosed a second 
time 48 h after the first treatment, no regeneration effects were seen at 72 h. In fact, at 
72 h even stronger effects were observed, indicating an increasing degeneration of 
these hepatocytes. The low dose experiments were not clearly separated from the 
controls, although they showed a tendency into the direction of the high dose 
experiments, indicating only a weak response to treatment. 
The data from both in vivo and in vitro experiments are consistent across both 
platforms, which showed a high concordance of the 7,271 common genes. The high 
similarity between the PCAs show that not only the basal level but also any changes in 
gene expression after treatment were detected reliably by both Affymetrix and Illumina. 
The extent of these changes can be explained by the expected toxicity of Tet. The 
initial treatment caused an acute immune response in the animals, which was over in 
the low dose animals by 24 h. In vitro, the initial effects were less pronounced but 
subsequently, analogous tendencies were observed. 
 
 
Figure 35: Number of genes significantly deregulated by treatment with Tet in either in vivo or in 
vitro experiments 
 
The findings of the previous analysis were reflected by the number of genes 
deregulated after treatment (Figure 35). In vivo, already 6 h after treatment a 
substantial number of genes were deregulated and the high dose had a greater impact 
than the low dose. 24 h After treatment, the high dose still showed strong deregulations 
in vivo whereas the low dose showed only minor alterations. After 72 h only slight 
disturbances in gene expression were observed. 
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The number of significantly deregulated genes in vitro rose only in the cells treated with 
high dose Tet over time. Cells treated with low doses were not noticeably affected. The 
early time point showed no substantial deregulation, indicating technical differences 
between in vivo and in vitro mechanisms. 24 h After the initial treatment, the number of 
genes deregulated rose to 937 (Illumina) and 876 (Affymetrix) and after 72 h a 
maximum of 1028/1368 deregulated genes was reached. 
To get insights into the molecular mechanisms of Tet activity, the significantly 
deregulated genes (fold change > 1.5 and pValue < 0.05), measured with Affymetrix 
and Illumina, were analyzed using the MetaCore™ pathway analysis tool (GeneGo). To 
account for time as well as dose dependency, two different time points, 6 h and 24 h, 
and both doses were analyzed for the in vitro samples and 24 h and 72 h time points 
were analyzed for the in vivo experiments. Results were examined for biological affects 
and both platforms compared  
Gene expression changes caused by Tet treatment were involved in a variety of 
cellular processes (Table 9). The most affected pathways were associated with lipid 
metabolism followed by genes involved in signal transduction and cation homeostasis, 
inflammation, nucleotide and nucleic acid metabolism, protein and amino acid 
metabolism and cell cycle. 
 
Down regulated Up regulated 
GeneGo „maps“ GO processes GeneGo „maps“ GO processes 
Cholesterol Biosynthesis Lipid metabolic process
PDGF signalling via 
STATs and NF-kB 
Nucleotide and nucleic 
acid metabolic process 
Regulation of lipid 
metabolism via LXR, NF-
Y and SREBP 
Cellular lipid metabolic 
process 
Histamine H1 receptor 
signalling in immune 
response 
RNA metabolic process
Regulation of fatty acid 
synthase activity in 
hepatocytes 
Positive regulation of 
chondrocyte 
differentiation 
Immune response_IL1 
signalling pathway 
Biopolymer metabolic 
process 
Triacylglycerol 
metabolism 
Organic acid metabolic 
process 
TPO signalling via JAK-
STAT pathway 
Primary metabolic 
process 
Role of CDK5 in cell 
adhesion 
Alcohol metabolic 
process 
MIF-mediated 
glucocorticoid regulation
Macromolecule 
metabolic process 
Glycolysis and 
gluconeogenesis 
Steroid metabolic 
process 
Apoptosis and 
survival_TNFR1 
signalling pathway 
Regulation of cellular 
metabolic process 
Unsaturated fatty acid 
biosynthesis 
Carboxylic acid 
metabolic process 
Leptin signalling via 
intracellular cascades 
Cellular metabolic 
process 
Table 9: Top 7 “maps” and GO processes significantly affected 6 h after treatment in vivo (here 
only the results from Affymetrix are shown, Illumina generally delivered resembling results). 
Thresholds: Fold change≥1.5; P-value≥0.05. 
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Whereas no severe morphological effects could be detected 6 h after treatment, more 
than 500 genes were significantly deregulated more than 1.5-fold. Listed in Table 9 are 
the top seven up and down regulated pathway maps and GO processes. Already at 
this early stage, cholesterol, lipid and energy metabolism were inhibited by high dose 
treatment of Tet. At the same time, inflammatory processes, such as the JAK/STAT 
signalling, the immune response and the metabolism of nucleic acids were activated. 
Altogether, this suggests early perturbations may lead to the accumulation of fatty 
acids and triglycerides in the cell and to a loss of energy production. Early responses to 
cellular stress combined with an up regulation of nucleotide, RNA and protein synthetic 
process was also observed. The latter might be a compensatory process due to the 
inhibition of protein synthesis by high doses of Tet on the level of translation. The fact 
that the inflammatory response is mainly mediated by hepatic macrophages, the 
Kupffer cells, explains the lack of an early inflammatory response in vitro. 
24 h After treatment, Tet caused concordant changes in gene expression in vivo and in 
vitro. Table 10 shows the top ranked commonly affected maps and GO processes for 
both conditions. Besides the already consistent down regulation of lipid metabolism, 
amino acid metabolism was also affected. When there is a lack of energy in the cells, 
amino acids are used for energy production (Woolfson, 1983) and, because of the 
relationship between energy and nitrogen metabolism, an increase of urea synthesis. 
Accordingly, genes involved in protein catabolic pathways, such as proteosomal 
subunits, were activated and amino acid anabolic processes were inhibited.  
Many intracellular signaling cascades were up regulated 24 h after dosing leading to 
large changes in gene expression (Table 10). The WNT signalling pathway is known to 
play multiple roles in hepatocytes, influencing the cytoskeletal composition, liver 
zonation and metabolism. Radisavljevic and González-Flecha showed in 2004 that 
oxidative stress activates signalling cascades essential for cell proliferation via 
sequential induction of mitogenic signalling genes, like phosphatidylinositol-3-kinase 
(PI3K), Akt and Ran (Radisavljevic & González-Flecha, 2004). Ran is a small GTPase 
that is essential for the translocation of RNA and proteins through the nuclear pore 
complex during interphase and has regulatory capabilities of mitotic spindle formation. 
Also noticeable is the collective increase of several aminoacyl-tRNA synthetases and 
proteins involved in RNA processing and ribosomal biogenesis. This can be considered 
as a cellular reaction to the inhibition of protein synthesis. 
Altogether, in vivo as well as in vitro, severe impairments of cellular metabolism, 
energy homeostasis and translation were detected and was consistent across both 
microarray platforms. 
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Down regulated Up regulated 
GeneGo „maps“ GO processes GeneGo „maps“ GO processes 
Tryptophan 
metabolism 
Carboxylic acid 
metabolic process 
TGF, WNT and 
cytoskeletal 
remodelling 
Nucleotide and 
nucleic acid 
metabolic process 
Regulation of lipid 
metabolism via PPAR, 
RXR and VDR 
Organic acid 
metabolic process 
Signalling via 
PI3K/AKT and 
MAPK cascades 
RNA processing 
Peroxisomal branched 
chain fatty acid 
oxidation 
Monocarboxylic acid 
metabolic process 
RAN regulation 
pathway 
tRNA metabolic 
process 
Cholesterol 
biosynthesis 
Lipid metabolic 
process 
Cytoskeleton 
remodelling 
Cellular metabolic 
process 
PPAR regulation of 
lipid metabolism 
Cellular lipid metabolic 
process 
Signal transduction, 
AKT signalling 
Ribosome 
biogenesis and 
assembly 
Mitochondrial long 
chain fatty acid beta-
oxidation 
Fatty acid metabolic 
process 
Chemokines and 
adhesion 
Smooth 
endoplasmic 
reticulum calcium 
ion homeostasis 
Leucine, isoleucine 
and valine metabolism 
Nitrogen compound 
metabolic process 
Aminoacyl-tRNA 
biosynthesis in 
cytoplasm 
Endoplasmic 
reticulum calcium 
ion homeostasis 
Table 10: Top seven “maps” and GO processes significantly affected in vivo and in vitro 24 h 
after treatment with Tet. (Only the results from Affymetrix are shown, Illumina generally 
delivered resembling results) Thresholds: Fold change≥1.5; P-value≥0.05. 
 
Hepatocytes were dosed a second time and therefore, no signs of recovery as seen in 
the animals from the in vivo experiments, were expected. Again, the top ranked 
pathways and GO processes illustrate the heavy impact of Tet on lipid and energy 
metabolism. The up regulation of ribosomal RNA production in the cells increases the 
need for new synthesized nucleotides indicated by the increased expression of genes 
involved in their synthesis (Table 11).  
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Down regulated Up regulated 
GeneGo „maps“ GO processes GeneGo „maps“ GO processes 
Cholesterol 
Biosynthesis 
Lipid metabolic 
process 
Aminoacyl-tRNA 
biosynthesis in 
cytoplasm 
RNA processing 
Cytoskeleton 
remodelling 
Cellular lipid metabolic 
process 
Cell cycle_Role of 
SUMO in p53 
regulation 
Primary metabolic 
process 
Cell 
adhesion_Plasmin 
signalling 
Carboxylic acid 
metabolic process 
Signal 
transduction_AKT 
signalling 
Cellular metabolic 
process 
Chemokines and 
adhesion 
Organic acid 
metabolic process 
GTP-XTP 
metabolism 
Metabolic process 
TGF, WNT and 
cytoskeletal 
remodelling 
Monocarboxylic acid 
metabolic process 
ATM/ATR regulation 
of G1/S checkpoint 
Biosynthetic process 
Propionate 
metabolism 
Fatty acid metabolic 
process 
CTP/UTP 
metabolism 
tRNA metabolic 
process 
Integrin outside-in 
signalling 
Carbohydrate 
metabolic process 
ATP/ITP metabolism
Cellular biosynthetic 
process 
Table 11: Top seven Maps and GO processes significantly affected in vitro 72 h after treatment 
with tetracycline. Thresholds: Fold change≥1.5; P-value≥0.05. (Again, only the results from 
Affymetrix are shown, Illumina generally delivered resembling results). 
 
Both microarray platforms detected deregulations of genes involved in the cholesterol 
biosynthesis pathway. Although some of the genes could not be detected in all 
experiments, the biological interpretation from each was consistent. Cholesterol 
biosynthesis is closely associated with the metabolism of lipids. It is an extremely 
important biological molecule that has roles in membrane structure as well as being a 
precursor for the synthesis of steroid hormones and bile acids. The rate limiting step of 
this process is the conversion of acetyl-CoA to 3-hydroxy-3-methyl glutaryl-CoA by 
HMG-CoA synthase. This gene has a complex regulation and was found, together with 
other key-genes in this pathway, to be down regulated at multiple time points. One 
source for the acetyl-CoA molecules needed for the synthesis of cholesterol is the 
mitochondrial β-oxidation of fatty acids (Figure 36). Massive interruption of this process 
was observed by both platforms, which may be one trigger that caused the deposition 
of fatty acids and triglycerides in the cell. Fatty acid binding protein (FABP) was one of 
the few genes that were affected differentially in vitro and in vivo. Whereas it was down 
regulated in vitro, a strong induction in vivo was detected. In vivo, the regulation of 
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FABP is closely connected to cholesterol biosynthesis and the cholesterol level in the 
cells (Montoudis et al., 2008). Even though this important protein was oppositely 
regulated, an accumulation of lipid droplets in cultured hepatocytes was taking place.  
 
+15.6-fold
1) Affymetrix in vivo
2) Illumina in vivo
3) Affymetrix in vitro
4) Illumina in vitro
1  2  3  4
1  2  3  4 1  2  3  4
1  2  3  4
1  2  3  4
1  2  3
1  2
1  21
 
Figure 36: Transcriptional regulation of lipid metabolism by PPARα. The expression of several 
genes involved in this pathway was repressed. Deregulation is indicated by either blue (up) or 
red (down) bars. The relative height resembles the extent of deregulation (modified from 
Metacore, GeneGO). 
 
Perturbations in intracellular signalling are also connected with microvesicular 
steatosis. One of the top ranked pathways found to be affected was the Janus kinase-
signal transducers and activators of transcription (JAK-STAT) signalling pathway. It 
plays an important role in the regulation of cellular development, growth and 
homeostasis and enables the cell to detect extracellular signals like cytokines, 
hormones, transporting them into the nucleus, consequently modulating gene 
expression by directly binding to promoter regions of genes. Waxman and his 
coworkers showed that cytochrome P450 enzymes, mainly Cyp2c11, are 
transcriptionally regulated by inhibition of this pathway (Waxman, 1999). Both, the 
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deregulation of the JAK-STAT pathway, as well as the inhibition of xenobiotic 
metabolism, could be shown in this study with both microarray platforms. 
Another consequence of activating the JAK-STAT cascade is the initiation of 
inflammatory processes and proliferation of the hepatocytes. Downstream genes of 
JAK-STAT signalling are important transcription factors, like c-Myc and NF-κB, which 
were also found to be activated by Tet treatment. c-Myc is, amongst many other 
functions, capable of driving cell proliferation by activating the expression of cyclins and 
inhibiting p21 expression. Gamma amino butyric acid (GABA), a neurotransmitter 
which also plays an important role in the regulation and inhibition of hepatocyte 
proliferation, was found to be consistently down regulated. Inflammatory processes 
were, analogous to the previous results, mainly seen 6 h after treatment and 
predominantly in vivo.  
 
 
STAT has a very important role in cellular growth and differentiation mechanisms and 
is responsible for the up regulation of ribosomal RNA synthesis. Tet preferentially binds 
to 70S ribosomes of bacteria inhibiting protein synthesis, but, with a lower affinity, they 
also inhibit the functionality of the 80S ribosome of eukaryotic cells (Ogata et al., 2000). 
In fact, a massive change in protein synthesis and related processes was detected.  
Several aminoacyl-t-RNA synthases, responsible for the generation of aminoacyl-t-
RNA, were induced, both in vivo and in vitro (Figure 37).  
Figure 37: Induction of several aminoacyl-t-RNA 
synthetases (modified from Metacore, GeneGO).
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Figure 38: Perturbations in RNA metabolism. A) Details of the RNA and nucleotide homeostasis 
in cells. The RNA-polymerase I and the exosome were heavily induced (Red circles) whereas 
the RNA polymerase II was repressed (blue circle). B) Translation initiation, deregulation is 
indicated by either blue (up) or red (down) bars. The relative height resembles the extent of 
deregulation (modified from Metacore, GeneGO). 
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Additionally, the induction of rRNA producing enzymes was observed, e.g. the 
induction of Polymerase I. tRNA synthetic processes and the generation of nucleoside 
triphosphates by the nucleoside diphosphate kinase (NDPK) (Figure 38A). At the same 
time, polymerase II, responsible for the transcription of mRNA, was repressed and 
genes belonging to the exosome complex, which is the key player in RNA degradation, 
were induced. Also downstream events of RNA-metabolic processes were affected. 
Furthermore, the initiation of translation- and elongation factors, such as elF3 or elE2B, 
was clearly induced. Rack1, elF2 and elF4E were only detected as significantly 
deregulated in vivo (Figure 38B). All these changes lead to an imbalance in RNA 
homeostasis and can be interpreted as a compensatory reaction of the cells to 
overcome the reduction of protein synthesis by the binding of Tet. 
All the effects described above were detected as deregulated in vivo as well as in vitro. 
Both platforms yielded comparable results, with regard to the number of deregulated 
genes, the dimension of deregulation and therefore the biological interpretation was 
identical.  
Besides the common effects of Tet on hepatocytes in vivo and in vitro, differences in 
cellular reactions were detected. The changes in gene expression 24 h after treatment 
were analyzed for mechanisms specifically affected only in vitro or only in vivo. Using 
the network building capability of MetaCore™, several networks, enriched with genes 
specific to either one of the two experiments, were generated and ranked by pValue 
(Table 12). 
 
Table 12: Top ranked networks based on genes detected only in vivo or in vitro.  
Unique for Tet in vitro Unique for Tet in vivo 
Network pValue Network pValue 
protein transport (21.4%), 
establishment of protein localization 
(21.4%), regulation of JAK-STAT 
cascade (7.1%) 
3.41E-79
DNA repair (25.0%), response to 
DNA damage stimulus (27.5%), 
DNA metabolic process (32.5%) 
1.69E-45 
 
cell cycle process (48.7%), cell 
cycle (48.7%), regulation of 
progression through cell cycle 
(41.0%) 
2.32E-33
cell cycle phase (39.0%), cell 
cycle process (48.8%), mitotic 
cell cycle (36.6%) 
9.27E-22 
vitamin metabolic process (36.8%), 
ventricular cardiac muscle cell 
differentiation (28.9%), cardiac 
muscle cell differentiation (28.9%) 
1.87E-24
intracellular signalling cascade 
(65.9%), protein kinase cascade 
(47.7%), signal transduction 
(79.5%) 
1.21E-11 
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Networks built from genes affected only in vitro were involved in the transport of 
proteins, parts of the JAK-STAT pathway, progression through cell cycle and induction 
of mitosis. Also mechanisms of cell adhesion and cellular reorganization were more 
pronounced than in vivo. On the other hand, mechanisms only affected in vivo were 
involved in DNA repair, inflammatory response and intra cellular signalling. The fact 
that both lists contained networks concerning cell cycle progression and other 
overlapping mechanisms indicate that the same underlying mechanisms were induced 
by Tet and that there might be different possibilities for the cell to fine-tune the exact 
regulation of gene expression. 
 
3.1.2 Conclusions of the platform comparison study 
Eventhough major difference exists between the paltforms, a high degree of similarity 
and comparability of the results was found. In this study, two large datasets were 
analyzed to elucidate the intra- and inter-platform comparability of two commercially 
available global gene expression platforms, the RatRef-12 Expression BeadChip 
(Illumina) and the Gene Chip® Rat Genome 230 2.0 Array (Affymetrix). Both platforms 
have fundamental differences in design and layout. They are based on different 
versions of the RefSeq sequence database and use different algorithms to design their 
probes. A mapping of the probe sequences of both platforms to the actual RefSeq 
Release 19 allowed the comparison of genes perfectly matched by both platforms. This 
mapping reduced the number of valid genes to 7,271 which were used in subsequent 
studies. The substantial size of the study provided the possibility to assess the 
characteristics of intra- and inter-platform differences with great statistical significance 
and to analyze the dataset in several different ways. 
The technical variation of the data, shown by the CV values, was lower than 10% 
showing a good repeatability of both techniques. The interplatform comparison was 
more susceptible to variances. Due to the complexity of producing these types of 
platforms, concentration variations of reagents during reverse transcription, the effect 
of time and performance and the personal factor contribute to this variability. One 
should be aware that only a few of these basic causes can be eliminated. Microarray 
techniques are very sensitive to deviations and need a high level of standardization to 
minimize extraneous influences 
The titration experiment demonstrated the sensitivity of both platforms. The 
measurement of a linear increase of intensity values was possible for medium 
expressed genes, whereas saturation effects for highly expressed genes were visible. 
However, a set of genes showed no correlation between the platforms. Due to the 
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identical samples measured on both platforms, there are mechanisms which may be 
causative for this observation. Most importantly, the location of the probe (-set) on the 
target cRNA sequence contributes to the variability of expression results. Stafford and 
Brun (2007) showed a correlation between the probe distance and measured results. 
Additionally, longer probe sequences, as used by Illumina (50mers), are less sensitive 
to degraded cRNA and possess different binding efficiencies. Differences in 
condensing algorithms, the data extraction and the multiple possibilities to analyze of 
the data also had great influence on the platform performance. Finally, a greater 
amount of genes showed no linear dependency if measured with Illumina suggesting 
saturation effects for the high expressed genes. 
Ranking genes by fold change gave more reliable results than pValue ranked lists. Fold 
changes were calculated by comparing the measured intensity values directly whereas 
the pValue incorporates the signal to noise ratio. Combining the fold change based 
approach with the statistical significance (pValue) additionally increased the overlap.  
The robustness of both microarray platforms was tested by applying a “real life” 
toxicogenomic test study. The implementation of biological replicates increased the 
variance in gene expression. Nevertheless, the concordance of ranked gene lists 
generated by pValue or fold change showed a large overlap. The size of this overlap 
was heavily dependent on the biological context of the samples and increased together 
with the number of genes deregulated by compound treatment. The data from the in 
vitro experiments seem to be more variable, the medians of the CVs tended to be 
higher than from the in vivo experiments. One possible explanation for this is the 
cellular stress caused by the perfusion and subsequent cell culture. Many changes in 
gene expression are caused during the perfusion procedure and related to the 
switching of hepatocytes from G0-phase of the cell cycle back into G1-phase (Papeleu 
et al., 2006). Additionally, it is also associated with various other effects like 
cytoskeletal perturbation (Baker et al., 2001; Chapman et al., 1973), dedifferentiation 
(Bayad et al., 1991), activation of immune response (Li et al., 2001), induction of 
apoptosis (Zvibel, Smets & Soriano, 2002; Czaja, 2002), the loss of polarization 
(LeCluyse, Audus & Hochman, 1994; Luttringer et al., 2002) and the activation of 
several intracellular signalling pathways (De Smet et al., 1998; Elaut et al., 2006a; 
2006b; Boess et al., 2003).  
A strong effect of time in culture on the variability between biological replicates may 
help explain the increased CV. However, this was not observed and it can be assumed 
that the effects of isolating the cells and culturing them in sandwich culture are only a 
minor reason for the increased CV. The fact that for the in vivo study a different rat 
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strain (Sprague-Dawley) was used than for the in vitro study (Wistar) may be a 
significant cause for the variance observed. 
This conformity of detection was also seen in the Tet toxicogenomic study. The data 
from both platforms, analyzed separately, led to the same biological conclusions. 
Although there might be a bias introduced by probe mapping and selection in terms of 
biological content, both platforms clearly showed the proposed mechanisms of action 
of Tet. Inhibition of the mitochondrial β-oxidation together with impaired intracellular 
RNA and protein homeostasis are mechanisms leading to the accumulation of lipids 
and triglycerides in the cells, which in vivo leads to the toxic endpoint, microvesicular 
steatosis. Contributing to this toxicity might be the increased protein catabolism 
causing the liberation of nitrogen, which is normally removed from the cell through urea 
production or is reused through the citric acid cycle. Both pathways were also affected 
by treatment with Tet and are therefore contributing to its mechanism of toxicity. 
The results of this study clearly show that both global gene expression techniques can 
be considered equally qualified and can be used for further toxicogenomic studies. 
Additionally, new details of the mechanisms of action of Tet were elucidated. 
Interestingly, these mechanisms were detected with high concordance not only in vivo, 
but also in vitro. The combination of an in vitro cell culture model with global gene 
expression approaches will facilitate the process of investigating mechanisms of action 
and in the prediction of possible toxic risk factors earlier then currently possible.  
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3.2 Establishment of a longer term cell culture of primary 
rat and human hepatocytes 
 
A recent report on the root causes of failed drugs over the last 10 years stated that 
hepatotoxicity and cardiovascular toxicity are the main reasons (Schuster, Laggner & 
Langer, 2005). Hepatotoxicity in humans has the poorest correlation to regulatory 
animal testing with only half of the cases of human hepatotoxicity found in clinical trials 
being confirmed with concordant signals in animal toxicity studies (Olson et al., 2000). 
The development of new, more predictive models for hepatotoxicity screening is 
therefore crucial for the improvement of the drug developmental process. The 
replacement of animal tests by in vitro methods allows the combination of early 
screening and mechanistic studies and the realisation of the 3R principle. Currently, 
there are several in vitro models used for screening for hepatotoxicity, each of these 
models with its own advantages and drawbacks with regards to availability, throughput, 
viability of the cells over time and the opportunity to analyse multiple of parameters 
(chapter 1.5). The process of dedifferentiation of hepatocytes leading to a loss of liver 
specific functions, as well as the complexity of other models that do not allow their use 
in a higher throughput, are two of the main limitations restricting hepatocyte use in 
toxicological screening or basic research. At the same time, the possibility to perform 
experiments under strictly controlled and standardized laboratory conditions is 
favourable. The refinement of the existing primary hepatocyte cultures, allowing their 
use for longer term toxicity testing, will be a step towards the acceptance of these 
techniques as standard screening methods and will help to reduce animal testing. The 
opportunity to increase incubation times allows one to study long-term effects and also 
to apply pharmacologically relevant concentrations of the test compound. Since the 
number of cells needed for the analysis of a specific parameter is usually low, multiple 
experiments can be conducted with one batch of cells at the same time, making it 
possible to obtain various data from the same source.  
The careful selection of endpoints, with respect to the relevance to the in vivo systems, 
is of great importance. One has to be aware that cells are always in contact with their 
surrounding tissue, other cell types and receive multiple signals from the entire 
organism under in vivo conditions and that these complex networks are not present in 
vitro. All results from isolated hepatocytes, as a mono-factorial model, have to be 
analyzed against this background.  
Hepatocytes cultured in monolayer (ML) not only loose 75% of their total CYP450 
during the first 24h after isolation, but also other liver specific functions and 
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differentiation markers (Gómez-Lechón et al., 2004; Davila & Morris, 1999; Farkas & 
Tannenbaum, 2005a). Several attempts to optimize the culture conditions have been 
reported, including the use of extracellular matrix (ECM) material, such as matrigel 
overlay (Schuetz et al., 1988) or collagen in a sandwich conformation (LeCluyse et al., 
1994), the use of optimized culture medium (Enat et al., 1984), medium supplements 
(Sidhu & Omiecinski, 1995) and co-culture with other cell types (epithelial cells, 
sinusoidal cells or Kupffer cells) (Begue et al., 1994; Donato, Castell & Gómez-Lechón, 
1994). These improvements allow the hepatocytes to regain cellular morphology, 
polarisation and to maintain physiological rates of albumin secretion (Dunn et al., 
1991). Whereas the classically used monolayer culture is not suited for longer time 
culture of hepatocytes, the sandwich culture has proven to maintain some liver specific 
features for longer times, at levels comparable to in vivo conditions (Kern et al., 1997; 
Dunn et al., 1989) and to slow down the process of dedifferentiation (Tuschl & Müller, 
2006).  
 
3.2.1 Morphological and functional characterization of 
primary rat hepatocytes 
Hepatocytes were isolated from male Wistar rats using a modification of the two-step 
perfusion method described by Seglen (Seglen, 1976). Cell viability was assessed by 
trypan blue dye exclusion and hepatocytes with >85% viability were plated as 
described previously. After seeding, cells appeared rounded and distinct from each 
other. In our laboratory, the SW culture was established using collagen I as an 
extracellular matrix environment, a serum free, amino-acid rich media composition 
(DMEM-F12) and dexamethasone and ITS as supplements (chapter 2.2.1). This 
culture was compared to rat hepatocytes cultured in ML culture with and without the 
addition of serum and SW culture with the addition of serum. 
 
3.2.1.1 Morphological examinations 
Cells were examined for morphological changes after seeding every day for up to two 
weeks. Already 4h after seeding, when media was changed from seeding media to 
culture media, a morphological distinction was seen between ML and SW cultures. 
Cells in ML had already regained their polygonal shape and started to establish 
extensive cell-cell contacts, whereas SW-cultured cells remained spherical and isolated 
for a longer period of time, probably resulting from the cells´ immersion in the three 
dimensional ECM environment of the collagen gel (Figure 39). Cells in monolayer 
3 RESULTS AND DISCUSSION 
 102
spread out and had a more flattened morphology, mainly due to their attempt to 
establish contact with the ECM, whereas cells cultured in SW, after an initial delay, 
remained polygonal in shape. Initially, the cytoplasm appeared clear and membranes 
were smooth in both culture systems.  
 
 
Figure 39: Effect of ECM environment and media formulation on morphological development 
and structural integrity of primary rat hepatocyte cultures. Cells were cultured for the indicated 
times on collagen monolayer or in a collagen gel sandwich with serum-free or serum-containing 
medium. Arrows indicate bile canaliculi-like structures. The white scale bar in the bottom right of 
each image corresponds to 200 µm. 
 
One day after seeding, cells in all types of culture had made contact with each other 
and started to build structures which are described as bile canaliculi (Gautam, Ng & 
Boyer; 1987; LeCluyse et al., 1994). The number and distinctiveness of these 
structures increased in cells cultured without serum, which is consistent with the 
findings of Terry and Gallin, who reported an inhibitory effect of serum on the formation 
of bile canaliculi (Terry & Gallin, 1994). Over time, cells in monolayer spread out until 
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confluency and therefore had a flattened appearance, accompanied by an increase in 
the size of the nucleus. There were no longer well-delineated plasma membrane 
borders and bile canaliculi-like structures disappeared almost entirely. They moved 
towards each other and built clusters of cells. This was accompanied by the a more 
fibroblast-like morphology. Together, this depicts the dedifferentiation process in ML 
with and without serum. The cytoplasm of cells cultured with serum appeared 
granulated and inclusion bodies were first detected on day 3. In contrast to this, cells 
cultured in SW without serum displayed a stabile polygonal morphology with extensive 
bile canaliculi networks and a clear cytoplasm. This was true up to 14 days of culture. 
Cellular mobility and re-entry into the cell cycle was observed for cells cultured with 
serum and cells cultured in ML which started detaching from the culture plate surface. 
All these findings are in accordance with previously reported effects of serum, the 
overlay of cells with ECM-material and media supplementation (Dunn et al. 1989; 
Musat et al., 1993; LeCluyse et al., 1994; Tuschl & Müller, 2006).  
It has been reported that changes induced by perfusion, morphological changes and 
intracellular energy and redox homeostasis are related to the dedifferentiation 
processes of hepatocytes (Greetje et al., 2006). However, the restoration of cell polarity 
combined with the regeneration of bile canaliculi and gap junctions leads to an 
increased expression of liver specific genes and a preservation of liver functions 
(Wilkinson & Dickson, 2001; Hamilton, Westmorel & George, 2001; LeCluyse et al., 
1994). Since hepatocyte differentiation, drug metabolism and toxicity are inherently 
linked, the liver specific metabolic capability should ideally be maintained on in vivo 
level for as long as possible. 
To acquire deeper insights into the functionality of the cultured hepatocytes, several 
cell type specific functions were examined. One of the most important features of 
hepatocytes is their ability to metabolise xenobiotics (chapter 1.3). The concentration of 
the specific CYP isoforms, regulated in multiple ways, has a major impact on the cells 
metabolic activity. Several transcription factors are responsible for the differential 
expression (Table 13), but a high degree of cross talk and interactive regulation has 
been reported (Yan & Caldwell, 2001; Guengerich, 2003; Dickins, 2004).  
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Enzyme 
Transcription 
factor 
Inducer Substrates 
Percentage of total 
CYP-enzyme in liver 
CYP 1A1 AhR BNF 
Polycyclic aromatic 
hydrocarbons 
1.2 
CYP 2b CAR PB 
Cyclophosphamide, 
Nicotine 
1.9 
CYP 2C GH/CAR/PXR PB Retinoids 65 
CYP 3A PXR/CAR/GR Dex various substrates 14.6 
Table 13: List of CYP isoforms tested in this study with appropriate transcription factors, potent 
inducers, typical substrates and their overall abundance in liver.  
 
3.2.1.2 CYP inducibility 
During this study, the inducibility of the CYP 1A, 2B, 2C and 3A isoforms was used as 
a sign of cell viability and differentiation status. Cells were cultured in ML and SW 
culture as previously described and dosed at 0 h, 3 d and 9 d with the appropriate 
inducer for 48 h. CYP 1A1 was induced with β-naphthoflavone (BNF; 10µM), CYP 2B 
and 2C with phenobarbital (PB; 500µM) and CYP 3A with dexamethasone (Dex; 
50µM). The expression of specific CYP mRNAs was determined by TaqMan-PCR and 
the relative enzyme activity was measured using specific spectrophotometric methods 
(results were generated as part of a joint work with Gregor Tuschl, PhD-student). 
Figure 40 shows that at early time points, the cells were still responsive to CYP 
induction. CYP 1A was heavily induced on the mRNA level in ML (160-fold) whereas in 
SW-culture the induction was only about 55-fold. Interestingly, on the enzyme activity 
level the activity of CYP 1A in SW culture superimposed the activity in ML. On the 
mRNA level, the inducibility of CYP 1A was consistent over time. In contrast, the 
induction of enzyme activity decreased over time in both culture systems. After 3 days, 
the activity of CYP 1A was 6 fold higher than the controls in ML and still 32-fold higher 
in SW. After 9 d in culture, CYP 1A could no longer be induced in ML but still reached 
18-fold induction in SW culture. In general, cells remained much more responsive to 
CYP 1A induction in SW culture, where after 9 d in culture marked increase of enzyme 
activity was still detected. 
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Figure 40: Relative induction of enzyme activity and mRNA expression for CYP1A, 2B, 3A and 
2C. Depicted are the results of two cell cultures, ML and SW without serum. Cells were induced 
with either 10 µM BNF, 50 µM PB or 500 µM Dex on days 0, 3 or 9 of culture and samples were 
taken 48h after induction. Bars illustrate changes in enzyme activity (red bars) or mRNA 
expression (blue bars) relative to time matched vehicle controls. Bars illustrate mean values of 
fold induction from triplicate measurements with standard deviation. 
 
The responsiveness of cells to PB and Dex mediated CYP 2B and CYP 3A induction 
was stable over time in both types of culture. The mRNA levels of CYP 2B and CYP 3A 
were about 50-100 times higher than in the uninduced control. Differences between 
both culture conditions were again detected on the enzyme activity level. Whereas no 
induction in enzyme activity was detected for ML culture, both enzymes were induced 
in SW culture at all time points. The activity level was 3-7 times above the control level 
and inducibility was retained until the end of the culture period. 
Unlike the other CYPs, CYP 2C was neither inducible on the mRNA nor on the enzyme 
activity level in ML culture at the 0 h time point. Over time no increase was detected on 
the activity level, but mRNA expression was two fold induced at later time points. In SW 
culture, a small increase (about 2-fold) was initially detected for activity and expression. 
The inducibility of CYP 2C mRNA expression increased over time up to 5 fold after nine 
days of culture. In contrast the enzyme activity inducibility remained stable over time. 
Additional western blot analyses showed good correlations with the previous results of 
gene expression and protein activity tests. Isolated protein was separated by SDS-
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PAGE, proteins were blotted and subsequently CYP isoforms were detected with 
specific antibodies. Figure 41 shows examples of the results for CYP 1A1, 2B and 3A1. 
The determined signals were detected at a molecular weight between 50 – 60 kDa and 
are therefore in good agreement with the calculated molecular weights of the CYP 
isoforms at 59 kDa, 56 kDa and 57 kDa, respectively. 
 
Figure 41: Protein extracts of induced hepatocytes were separated by SDS-PAGE and CYP 
isoforms were subsequently detected by western blot analysis as described. The red arrow 
highlights the induced CYP-isoforms. 
 
CYP 1A1 was unchanged at 0 h but was weakly induced on protein level after 9 d in 
ML-FCS culture by BNF. In contrast to this, CYP 1A1 already was induced at the early 
time point in SW-FCS culture and inducibility endured over the time of culturing. The 
CYP 2B isoform could not be induced at the starting point in either culture but after 9 d, 
PB caused a slight increase in both cultures which was more pronounced in SW-FCS 
culture. The CYP 3A1 isoform was induced in both types of cell culture at all time 
points by DEX. Whereas the decreasing signal intensity over time for ML-FCS cultured 
cells implicates a decreasing inducibility, SW-FCS cultured cells showed exactly the 
opposite effect. Additionally, cells cultured in SW-FCS exhibited an increased level of 
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CYP 3A1 after treatment with PB, which could also be seen on the activity level (data 
not shown) and which was not true for cells cultured in ML-FCS conformation. 
In general, the enzyme activity and the inducibility on mRNA and protein level of the 
CYP isoforms tested was higher and more stable over time in SW culture. This is an 
indication of a higher capability and a more differentiated status of these cells.  
 
3.2.1.3 Canalicular transport 
The reestablishment of cell-polarity, the formation of bile canaliculi together with the 
expression of genes encoding for the transport of xenobiotics are a prerequisite for 
functional transport processes in cultured hepatocytes. It was previously demonstrated 
that SW-cultured hepatocytes re-established functional polarity and form bile canaliculi 
at their contact sites (LeCluyse et al., 1994; Talamini, Kappus & Hubbard, 1997). The 
ATP-dependent canalicular anion transporter Mrp2 (Multidrug resistance-associated 
protein 2) is responsible for the transport of multivalent organic anions, including 
glutathione and glucuronide conjugates (Akerboom et al., 1991; Elferink et al., 1995). 
As canalicular efflux may be the rate limiting step in biliary excretion of xenobiotics, the 
influence of culture conditions on the functionality of according transporters was 
examined. Cells were incubated with carboxy-DCFDA, a fluorescent substrate for 
Mrp2, and therefore the dye efflux from hepatocytes cultured in either ML or SW culture 
into the bile canaliculi was determined over time. 
At the beginning of the culture, on day 0, no canalicular structures were seen and 
consequently, no transport was detected. Together with the reestablishment of cellular 
polarity, canalicular structures developed at the contact site of cells with longer times. 
As previously stated, these structures were more pronounced in cells cultured without 
the addition of serum and were more stable in SW culture. The fluorescent substrate 
accumulated in cells without contact to other cells. It was transported out of the cells 
only if the canalicular structures in between the cells were established (Figure 42). 
After 3 days in culture, only cells cultured in SW culture without serum showed 
pronounced canalicular networks which remained active until the end of culture on day 
9. As expected, other culture methods were unable to to obtain transport activity of the 
substrate. After 3 days in ML culture, some cells appeared to have integrated the 
fluorescent substrate into granular structures of the cell (Figure 42, arrow 1). This could 
be caused by Mrp2 molecules being accumulated in intra-hepatocytic vesicles. 
Previous studies showed the storage of hepatic transporters inside the cell where they 
are delivered to the canalicular domain following increased physiological demand 
(Wakabayashi, Kipp & Arias, 2006; Kipp & Arias, 2002). The lack of cellular polarization 
and canalicular structures may cause an accumulation of these vesicles. 
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Figure 42: Microscopic pictures of hepatocytes cultured in ML and SW with and without serum. 
To visualize canalicular transport processes, they were incubated with carboxy-DCFDA and 
cells were cultured for up to 9 d. Arrows indicate 1) the accumulation of the dye in granular 
structures and 2) the accumulation of the dye in canalicular structures. 
 
3.2.1.4 Conclusions of the morphological and functional data 
Primary hepatocytes are a widely used model to study acute toxic effects or drug 
metabolism. Primary cultures of isolated hepatocytes, as a mono-factorial model, 
display most of the metabolic liver functions and are therefore well suited for this 
purpose. 
The use of strict standardization, higher throughput and consistent capabilities of 
primary cells for toxicological issues are major advantages of in vitro systems. A lot of 
work has been undertaken to establish and optimize a culture method for primary 
hepatocytes that overcomes the disadvantages of dedifferentiation. The study 
described above showed clearly that the environment of an in vitro culture has a critical 
impact on liver specific functionality of primary hepatocytes, including morphology, 
gene and protein expression, as well as the loss of other cell type specific attributes. 
The beneficial effects of ECM overlay in SW culture showed an ability to retain a 
differentiated status and some important liver specific functions, like albumin secretion, 
biliary transport processes or metabolism (Dunn et al., 1989; LeCluyse et al., 2000; 
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LeCluyse et al., 1994). The time of culture could thus be prolonged up to several weeks 
without severe morphological changes (suggesting reduced dedifferentiation). By 
optimizing the media composition and a careful selection of media supplementation, 
the formation of functionally active bile canaliculi was promoted. In this chapter, the 
beneficial effects of ECM overlay on the survival rate, on cell morphology and several 
essential functional aspects of hepatocytes were clearly shown. Already the 
morphological examination of primary hepatocytes over time showed distinct 
differences in cellular behavior in different cell cultures. Cells cultured in SW-FCS were 
organized in acinar structures characteristic of the tissue of origin (Farkas & 
Tannenbaum, 2005b; LeCluyse et al., 2000). Further details of improved structural 
components have been previously described by Davila (Davila & Morris, 1999).  
In addition to the polygonal shape, the three dimensional environment has positive 
effects on gene expression. The SW-FCS culture showed not only the preservation of 
morphological properties but also an increased inducibility of several CYP isoenzymes, 
both on the level of gene, on protein expression and on the enzymatic activity. These 
results are in agreement with other researchers, who also reported improved viability 
and phase 1 metabolism (LeCluyse et al., 1994; Dunn et al. 1989; Tuschl & Müller, 
2006; Gebhardt et al., 2003; Hamilton et al., 2001), even when other media 
compositions or Matrigel was used. The key signal for this improvement therefore 
seems to be the introduction of a third dimension by plating the cells into a gel and 
giving them the possibility to retain their physiological form instead of a flattened 
morphology as for ML cultures. 
These results support the applicability of long-term hepatocyte cultures for CYP-
induction studies. It has even been suggested that serum-free collagen sandwich 
cultures can be used to examine CYP induction of several test compounds 
consecutively in one culture with recovery phases between treatment stages 
(PRIMACYT Cell Culture Technology GmbH, personal communication). This would be 
a step towards higher throughput and also help to further reduce animal usage in 
preclinical drug development. A recently published report explicitly promoted the 
addition of several CYP inducers into the culture media to keep the cells induced and 
to maintain elevated levels of metabolic enzymes throughout the culture (Kienhuis et 
al., 2007). The ability of this system to obtain results physiologically relevant results 
has still to be proven. 
The reorganization of canalicular structures could be enhanced by serum free media 
and the addition of Dex. These structures were stable and functionally active over the 
whole time of SW culture, shown by the transport experiments with carboxy-DCFDA. 
The lack of transport activity at early time points of culture may be caused by 
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endocytotic processes removing Mrp2 from the cell surface during the process of 
perfusion, which is only reversed by the reestablishment of cellular polarity (Graf & 
Boyer, 1990). The fact that canaliculi-like structures are stable over time makes these 
cultures especially valuable for transport studies. An additional effect of Dex is the 
inhibition of spontaneous apoptosis by inhibiting caspase-8 activation and increasing 
anti-apoptotic signals like Bcl-2 and Bcl-xL (Bailly-Maitre et al., 2002).  
Altogether, these results show that hepatocytes cultured in serum-free collagen 
sandwich conformation partly recover from stress during liver perfusion, adapt to the 
cell culture conditions and stay morphologically unchanged for several weeks. They 
regain their functionally important cell polarity, rebuild cell borders (tight junctions, bile 
canaliculi) and retain several aspects of their functionality over time in culture offering 
the ability to investigate alterations in cellular structures induced by chemical treatment 
with classic light microscopy. Furthermore, the increased use of human cells will add 
additional value to the results. 
 
3.3 Global expression studies with different human and rat 
cell culture systems 
 
The utility of in vitro cultured hepatocytes for toxicological studies is highly dependent 
on the preservation of biochemical and metabolic functionalities. 
The application of novel “-omics” techniques allows the design of new strategies and is 
expected to be applicable in early screening and mechanism-based risk assessment in 
toxicology (Stubberfield & Page, 1999; Suter, Babiss & Wheeldon, 2004; Pennie et al., 
2000). Recent studies showed the principal applicability of in vitro systems in 
combination with “-omics” technologies to generate valid and useful data concerning 
hepatotoxicity (Farkas & Tannenbaum, 2005b; Groneberg et al., 2002). However, there 
is still a need for improving the culturing conditions to increase predictivity and 
significance of these in vitro models (Beigel et al., 2008). The possibility of getting 
insight into the mechanisms affected by a compound after treatment has to be 
analyzed against the background of basal gene expression. Additionally, the 
knowledge of the underlying mechanisms of toxicity is expected to facilitate species 
extrapolation and to help predict possible risk factors. 
Currently, rodent in vivo systems are the experimental models of choice, but in vitro 
systems such as primary hepatocytes in SW culture, are now being established and 
used as replacement or at least as an early screening. For the application of in vitro 
toxicity studies and the interpretation of data generated by toxicogenomic studies in 
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vitro, new aspects have to be considered. As cells are cultured in an artificial 
environment, it is crucial to be familiar with the basal gene expression for each culture 
method. Several factors have been suggested to contribute to the phenotype of mature 
hepatocytes in vivo. The concentration gradient of a large number of hormones and 
other signals, like metabolites and oxygen, transported with the blood flow, allow the 
cells to detect and respond to the actual physiological status of the body (Sell, 2001; 
Püschel & Jungermann, 1994). In addition, the tissue architecture and composition 
(Bedossa & Paradis, 2003; Reid et al., 1992), paracrine signalling and the direct 
communication with other cell types of the liver (González et al., 2002) affect the 
metabolic state of hepatocytes. The temporal loss of liver specific functions, the main 
obstacle of using primary hepatocytes, could be due to the loss of external signals.  
In the case of longer-term culture of hepatocytes, the adaptation to the cell culture 
conditions and the change of gene expression over time has to be carefully considered 
before starting toxicological studies. The procedure of isolating the hepatocytes has an 
influence on cellular gene expression and induces inflammatory and dedifferentiation 
processes (De Smet et al., 1998; Bayad et al., 1991). Further alterations may be 
introduced by adaptation processes to the culture conditions and by the duration of 
culture and are highly dependent on the type of culture. Morphological changes over 
time in culture, as observed in ML culture, are inherently connected to fundamental 
changes in gene expression.  
This study was conducted to gain a better understanding of how varying culture 
conditions affect gene expression in primary human and rat hepatocytes, to examine 
the principal applicability for toxicological studies and to select a system of choice for 
subsequent studies. Functional differences between the different cell cultures relative 
to the liver were revealed as important for data interpretation. Special emphasis was 
put on initial changes introduced by the preparation and plating of the cells, the 
changes over the time in culture and the influence of the overlay with collagen to 
generate a three dimensional ECM environment. Generally, two types of cell culture, 
short-term cultures and longer-term cultures, have to be discriminated (Figure 43, 
Details see Chapter 1.5). Culture methods used for short-term toxicity testing were liver 
slices and cell suspensions. Whereas the latter is used for metabolic studies for only a 
few hours (Gebhardt et al., 2003; Cross & Bayliss, 2000), liver slices have been 
characterized for up to 48h in culture (Lupp, Danz & Müller, 2001). In contrast to 
isolated hepatocytes, liver slices contain all cell types of the liver and therefore gene 
expression data will be different to hepatocytes alone. To account for this factor, the 
whole liver was used as the reference system for liver slices.  
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Hepatocytes in ML culture and in SW culture were cultured for up to 9 d as already 
described. In the rat experiments, cells were incubated with (ML+/SW+), or without 
(ML-/SW-) the addition of serum, human hepatocytes were only cultured without 
serum. Additionally, the gene expression of an established cell line (for rat FaO cells, 
for human HepG2 cells) was analyzed. As a new and promising approach, the 
HepaRG cell line was analyzed. For all isolated cell culture methods, freshly isolated 
hepatocytes were used as a reference for the change of gene expression over time. 
Samples were taken and hybridized to either an Illumina RatRef-8 or a HumanRef-6 
BeadChip array. All culture conditions and time points were measured in biological 
triplicates. Data was uploaded into Expressionist®Analyst (Genedata), normalized with 
the LOESS algorithm and analyzed for each culture type separately. Results of the 
subsequent pathway analyses in MetaCore™ (GeneGo) were compared across 
different cultures and time points. Gene expression changes of 45 genes were 
confirmed with TaqMan RT-PCR. 
 
 
Figure 43: Overview of the different cell culture models used in this study. The time intervals 
where samples have been taken are specified.  
 
The main goal of all clustering algorithms is to order experiments according to their 
inter-cluster difference and thereby gaining a logical overview of their relationship to 
each other. Figure 44 shows a hierarchical clustering of the different culture types 
conducted with rat and human hepatocytes. It is clear that the gene expression profiles 
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of short term cultures (liver slices and suspension culture) are relatively similar to the 
liver and freshly isolated cells (blue cluster). Interestingly, the liver slices separated 
from this cluster already after 6 h. For the long-term rat hepatocyte cultures, a separate 
cluster was built, which split into three sub-clusters. The first one (green) contains early 
time points of ML as well as SW cultures. The later time points (4 d until the end of 
culture) built the second sub-tree of this cluster which in turn can also be subdivided 
into SW and ML cultures cultured without serum. The third sub-cluster, clearly 
separated from the other two, was built up from cells cultured with the addition of 
serum. Two small groups completely separated from all other experiments, cells 
cultured in ML with serum and the hepatoma cell line (FaO). 
 
 
Figure 44: Hierarchical cluster analysis of the different culture types conducted with rat and 
human hepatocytes. Groups of experiments for each time point and culture type were pooled 
and are shown here as one data point. The cluster height reflects the inter-cluster difference, 
the colour of the tree-segments indicate groups of experiments with high concordance in gene 
expression. 
 
The cluster analysis of human gene expression resulted in slightly different results from 
the rat analysis. Short-term experiments clustered together with the FC and liver for the 
initial period of culture and separated after one day in culture (green and red). The ML 
and SW cultures separated from the other conditions, but as two distinct sub-clusters. 
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As human hepatocytes showed better stability in gene expression, all time points were 
grouped together, even after 11 d in culture. The outlier group (light blue) was built 
from data of the HepG2 cell line. All time points and both culture conditions of HepaRG 
cells formed one large cluster with two separated sub-clusters, which was much closer 
to primary hepatocytes than to the other cell line used in these experiments (HepG2). 
 
Given the immense amount of data and the large number of genes found to be 
deregulated in all of the cell cultures, only general trends are discussed in this chapter. 
Gene expression changes caused by the different types of cell culture, mechanisms 
and pathways important for toxicological studies and the liver specific character of 
hepatocytes will be highlighted. 
 
3.3.1 Initial changes introduced by the process of perfusion 
3.3.1.1 Primary rat hepatocytes 
Changes in gene expression related to the perfusion itself were analysed by a 
comparison of freshly isolated hepatocytes (FC) with the liver. 535 Genes were found 
to be significantly (pValue < 0.01) deregulated more than two-fold, 403 of these were 
decreased and the expression of the other 132 genes was increased (Appendix 7 and 
Appendix 8). The higher number of genes being reduced is already an indication for the 
causative process, as the change of mRNA abundance may reflect more the lack of 
other cell types with different gene expression than a change of gene expression in 
hepatocytes themselves. To confirm this hypothesis, these two groups of genes, and 
the affected pathways and processes, were analyzed (Table 14). Genes found to be 
down regulated were involved in inflammatory processes, like antigen presentation or 
interferon signalling, cell-matrix interactions, blood coagulation or angiogenesis. These 
mechanisms are, at least partially, the task of the other cell types in the liver. 
Kupffer cells are resident tissue macrophages, which play a key role in inflammatory 
processes in the liver. They are able to produce a variety of cytokines, which act in a 
paracrine manner on hepatocytes (Ramadori & Armbrust, 2001) by binding to highly 
specific cell-surface receptors. This binding may activate a vast number of intracellular 
signalling cascades, with clear changes on gene expression. Interleukin 18 (IL18), for 
example, which was found to be decreased after perfusion, has the potential to activate 
inflammatory responses and to activate the release of atopic effector molecules, such 
as histamine, in mast cells and basophiles. IL-18 and IL-12 act synergistically to 
stimulate natural killer cells to produce IFN-gamma, an immunomodulatory cytokine 
(Gracie, Robertson & McInnes, 2003). Therefore, endogenous IL-18 plays a major role 
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in induction of some types of liver injuries in mice and human (Tsutsui et al., 2003). 
Other inflammation related genes and genes involved in antigen presentation and 
leukocyte trans-endothelial migration were found to be less abundant after perfusion, 
indicating the loss of Kupffer cells. Endothelial cells are reported to be actively involved 
in inflammatory processes (antigen presentation), which was also found to be reduced. 
The ECM environment of the liver is important not only for cellular attachment but also 
for intra- and intercellular signalling. In vivo, signalling occurs via several molecules 
produced by the different cell types. Decorin is a small proteoglycan that is able to 
regulate cell proliferation, migration and different growth factors' activities. It has been 
reported to be produced by Ito and endothelial cells, but not in hepatocytes and Kupffer 
cells and to be induced during acute liver damage (Gallai et al., 1996). Here, it was 
found to be less abundant after perfusion (-7.8-fold). Additionally Type I, Type III and 
Type IV procollagen expression was found to be reduced, which normally takes place 
predominantly in nonparenchymal cells (Milani et al., 1989), indicating the absence of 
cell types producing these collagens. 
 
 
Down regulated Up regulated 
Cell adhesion; Cell-matrix interactions Cell cycle; G1-S Interleukin regulation 
Proteolysis; ECM remodelling 
Reproduction; FSH-beta signalling 
pathway 
Blood coagulation 
Signal transduction; ERBB-family 
signalling 
Proteolysis; Connective tissue degradation Cell cycle; G1-S Growth factor regulation 
Cell adhesion; Platelet-endothelium- 
leucocyte interactions Signal transduction; Leptin signalling 
Development; Blood vessel morphogenesis Reproduction; GnRH signalling pathway 
Apoptosis; Apoptosis mediated by external 
signals Inflammation; IL-6 signalling 
Proliferation; Negative regulation of cell 
proliferation DNA damage-Checkpoint 
Inflammation; Interferon signalling 
Signal transduction; ESR1-nuclear 
pathway 
Development; Regulation of angiogenesis Inflammation; Histamine signalling 
Table 14: Top 10 ranked GO processes found to be deregulated in relation to the liver after 
isolation of rat hepatocytes. 
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Nevertheless, processes such as cell cycle, intracellular signalling pathways or 
inflammatory processes (e.g. IL-6 and histamine signalling) were found to be induced 
(Table 14). It is known that hepatocytes are primed for proliferation during isolation 
(Etienne et al., 1988; Loyer et al., 1996), which could clearly be reflected in this data. 
Although IL6 was not directly deregulated, pathways and processes induced by IL6 
were observed to be induced. IL6 together with IL1 activate the MAPK (mitogen-
activated protein kinase) cascades and the JAK/STAT pathway (Heinrich et al., 2003). 
The activated MAPK pathway is linked to cell cycle progression. Activating the 
JAK/STAT pathway results in multiple changes in gene expression, as it is involved in 
the immune response, principal cell fate decisions, regulating the processes of cell 
proliferation, differentiation and apoptosis. 
Altogether, these results show the effective elimination of nonparenchymal cell types. It 
is important to note that inflammatory processes mediated by these cells will only take 
place in a limited manner in culture. Although the time from perfusion to sampling was 
relatively short for rat, some early inflammatory processes could already be detected. 
This may have been initialized during the perfusion of the liver (via signalling of the still 
existing nonparenchymal cells). Intracellular signalling pathways connected to 
inflammation and cell cycle processes were activated in FC, indicated by the up-
regulation c-Jun, ATF and Gadd45 d. Changes in cytoskeletal structure and processes 
concerning ECM remodelling are inherent to the perfusion procedure and can not be 
overcome. 
Liver slices, which were not perfused, retain their original architectural structure and the 
inherent liver cell heterogeneity with their cell-cell interactions, were directly compared 
to the liver. At the beginning of culturing (0 h) 1,074 genes were found to be 
deregulated, 452 were up, 622 down regulated. These genes represented inflammatory 
responses, response to wounding and several intracellular signalling pathways. 
Noticeable was the induction of translational processes, but also genes correlated to 
DNA-damage and signal transduction (related to stress response) were up regulated.  
 
3.3.1.2 Primary human hepatocytes 
It is well known that species-specific differences in gene expression and metabolic 
activity can cause completely different behaviour of the cells in culture (Hengstler et al., 
2000; O'Brien, Chan & Silber, 2004; Richert et al., 2002). For a direct comparison, 
human hepatocytes were observed under the same conditions so that results of global 
gene expression data were analyzed with regard to similarities and differences to the 
processes taking place in rat hepatocytes.  
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Primary human hepatocytes were prepared from pieces of liver obtained from partial 
lobectomy. The time from operative intervention in the hospital to isolation of the 
hepatocytes was longer than the “in lab” procedure of rat liver perfusion. Kupffer cells 
secrete signalling molecules, like TNFα and other cytokines, thereby activating an 
inflammatory response in hepatocytes. This fact was reflected by additional differences 
in gene expression. 
 
B
A
 
Figure 45: Cellular surface receptors and their connection to cellular signalling. A) Cell-surface 
related genes and their expression values in freshly isolated hepatocytes in relation to the liver. 
The fold change is shown as bars (1= rat orthologue; 2= human), blue means down regulated, 
rad means up regulated. B) Network of G protein signalling and cAMP associated genes 
deregulated after perfusion of liver. The genes underlined in red were found to be reduced in 
freshly isolated cells.  
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As expected, the major changes in gene expression between liver and FC resulted 
from the removal of other hepatic cell types. In particular adhesion molecules, like 
integrins and cell surface markers, or ECM related genes were found to be significantly 
reduced. T-cells, for example make brief contact with antigen-presenting cells (APCs) 
facilitated by chemokines and adhesion molecules, including integrins. The TCR-CD3 
(T-cell receptor complex) recognizes the peptide-major histocompatibility complex 
MHC class II. Integrins like Itgb2 (Integrin beta2) are then dynamically redistributed to 
the site of contact. Cd2, a cell surface antigen involved in T lymphocyte activation and 
proliferation was reduced, as was Cxcr4, a Gi protein-coupled receptor for the 
chemokine Sdf-1 (stromal cell-derived factor-1) (Wettschureck & Offermanns, 2005) 
(Figure 45). Downstream processes of these Gi proteins are coupled via 
phosphoinositide-specific phospholipase C (PLC-gamma1) (Illenberger et al., 2003) 
and PI3K (Brock et al., 2003) to intracellular second messenger mechanisms, 
mediating the immune response and a variety of other intra cellular processes. As an 
example, a network was built from the down regulated genes, integrating G-protein 
signalling, cAMP-mediated signalling and the regulation of adenylate cyclase activity, 
which in turn regulates multiple processes. 
Many genes involved in the functional reorganization and biogenesis of the 
cytoskeleton and ECM remodelling processes were lost. Genes involved in xenobiotic 
metabolism related processes were also affected. 
In contrast to the rat hepatocytes, cell cycle related processes were not found to be 
induced to a large extent, indicating that no proliverative mechanisms were taking 
place at this early time point in human hepatocytes. Additionally, stress induced 
processes were detected resulting in a rise of genes involved in the inflammatory 
response (Complement system of inflammation). Another difference to the situation in 
rat was that many genes involved in translational and transcriptional processes were 
induced, reflecting the reaction of human hepatocytes to an increased need to produce 
proteins and maybe the longer time to react to the external signals caused by the 
extended time from dissection to cell isolation. In rats, these processes were found to 
be deregulated only to a minor degree. Correspondingly, there was an induction of 
several enzymes responsible for amino acid and energy metabolism, indicating a 
raised need for energy in the cells.  
Interestingly, several major hepatic pathways were induced, including steroid 
inactivation, the hydroxylation by CYP enzymes and conjugation with glucuronide and 
sulphate. The induction of steroid biotransformation enzymes is partly mediated as a 
feedback loop through a group of nuclear receptors, including the glucocorticoid 
receptor (GR), the constitutive androstane receptor (CAR), the pregnane X receptor 
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(PXR), and the peroxisome proliferator activated receptors (PPARs) (You, 2004). 
These transcription factors also have important roles in regulation of liver specific gene 
expression and xenobiotic metabolism. Additionally, GR activation has 
immunosuppressive abilities by preventing the transcription of immune related genes 
and leads to increased plasma amino acids (Hayashi et al., 2004).  
Down regulated Up regulated 
Cell adhesion; Cell-matrix interactions  Translation initiation 
Cell adhesion; Platelet-endothelium-leucocyte 
interactions 
Proteolysis; Ubiquitin-proteosomal 
proteolysis 
Cytoskeleton; Actin filaments Response to hypoxia and oxidative stress 
Cytoskeleton; Regulation of rearrangement Proteolysis in cell cycle and apoptosis 
Development; Neurogenesis: Axonal guidance Translation in mitochondria 
Proteolysis; ECM remodelling Inflammation; Complement system 
Proteolysis; Connective tissue degradation Translation; Elongation-termination 
Cell adhesion; Leucocyte chemotaxis Transcription; mRNA processing 
Inflammation; Histamine signalling Transport; Iron transport 
Cell adhesion; Integrin-mediated cell-matrix 
adhesion Transport; Manganese transport 
Table 15: Top 10 ranked GO processes found to be deregulated in relation to the liver after 
isolation of human hepatocytes  
 
3.3.2 Temporal changes in global gene expression 
 
For a full characterization of the impact of culture conditions on the behavior and 
functionality of hepatocytes over time, transcriptional changes were analyzed globally 
across the complete dataset. Therefore, fold-changes and statistically significance 
were calculated in relation to the particular starting points of the culture, which was 
defined as the reference sample (Appendix 3 and Appendix 4). For the short term 
culture methods, such as liver slices and suspension cultures, reference samples were 
defined as the 0 h time point after isolation, which means freshly cut liver slices or 
freshly isolated hepatocytes, respectively. The latter was used to eliminate the 
background of gene expression changes due to the lack of other cell types.  
As previously described, the process of isolating hepatocytes caused a large number of 
gene expression changes which, at least in part, can be considered as common and 
therefore are present in all types of cultures. Consequently, the 1 d time point after 
plating was defined as the starting point for the longer term culture methods. The initial 
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changes were thereby excluded from the analysis and evaluated separately. Due to the 
fact that the human hepatocytes were prepared and plated in France, the first time 
point analyzed, 2 d after perfusion, was used as the reference sample.  
 
Short term cultures generally showed a high correlation to their reference experiments 
(Figure 46). This is true not only for the liver slices, which still contain all liver-typical 
cells, but also for the hepatocyte suspension cultures. Major effects were first detected 
after 6 h for liver slices and suspension cultures and after 1 day in culture, clear 
differences were seen. After one day, the gene expression in both cultures was 
measurably different to controls correlating with the decline in viability observed for 
these cells. 
 
 
Figure 46: Heat maps of the correlation coefficients of rat cell culture experiments compared to 
the reference system over time. Each square in a column or line represents the gene 
expression correlation of a given sample at a certain time point (arrow) relative to the reference 
experiments. The intensity-changes in global gene expression were used as the basis for the 
calculation of the correlation. Long-term experiments were split: the upper part of the square 
shows the correlation of the experiments to freshly isolated cells, the lower part indicates the 
correlation to the 1 d sample, which was defined as the reference experiment for later analyses. 
Red squares indicate high correlation (>0.9), whereas green indicates a low correlation. The 
pictures show cells of each longer-term culture at day one (left) and day 10 (right) of culture. 
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The longer term cultures were compared to FC as well as to cells in culture for one 
day. Shown in the lower part of Figure 46 are the heat maps visualizing the correlations 
between each time point and FC (above white line in each square) and day one of 
culture (below white line in each square). A reduction of the correlation coefficient, 
visualized by a shift from red to black to green, indicates significant changes in global 
gene expression in comparison to the references. For all cultures, by day one a 
reduced correlation was seen, although it was most pronounced in ML+FCS. As shown 
in the previous chapter, the initial changes introduced by the elimination of other cell 
types and the initial adaptation processes are likely to cause similar changes in all 
types of cultures.  
The correlation coefficient of ML+FCS cultured cells decreased over time when 
compared with gene expression in FC and with cells one day in culture, reflecting the 
advancing dedifferentiation processes. This result perfectly correlates to the 
morphological analyzes described before with no stabilization of gene expression 
detected. 
The removal of FCS from the culture media and the addition of Dex improved the 
correlations. The extent of initial changes was reduced and processes moving the cells 
away from hepatocyte-like gene expression were significantly slowed down, at least 
globally, after two days in culture. Until the end of culture, the gene expression of these 
cells showed more stability. As the aim of toxicogenomics is the detection of gene 
expression changes caused by compound treatment, it is important, especially for in 
vitro models, to reduce the background of genes changing due to other factors, such as 
the culturing, to a minimum.  
Cells cultured in SW in the presence of serum showed the initial changes which were 
less pronounced compared to ML+FCS. Globally, the cells remained in this state until 
day four. Afterwards, a reduction of the gene expression correlation coefficient was 
detected. This process was intensified at later time points indicating the onset of 
dedifferentiation in these cells. 
In SW culture without serum the addition of Dex had additionally positive effects on 
global gene expression. The gene expression changes due to the isolation process and 
adaptation to the culture environment, although still quite high, were least pronounced 
and global gene expression over time was most stable of all cultures tested. From two 
days in culture until the end of the culture, an increase in correlation to FC was 
observed suggesting some regenerative processes were taking place in these cells. 
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Figure 47: Heat map of genes transiently deregulated one day after perfusion in sandwich 
culture without serum. 
Genes found to be transiently deregulated after one day in culture and returning to their 
original expression level (Figure 47) were mainly genes known to be involved in early 
stress response, inflammatory mechanisms and intracellular signalling. Networks built 
from these specifically deregulated genes (confidence of 95% to be only deregulated at 
1 d in SW-FCS) confirmed these findings but also showed a link to the regulation of 
fatty acid biosynthetic processes (Table 16). The expression of the PPARs was 
reduced 1.8-fold. This transcription factor is known for its ability to induce 
gluconeogenesis and to reduce fatty acid β-oxidation. 
 
Processes Size Target p-Value
immune system process (40.0%), V(D)J recombination (7.5%), nitric 
oxide transport (5.0%) 
50 10 1.05e-21
protein kinase cascade (44.0%), stress-activated protein kinase 
signaling pathway (26.0%), protein amino acid phosphorylation (44.0%)
50 10 1.64e-21
fatty acid biosynthetic process (23.1%), carboxylic acid biosynthetic 
process (23.1%), organic acid biosynthetic process (23.1%) 
50 8 8.45e-18
regulation of biosynthetic process (20.6%), regulation of cellular 
biosynthetic process (20.6%), biological regulation (79.4%) 
50 9 2.35e-19
response to stress (65.1%), positive regulation of cellular metabolic 
process (46.5%), positive regulation of metabolic process (46.5%) 
50 8 7.23e-17
Table 16: Top five networks highly enriched with genes found to be deregulated only at day one 
in SW-FCS cultured hepatocytes. “Size” refers to the number of network objects contained and 
“Target“ is the number of affected objects contained in these networks. 
 
Figure 48 shows the correlation of global gene expression for the different human cell 
cultures tested. Again, the short term suspension culture retained liver specific gene 
expression only for a short time. After 6 h, global gene expression was still hepatocyte-
like, but after this time point a rapid change was detected. 
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Figure 48: Heat maps of the correlation coefficients of human cell culture experiments to their 
reference systems over time. Experiments were ordered according to the time scale (big arrow) 
and separated into short- and long-term experiments. The intensity-changes in global gene 
expression were used as the basis for the calculation of the correlation. Long-term experiments 
are split up; the upper part of the square shows the correlation of the experiments to freshly 
isolated cells, the lower part indicates the correlation to the status 1 d after plating which was 
defined as the reference experiment for later analyses. Red squares indicate high correlation, 
green indicate low correlation. The pictures show cells of each longer-term culture at day one 
(left) and day 10 (right) of culture. 
 
The results of the long term cultures displayed differences from the results gained with 
rat hepatocytes. Due to technical reasons, the 2 d time point was the first sample to be 
taken and therefore this was defined as a second reference, together with FC. For ML 
and SW cultures, a distinctly worse correlation was detected at the initial time points. 
This change of gene expression was less pronounced in ML culture indicating a greater 
stability of these cells. Over time, both cultures demonstrated only minor changes 
pointing to a generally better stability of gene expression in human cells compared with 
the situation in rat. Another source of variance when working with primary human cells 
is the large inter-individual donor difference. Both the basal gene expression and the 
individual reactions of the cells can be remarkably different. This was confirmed by our 
data. Four different donors were clearly differentiated, based on their gene expression 
and the extent of gene expression changes over time (Figure 48 ML and SW). The 
correlation “in-between” donors at a certain time point was 0.97 for primary cultured 
human hepatocytes. For the suspension culture, the level of correlation between 
different time points was in the same range (0.95). Therefore, genes found to be 
differentially deregulated may be influenced more by donor specificity than by time in 
culture. 
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Figure 49: Plot of intra 
group and inter group 
correlation coefficients 
of human hepatocyte 
cultures. 
 
Experiments with primary human hepatocytes should be carefully analyzed with 
respect to donor specific gene expression. If possible, more than three biological 
replicates should be included to ensure that general biological trends are visible above 
any individual variances.  
For both rat and human, the established cell lines (FaO and HepG2, respectively) were 
found to vary greatly from primary cells, showing many differences in global gene 
expression. Another cell line, the recently established HepaRG, showed a high stability 
of gene expression over time. Additionally, the gene expression was closer to that of 
primary human hepatocytes than that of HepG2 cells. Large differences were detected 
compared to FC, maybe due to the lack of inter-individual differences and the 
increased stability of gene expression over time in culture. These cells may therefore 
be a suitable experimental system for toxicogenomics studies. Further analyses have 
to be conducted, including the monitoring of the existence of certain metabolic 
enzymes, which allows liver-like metabolism in these cells (chapter 3.3.6.4). 
 
3.3.3 Analysis of protein expression with SELDI-TOF 
Proteins, as the effector-molecules in cells, are dependent not only on the amount of 
transcribed mRNA but also on multiple post-transcriptional and translational 
mechanisms. It is well known that the amount of a protein is not necessarily correlated 
with the gene expression (Gygi et al., 1999; Chen et al., 2002). To study if gene 
expression changes during culture of primary hepatocytes translated into differences in 
protein expression studies were conducted using the SELDI technology. The 
abundance of certain protein masses in ML-FCS and SW-FCS cultured primary rat 
hepatocytes were measured and analyzed (Figure 50). 
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Figure 50: Representative SELDI-spectra detected by analysis of protein samples of either ML-
FCS (upper spectrum) or SW-FCS (lower spectrum) cultured rat hepatocytes. Four biological 
replicates were measured per time point and culture condition and subsequently analyzed for 
changes over time. 
 
The ProteinChip CM10 array was used to bind and detect positively charged proteins. 
A hierarchical clustering based on significant mass-ion-peaks detected within the 
spectra showed a clear separation of early (0 h – 1 d) and late (3 d – 9 d) time points 
for both culture types. Inside both clusters, individual time points were partially 
separated. To improve discrimination, only mass-ion-peaks which were significant in all 
spectra of all animals were identified and chosen as the basis for further analysis. This 
resulted in 33 mass-ion-peaks for ML-FCS cultured cells, and 26 for SW-FCS. Time 
points were analyzed for changes in peak intensity separately and compared to the 
protein profile of freshly isolated cells. Although the resulting heat map representing the 
correlation of the protein expression to the reference (Figure 51 A) shows no clear 
separation of ML-FCS and SW-FCS, more severe changes in protein expression were 
detected in ML-FCS indicated by the stronger colours representing positive or negative 
changes in correlation. 
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Figure 51: A) Correlation map of 59 mass-ion-peaks detected in samples of ML-FCS and SW-
FCS cultured cells. Green resembles a low and red a high correlation to the reference 
spectrum. B) Two-dimensional PCAs computed by using the SELDI-Spectra analysis of 
technical replicate measurements of four biological replicates. 
 
Shown in Figure 51B are two-dimensional PCAs, demonstrating the spread of the data 
within each experiment. At early time points, differences between cell cultures and 
freshly isolated cells were less pronounced and therefore the data clouds overlapped. 
FC were only slightly separated and ML-FCS cultures tended to be located closer to 
FC than SW-FCS cultures, although this result was not statistically significant. At later 
time points, clouds separated as individual groups. After 5 d in culture, the protein 
expression of SW-FCS cultured cells was closer to FC than ML-FCS cultured cells. 
This effect was enforced after 9 d in culture, protein expression of SW-FCS cultured 
cells was detected to be less changed and therefore to be more hepatocyte like than 
the continuously changing protein expression of ML-FCS cultured cells. 
 
Although protein profiling does not allow an exact identification of the proteins 
underlying the 59 mass-ion-peaks, these results fit well with the results of gene 
expression, which indicated changes at early time points in culture and a greater 
stability of SW-FCS cultured cells. Improvements of the SELDI technology, to allow 
identification of single peaks and to improve the sensitivity of peak detection, will 
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further enhance the usability and utility of this technique for identifying protein patterns. 
By combining both genomic and proteomic approaches, possibilities to further elucidate 
mechanisms of toxicity using cultured primary hepatocytes will be improved. 
 
3.3.4 Gene expression in established cell lines used as 
reference 
The gene expression in established cell lines was compared to FC. FaO is a rat 
hepatoma cell line with a hepatocyte like phenotype. Some liver-specific enzymes and 
liver-enriched transcription factors were found to be expressed, although in lower 
abundance (Clayton, Weiss & Darnell, 1985) than in vivo. It has been used for 
mechanistic analyses for PPARalpha target genes and the induction of apoptosis 
(König & Eder, 2006; Coyle et al., 2003), lipid metabolism (Latruffe et al., 2000) or CYP 
expression studies (Hakkola, Hu & Sundberg, 2003). 
In comparison to FC, substantial differences in gene expression were detected, 4952 
genes were differentially expressed in this cell line. Of the 2951 down regulated genes, 
many were involved in the regulation of lipid metabolism, MAPK signalling, metabolism 
of xenobiotics by cytochrome P450 and several important metabolic pathways. 
Additionally, cellular adhesion was found to be impaired, implying that the cells are less 
responsive to extracellular stimuli. It’s not surprising that many of the higher expressed 
genes were involved in cell cycle progression and DNA replication, but also several 
intracellular signalling cascades, like the ERK, Wnt, Insulin and ErbB pathways, 
showed increased expression.  
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Figure 52: Example of canonical pathway maps showing over and underexpressed 
genes in the stable cell lines FaO (rat) or HepG2 (human). A) Detail of the anaphase 
promoting complex (APC). B) Detail of the estradiol metabolism pathway (modified from 
Metacore, GeneGO). 
 
The human hepatoma derived HepG2 cell line, analogous to the FaO cells, is often 
used for mechanistic studies, although there is only poor predictivity to the in vivo 
situation (Brandon et al., 2003; Knasmüller et al., 2004). Some differences in gene 
expression to FaO cells (rat) were detected, however the predominant tendencies were 
underexpressedB
-744 -fold -263 -fold
overexpressedA
+21 -fold
1) FaO (rat)           2) HepG2 (human)
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found to be similar. Cell cycle related genes and adhesion molecules were 
overexpressed and genes involved in cellular differentiation, especially intracellular 
signalling and xenobiotic metabolism, were deregulated.  
Figure 52A shows the anaphase promoting complex (APC), which is an important 
regulator of cell cycle progression, which targets the mitotic cyclins for degradation. 
This, and several other cell cycle related proteins, was found to be overexpressed in 
both cell types. Figure 52B depicts the estrogen metabolism pathway including many 
repressed genes, which also play important roles in xenobiotic metabolism. 
Taken together, pronounced differences in many of the cellular mechanisms were 
detected in both established cell lines. It must be assumed that these changes have 
severe consequences on cellular mechanisms and therefore also on liver specific 
functionality. Toxicity experiments conducted in either one of these cell lines should 
therefore be carefully planned and the data generated treated with caution. 
Additionally, there is a need for knowledge about the metabolism of any test 
compound. Extrapolation to the in vivo situation has to be performed very carefully to 
circumvent misinterpretation. These cell lines should be used only for special 
toxicological questions and results should be interpreted against the background of 
reduced metabolic activity and altered intracellular signalling leading to non-
physiological reactions. 
 
3.3.5 Changes of gene expression early in culture - Cellular 
adaptation processes in primary hepatocytes 
It has been shown that the most dramatic change in gene expression occurs during the 
first day of culturing (our data, Beigel et al., 2008). To review this processes taking 
place in cultured hepatocytes, the initial changes of gene expression on the first day 
after plating were studied separately. The gene expression of freshly isolated cells was 
compared to the gene expression of cells cultured for one day in either SW or ML 
culture with or without the addition of serum. To obtain relevant results, commonly 
affected genes were selected and processes taking place in all types of culture were 
analyzed. 
As can be seen in Table 17, more than 50% (1,838) of genes were commonly 
deregulated in all four types of cell culture. This remarkably high percentage indicates 
common processes which are ongoing and are probably due to the isolation of cells 
and general adaptation processes to the new environment. Many of these processes 
are of course independent from the culture conditions. 
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Table 17: Number of genes deregulated after one day in culture. The Venn-diagram on the right 
side shows the overlap of the overall-gene lists. 1,838 Genes were commonly deregulated and 
used for further analyses. 
 
To further analyze these common mechanisms and highlight any differences in the 
adaptation processes between different culture conditions, genes differentially 
expressed compared to FC in any of the cultures were chosen. Table 18 shows the top 
10 canonical pathways affected by the adaptation process. 
Among the most affected pathways, amino acid and energy metabolism were ranked at 
the top, indicating a reduction of amino acid synthesis. Two processes may contribute 
to this effect. First, hepatocytes are very metabolically active cells in vivo, with a large 
number of proteins produced and secreted into the system. The lack of external 
signalling may lead to a reduction in these processes, thereby slowing down the 
synthesis rate and therefore the high need for the production of amino acids is 
reduced. Second, at least parts of these pathways were induced by the perfusion 
process and their reduction after 1 d in culture can therefore be seen as a recovery 
process by returning to their original (lower) expression levels. 
The top ranked down-regulated pathway was the regulation of lipid metabolism via 
several transcription factors. This is of importance because the lipid metabolism is not 
only closely related to xenobiotic metabolism, but also these transcription factors are 
responsible for the induction of several enzymes involved in metabolism, cell cycle and 
inhibition of apoptosis (Latruffe et al., 2000; Kersten et al., 2001; Kliewer et al., 1999). 
Additionally, fatty acids themselves have the ability to bind to transcription factors and 
therefore influence the overall gene expression of the cells (Wolfrum & Spener, 2000; 
Wolfrum et al., 2001; Sampath & Ntambi, 2004). Other processes found to be 
negatively affected were inflammation-related, such as parts of the complement 
system, the kallikrein-kinin system, both of which depend on blood circulating proteins 
and therefore were expected to be reduced. 
 
 
 
Culture system  Overall  
Down 
regulated 
Up 
regulated 
ML culture + FCS  3780  1681 2099 
ML culture - FCS  3025  1612  1413 
SW culture + FCS  3112  1650 1462 
SW culture - FCS  3621  1920 1701 
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Down regulated Up regulated 
Regulation of lipid metabolism via PPAR, 
RXR and VDR Cytoskeleton remodelling 
Glycine, serine, cysteine and threonine 
metabolism  
Cell adhesion; Integrin mediated cell 
adhesion 
Leucine, isoleucine and valine metabolism 
 
Role of tetraspanins in the integrin-mediated 
cell adhesion 
Alanine, cysteine and L-methionine 
metabolism TGF, Wnt and cytoskeletal remodelling 
Oxidative phosphorylation 
Endothelial cell contacts by non junctional 
mechanisms 
Peroxisomal branched chain fatty acid 
metabolism Signal transduction; Akt signalling 
Propionate metabolism 
Regulation of actin cytoskeleton by Rho 
GTPases 
Tryptophan metabolism 
Transcription; Role of Akt in hypoxia induced 
HIF1 activation  
Mitochondrial ketone bodies biosynthesis 
and metabolism Fibronectin-binding integrins in cell motility 
Immune response; Lectin induced 
complement pathway 
Translation; Insulin regulation of protein 
synthesis 
Table 18: Top 10 canonical pathways affected by genes commonly deregulated as part of the 
adaptation process to cell culture. 
 
The pathways found to be heavily induced were involved in cellular adhesion, 
cytoskeletal remodelling and the corresponding intracellular signalling dependent on 
these processes. After perfusion, the cells have to adhere to the surface of the culture 
dishes and to rebuild cellular contacts. Along with this, the reestablishment of their 
polarization and their polygonal shape is going on. All these processes require 
cytoskeletal remodelling and are known to influence gene expression, especially 
integrins. These transmembrane molecules are not only connected to the cytoskeleton 
but also to intracellular signalling mechanisms, again directly influencing gene 
expression (Stupack, 2007; Giancotti & Ruoslahti, 1999; Giancotti & Tarone, 2003; 
Häussinger, Reinehr & Schliess 2006). AKT signalling, for example, is downstream of 
integrin mediated signalling and influences cell adhesion and intracellular structural 
protein formation. Figure 53 shows the induction of several genes involved in this 
pathway. 
Interestingly, several inflammatory pathways were induced indicating that hepatocytes 
themselves are partially capable of initiating an inflammatory response alone. The Jak-
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Stat pathway is known to be initiated through certain cytokines, like IL-6, which is one 
of the most important mediators of the acute phase response. Although the initial 
signal, IL-6, is secreted by macrophages; downstream receptor mediated events take 
place in other cell types.  
 
Figure 53: Canonical pathway map showing the changes in the expression of genes involved in 
signal transduction by AKT signalling. Red bars indicate induction, blue bars the repression of 
gene expression. Red circles indicate genes found to vary in expression between the different 
types of culturing on day one (modified from Metacore, GeneGO). 
 
The previous results reported in this work showed that the SW culture without the 
addition of serum both, morphologically and in terms of global gene expression, 
conserved best the in vivo situation of the liver. At this early time point (1 d), the 
differences between the cell cultures were only minor with none of the top ranked 
pathways or processes being affected in one and not in the other cell cultures. The 
differences were restricted to the degree of expression changes of a gene between the 
cultures and to single genes found in only one sample. This may be explained by the 
1) SW +FCS     3) SW -FCS     2) ML +FCS     4) ML -FCS
+3.6 -fold
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cut-off values selected, which filtered genes expressed just below in one sample 
whereas they pass in other samples. Therefore, the initial processes can be considered 
as common to all cultures, only the extent can be influenced by the type of cell culture. 
About 46% of genes found to be more than 1.5 fold deregulated in either ML-FCS or 
SW-FCS cultures, (pValue <0.05) were found to be deregulated just below this level in 
the other cultures (Table 19). These results illustrate a central problem in the analysis 
of global gene expression. The setting of cut-off values is always correlated with a loss 
of information, which in turn may be biologically important. Different approaches have 
been proposed to overcome this drawback (Guo et al., 2006; Chen et al., 2007).  
These specifically filtered genes play important roles in cellular fate. Mbtps1, a serine 
protease that cleaves ER membrane-bound sterol regulatory element-binding proteins 
(SREBPs), plays a central role in the regulation of lipid metabolism. This 
transcriptionally active fragment of SREBP is released from the membrane for 
translocation to the nucleus. Hsbp1 may be involved in the stabilization or repair of 
cytoskeletal elements and Bcl2l11 and Bcl2l2 both belong to the BCL-2 protein family, 
the first promoting and the latter inhibiting apoptosis. 
 
Name Description 
pValue 
SW-FCS 
Fold-
Change 
SW-FCS 
pValue 
ML-FCS 
Fold-
Change 
ML-FCS 
Mbtps1 Membrane-bound transcription factor protease 3.84E-04 -2.19 4.64E-02 -1.47 
Ca3 Carbonic anhydrase 3 2.52E-02 -1.34 8.16E-04 -1.61 
Ilkap 
Integrin-linked kinase-associated 
serine/threonine phosphatase 2C 
9.73E-05 -1.51 1.24E-03 -1.33 
Hsbp1 Heat shock factor binding protein 1 7.86E-07 -1.86 5.48E-04 -1.39 
Mt3 Metallothionein 3 3.81E-06 1.63 1.57E-03 1.42 
Ikbkap 
Inhibitor of kappa light polypeptide enhancer in 
B-cells, kinase complex-associated protein 
6.55E-03 1.39 9.51E-05 1.74 
Arnt Aryl hydrocarbon receptor nuclear translocator 6.17E-06 2.38 4.73E-03 1.34 
Tsg101 Tumor susceptibility gene 101 2.59E-03 1.42 1.55E-04 1.60 
Edn1 Endothelin 1 2.57E-03 1.30 6.18E-05 1.57 
Creb1 cAMP responsive element binding protein 1 6.15E-05 1.48 3.23E-06 1.61 
Bcl2l11 BCL2-like 11 (apoptosis facilitator) 5.52E-07 1.59 8.07E-09 1.48 
Bcl2l2 Bcl2-like 2 2.75E-07 1.75 2.42E-03 1.47 
Table 19: Selection of genes found to be filtered out in either SW –FCS or ML –FCS due to just 
one value not fulfilling the cut off values. 
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3.3.5.1 Liver slices  
When analyzing the gene expression changes over time in relation to the reference 
experiment, the 6 h time point showed especially striking results in liver slices. 
Whereas in all other culture systems the number of deregulated genes increased 
continuously over time, the maximum of 1824 genes was deregulated at 6 h in liver 
slices (Figure 54). After this peak, the number of deregulated genes significantly 
declined, implicating a transient mechanism only active for the first few hours in culture. 
The 790 genes affected only at this certain time point (Figure 54) were filtered out and 
analyzed for mechanistic function.  
 
Figure 54: Venn-
diagram of 
deregulated genes at 
certain time points. 
The number of genes 
in each overlapping 
segment indicates 
genes commonly 
deregulated in these 
experiments. The red 
circle indicates the 
number of genes only 
deregulated 6 h after 
culturing. 
 
Many of the genes induced were involved in chemotaxis, inflammatory response, cell 
adhesion and downstream signalling. These are processes which normally take place 
because of wounding, cellular stress or other pro-inflammatory stimuli activating 
cytokine signalling. Indeed, several cytokines were found to be heavily up regulated 
indicating a strong influence of activated Kupffer cells on gene expression. 
Table 20 shows the top ranked networks built with genes commonly deregulated in 
liver slices with the percentage of certain cellular processes indicated in parentheses. 
Networks showing mostly down-regulated genes showed affects on several 
mechanisms concerning cellular biosynthetic processes, metabolism and replication. 
Interestingly, an apoptotic mechanism, the activation of caspase via cytochrome c, was 
reduced which contradicts the general trend of induced cellular stress. This indicates 
the delicate balance of regulation of apoptotic processes in cells with several pro- and 
anti-apoptotic mechanisms taking place simultaneously.  
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common down regulated  p-Value common up regulated  p-Value 
neurotransmitter metabolic process (13.6%), 
nitrogen compound metabolic process (27.3%), 
ketone body biosynthetic process (4.5%) 
2.54E-32  
small GTPase mediated signal 
transduction (29.5%), cell 
morphogenesis (40.9%), cellular 
structure morphogenesis (40.9%) 
6.65E-08 
response to chemical stimulus (36.8%), protein 
export from nucleus (10.5%), male somatic sex 
determination (5.3%) 
9.87E-26  
cell-matrix adhesion (18.4%), cell-
substrate adhesion (18.4%), cell 
adhesion (28.9%) 
8.7E-30 
caspase activation via cytochrome c (13.3%), 
apoptotic program (23.3%), complement 
activation (16.7%) 
1.15E-26  
response to stress (44.7%), 
biological regulation (74.5%), 
response to external stimulus 
(29.8%) 
2.64E-26 
phosphoinositide-mediated signalling (25.0%), G-
protein signalling, coupled to IP3 second 
messenger (phospholipase C activating) (21.4%), 
positive regulation of protein kinase activity 
(25.0%) 
5.6E-18  
wound healing (20.5%), blood 
coagulation (15.9%), coagulation 
(15.9%) 
2.49E-22 
chromatin silencing at telomere (8.0%), telomeric 
heterochromatin formation (8.0%), chromatin 
silencing at rDNA (8.0%) 
8.19E-20  
chemotaxis (37.5%), taxis (37.5%), 
locomotory behavior (39.6%) 
1.57E-14 
Table 20: Cellular mechanisms affected by time induced gene expression changes in liver 
slices. 
 
Building the networks based on the 790 genes specifically deregulated after 6 h 
principally confirmed the results of the time course analysis with the induction of 
inflammatory response, stress-activated protein kinase signalling and the induction of 
the cell cycle as a signal for the start of early regenerative processes taking place. 
Simultaneously, the expression of genes involved in nucleic and amino acid 
metabolism was clearly reduced which may be a consequence of oxidative stress. This 
is a major cause of liver damage that can be initiated by ischemia/reperfusion due to 
missing blood flow, thus generating an oxygen deficit in the inner layers of the slices. 
The main sources of reactive oxygen species (ROS) for hepatocytes are internal CYPs, 
Kupffer cells and neutrophils, with the latter two being missing in isolated hepatocyte 
cultures. It has been shown that an imbalance between the generation of ROS and the 
antioxidant defence capacity of the cell affects major cellular mechanisms, including 
the metabolism of lipids, proteins and DNA (Cesaratto et al., 2004). ROS can also 
influence gene expression profiles by affecting intracellular signal transduction 
pathways (Cesaratto et al., 2004). Signalling by activated Kupffer cells, involving TGF 
beta and other cytokines, leads to stimulated proteoglycan synthesis, proliferation, and 
transformation into myofibroblast-like cells. 
Several chemo-attractant genes, like cytokines, were up regulated indicating an 
activation of hepatic macrophages and an ongoing immune response were de-
3 RESULTS AND DISCUSSION 
 136
regulated (Figure 55). At the same time, anti-inflammatory processes were induced, 
indicated by thioredoxin reductase 1 (Txnrd1), which was 3-fold induced exclusively at 
6 h and is a critical antioxidant enzyme for the protection against oxidative stress. 
Stefin A2 (Stfa2), the expression of which was induced 17.8-fold, acts as a cysteine 
protease inhibitor, amongst which the caspases are an important group.  
 
Unique for down regulated Slices 0 
h/6 h 
p-Value
Unique for up regulated 
Slices 0 h/6 h 
p-Value 
amino acid transport (12.0%), L-amino acid 
transport (8.0%), amine transport (12.0%) 
2.63E-60  
intracellular signalling cascade 
(46.7%), cell development (55.6%), 
cellular component organization and 
biogenesis (62.2%) 
9.16E-11 
DNA metabolic process (50.0%), DNA repair 
(33.3%), response to DNA damage stimulus 
(35.7%) 
1.8E-28  
response to stimulus (62.8%), 
response to stress (44.2%), stress-
activated protein kinase signalling 
pathway (14.0%) 
8.42E-17 
transcription from RNA polymerase II promoter 
(41.7%), macromolecule metabolic process 
(80.6%), cellular metabolic process (86.1%) 
1.76E-24  
regulation of progression through cell 
cycle (31.2%), regulation of cell cycle 
(31.2%), insulin receptor signalling 
pathway (12.5%) 
4.29E-15 
Table 21: Cellular mechanisms affected by gene expression changes exclusively in liver slices 
after 6 h in culture 
 
The changes in gene expression in liver slices in general were characterized by a very 
intense immune response at all time points. This is potentially a large disadvantage 
and thus it has to be questioned whether their use in global gene expression studies 
makes sense against the advantage of retaining the liver specific architecture, cellular 
composition and therefore liver specific responses. The immune cells of the liver are 
already activated by the process of generating the slices. Additionally, the lack of blood 
flow drives the hypoxia in the inner layers of the slice leading to multiple reactions and 
increased effects on gene expression in these cells. These processes lead to a 
transient induction of inflammatory processes in slices after 6 h in culture (Table 21 and 
Figure 55). These processes may potentially overlay any additional effects caused by 
compound treatment. However, for the analysis of direct toxicity that affects non-
parenchymal cells, liver slices are one of the few in vitro system options available. 
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Figure 55: Time course of gene expression changes in liver slices. Shown is a part of the IL1 
signalling pathway indicating a strong activation at early time points with the return to moderate 
expression levels by day 2. Red bars indicate induction, blue bars the repression of gene 
expression (modified from Metacore, GeneGO). 
 
3.3.6 Molecular mechanisms affected over time in culture 
3.3.6.1 Overview of the affected mechanisms in rat hepatocytes 
In order to investigate the differences in gene expression taking place during culturing, 
with a special emphasis on the differences in the experimental systems used, genes 
were grouped according to gene ontology in several functional categories and further 
analyzed (Figure 56). This approach was chosen to reduce the number of genes, which 
introduced a high background noise into the data when taken as a whole. Additionally, 
it has the advantage of filtering the data while minimizing the loss of important and 
specific information. 
The gene expression of short-term cultures (liver slices and suspension culture) shared 
a high correlation to the reference (freshly isolated hepatocytes) indicating the 
advantage of short term culturing. As early as 6 h after the isolation of the cells, larger 
changes in gene expression were seen, which increased over time. 
1) Slices 2h     2) Slices 6h     3) Slices 1d     4) Slices 2d 
+23.7 -fold
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The long-term cultures all failed to preserve this high level of correlation to fresh 
hepatocytes over time. Generally, hepatocytes cultured with the addition of FCS tended 
to show changes in gene expression after 2 – 5 d, in all gene groups, indicating a 
strong dedifferentiation processes. The same effect was seen in cells cultured in ML 
culture, where initial gene expression changed rapidly, followed by a more gradual 
change over time. The gene expression of cells cultured in SW culture without FCS 
was more stable over time. In this culture system initial changes did take place 
indicating an adaptation process to the culture conditions. For the later time points, the 
gene expression stabilized or even recovered, indicated by an increasing correlation, 
for example for protein metabolism, mRNA processing or lipid metabolism when 
compared to the starting point of the culture. 
 
 
Figure 56: Temporal correlation plots of functional gene groups representing important cellular 
and liver specific mechanisms for different primary rat hepatocyte culture methods. Changes in 
the correlation of gene expression in comparison to the reference experiments (FC) are 
indicated by a change of colour. The calibration bars on the right side indicate the colour 
scheme which was chosen for an optimal visualization.  
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The functional classification of genes revealed the involvement of several biological 
processes as well as clear differences between the culture systems used. It is not 
intended here to describe all changes in gene expression taking place during culturing, 
instead, by discussing few, discriminating genes, the differences between the culture 
systems are discussed and general tendencies of gene expression changes 
elucidated.  
 
3.3.6.2 Response to wounding, oxidative stress and immune response  
Genes which are known to code for markers of hepatotoxicity or cellular stress, such as 
heme oxigenase1 (Hmox1), paraoxonase1 (Pon1) and several cytokines, were 
amongst the genes found to be differentially deregulated between the cultures (Table 
22). Hmox1 is an essential enzyme in heme catabolism which has also a protective 
role against cellular stress, especially during inflammatory processes and oxidative 
stress (Wunder & Potter, 2003). It is induced by cytokines, hypoxia or ROS and is 
hypothesized to contribute to the decrease of CYP activity in culture (Kutty et al., 
1988). This gene was induced initially in all cultures but reduced in expression over 
time in FCS-free long term cultures.  
Already in short-term cultures a transient induction of cytokines and pro-inflammatory 
genes was detected. The chemokine ligand 1 (Cxcl1) acts as a neutrophil 
chemoattractant and was heavily induced during early stages of culture. In longer time 
cultures, especially in SW-, the expression of Cxcl1 was reduced again to an 
expression close to the control. Other cytokines, like Interleukin1 (Il1a), which is 
involved in various immune responses and inflammatory processes, are normally 
expressed in macrophages and monocytes and are therefore likely to be reduced in 
hepatocyte cultures. The alpha-2-macroglobulin (A2m), a protease inhibitor and 
cytokine transporter is a classic marker for activated immune responses in the liver 
(Kurokawa et al., 1987). It was induced during suspension culture, in ML-FCS culture 
and in early stages of SW-FCS. 
The inflammatory process of hydrolyzing oxidized phospholipids to generate free 
oxidized fatty acids is mediated by platelet-activating factor acetylhydrolase (Pla2g7), 
which was induced in suspension and long term cultures with FCS. Hydroxisteroid (11-
beta) dehydroxigenase1 (Hsd11b1) was reduced in all long term cultures with the 
exception of SW-FCS. This enzyme catalyzes the conversion of the stress hormone 
cortisol to the inactive metabolite cortisone. 
Another gene indicating an increase of oxidative stress was the reduction of thioredoxin 
(Txn) expression in ML cultures. Txn is a small, di-thiol containing protein and a key 
3 RESULTS AND DISCUSSION 
 140
player in maintaining cellular redox status and redox-controlled cell functions by 
transferring reducing-equivalents to disulfide groups (Burke-Gaffney, Callister & 
Nakamura, 2005). Besides this, several transcription factors, like p53, NFκB, AP1 and 
the glucocorticoid receptor, are known to possess thiol groups and to be partly 
regulated by Txn, thereby altering various essential cellular processes.  
 
Susp Slice ML+FCS ML-FCS SW+FCS SW-FCS Symbol Accession-Nr. 1 d 1 d 1 d 6 d 10 d 1 d 6 d 10 d 1 d 6 d 10 d 1 d 6 d 10 d 
A2m NM_012488 3.8    2.5 43.8 9.9 12.3   2.9 51.4   
Ccnd1 NM_171992  -3.0  2.6 5.4 -8.8 -2.3     2.6 -10.3 -4.8 -4.1
Cpb2 NM_053617  -2.4  -6.1 -11.1  -3.3 -3.4 -2.1    -2.8 -2.4 
Crp NM_017096 -5.3 -4.2 -40.9 -31.4  -5.2 -3.2  -3.4 -3.5     
Cxcl1 NM_030845 22.9 15.1 39.3 15.1 13.5 13.7 6.5 6.2 46.1 15.2 15.6 12.8 3.4 2.7 
Cxcl2 NM_053647 4.1 3.3 22.6 8.5 3.9 4.7 4.4 4.2 18.6  2.2 6.8   
F10 NM_017143 -3.6 -2.4 -3.1 -36.9 -46.7 -2.3 -9.3 -10.4  -4.0 -3.7  -3.6 -2.6 
Hmox1 NM_012580 8.4 4.8 11.3 4.3 7.0 7.3   22.9 4.1 7.9 17.0   
Hrmt1l2 NM_024363 4.0 2.5 2.2 4.5 4.2  2.0 2.3 2.0 2.4 2.5    
Hsd11b1 NM_017080   -47.2 -24.8  -2.5 -2.5  -8.5 -7.6     
Il1a NM_017019 -4.1 -2.7   -4.6 -6.7 -5.5 -2.9   -5.3 -5.2 -5.6 -5.7 
Il1b NM_031512     -2.3 -3.0 -3.0    -2.3 -2.4 -2.5 -2.8 
Ndst1 NM_024361    -3.4 -4.1  -2.79 -3.2  -2.0 -2.5    
Pla2g7 NM_001009353 3.5   2.3 9.8      3.0    
Pon1 NM_032077   -97.6 -110.5  -13.4 -14.7  -3.4 -5.4  -4.1 -3.9 -8.5 
Proc NM_012803   -4.5 -20.0 -25.1 -2.4 -8.0 -6.5 -2.6 -5.5 -5.3 -2.2 -3.5 -2.5 
Saa4 NM_001009478  -2.2 -105.3 -59.1  -2.6 -2.5  -2.2 -2.2     
Serpind1 NM_024382 -3.9 -13.3 -14.7 -220.9 -226.4 -12.3 -110.9 -125.2 -13.7 -8.7 -9.8 -10.2 -69.1 -97.8 
Txn2 NM_053331   -2.2 -2.7 -2.6  -2.0 -2.2         
Tp53 NM_030989 2.4 2.6 4.0   2.3 2.3 2.5 2.7 2.4     
Table 22: Fold change values of several genes concerning the response to wounding, oxidative 
stress and the immune response. Genes selected were at least 2-fold deregulated at multiple 
time points and had a significance level of lower than 0.05 in at least one of the cultures.  
 
It is known that hepatocytes are primed to re-enter the cell cycle during hepatocyte 
isolation, a process known to be triggered by inflammation and to underlie the 
dedifferentiation process of cultured hepatocytes (Papeleu et al., 2006). For cell cycle 
progression, additional growth factors, like EGF (Epidermal Growth Factor) or HGF 
(Hepatocyte Growth Factor) are required. The expression of Cyclin D1 (Ccnd1), found 
to be induced in hepatocytes cultured with FCS, separates the cells from these signals 
and initiates the proliferation. 
Another process affected was the regulation of blood coagulation. Under normal 
conditions, hepatocytes are triggered to increase the synthesis of coagulant and 
complement factors and protease inhibitors by proinflammatory cytokines, as a 
response to wounding (Dhainaut et al., 2001). In culture, the expression of serpin 
peptidase inhibitor (Serpind1), which rapidly inhibits thrombin, carboxypeptidase B2 
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(Cpb2), which down regulates fibrinolysis, and protein C (Proc), a zymogen that 
catalyzes the inactivation of blood coagulation cofactors like coagulation factor X (F10), 
are clearly repressed in all types of culture. This can be seen as a physiological 
response to wounding and induction of wound healing processes due to the isolation 
procedure itself.  
 
3.3.6.3 ECM, cytoskeleton and tissue remodelling 
Large differences were also detected in the gene expression of ECM components, cell 
adhesion and cytoskeletal related genes (Table 23). The cellular morphology and 
formation of cell-to-cell and cell-to-matrix- contacts have proven to be of essential 
importance for cellular survival and functionality (Dunn et al. 1989; Richert et al., 2002; 
Hamilton et al., 2001) and are one of the key differences distinguishing the cell cultures 
from each other.  
Collagens are the main constituent of the ECM. Collagen 1a1 and 3a1 (Col1a2 and 
Col3a1) were heavily down regulated during the perfusion, indicating the loss of 
several collagen expressing cell types. Especially Col3a1 is known to be expressed in 
connective tissues and blood vessels. Whereas the collagen expression in cultures 
without FCS remained stable, although at a low level in freshly isolated hepatocytes, 
the expression rose again over time when cultured with FCS. This may be a sign of the 
progressive dedifferentiation of hepatocytes towards a fibroblast like cell type and the 
induction of proliferation. 
Table 23: ECM, adhesion or cytoskeletal related genes distinguishing the different cell cultures 
from each other. 
Susp Slice ML+FCS ML-FCS SW+FCS SW-FCS Symbol Accession-Nr. 1 d 1 d 1 d 6 d 10 d 1 d 6 d 10 d 1 d 6 d 10 d 1 d 6 d 10 d 
Actb NM_031144   3.0 2.8 3.0 2.8 2.7 2.7 3.7   2.8   
Actn1 NM_031005   2.2 4.9 5.1  4.0 4.3  2.8 2.1    
Cfl1 NM_017147   2.5 2.6 2.5 2.3 2.6 2.5  2.2 2.2    
Col1a2 NM_053356 -2.1 -15.5 -37.9  4.3 -33.6 -15.0 -3.0 -27.0  5.0 -31.6 -28.1 -9.9 
Col3a1 NM_032085.1 -2.7 -11.2 -14.4 -8.0  -14.1 -13.5 -9.0 -13.9 -9.0  -14.6 -14.5 -13.6
Defb1 NM_031810   6.3   28.9 17.7 11.4 2.3   23.8 32.2 20.9 
Gja1 NM_012567  -4.5 -10.1 11.5 12.2 -10.8 -9.2 -3.9 -9.0  6.6 -12.5 -11.9 -5.8 
Lamc1 XM_341133  2.4  2.2 2.5 2.8 2.7 3.1    2.3   
Mgp NM_012862  -8.5 -12.9 -3.2  -12.5 -12.3 -5.8 -9.9 -2.3  -12.6 -12.4 -9.7 
Mmp12 NM_053963 24.5   116.1 226.1     43.5 104.1    
Msn NM_030863    5.6 14.8  3.6 4.6  3.1 3.9    
Myh10 NM_031520   3.1 5.2 5.2  2.5 2.9 2.2 3.0 3.0    
Nexn NM_139231    4.6 3.5  2.4 2.6       
Pfn2 NM_030873    4.3 4.9  2.7 3.8  2.3 2.5   2.2 
Spp1 NM_012881 18.6   100.6 199.4     22.6 78.7    
Timp1 NM_053819 7.5 -2.96 2.3 11.2 13.4   2.6  4.9 7.3  -2.4 -2.4 
Tpm1 NM_019131    6.3 5.8  2.3 2.2  3.2 3.0    
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The influence of FCS on inflammatory processes in isolated primary hepatocytes is 
demonstrated by matrix metalloproteinase12 (Mmp12), which is also called 
macrophage elastase and is involved in the breakdown of extracellular matrix in 
physiological as well as inflammatory processes (Mohammed et al., 2005). This 
enzyme is normally found in epithelial tissue and contributes to wound healing, but is 
also found in hepatoma cells triggering neovascularisation (Lyu & Joo, 2005). Mmp12 
was found to be induced only in suspension and in late time points of ML and SW 
culture when cultured with FCS. The endogenous metalloproteinase inhibitor (Timp-1) 
was induced in all cultures except for SW-FCS, indicating changes in the 
reorganisation of the ECM environment as a reaction to cellular damage and 
inflammation or growth which may help explaining the change in cell morphology.  
The cytoskeleton and their contact to the ECM by cell adhesion molecules and external 
signalling are connected to intracellular signalling cascades and mediate specific and 
important cellular processes. The reestablishment of these contacts, together with the 
re-establishment of cellular polarity and the stability of the actin cytoskeleton, are 
crucial requirements for hepatotypic functionality and for reducing the cellular stress 
(Page et al., 2007). The Gap junction protein alpha (Gja1) was reduced at early time 
points in culture but induced later on, except for SW– cultured cells. Gja1 is associated 
with endothelial cells and immature hepatocytes, again indicating the dedifferentiation 
processes in culture after addition of FCS (large induction ML+FCS 124-fold induced 
and SW+, 59-fold) (González et al., 2002). 
The contact between ECM and the reorganisation of the actin cytoskeleton in response 
to external signals is mediated by profilins (Pfn 2), tropomyosin 1 (Tpm1) and moiesin 
(Msn), which were all induced in long term cultures, except for SW-. Actin itself (Actb) 
was mainly induced in ML cultured cells reflecting the need to reorganize the 
cytoskeleton due to their flattened shape. Finally, myosin heavy polypeptide 10 
(Myh10) and secreted phosphoprotein 1 are physiologically expressed in immature 
smooth muscle cells and endothelial cells (Hiroi et al., 1996) and were induced by ML 
culturing and after the addition of FCS. 
 
3.3.6.4 Metabolic competence 
The metabolic competence of hepatocytes is one of the key elements defining their 
usability for toxicological studies. Besides the inducibility of CYP enzymes, which has 
been discussed extensively in chapter 3.2, there are several other genes involved in 
phase 1, phase 2 and phase 3 metabolisms. Previous studies have demonstrated 
predominantly a down regulation of phase 1 metabolism in cultures already over night 
as well as in later stages of culture (Baker et al., 2001; Lupp et al., 2001; Richert et al., 
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2002). These findings were generally corroborated by our studies, but in SW-FCS 
cultured cells the decrease was less pronounced and they displayed a more stable 
gene expression over time. 
 
Susp Slice ML+FCS ML-FCS SW+FCS SW-FCS Symbol Accession-Nr. 1 d 1 d 1 d 6 d 10 d 1 d 6 d 10 d 1 d 6 d 10 d 1 d 6 d 10 d 
Adh1 NM_019286   -18.8 -67.4 -46.9  -2.5 -2.9 -7.7      
Adh4 NM_017270   -3.0 -5.5 -6.1 -2.5 -2.6 -2.8 -3.1 -3.0 -3.4 -2.9   
Adhfe1_
predicted XM_342794 -17.1 -8.6 -6.5 -123.3 -104.0 -4.0 -33.3 -22.6 -6.5 -25.0 -40.0 -3.9 -4.7 -2.6 
Cyp1a1 NM_012540    3.1 3.8  2.6 5.1     4.0 11.9 
Cyp1a2 NM_012541   -5.4 -138.7 -100.4 -3.5 -103.5 -70.8 -8.4 -92.6 -83.9 -4.3 -64.7 -69.2
Cyp2a1 NM_012692 -8.0 -5.1 -8.9 -55.7 -50.6 -4.6 -18.8 -18.3 -4.3 -4.0 -4.2 -3.9 -3.0 -2.4 
Cyp2c NM_019184 -3.7 -4.7 -2.6 -276.3 -188.6 -2.5 -4.7 -7.0 -2.8 -36.8 -119.5 -2.4 -3.0 -2.4 
Cyp2e1 NM_031543 -2.5 -3.6  -360.9 -336.4  -216.4 -262.4  -170.1 -267.7  -100.1 -91.5
Cyp3a1 NM_173144 -2.9 -2.7 -2.1 -403.2 -397.8  -2.0 -2.0 -2.2 -42.6 -100.0    
Cyp3a3 NM_013105 -5.4 -3.7 -2.4 -278.7 -233.4    -2.4 -47.1 -78.9    
Cyp8b1 NM_031241 -43.4 -9.1 -66.0 -222.0 -171.4 -46.2 -46.8 -20.8 -39.7 -56.4 -13.9 -39.8 -4.6 -2.3 
Fmo1 NM_012792 -22.2 -19.1 -4.3 -59.1 -57.3 -16.7 -31.2 -40.7 -4.7 -50.3 -55.1 -14.7 -23.1 -15.5
Table 24: Phase 1 metabolism genes found to be differentially regulated. (Fold change>2 and 
pV<0.05). 
 
Table 24 shows genes involved in phase 1 metabolism, which were differentially 
deregulated in primary rat hepatocyte cultures. The gene expression of several CYP 
isoforms was strongly repressed, however the extent of deregulation differed greatly. 
For example Cyp8b1 was repressed in all cultures, but whereas the expression was 
reduced up to 171-fold in ML+FCS, 21-fold in ML-FCS and 14-fold in SW+FCS on day 
10 in culture, it was reduced only 2.3-fold in SW-FCS cultures. Other CYPs, like Cyp2c 
and Cyp3a1, were inhibited by the addition of FCS to the culture media but not in DEX 
containing, FCS free cultures. The three dimensional environment of SW culture had a 
positive effect on Cyp2a1 expression, Cyp1a2 however was unaffected and its 
expression was reduced equally in all cultures. 
UDP glucuronosyltransferases (Ugt) have a broad substrate specificity and mediate the 
glucoronidation of intermediate metabolites. Although DEX was previously shown to 
induce UGT transcription in vitro (Jemnitz et al., 2000), these results could only be 
confirmed for Ugt1a7 during this study. The other isoforms remained unaffected in SW-
FCS culture and were reduced in expression in short term and in ML cultures. 
Also of importance for xenobiotic detoxification is the transfer of sulfonate groups from 
3'-phosphoadenosine 5'-phosphosulfate (PAPS) to target nucleophilic metabolites, 
which is mediated by sulfotransferases (Sult). These enzymes have overlapping 
substrate specificities with Ugts, but higher affinity and lower activity. The expression of 
the different isoenzymes differed from each other as well as between the different 
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cultures. In short-term cultures and in cells cultured with FCS, all sulfotransferases 
were reduced whereas in FCS free cultures Sult1a1 and Sult1b1 were not affected. 
 
Susp Slice ML+FCS ML-FCS SW+FCS SW-FCS Symbol Accession-Nr. 1 d 1 d 1 d 6 d 10 d 1 d 6 d 10 d 1 d 6 d 10 d 1 d 6 d 10 d 
Gss NM_012962  3.5 4.4 2.2  2.4 2.5 2.5 3.8 2.8 2.5  2.2 2.8 
Gsta2 NM_017013 -7.4   -17.8 -15.2 -2.3 -11.4 -10.0    -2.6 -4.3 -5.5 
Gstm3 NM_031154 -9.1 -3.2 -8.3 -24.0 -21.4 -6.5 -16.9 -15.8 -7.8 -19.1 -18.2 -5.9 -7.8 -3.8 
Gstp1 XM_579338  21.5 23.6 51.6 55.3 4.4 20.0 32.0 19.5 63.2 63.7  12.6 11.2 
Sult1a1 NM_031834 -3.5 -12.0 -26.8 -108.2 -104.6    -19.3 -8.2 -12.3    
Sult1b1 NM_022513 -3.1 -2.3 -10.3 -29.2 -37.0    -9.7 -2.6 -3.0    
Sult1c1 NM_031732 -51.7 -41.9 -24.9 -352.9 -326.9 -22.7 -237.0 -296.6 -27.0 -10.0 -31.5 -18.0 -140.9 -139.5
Sult1c2 NM_133547 -10.3 -3.8 -11.2 -17.2 -17.4 -9.3 -13.6 -11.9 -10.3 -12.7 -13.4 -5.2 -9.3 -12.5 
Ugt1a7 NM_130407      6.8 5.6 6.1    5.7 6.6 5.5 
Ugt2b NM_031533 -3.2   -5.8 -9.3      -2.2    
Ugt2b10 XM_223299 -5.6 -5.9 -6.9 -16.9 -8.7 -3.1 -3.4 -2.9 -5.8 -3.0 -3.1 -3.0   
Ugt2b3 NM_153314 -3.0   -4.4 -7.2  -2.1    -2.1    
Ugt2b4 NM_001004271 -3.1   -4.8 -4.3  -2.0    -2.5    
Ugt2b4 XM_579544 -2.3   -2.7 -2.3  -2.2        
Ugt2b5 NM_001007264 -3.1 -2.4  -10.4 -17.3  -3.1 -2.7  -2.3 -2.9    
Table 25: Genes of the phase 2 metabolism found to be differentially regulated (fold change>2 
and pV<0.05). 
 
Glutathione is essential, not only for phase 2 metabolism, but also for intracellular 
redox homeostasis. Glutathione synthase (Gss) expression was induced in all types of 
culture, whereas the expression of several Glutathione S-transferases (Gst) was 
reduced. Gsts are a large group of enzymes responsible for detoxification by 
conjugating several electrophilic intermediates to glutathione. They are encoded by at 
least five gene families (alpha, mu, pi, sigma, and theta) and are an essential 
component of cellular antioxidant defence mechanisms. The placental Gstp1, known 
for its specific expression during rat hepatocarcinogenesis, is a well defined 
dedifferentiation marker (Vanhaecke, Elaut & Rogiers, 2001) and also used as a 
tumour marker (Sakai & Muramatsu, 2007). It was induced in long term cultures, 
especially in the presence of FCS, and minimally in SW-FCS. Gsta2, the most 
abundantly expressed Gst in liver, was reduced, but was more stable in SW cultured 
cells. 
 
3.3.6.5 Intracellular signalling and transcription factors 
As mentioned earlier, ligand activated transcription factors coordinately regulate the 
expression of a vast number of genes involved in detoxification and many other cellular 
processes. They often form obligate heterodimers with the retinoid X receptor (RXR) 
and hence, the importance of keeping the expression levels of these genes as similar 
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to fresh liver as possible, to preserve liver-like detoxification function, is essential. 
Other transcription factors are important for cellular differentiation and the regulation of 
genes involved in cell cycle, inflammatory processes or energy metabolism. 
Hepatocyte nuclear factor 4α (Hnf4a) plays a critical role in the maintenance of 
hepatocyte phenotype, lipid and bile acid metabolism (Sladek, 1994). Moreover, the 
expression of other transcription factors, like pregnane X receptor (PXR) and liver X 
receptor (LXR), and of several CYP isoforms require HNF4a activity (Tirona & Kim, 
2005). In culture, FCS reduced the expression of this important TF whereas it was 
unchanged in serum free cultures (Table 26). Many ligand activated receptors, like 
RXR, PXR, CAR or Ahr, were repressed in liver slices and long-term cultures, except 
for SW-FCS cultures. This culture system seems to retain liver specific transcription of 
these important genes at physiological levels over longer times. 
Epidermal growth factor (EGF) and connective tissue growth factor (Ctgf) both showed 
no difference in expression between the different cell cultures. Whereas EGF, 
important for liver regeneration and the reentry into the cell cycle after lesions, was 
continuously reduced in all types of culture, Ctgf was strongly induced in all but 
suspension cultures. Ctgf promotes cell adhesion and cell motility in nonparenchymal 
liver cells and therefore cell activation during liver regeneration following injury (Pi et 
al., 2008). 
 
Table 26: Gene expression changes of liver enriched transcription factors (fold change>2 and 
pV<0.05). 
Susp Slice ML+FCS ML-FCS SW+FCS SW-FCS Symbol Accession-Nr. 1 d 1 d 1 d 6 d 10 d 1 d 6 d 10 d 1 d 6 d 10 d 1 d 6 d 10 d 
Ahr XM_579375 -6.2 -2.6 -2.7   -2.1   -3.8   -2.3   
Aif1 NM_017196 -2.2 -20.0 -36.9 -3.7  -31.6 -56.8 -53.0 -23.3 -2.9  -31.3 -49.1 -45.0
Arntl NM_024362    -2.6 -3.0  -2.2 -2.1  -3.4 -2.8    
Cd53 NM_012523  -4.5 -3.7 2.6 5.7 -4.1 -5.2 -4.9 -4.0  2.4 -4.1 -5.2 -4.8 
Ctgf NM_022266  3.7  30.4 31.3 30.1 28.4 26.9 -2.3 33.5 32.0 21.3 35.4 33.3 
Egf NM_012842 -5.1 -4.2 -4.1 -7.5 -9.7 -2.7 -6.4 -7.0 -3.5 -3.9 -5.3 -2.2 -3.1 -2.9 
Hnf4a NM_022180    -4.3 -3.8     -2.4 -2.2    
Khdrbs1 NM_130405    3.0 3.0  2.1 2.1  2.4 2.3    
Nr1h3/LXR NM_031627  -2.3 -3.3 -5.7 -5.4 -2.2 -3.2 -3.1 -2.7 -3.6 -3.2 -3.6  -2.0 
Nr1h4/FXR NM_021745  -3.1 -4.0 -10.6 -13.5 -2.5 -4.4 -4.6 -3.3 -2.0 -2.5 -4.7  -2.0 
Nr1i2/PXR NM_052980 -2.3 -3.8 -4.0 -5.7 -5.7    -2.9 -2.7 -2.7    
Nr1i3/CAR NM_022941  -5.2 -5.7 -13.1 -13.1 -2.5 -6.6 -4.8 -4.7 -8.2 -8.0 -4.6   
Nrp1 NM_145098 -2.1 -5.2 -5.5   -5.7 -5.3 -4.3 -5.7 -3.9  -5.8 -5.9 -5.7 
Pdzk1 NM_031712 -2.4 -4.7 -4.0 -12.4 -15.5 -3.5 -4.8 -5.7 -2.3   -3.0 -2.7 -2.6 
Rgs2 NM_053453 2.2   31.8 34.9 -2.6  3.8  15.9 23.2 -2.4  3.9 
Rgs3 NM_019340     2.3  -3.9 -2.7  2.3 2.7  -3.9 -3.7 
Rxra NM_012805 -2.3  -2.5 -3.5 -3.4  -2.6 -2.9  -2.1 -2.1    
Tcf4 NM_053369  -2.2    -2.2  -2.1 -2.1 -2.2  -2.1 -2.4 -2.3 
Thrb NM_012672 -3.2  -2.3 -4.0 -5.2  -2.7 -3.3 -2.4      
Tnfsf13 NM_001009623   -3.1   -3.7 -2.3 -2.4 -2.4   -4.0 -3.8 -3.6 
Vldlr NM_013155   6.7 5.0 5.4 4.4   5.3 4.3 4.6 8.5   
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The expression of CD53, initially repressed in all cultures, was increased over time in 
FCS containing cultures. CD53 is a transmembrane protein mediating signal 
transduction events that plays a role in the regulation of cell development, growth 
regulation and motility by forming complexes with integrins.  
 
3.3.6.6 Affected mechanisms in human hepatocytes 
In contrast to rat hepatocytes, the human orthologue genes, again clustered together to 
functional groups, were much more stable over time (Figure 57). In most of the groups 
no clear differences in the dedifferentiation processes were detected over time and 
gene expression changes in ML and in SW cultures were comparable. Interestingly, the 
liver progenitor cell line HepaRG showed partly specific hepatotypic gene expression 
and displayed stabile expression over time. Clear differences were found in the 
expression of genes involved in cellular signalling, mRNA-processing, ECM-proteins, 
cell adhesion and metabolism. 
Table 27 shows genes which displayed differences in expression in some mayor 
functional categories. Most important for toxicology, the deregulation of xenobiotic 
metabolism was less severe than in rat hepatocytes with some of the main enzymes 
mediating phase 1 metabolism (Cyp1a1 and 2E1) being down regulated. The 
glutathione system, which is encoded in distinct genomic clusters and represented here 
by Gstm3 and Gsp1, was less expressed in HepaRG cells, whereas Gsta was 
inversely regulated. Gsta´s are are the main enzymes for the detoxification of lipid 
peroxidation products whereas the other isoforms are mainly responsible for the 
detoxification of other electrophilic metabolites (Pham, Barber & Gallagher, 2004). 
Some of the differences found between HepaRG cells and primary human hepatocytes 
can be explained by the lower expression of certain transcription factors. The activating 
transcription factor 3 (ATF3), CCAAT/enhancer binding protein α (CEBPA) and the 
glucocorticoid receptor (Nr3c1) were found to be lower expressed in HepaRG cells 
than in liver. This glucocorticoid receptor can act as both a transcription factor and as a 
regulator of other transcription factors. ATF3 is a member of the activation transcription 
factor/cAMP responsive element-binding (CREB) protein family and binds to certain 
promoter and enhancer sequences. In addition to the positive or negative regulation of 
transcription, CEBPA is known to inhibit cyclin dependent kinases (CDK2 and CDK4), 
thereby causing growth arrest in cultured cells. 
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Figure 57: Group wise correlation analysis of the gene expression of primary human 
hepatocytes. The correlation plots represent important cellular and liver specific mechanisms for 
different primary rat hepatocyte culture methods. Changes in the correlation of gene expression 
in comparison to the reference experiments (FC) are indicated by a change of colour. The 
calibration bar on the right side indicates the colour scheme which was chosen for an optimal 
visualization. 
 
The expression levels of several genes correlating with inflammatory response and 
cytoskeletal and ECM rearrangement, like the formiminotransferase cyclodeaminase 
(Ftcd), which binds vimentin intermediate filaments, thereby regulating cytoskeletal 
rearrangement, were found to differ from the levels in liver, implicating the onset of 
restructuring in primary hepatocytes which in general was different in HepaRG cells.  
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Susp HepaRG (Basal) HepaRG (DMSO) ML-FCS SW-FCS Symbol Accession-Nr. 
1 d 1 d 6 d 10 d 1 d 6 d 10 d 1 d 6 d 10 d 1 d 6 d 10 d 
ALDH3A1 ILMN_6390  17.6 18.4 23.7 26.1 19.1 31.1   2.6 2.5 2.8 3.0 
APOA2 ILMN_18670  -2.8  -2.7 -11.3 -8.0 -13.2       
ATF3 ILMN_6468  -4.5 -2.8 -4.0 -4.4 -3.9 -3.5   2.2    
CD44 ILMN_7737  2.9 3.5 3.4   2.2 -2.1 -2.7  -2.1 -3.2  
CEBPA ILMN_27029  -3.6  -2.3 -3.0 -2.1 -2.9 -3.4      
CTGF ILMN_3374  2.5 2.4 2.9    -6.0 -2.6 -3.7 -8.8 -4.3 -3.3 
CYP1A2 ILMN_19528 -8.0 -49.3 -62.8 -54.5 -47.5 -37.0 -39.5 -13.1 -2.4 -3.0 -7.0  -3.2 
CYP2E1 ILMN_27893  -31.1 -11.3 -14.8 -9.0 -4.7 -12.1 -2.4 -20.1 -34.5  -10.0 -8.3 
CYP4B1 ILMN_25411  24.7 27.5 33.6 29.5 32.7 26.0       
EGFR ILMN_15615  -3.2 -2.6 -2.5 -2.4 -2.4 -2.0     -2.0  
FABP1 ILMN_11988 -3.6 -2.3  -2.6 -3.0  -6.5 -24.7 -7.6 -9.2 -15.2 -3.0 -5.1 
FBP1 ILMN_16804 -5.5 -250.3 -275.3 -268.2 -273.0 -220.1 -234.5 -14.3 -11.1 -13.3 -7.1 -6.1 -7.6 
FTCD ILMN_8918 -3.8 -193.6 -210.3 -193.2 -192.4 -158.3 -179.2 -4.3 -4.9 -4.8 -3.2 -2.9 -3.3 
GSTA1 ILMN_30031       -2.6 -3.4 -5.1 -5.0 -4.4 -4.9 -3.3 
GSTM3 ILMN_2804  -3.0 -3.0 -3.1 -3.0 -2.7 -2.9       
GSTP1 ILMN_10475 -2.8 -11.0 -13.2 -13.7 -11.2 -10.1 -10.1  -2.1     
HMOX1 ILMN_25059 2.6 -4.0 -4.9 -5.5 -3.3 -3.3 -2.4       
ISL1 ILMN_25965  3.7 3.7 4.6 5.6 5.0 5.4       
LPL ILMN_2233  10.5 10.6 7.5 16.0 12.6 9.2       
MAOA ILMN_11566  2.1 2.1 2.0 2.5 2.2 2.2    -2.5   
MMP7 ILMN_9188  7.0 11.3 17.0 4.0 3.7 4.4       
NQO1 ILMN_27575        2.2 4.4 7.8 2.0 5.7 8.1 
NR3C1 ILMN_21266  -2.7 -3.4 -3.2 -2.8 -2.4 -2.9       
PON1 ILMN_24208 -7.4 -3.3 -3.5 -4.5 -5.6 -4.4 -6.9 -14.7 -8.3 -14.2 -11.8 -6.3 -8.1 
PPARGC1A ILMN_16547 -6.2 -4.7 -3.7 -4.3 -4.1 -4.3 -5.4 -9.2 -8.4 -9.5 -10.6 -16.7 -14.4 
S100A6 ILMN_13161  -6.1 -8.2 -7.4 -7.9 -6.9 -7.6 2.2 14.1 24.5 2.0 14.1 15.2 
S100A8 ILMN_13072 -2.5 4.0 2.4  2.3 2.4 2.1 -4.9 -13.3 -12.4 -2.8 -9.7 -7.2 
SGK ILMN_2451  -2.5 -4.4 -3.1 -4.3 -5.0 -4.9 -8.4 -18.9 -18.7 -6.1 -21.2 -16.2 
SLC7A7 ILMN_16478  10.4 11.5 12.9 8.4 7.2 7.5  -2.1 -2.0   -2.2 
SPP1 ILMN_9394  9.7 8.7 4.6 2.4 2.2  -2.1 -2.1 -2.0 -2.2 -2.0  
SULT2A1 ILMN_16119 -13.7 -2.8 -2.4 -2.1    -8.9 -9.6 -7.2 -14.1 -9.8 -7.9 
TIMP1 ILMN_3162  3.6 2.9 3.3 3.3 3.8 4.1       
TNFRSF11
B ILMN_6495  22.9 24.0 9.6 8.5 7.0 6.5       
Table 27: Subset of genes differentially expressed in human primary hepatocytes and HepaRG 
cells. factors (fold change>2 and pV<0.05). 
 
3.3.7 Confirmation of the microarray results with TaqMan 
PCR 
Over all, more than 4000 genes were found to be differentially regulated between the 
different cell cultures and the liver or freshly isolated hepatocytes. The genes were 
selected by statistical significance (pValue<0.01) and fold change (either 1.5-fold or 2-
fold). Even though the technique used (Illumina BeadChip arrays) is highly 
standardized, there is still a possibility to obtain false positive results.  
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The data obtained by microarray experiment were confirmed by two different ways. 
First, the comparison to previously published gene expression data, which partly 
covered the experiments described here (Groneberg et al. 2002; Holme, 1985; Baker 
et al., 2001; Boess et al., 2003; Tuschl & Müller, 2006; Beigel et al., 2008) revealed 
every close resemblance in the general tendencies and pathways affected. In Addition, 
TaqMan PCR was used to verify the results of the global gene expression 
measurements. Therefore, TLDA cards were designed for high, moderate and low 
expressed rat and human genes of toxicological importance which were found to be 
significantly deregulated in culture. Experiments were conducted as stated in chapter 
2.2.4.3, using the same RNA as starting material which previously was used for the 
microarray experiments (results were generated as part of a joint work with Gregor 
Tuschl, PhD-student). 
TaqMan PCR was conducted with samples of 15 rat cell culture conditions (FaO cells, 
liver slices and suspension culture after 1 d in culture, ML+/-FCS and SW+/-FCS after 
1 d, 6 d and 10 d in culture) and with 43 genes of toxicological relevance resulting in an 
overall number of 645 genes tested in biological triplicates (Appendix 3 and Appendix 
4). 530 Of these genes fulfilled the quality cut-off values of being either >2-fold 
deregulated in the TaqMan experiments or being >2-fold deregulated with a pValue 
below 0.05 in the microarray experiment. From these 530 genes, 89% (471) were 
accordingly detected as deregulated with both techniques. None of these 471 genes 
differed in terms of direction of deregulation resulting in 100% consistent results with 
the selected parameters for the rat experiments. 
The results of human TaqMan analysis revealed slightly different results. In this case, 
34 genes were tested in 13 cell culture conditions (Suspension culture after 1 d, 
HepaRG cells in Basal/DMSO-media, at 1 d, 2 d, and 9 d, ML-FCS and SW-FCS at 2 
d, 7 d and 11 d) resulting in an overall number of 442 genes tested in biological 
triplicates (Appendix 5 and Appendix 6). Of these genes tested only 285 items were 
significantly deregulated. From these 285, only 37% (105) were commonly detected as 
deregulated with both techniques, but none of these items were detected to be 
inversely deregulated. The significantly lower rate of detection can be explained by the 
large human donor variation (Figure 49). The individual differences in gene expression 
lowered the number of genes matching the significance level cut off and therefore the 
overall detection rate. Nevertheless, the cut of values chosen guaranteed high quality 
and trustworthy results in both species. The TaqMan confirmation of some 
toxicologically important genes validated the results from the microarrays.  
Further analysis of the entire data set might give more details of the general adaptation 
processes taking place after perfusion and the differences between the different culture 
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systems. A very interesting aspect for future studies is the implementation of HepaRG 
as a new cell line displaying partly distinct, liver specific and stable gene expression. 
 
3.3.8 Conclusions from the characterization of primary 
hepatocytes in culture 
The application of toxicogenomic methods in combination with longer term cultured 
hepatocytes is a promising, but currently an error prone, approach. As gene expression 
is a highly dynamic and complex process, an optimization and standardization of the 
liver perfusion and culture conditions is crucial to maintain liver specific properties and 
gene expression and to generate reproducible and reliable results. Generally, the 
application of global gene expression serves two main goals. Firstly, it allows an exact 
characterization of the processes going on in the primary hepatocytes after perfusion 
and therefore leads to a greater understanding of these underlying processes and 
regulatory mechanisms controlling gene expression. Secondly, it is an essential 
prerequisite for each experimental model, especially for new and alternative in vitro 
models, to exactly characterize all relevant features and to estimate the capabilities 
and the value with respect of the expected results. 
Although previous studies showed the existence of various posttranscriptional and 
posttranslational modifications influencing the correlation between mRNA and proteins, 
the relatively small dataset shown here, four CYP-isoforms measured on mRNA, 
protein and activity level, showed comparable results. Additionally, the results from 
global gene expression analysis are supported by proteomic profiling. Even though 
fewer mass peaks were significantly detected in comparison to the gene expression, 
these profiles were sufficient to support previous results. The peak patterns clearly 
clustered according to time in culture and separated the different culture systems 
suggesting that SW-FCS is the most “liver-like” long term culture system. The major 
disadvantage of SELDI technology is that it is not clear which proteins were present.  
Changes in gene expression were detected already directly after the perfusion. These 
initial changes can be seen as a result of fundamental changes of cellular morphology 
and tissue disruption, as a result of stress during perfusion, the lack of signalling by 
other cell types and hormones and finally as an adaptation processes to the new in 
vitro environment. Some of these changes are inherent to the procedure of perfusion 
and were therefore expected. They can be minimized with the help of the serum 
composition. For example the lack of hormonal stimulation was balanced by the 
addition of Dex, a glucocorticoid analogue known to preserve metabolic activity and 
differentiation status in hepatocytes. Other processes are harder to avoid. The oxygen 
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gradient between perivenous and periportal hepatocytes and Wnt signalling by 
endothelial cells are known for their contribution to functional liver zonation (Braeuning 
et al., 2006; Kienhuis et al., 2007), but are obviously missing from all culture systems.  
The results of the global gene expression and from proteomic SELDI analysis clearly 
show the importance of an exactly defined and standardized cell culture. As the 
regulation of gene expression is a dynamic process, the degree of change is highly 
dependent on the type of culture and the time points chosen. To gain further insights 
into the processes taking place and to link their importance and relevance to 
toxicology, pathway analysis was conducted with genes found to be significantly 
deregulated. 
Over all, more than 4000 genes were found to be differentially expressed in all of the 
cell cultures compared to the liver or freshly isolated hepatocytes over time. It is 
obvious that the multiple effects and consequences can only be partially discussed 
here and so the study focused on changes accumulated over time in different cultures 
on a global level, as well as on specific toxicologically important and functionally related 
sets of genes. Special emphasis was put on a key function of these cells, i.e., their 
metabolic competence.  
Previous studies showed that most of the changes in culture are taking place during 
the first 24 to 48 h after plating (Beigel et al., 2008). These results were confirmed by 
this study. Additionally, the results of the global gene expression allowed a detailed 
view on the processes taking place during this time. The perfusion itself caused many 
changes in gene expression. Inflammatory responses and adaptation processes to the 
cell culture environment were characterized by the induction of many pro-inflammatory 
early response genes, like cytokines. In turn, this was accompanied by ECM 
reorganization, changes in intracellular signalling and the previously mentioned 
proliferative effects. Interestingly, many genes regulating blood flow and blood vessel 
buildup were induced, emphasizing the importance of the liver for these processes.  
Previous studies suggest that phase 2 metabolism is better preserved by cells in 
culture than phase 1 enzymes (Kern et al., 1997; Rogiers & Vercruysse, 1998). Our 
data contradicted this and revealed the deviations in expression levels of these 
enzymes when compared to the liver. Also here the SW-FCS culture delivered the 
most “liver-like” gene expression over a longer time for both phase 1 and phase 2 
enzymes. 
The addition of Dex not only improved the morphological appearance but also 
significantly increased the levels of metabolic enzymes such as CYP isoforms, several 
phase 2 isoenzymes and cellular transporters. Dex is known to induce a variety of 
enzymes including phase 2 enzymes by binding to hormonal activated transcription 
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factors (Waxman, 1999; Jemnitz et al., 2000). Figure 7 shows the main transcription 
factors and their complex interactions which can influence several important cellular 
processes. It is obvious to see that changes in transcription factors can lead to multiple 
modifications in cellular physiology. We showed here that the long-term culture system 
preserved best many transcription factors and several of the downstream processes. 
The short term cultures tested (liver slices and suspension culture) both showed a 
rapid decline in viability and gene expression. They are used for CYP-induction, 
biotransformation and cell viability studies. All of these studies rely on the proteins that 
are still present while in the liver and therefore deliver reliable results. Because of the 
rapid loss of hepatotypic functionality and gene expression, gene expression analyses 
have to be questioned, due to their poor reliability and correlation to the in vivo 
situation. Additionally, in liver slices, an overwhelming inflammatory response was seen 
with extensive signalling between the cell types (especially Kupffer cells, endothelial 
cells and hepatocytes) leading to the generation of nitric oxide (NO), oxidative stress 
and therefore increasing cellular stress. In addition, liver slices are thought to represent 
the in vivo situation better by the retention of the original ECM and cellular composition, 
this might mask many additional changes introduced by compound treatment making 
this culture system only suited for special applications such as a model for non-
parenchymal mediated hepatotoxicity, cell-interaction studies or for canalicular 
transport studies. 
Primary human hepatocytes generally showed much more stabile gene expression 
than rat hepatocytes in ML as well as in SW culture. In contrast to rat, based on the 
gene expression, no clear difference between ML and SW cultures was detected. 
Classical dedifferentiation markers like Gstp1 were not affected in either culture and 
the enzymes driving metabolism were mostly stabile and closer to the liver expression 
than in rat. For example, the CYP isoforms 1A2 and 2E1, which were heavily reduced 
in rat hepatocytes at later time points were much less deregulated in human 
hepatocytes and showed no difference between ML and SW. The massive immune 
response seen in rat hepatocytes was not observed in human cells to the same extent. 
This might be due to the fact that the experiments started one day later after perfusion. 
The correlation analysis of the gene expression data suggests less oxidative stress, 
less perturbations in the cellular cytoskeleton and a more liver like expression of the 
cellular transcription factors (Figure 56 and Figure 57). 
Despite the fact that primary human hepatocytes are much more difficult to obtain and 
much more expensive, their excellent stability makes them an ideal experimental 
system for toxicogenomics. Previous studies by Richert and her co-workers identified 
the use of cryopreserved hepatocytes as an alternative making this test system 
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independent from surgery, time and place (Richert et al., 2006; Alexandre et al., 2002). 
The studies conducted were short term (24 h), therefore the possibility to prolong the 
time in culture with cryopreserved human hepatocytes without additional loss of 
specific functionality has to be proven. 
When conducting studies with human hepatocytes, there are other major obstacles to 
be aware of. Human donors show great variability. First of all, genetic variability plays a 
significant role. The medical history and the moral conduct of the individuals has also a 
big influence, all together resulting in much larger inter-individual differences and 
making it harder to reach statistical cut-off values. Additionally, the genetic 
polymorphisms persent in phase 1, phase 2 and phase 3 enzymes in some individuals, 
making them exceedingly fast or slow metabolizers, influences the results of the 
toxicological studies. Therefore, a special emphasis has to be put on the statistical 
analysis of the individual human donors. 
Established cell lines, both rat and human, differed significantly from all other cultures. 
Dramatically lower expression of many metabolically important enzymes and the lack 
of inducibility might result in an underestimation or even complete lack of compound 
toxicity. Previous studies have reported an identification rate for cytotoxicity of only 
70% when compared with known toxicity in either in vitro assays in primary 
hepatocytes, in in vivo assays in rats, or in pre-clinical development (Westerink & 
Schoonen, 2007).Despite these disadvantages, hepatoma cell lines still have 
significant benefits as an easy-to-handle and stable test system for special 
applications. An exception was the human hepatoma cell line HepaRG. This relatively 
new established cell line has, compared to the other cell lines used, significantly 
elevated levels of metabolic enzymes as well as many other typical hepatocyte 
features (Parent et al., 2004). Previous findings from Kanebratt (Kanebratt & 
Andersson, 2008) were corroborated and even expanded upon these studies. They 
reported that the expression of CYP enzymes, transporter proteins, and transcription 
factors was stable in differentiated HepaRG cells over a period of 6 weeks. Most CYPs 
were lower but still stably expressed compared to primary hepatocytes, except for 
CYP3A4 and CYP7A1 (Kanebratt & Andersson, 2008). In these studies, the expression 
level of CYP4B1 was about 30 fold higher in HepaRG cells than in hepatocytes. This 
enzyme is suspected to activate certain carcinogenic compounds and thereby 
contribute to cellular damage. The expression of CYPs generally decreased slightly 
when cells were cultured in basal media without DMSO, whereas phase 2 enzymes 
and phase 3 transporters and other liver-specific factors were unaffected. Transporter 
studies showed the existence of active transporters at the contact surfaces of these 
cells (data not shown). Additionally, the global gene expression showed a higher 
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correlation of these cells to primary hepatocytes than to HepG2 cells, indicating at least 
partially differentiated cells.  
 
Taken together, the above described results of the morphological analyses, the 
functional tests, proteomic and global gene expression analysis clearly showed an 
advantage of the SW-FCS culture over the other cell cultures of primary rat 
hepatocytes. Alterations in xenobiotic metabolism and other hepatocyte-specific 
cellular functionalities, while still changing, were least pronounced. SW-FCS cultured 
cells showed the highest sensitivity to CYP inducers as well as being functionally active 
for over two weeks. Another important fact is the increased stability of gene expression 
from two days in culture up to two weeks. In some cases, even an increase in 
correlation to FC was observed suggesting some regenerative processes were taking 
place in SW-FCS. 
All together, these results make SW-FCS the culture system best suited for 
toxicogenomic studies for the generation of high-quality quantitative data under 
standardised cell culture conditions. 
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3.4 Development of an in vitro liver toxicity prediction 
model based on longer term primary hepatocyte 
culture 
3.4.1 Introduction to the in vitro prediction model 
The comparison of gene expression profiles from animals exposed to compounds 
belonging to the same class has been reported to result in a relatively high correlation, 
including the comparisons between different species treated with the same compound 
(Amin et al., 2002; Hamadeh et al., 2002a; 2002b). The assumption that compounds 
causing the same toxic endpoints also generate a unique gene expression signature 
has led to attempts to classify compounds according to their genomic profile. Up to 
now, several studies e.g. by Zidek et al. (2007) and Ellinger-Ziegelbauer et al. (2008), 
have shown the possibility to use this approach for the successful classification of 
unknown compounds. However, there are still many drawbacks, which have to be 
resolved. All the studies reported so far were conducted in vivo and therefore, they do 
not help for early screening in drug development. The fact that huge reference 
databases are required to generate classification results of high quality and predictivity 
shows that further progress in the development of these techniques is required. 
Meanwhile there are commercial service providers with large databases (mainly based 
on in vivo experiments) and automated profile analysis, but they are very expensive. In 
vitro data is highly dependent of the culture system used which, as already mentioned, 
is not standardized yet and therefore the data generated is not totally trustworthy. 
To test whether we can overcome the ethical, time and financial bottleneck of animal 
usage, our in vitro system was tested with 15 well known model compounds, as a proof 
of concept study. Subsequently, a blinded control study was conducted to validate the 
test system. Based on the results described in chapter 3.2, the SW-FCS conformation 
was defined as best cell system suited for further toxicogenomic studies. The aim of 
this study was therefore to generate a robust dataset, which could be used to generate 
a computational model for the classification of hepatotoxic compounds and negative 
controls samples in vitro.  
 
3.4.2 Short description of the test compounds 
The compounds used in this study are classic model compounds for hepatotoxicity and 
they were selected according to previous in-house data and published in vivo studies 
(Zidek et al., 2007). For all of the hepatotoxic compounds (Figure 58), there is already 
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information available about their mechanism of action, or at least of their adverse 
effects in vivo. Additionally, a former drug candidate from Merck KGaA, which was 
stopped during development due to hepatotoxicity, was employed as a blinded control 
sample for the verification of the test system. 
 
 
Figure 58: Molecular structures of the toxic and non-toxic compounds used in the classification 
model. *Acetaminophen, was not included in the model because of a lack of toxicity in the in 
vitro model (details see Figure 59) 
 
Tetracycline is a bacteriostatic antibiotic widely used in daily practice and therefore of 
importance to toxicological research. Dose dependently, it causes microvesicular 
steatosis. The mechanism of action was discussed in detail in chapter 3.1. 
 
Chlorpromazine (Cp) is an aliphatic phenothiazine which is used therapeutically as an 
anti-psycotic drug. The mechanism of action is still poorly understood, but liver injury 
and a periportal inflammatory reaction causes cholestasis, as well as a significant 
elevation of serum alanine aminotransferase (ALT). 
 
The toxicity of Erythromycin-Estolate (EE), a macrolid bacteriostatic antibiotic, is 
clinically similar to Cp. However, the progression to chronic liver damage from this drug 
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has not been clearly established. There is evidence that the effects of EE result from 
both metabolite-dependent and hypersensitivity-mediated processes (Westphal et al., 
1994). EE was also reported to cause reductions of bile flow and bile acid excretion in 
a dose dependent manner (Gaeta et al., 1985; de Longueville et al., 2003). 
 
In 1968, Desmet et al. reported the ability of α-naphthyl-isothiocyanate (ANIT) to 
directly cause hepatobillary cholestasis in the rat. It was used as a classic model 
compound to study the mechanisms of intrahepatic cholestasis. Although not finally 
clarified, it is proposed that ANIT causes liver injury in a dose dependent way by a 
reduction of the hepatic antioxidant defence system mediated by SOD and catalase, 
which in turn could contribute to the development of hepatic lipid peroxidation (Ohta et 
al., 1999). Additionally, the unstable thiocarbamoyl-GSH conjugate (GS-ANIT) is 
exported in the bile canaliculi and, after dissociation, ANIT accumulates, thereby 
leading to damage of biliary endothelial cells (Jean & Roth, 1995).  
 
The toxicity of Acetaminophen (AAP), a commonly used analgesic, is the most 
common cause of acute liver failure in man (Larson et al., 2005). It is catalyzed by CYP 
enzymes, mainly by CYP2E1 and CYP1A2, to a toxic intermediate which in turn is 
deactivated by building adducts with glutathione (Mutschler et al., 2008). Excessive 
amounts of the metabolite leads to a depletion of glutathione resulting in adduct 
formation and to increased susceptibility to oxidative stress. It was reported that an 
inhibition of metabolism led to a resistance against AAP (Zaher et al., 1998).  
 
Troglitazone (Tro) is an anti-diabetic and anti-inflammatory drug which was withdrawn 
from the market in 2000 due to idiosyncratic reaction leading to drug-induced hepatitis. 
It belongs to the class of thiazolidinediones, the same class as Rosiglitazone (Rosi). 
The mechanism of action is proposed to act via activation of peroxisome proliferator-
activated receptors (PPARs), mainly the γ-Type. The anti-inflammatory effects are 
correlated with a reduction of nuclear factor kappa-B (NFκB) accompanied by an 
increase in its inhibitor (IκB) (Aljada et al., 2001). In vitro studies of Tro and Rosi 
cytotoxicity in human hepatocytes revealed differences in the toxicity of Tro and Rosi 
whereby Tro appeared to be more toxic than Rosi, by all endpoints (Lloyd et al., 2002). 
 
Another PPAR activator is one of the non-toxic compounds used in this study, 
Clofibrate (Clo). By activating PPARα, it causes a lowering of triglyceride-levels in the 
blood and activates the lipoprotein lipase (Lpl) (Mutschler et al., 2008). As with all 
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PPAR activators, this compound may have carcinogenic potential in long-term 
experiments, but it causes no acute liver damage. 
 
Metformin (Met), analogous to the thiazolidinediones Tro and Rosi, lowers glucose 
production in the liver and is therefore used as an oral antihyperglycemic drug in the 
management of type 2 diabetes. In contrast to Tro and Rosi, Met acts primarily by 
decreasing endogenous gluconeogenesis, whereas Tro acts by increasing the rate of 
insulin mediated peripheral glucose disposal (Inzucchi et al., 1998). Even so, this drug 
has been in clinical use for up to 40 years now and detailed molecular mechanisms 
remain unclear. Recent gene expression studies found several genes deregulated 
linked to metabolic pathways involved in gluconeogenesis and lipid metabolism (Heishi 
et al., 2006). 
 
Theophylline (Theo) is a caffeine related xanthine derivative, an alkaloid which is used 
for the treatment of respiratory diseases. It acts by inhibition of phosphodiesterase 
activity and has additionally anti-inflammatory effects. It is metabolized extensively in 
the liver (up to 70%) and undergoes N-demethylation via cytochrome P450 1A2 
(Mutschler et al., 2008). This compound is not known to cause liver damage, but 
nevertheless, due to its several other side effects, it is only used as a second- or even 
third-line clinical solution (Boswell-Smith, Cazzola & Page, 2006) 
 
17β-Estradiol (17bEs) is an important naturally occurring steroid hormone. It acts as a 
female sex hormone and causes prostate enlargement in males (Mutschler et al., 
2008). It was shown that in chronic studies that this compound increased the incidence 
of tumours in several organs (Shull et al., 1997), but no direct adverse effects on the 
liver are known. 
 
The synthetic glucocorticoid Dexamethasone (DEX) has an immunosuppressive 
activity and also inhibits inflammatory processes. Due to these effects, it is used in 
clinics as an antagonist for liver damage caused by inflammation. Additionally, by 
binding to intracellular receptors, the transcription of multiple genes, e.g., metabolic 
enzymes, is modulated.  
 
Naloxone (Nal) antagonizes opioid effects by competing for the same receptor sites. It 
is therefore a pure narcotic antagonist without the side effects of respiratory 
depression, psychotomimetical effects or pupillary constriction, it exhibits essentially no 
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pharmacological activity (Sadée et al., 2005). It is metabolized in the liver, primarily by 
glucuronide conjugation and excreted in urine. 
 
Quinidine (Q) is an antiarrhythmic agent. Additionally, it is used as an antimalarial 
schizonticide. It acts by inhibiting mainly the fast inward sodium transporter of neurons 
(INa). It also inhibits the CYP2D6 which can cause increased blood levels of the drug. 
By inhibition of transporter proteins, it can cause some peripherally acting drugs to 
have CNS side effects, such as respiratory depression, if the two drugs are co-
administered (Sadeque et al., 2000). Quinidine is metabolized by CYP3A4 and there 
are several different hydroxylated metabolites, some of which have antiarrhythmic 
activity (Nielsen et al., 1999). 
 
The new compound EMD X is an internal Merck Serono compound. It was accepted to 
be used for the verification of the classification model but detailed background 
information, as well as the molecular structure, are proprietary. 
 
3.4.3 Experimental setup and dose finding 
The culture of primary rat hepatocytes was conducted in SW-FCS conformation. After 
plating, cells were incubated for three days to adapt to the cell culture environment. 
Previous results showed that most changes in gene expression occur in the first two 
days after perfusion and that, in SW-FCS culture, gene expression stabilized 
afterwards (chapter 3.3). This time of pre-culturing was chosen to avoid a high level of 
false positive genes which may mask any compound specific effects.  
For dose finding, two different cytotoxicity tests were conducted with membrane 
integrity (LDH-test) and cell viability (ATP-test) as the endpoints. For each compound, 
a series of multiple concentrations was run at least in biological triplicates for all time 
points tested to ensure statistical validity of the results. EC20 values were calculated for 
both cytotoxicity tests at all time points. The EC20 is the concentration of 
drug/xenobiotic required to induce a 20% loss of membrane integrity (LDH-test) or a 
20% reduction in ATP content (ATP-test). 
The final test concentrations for each compound were selected by combining the 
results from the LDH- and ATP-tests. One fifth of the EC20 value was taken as a 
second concentration. This non-cytotoxic dose is still expected to have effects on gene 
expression. 
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ANIT, as a positive compound showed a clear dose and time dependency in its 
cytotoxic effects, with a suggested threshold of about 50µM. For Theo, a non-liver toxic 
compound, no effects were detected up to the limit of solubility. In this case, the highest 
soluble concentration was defined as the high dose and one fifth as the low dose. Dex 
showed a very unusual dose response. No toxicity was detected, but instead, an 
increase of cellular viability at a medium concentration of 500µM was seen (Figure 
59C). As discussed previously, Dex has a positive effect on liver gene expression and 
stabilizes cell viability and gene expression in culture. Nevertheless, at high doses, 
other mechanisms seem to be having a negative effect on cell viability. Additionally, 
morphological changes were observed at all doses (Figure 60). The number and 
diameter of the bile canaliculi was significantly increased. Up to the medium dose, this 
was accompanied by an increase of canalicular transport, demonstrated by an 
accumulation of a fluorescent substrate in the canaliculi. However, at high doses of 
Dex, even though the bile canaliculi were again increased in diameter, this transport 
mechanism was inhibited and biliary transport was reduced (data not shown). To allow 
for these findings, three doses were used for Dex. 
Figure 59: Example of the toxicity 
tests conducted for dose finding. 
Shown are the results form ATP-
tests of A) the toxic compound 
ANIT, B) the non-liver toxic Theo 
and the two special results 
obtained with C) Dex and D) AAP. 
E) EC20 values were calculated 
with a sigmoidal curve fit in Origin®. 
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Figure 60: Primary rat hepatocytes in SW-FCS 9 d after dosing with three concentrations of 
Dex. The red arrows indicate the bile canaliculi.  
 
AAP, a classic liver toxic compound, did not show any toxicity in SW-FCS cultured 
hepatocytes. This is in contrast to previously reported studies, which clearly showed a 
toxic effect (Thedinga et al., 2007; Mingoia et al., 2007; Suzuki et al., 2008; Ullrich et 
al., 2007). A major difference between previous studies and this approach is the time in 
culture and the time of dosing. Whereas other studies were mainly short term with the 
compound treatment 4 h or 24 h, cells were treated in this study after 3 days. Looking 
at the mechanism of action, it becomes clear that AAP is not toxic itself but is 
metabolized to toxic intermediates by CYP isoforms, mainly CYP2E1. By looking at the 
gene expression data of rat hepatocytes in culture (Table 24), a strong reduction in 
CYP2E1 expression was seen. Jemnitz and his co-workers showed a clear 
dependency of AAP toxicity and time point of dosing with a greatly increased 
resistance to toxicity at later time points, in different species. Interestingly, they found 
no clear correlation of AAP toxicity to CYP2E1 activity ( Jemnitz et al., 2008). These 
results show the importance of a detailed knowledge of the test system and ideally of 
the mechanism of action and metabolism of the compound tested. Due to these results, 
AAP was removed from the dataset and was not used for the calculation of the 
prediction model.  
As a result of the toxicity tests, the concentrations noted in Table 28 were used as the 
final concentrations used in the gene expression profiling experiments. For clarification, 
the higher concentration will be named “high” and the lower concentration will be 
named “low”.  
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Compound 
Low Dose 
[µM] 
High Dose 
[µM] 
Compound
Low Dose 
[µM] 
High Dose 
[µM] 
Tet 40 200 Cp 4 20 
Clo 200 1000 Q 20 100 
Theo 50 250 DEX 200/500 1000 
ANIT 9 45 Rosi 16 80 
Nal 12 60 Tro 14 70 
EE 17 85 Met 300 1500 
17bEs 0.05 0.25 
EMD 
335825 
200 1000 
AAP 1000 5000 
Table 28: Concentrations of the test compounds used. The high concentration resembles the 
approximation of the EC20 of both cytotoxicity tests conducted (LDH- and ATP-test), the low 
concentration is one fifth of this value. Dex, as a special case, has a third concentration due to 
the fact that at this concentration a positive effect on cell viability was detected. 
 
Cells were exposed to the test compounds continuously for 9 d with media change 
every second day and observed for morphological changes (Figure 61). To exclude 
any solvent effects which may have influenced gene expression, compounds were 
concordantly dissolved in DMSO as a 200x stock resulting in an end concentration of 
0.5% of DMSO in the media. In the case of Met, which itself is not soluble in organic 
solvents, the DMSO was added directly to the media to guarantee standardized 
conditions. Therefore, time matched vehicle controls were treated with 0.5% DMSO.  
Samples were taken at 2 h, 1 d, 3 d, 5 d, 7 d, and on day 9 after the first dosing. RNA 
was reverse transcribed, labelled and hybridized on Illumina RatRef-12 BeadChips. 
Data analysis was conducted in BeadStudio (Illumina Inc.) and Expressionist Analyst 
(Genedata). Data was normalized with the LOESS algorithm in order to compare 
multiple arrays. Fold changes and statistical analysis were calculated in regard to the 
time matched vehicle controls. 
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Figure 61: Cells dosed with either the high or low dose of ANIT, Clo, Rosi, Q, EE or Tet on day 
nine of treatment. Interestingly, not only the hepatotoxic but also non-hepatotoxic compounds 
caused morphological changes, including the accumulation of lipid droplets (Clo, Q). On the 
other hand, ANIT did not significantly alter the morphology of the hepatocytes. Most severe 
changes were detected in cells dosed with high concentrations of Tet. These results fit to 
previously published in vivo data (Zidek et al., 2007). 
 
3.4.4 Data Analysis and establishment of an in vitro 
prediction model for hepatotoxicity 
As a first overview of the data a hierarchical clustering was performed with all time 
points tested (2 h, 6 h, 1 d, 3 d, 5 d, and 9 d after dosing). As shown in Figure 62, no 
clear separation was achieved at any of these time points. On days one and five, Rosi 
and Clo separated from the other experiments, but on day one also the livertoxic 
compound Tet grouped together with them. All other experiments were organized in 
two large groups but clearly not based on toxicity. At later time points, cells treated with 
all three doses of Dex separated from the other experiments and built their own cluster. 
These findings were also shown by other clustering methods, such as PCA (Figure 63).  
These results re-enforce the difficulty in establishing a model based on global gene 
expression. Also toxic compounds have specific mechanisms of action with specific 
gene expression changes, and these differences can be hidden by the large number of 
unaffected genes. To establish a model capable of discriminating between the two 
defined groups, other techniques are needed. 
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Figure 62: Hierarchical clustering from global gene expression data from compound treated 
primary rat hepatocytes. Shown are the results from cells dosed for 1 d, 5 d and 9 d with the 
previously described model compounds. No obvious separation of toxic and non-toxic 
compounds was achieved at any time point. 
 
The normalized data was grouped by compound, time point, and dose. Finally two 
groups, toxic and non-toxic, were defined according to the previously defined toxicity 
(see Figure 58). First, the possibility to create a functional classification model was 
tested. Therefore, trainings 
sets were created for all 
time points and for the high 
and low doses separately 
as well as for both together. 
The classification was 
conducted with four different 
classification algorithms to 
account for any potential 
“peculiarities” in the dataset. 
The support vector machine 
algorithm (SVM), the sparse 
linear discriminant analysis, 
the fisher linear discriminant 
Figure 63: PCA with global gene expression data from 
cells treated for 9 d with previously described model 
compounds. 
9d
Non-livertoxic
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analysis and the K-nearest neighbour analysis, all of which are supervised learning 
methods, were used. They were applied on the same dataset that was used for the 
training, but in this case, the leave-one-out cross-validation method was applied. This 
means that the training set was applied 1,000 times on the whole dataset, but in every 
run, 15% of the dataset were removed and the remaining data was classified. This 
classification method was checked for its accuracy afterwards and misclassification 
rates for each of these algorithms were calculated. This number defines the percentage 
by which the samples were allocated to the wrong group. At the same time, genes 
were ranked according to their importance for this discrimination and the number of 
genes needed for best results were calculated. Results are shown in Figure 64.  
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Figure 64: Construction of the classification models and gene rankings. Four different 
algorithms were applied to discriminate between two previously defined groups (toxic and non-
toxic). For each algorithm, the misclassification rate and the number of genes needed for best 
results were calculated.  
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In most cases, the classification algorithm of K nearest neighbour resulted in the best 
predictions. Generally, the misclassification rates were lower for the samples treated 
for 9 d than for samples treated for shorter times. By analysing only the low dose 
samples, a misclassification rate of approximately 32% was detected one day after 
dosing. This result was only slightly, but not significantly, improved at later time points.  
Taking only the high dose groups into the model resulted in a misclassification rate of 
19% after one day of dosing and 11% after 9 d. Best results were obtained with 
samples dosed for 9 d in culture taking both doses together into the model. In this 
case, the misclassification rate was reduced to 7.5%. To reach this rate, only 724 
genes were needed and were sufficient. 
Figure 65 shows examples of 
the results of the cross 
validations, 1 d and 9 d after 
dosing. It is clear to see the 
reduction of misclassified 
samples for the later time point. 
Whereas in the early samples 
the computer estimated both 
false positive and false negative 
samples, at later time points 
there were no falsely positive 
predicted samples. Only three 
samples were misclassified, all 
of which were low dose 
samples. One biological 
replicate of each, Tro, Tet and 
ANIT was wrongly predicted to 
be non-toxic. However, the 
whole group was still classified 
as toxic. All three groups had a 
classifier output of below 0.5, 
which means that they were 
relatively close to the imaginary 
midline between both groups 
and do not significantly differ. 
All together, this shows the 
need for replicate experiments 
1 d after dosing               9 d after 
Figure 65: Visualization of the “leave one out” cross 
validation showing the defined groups (left side) as basis 
for the calculation. The calculated significance is 
indicated by green as toxic and blue as non toxic (see 
side bar). The computer estimation for the whole dataset 
is shown on the right side of the figures. Shown are the 
results (both doses) on day 1 and 9 after dosing. 
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to increase robustness of the model by tolerating single experiments to be misclassified 
but retaining the overall correct result. 
The main objective of this study was to determine whether it would be possible to 
distinguish between hepatotoxic and non-hepatotoxic compounds with the help of an in 
vitro system and global gene expression analysis. The clustering analysis of the global 
gene expression data alone did not allow such discrimination. By using the support 
vector machine algorithm together with a cross-validation, it was possible to obtain a 
subset of genes that allowed the discrimination, with a false discovery rate of only 
7.5%. These results clearly show the advantage of longer term dosing for the 
establishment of gene expression changes, which clearly contribute to the 
discrimination of the two groups. Short term experiments only show the acute effects of 
a compound, like inflammatory or immune responses. This is not sufficient in in vitro 
experiments, because of the lack of certain cell types and therefore specific 
mechanisms may be missing. Dosing for longer times has the advantage of increasing 
compound specific gene expression changes and therefore enables the discrimination 
algorithms to find basic differences between toxic and non-toxic compounds in the 
dataset. 
At the same time, the combination of two different dosing schemes also contributed to 
a better model. This could be simply due to the fact that more data was available for 
the algorithm, making the comparison more valid. Additionally, by combining high and 
low doses, further information hidden in the global gene expression data set may be 
accessible to the algorithm. It is noticeable that the low dose treated samples alone 
were poorly distinguishable by the algorithms but improved the result of the whole 
dataset. This shows that this effect is not just additive but that there is really additional 
information introduced into the calculation by the low dose samples. For future 
applications these results imply that large datasets and, if possible, two (or more) 
doses are required for these kind of calculations. 
As detailed above, the aim of such prediction models is the classification of new data 
from novel compounds. This would not be possible by simple clustering methods but by 
ranking genes according to their contribution to the discrimination of the predefined 
groups and generation classifiers, this goal was achieved.  
For the verification of this prediction model, the potential hepatotoxicity of EMD X was 
predicted. Dosing and data acquisition for this compound was conducted exactly as 
described for the model compounds. Additionally, the same classifier was applied to 
the whole dataset, including the data from AAP and the model compounds used for the 
calculation of this model as a retrospective verification of the previously analyzed data.  
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With altogether 120 experiments, the calculated 
misclassification rate of 7.5% would allow nine 
experiments to be wrongly classified (partly shown 
in Figure 66). Overall, only eight experiments were 
misclassified. In most cases, all experiments were 
classified correctly, independent of the dose. For 
Tet, two out of five low dosed and one of the high 
dosed experiments were misclassified. Even so, 
because of the five biological replicates, the 
majority of these experiments were still correctly 
classified resulting in an overall correct 
classification for Tet. The new compound EMD X, 
was classified as hepatotoxic. All experiments were 
clearly allocated to this group resulting in a robust 
classification. This result corroborated perfectly with 
previously obtained results from other in house 
studies (data not shown). 
Another interesting result was obtained by the 
classification of AAP. Even so no toxicity was 
detected in the cytotoxicity tests (LDH and ATP 
test), the compound was still classified as 
hepatotoxic in both high and low dose treatment 
groups based on the global gene expression. A 
closer look on the single experiments revealed that 
in both doses, one experiment was classified as 
non toxic and two as toxic. The classifier output in 
most cases was unequivocal suggesting borderline 
classification. This means that the classification of 
this compound is less robust than for EMD X. 
Nevertheless, the classification showed an effect 
which could not be detected by cytotoxicity tests, 
but is well known in vivo. 
 
 
Figure 66: Result of the classification 
of data gained from primary rat 
hepatocytes treated for 9 d with Tro, 
Theo, Tet, EMD X and AAP. Shown 
are the concordances to the 
classifier, where green means high 
and blue means low concordance, 
and the final estimation of the 
algorithm. 
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3.4.5 Analysis of the top ranked genes of the prediction 
model  
During the process of calculating the prediction model, the genes were ranked by 
importance for the discrimination process. This ranking was achieved by ANOVA, a 
variance analysis method. The results showed 724 genes to be essential for the best 
classification of the experiments at 9 d (Appendix 13). These genes were analyzed for 
their molecular function and their involvement in toxicologically important cellular 
processes.  
The dataset, although quite large, is certainly not sufficient to discriminate between 
different types of hepatotoxicity. There are multiple pathways leading to toxicity, with 
complex and intersecting mechanisms. The aim of this work was to evaluate the 
possibility to detect and predict general hepatotoxicity. 
It is important to mention that the algorithm used for gene ranking is not selecting the 
genes according to their fold change, their statistical significance or their biological 
functions but according to their contribution to the classification. Nevertheless, it might 
be helpful to have a closer look at the genes that differentiated between hepatotoxic 
and non-hepatotoxic compounds.  
Figure 67 shows the result of a k-means clustering, which grouped the genes 
according to their gene expression profile in all samples. It can be seen that none of 
the clusters were discriminative on their own. But taken together, the information 
contained in these profiles is the basis for the discrimination model generated.  
 
 
Figure 67: Results of a k-means clustering with all samples used for classifying and the 724 top 
ranked genes at day 9 of treatment. Genes were grouped according to their gene expression 
profile. 
 
The PCA in Figure 68 was calculated with the 724 top ranked genes. In comparison to 
the PCA shown in Figure 63, which was calculated with the whole dataset, both groups 
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have now separated at least to a certain degree, although still no complete separation 
was seen. Thus, these genes clearly have inherent information that enables the 
separation of these groups, but at the same time, they are not sufficient for a 100% 
separation, explaining the false classification rate of 7.5%. 
 
 
 
 
 
 
 
 
 
 
 
Figure 68: PCA with the 724 top ranked 
genes from the model previously 
described.  
 
The top “hit” when a Fisher’s Exact Test analysis was performed was proteasome 
complex and protein degradation. In total, 17 protein subunits of the proteasome were 
important for discrimination. The proteasome is a multiprotein complex which has an 
important function in protein degradation in an ATP/ubiquitin-dependent process, in a 
non-lysosomal related fashion. A modified proteasome, the immuno-proteasome, is 
responsible for the processing of class I MHC peptides and is therefore involved in 
immunogenic responses. Another function of the proteasome is the directionality of the 
cell cycle by degrading the polyubiquitinated cyclins. Changes in cell cycle are often 
the result of cell damage or the recovery process following, for example, a necrotic 
event. The impairment of the cell cycle is also documented by cyclin-dependent 
kinases (Cdk7) or s-phase related proteins, which were also part of this gene selection. 
Several genes, Myc, Egf, the MAP kinase activated protein kinase2 (Mapkapk2), Tgfβ2 
and the inhibitor of kappaB kinase (Ikbkb), play important roles in intracellular signalling 
and thereby influence cellular fate, growth, cell cycle or metabolism. Other signals may 
drive the cell in the direction of apoptosis or survival as a reaction to oxidative stress or 
cell damage.  
The involvement of energy metabolism in liver toxicity was highlighted by lactate 
dehydrogenase B (Ldhb), triosephosphate isomerase (Tim) and Enolase. Also directly 
Liver
FC
Non-hepatotoxic
Hepatotoxic
FaO-cells
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linked to ATP production are genes such as ATP synthase C1 and d subunits, 
cytochrome c reductases NADH dehydrogenases. Other genes function as part of 
cellular adhesion complexes, for example the junctional adhesion molecule 3 (Jam3) 
and claudin 10, which are part of the tight junction complex and integrin-mediated cell 
adhesion. Both proteins are important for canalicular functionality.  
Xenobiotic metabolism genes were also contained in the selection. CYPs 1A1 and 2E1 
have important functions in the detoxification of a large number of compounds and 
therefore it is not surprising to find them included. Microsomal Gst 2 is an important 
phase 2 enzyme for drug detoxification and is involved in the production of leukotrienes 
and prostaglandin E, which are important mediators of inflammation.  
Taken together it is clear that many of the discriminative genes ranked are linked to 
mechanisms known to be related to toxicity or cellular damage. Again, it is important to 
note that the compounds used for this model work via a variety of mechanisms, which 
is shown by many genes affecting multiple important pathways.  
 
3.5 Insights into the mechanisms of action for selected 
compounds 
From the beginning, the aim of this study was the establishment of a model that can 
predict general hepatotoxicity in an in vitro system. Nevertheless, the amount of data 
collected during our study allows to perform additional mechanistic analyses. The 
comparison of the data generated from an in vitro toxicogenomics study with Tet 
showed high correlation to the results of an in vivo study with the same compound 
(chapter 3.1.1.4). Of course, not all the compounds can be conferred here in this detail, 
but some interesting new findings are discussed. Details of the mechanism of action of 
EMD X, which clearly showed toxicity in cell culture and was classified as toxic by the 
predictive model is be discussed in this chapter. Additionally, AAP is discussed, 
because the result from the predictive model (supported by in vivo data) differs from 
the results gained with standard in vitro cell viability testing. To show that genomic 
profiling can have conflicting results, too, some effects of Dex will be discussed in the 
context of cell morphology. 
 
3.5.1 EMD X 
The proprietary Merck compound EMD X, was used for validation of the model 
because of the availability of extensive in-house data. In fact, while being blinded for 
the model testing, it is known to cause hypertrophy of hepatocytes and, in high doses, 
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bile duct inflammation, hyperplasia and liver cell necrosis. At least some of these 
hepatotoxic effects seem to be present in vitro as well, leading to a clear classification 
of EMD X as hepatotoxic. 
Looking at the induced genes and mechanisms, it is obvious that this compound 
affected fatty acid and energy metabolism. The top ranked mechanisms there included 
the activation of fatty acid synthase activity, regulation of lipid metabolism via LXR, NF-
Y and SREBP. Also fatty acid oxidation and PPARα dependent genes, like Acox1, 
Cpt1α and β, Cte1 and CYP4A, were induced (Figure 69). Acyl-CoA thioesterases 
(Cte), which generates carboxylic acid and free Coenzyme A, were induced, whereas 
the generation of acetyl-CoA by acyl-CoA synthetases (ACSL) was reduced 
simultaneously. A metabolic activation was found to result as a response to an external 
stimulus, probably to EMD X treatment. Although the PPARα activation is not directly 
proven, these results show a high correlation to the results of the in vivo in-house data 
and exhibit clear characteristics of PPAR-dependent gene expression changes.  
CYP4A11 catalyzes the omega-hydroxylation of various fatty acids and was 
consistently induced, as was carnitine palmitoyltransferase (Cpt1a), the enzyme that 
catalyses the transfer of long chain fatty acids to carnitine for translocation across the 
mitochondrial inner membrane. These changes imply an increased need for energy of 
the cells after compound treatment. Whether this is a direct effect of EMD X treatment 
or a secondary effect due to the recovery after cellular damage can not be concluded 
from this data and needs to be further studied.  
The strong induction of several Gst enzymes indicates a reaction to oxidative stress 
within the cells. This might be caused by an increased metabolism resulting in 
increased amounts of ROS generated or by inflammatory processes. In support of the 
latter is the activation of AKT kinase (mediating survival to oxidative stress) at early 
time points and the finding that apoptosis related mechanisms being activated including 
the transcriptional up-regulation of caspases.  
Several genes involved in cellular adhesion, fibronectin, actin and other genes, were 
found to be reduced, implying cytoskeletal remodelling and a reduction of cellular 
anchoring, which may have been caused by the increase in cell volume, shown by 
histopathological investigations. Additionally, E-cadherin, which is used as a prognostic 
marker for hepatocellular cancer (Iso et al., 2005) was reduced at all time points and all 
doses. 
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Figure 69: Details of the omega-oxidation pathway of fatty acids (A) and the CoA 
biosynthesis pathway (B). Both pathways were found to be induced by EMD X 
treatment (modified from Metacore, GeneGO). 
 
Noticeable was the strong reduction of the complement pathway at all time points at 
both doses (Figure 70). This pathway, consisting of more than 30 proteins mainly 
synthesized in the liver (more than 90%), is part of the innate immune system and 
works by proteosomal activation after stimulation. The complement cascade leads to 
massive amplification of the response and to activation of the cell-killing membrane 
attack complex, thereby functioning as a pathogenic defense mechanism (Mayer, 
1984). Other functions include the attracting of immune cells, increasing the 
permeability of vascular walls and the initiation of inflammation. Earlier studies showed 
that transcription is induced during acute phase response following liver injury (Prada, 
Zahedi & Davis, 1998; Stapp et al., 2005).  
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The expression of complement factors is thought to be transcriptionally controlled by 
several liver specific transcription factors (TFs) (such as HNF´s and C/EBP´s) 
(Pontoglio et al., 2001; Garnier, Circolo & Colten, 1996). Interestingly, these factors 
were only slightly affected. The effect that EMD X has on these TFs, and the resulting 
strong inhibition of the complement pathway, is important and still needs to be 
confirmed. 
 
Figure 70: Genes of the classical complement pathway were found to be heavily reduced after 
EMD X treatment, independent of time and dose (modified from Metacore, GeneGO). 
 
These results are in good concordance with in house in vivo data, where in rats treated 
with EMD X a reduction of C1s and C6 was detected. However, C4bp, reduced in vitro, 
was nearly unaffected in vivo. A loss of complement activity results in diminished liver 
regeneration, accompanied by transient or fatal liver failure after partial hepatectomy 
(Strey et al., 2003). It may therefore be concluded that an impaired recovery after 
cellular damage may contribute to the hepatocyte necrosis seen in the histopathology 
after treatment.  
 
3.5.2 AAP 
AAP is one of the best studied compounds in respect to liver toxicity, because of two 
reasons. It was previously shown that primary hepatocytes loose their sensitivity to 
AAP and become resistant over time in culture (Jemnitz et al., 2008). These results 
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were confirmed by our negative cytotoxicity tests. If dosed 4 h or 1 d after plating, cells 
clearly showed reduced viability and increased LDH release (data not shown). 
Treatment 3 d after plating had no effect on ATP content or membrane integrity. 
Nevertheless, AAP was classified as hepatotoxic by our prediction model. The 
mechanistic gene expression analysis revealed clear adverse effects, but also showed 
a reduction of these effects over time. 
 
Figure 71: Genes of the phase 1 and phase 2 metabolism deregulated by AAP treatment in 
culture. Red bars indicate induction, blue bars the repression of gene expression (modified from 
Metacore, GeneGO). 
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AAP causes centrilobular hepatic necroses, via the CYP-generated reactive 
electrophilic metabolite N-acetyl-p-benzoquinone (NAPQI) (Tonge et al., 1998). The 
main players are the CYP-isoforms 1A2, 2E1 and 3A4. Normally, NAPQI is detoxified 
by an addition-reaction to GSH. This causes a depletion of GSH at higher doses and 
leads to covalently bound protein adducts, which finally cause the toxic effect (James, 
Mayeux & Hinson, 2003; Mitchell et al., 1973).  
Overall, the deregulations observed were more intense at the beginning of treatment, 
with return to the baseline expression than at later time points of culture. CYP 1A2 and 
2E1 were found to be significantly down regulated over time in cultures suggesting this 
as the reason for the increasing immunity of cells in culture. However, the same 
isoforms were found to be induced by AAP, making it possible that small amounts of 
the toxic metabolite may have been produced. Other isoforms, such as CYP 3A4 or 
2C19, were heavily down regulated by AAP (Figure 71).  
Generally, a reduction of phase 1 xenobiotic metabolism was observed whereas phase 
2 metabolism showed an inconsistent picture. Sult1B1 and UGT isoforms were 
reduced, and several Gst isoforms were induced. UGTs were previously shown to be 
less expressed during liver regeneration after AAP treatment (Tian et al., 2005). 
Together, these results can be interpreted as a cellular mechanism for the protection of 
the cell against oxidative stress and the increased need for antioxidants, like GSH, to 
overcome the toxicity caused by AAP treatment. Deregulations in the AKT kinase 
pathway (Figure 72A) were time dependent. At early time points, HSP90, a molecular 
chaperone involved in ATP-dependent folding of proteins and in sequestering damaged 
proteins, was strongly reduced. Deregulations of genes downstream of AKT kinase 
imply a toxic mechanism early after dosing. MDM2 is a protein which affects the cell 
cycle, apoptosis and carcinogenesis by inactivating p53 and by interacting with other 
proteins (Bose & Ghosh, 2007). While this antagonist is repressed, p53 as well as 
caspase 9 and NFκB were induced, driving the cells towards apoptosis.  
Figure 72B and C show the reduction of other important cellular mechanisms. CDK7 is, 
as a complex with cyclin H and MAT1, an essential component of the transcription 
factor TFIIH, which is involved in transcriptional initiation and DNA repair. All three 
genes were reduced initially by AAP treatment. Additionally, the initialisation of 
translation was reduced. Together with the building of protein adducts by NAPQI, this 
reduction of correctly folded proteins may contribute to the toxicity of AAP.  
All these effects may be the consequence of cellular stress caused by AAP and may be 
the reason that our model classified AAP into the category hepatotoxic. This result 
suggests the possibility to detect underlying toxic mechanisms that cannot be detected 
with other, established in vitro methods. The fact that most effects detected were only 
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transiently visible and no effects could be detected by cell viability tests may be an 
initial step to further studies, which are needed to uncover the mechanism of the 
increasing lack of response of primary hepatocytes in culture.  
 
Figure 72: Deregulations caused by AAP treatment. A) AKT-kinase pathway, B) section of the 
cell cycle, C) translation initiation. Red bars indicate induction, blue bars the repression of gene 
expression (modified from Metacore, GeneGO). 
 
3.5.3 Dex 
As previously noted, Dex had a positive effect on cell viability and biliary transport, but 
only at the medium dose (500µM) group. It is known from previous studies that Dex 
inhibits hepatocellular proliferation at high doses by inhibiting tumor necrosis factor 
(TNF) and IL-6 (Nagy et al. 2003). The analysis of the gene expression data revealed 
an induction of nucleotide metabolism and transcription by RNA polymerase II, only at 
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by an induction of oxidative stress related genes only in low and high dosed cells, but 
not in the medium dose. In contrast to this, pyruvate metabolism and insulin dependent 
signaling were reduced. The insulin pathway is critical for the regulation of intracellular 
glucose levels. The activated nucleotide production and the increased mRNA 
production are both energy consuming processes. At the same time, the energy 
producing pathways were reduced. These changes in gene expression are direct effect 
of Dex as a glucocorticoid and basal to the morphological and functional changes 
observed still needs to be analyzed. A real understanding of the underlying 
mechanisms taking place at the different concentrations could not be elucidated with 
this data. 
 
The different compounds showed relatively large overlaps in gene expression changes. 
At the same time, all had some unique gene expression profiles (as discussed here). In 
cases were the same mechanism of action is involved, (e.g. Tro and Clo as PPARα 
activators), known target genes like CYP4A and Cte were induced, but also clear 
differences were detected. For other compounds, unknown target genes and pathways 
were uncovered, which may give the beginning for future mechanistic investigations. 
In contrast to previously conducted in vivo studies, no universal gene regulations were 
detected confined to in one of the both predefined compound-groups (Zidek et al., 
2007). None of the genes were deregulated in one direction by all hepatotoxic 
compounds. Instead, sets of genes involved in the same cellular mechanism were 
detected, together building a network of regulatory processes and cellular reactions 
after compound treatment. Sometimes it is not easy to discriminate direct effects from 
secondary effects. For example, the induction of cell cycle related genes could be 
indicative for a mitogenic effect of a compound, or the initiation of the cell cycle could 
be a reaction to generated cellular damage. It is known that regenerative processes 
occur after liver necrosis and include proliferation (Viebahn & Yeoh, 2008). 
Often energy metabolism was affected, including changes in fatty acid oxidation, 
glycogenolysis and acetyl-CoA synthesis. This was also true for compounds which are 
non hepatotoxic. In general, all cellular reactions need or deliver energy equivalents, so 
it is not surprising to find changes in gene expression as a reaction to the cellular need. 
As a normal reaction, the cells are capable of handling these changes and to produce 
enough energy to sustain their metabolism. If energy consumption is too high or the 
production falls below the minimum needed for proper function, additional mechanisms 
are activated causing cell damage or driving the cell into necrosis or apoptosis 
(Nieminen, 2003). 
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4 CONCLUDING REMARKS AND FUTURE 
PERSPECTIVES 
 
In this work, new in vitro and molecular techniques were applied to establish a new, 
early test system for toxicological research. A wide range of alternative approaches are 
currently being developed to gain mechanistic information, to speed up the process of 
early screening in drug development, to improve the toxicological testing procedure 
itself and, of course, to reduce the number of animals used for toxicity testing. At the 
same time, new technical developments and options are being adopted into toxicology 
laboratories and tested for their suitability and robustness. One promising approach is 
the analysis of gene expression changes by microarrays (Amin et al., 2002). The 
combination of both of these basic approaches, in vitro experiments and modern 
technology, will help to answer some of the key questions faced by toxicology. 
Primarily, the applicability of two commercially available gene expression platforms was 
examined by a thorough comparative study of data gained from in vitro as well as in 
vivo experiments. Our results demonstrated that the high quality and correlation of 
generated data on a technical level lead to a high concordance in terms of the 
biological interpretations, making both platforms applicable for use in toxicological 
studies. This result was supported by the high correlation with TaqMan gene 
expression data. Recently, the FDA initiated a microarray “control” study (MAQC), 
which clearly showed the intra- and interlaboratory comparability of microarray results 
as well as the consistent results obtained from different microarray platforms (Guo et 
al., 2006; Shi et al., 2006).  
The comparison of several in vitro culture systems, each with their own advantages 
and disadvantages in terms of throughput, viability and metabolic activity (Table 2), on 
both morphological and functional levels, as well as the global gene expression level 
permitted insights into basal mechanisms which take place during cell culture. The 
combination of both global gene expression and primary hepatocytes has been 
performed before in smaller studies covering only limited, more specific questions, 
when compared to the data presented here in this thesis (Baker et al., 2001; Boess et 
al., 2003; Braeuning et al., 2006). This PhD work was an important step towards the 
understanding of how varying culture conditions affect hepatocellular differentiation and 
function.  At the same time, this comparison and subsequent optimizations lead to the 
establishment of a standardized and robust long-term hepatocyte culture system with 
clearly characterized morphological, functional and gene expression functions.  
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All of this data was necessary to allow for good data interpretation based on the 
background level of gene expression during culturing and to define the horizon of 
expectation to ensure the reliability of this test system.  
The main problem of all primary hepatocyte cultures is the reduction of metabolic 
activity over time in culture. While this is true for short term cultures like suspension 
cultures, liver slices and ML cultures, our data showed a deceleration of this process by 
culturing the hepatocytes in the SW conformation without FCS. Not only the basal gene 
expression of several CYPs was found to be higher in SW- cultures, but also the 
treatment with well known inducers resulted in an improved inducibility of the four 
CYPs tested. These findings are supported by published data on both the functional 
level as well as in terms of gene expression (Elaut et al., 2006a; LeCluyse et al., 2000; 
Richert et al., 2002; Rogiers & Vercruysse, 1998; Coecke et al., 2005).  
These results provided us with confidence to go forward with this in vitro culture system 
for a toxicogenomics study using several well known hepatotoxicants to show 
compound dependent gene expression changes and to compare different mechanisms 
of action. This data was not only used for mechanistic analyses but also to successfully 
develop a computer based discrimination model for hepatotoxicity. Up to now, studies 
employing such predictive models are based on in vivo data and are mainly focused on 
acute toxicity (Hamadeh et al., 2002b; Zidek et al., 2007; Ellinger-Ziegelbauer et al., 
2008; Ruepp et al., 2005). This model is the first study combining in vitro toxicology 
and toxicogenomics to test the possibility of using primary hepatocytes dosed for 9 d to 
depict sub-chronic toxicity.  
Surprisingly, even though a relatively small database was used, the classification of the 
compounds used was successfull, with a misclassification rate of only 7.5% after 9 
days. Knowing the fact that multiple gene expression changes are caused by the 
perfusion itself and the adaption to the culture conditions, this is a high-quality result 
and reflects the robustness of this in vitro system to predict the in vivo outcome. 
The resulting discrimination model was challenged with two blinded compounds to 
prove its ability do detect hepatotoxicity based on global gene expression. EMD X is a 
former Merck compound which was stopped in development and is known to be 
hepatotoxic. Using our model it was clearly predicted to be hepatotoxic. AAP has been 
reported to lose toxic potency in primary hepatocytes over time in culture (Jemnitz et 
al., 2008), which was also seen in our dose finding experiments. Nevertheless, it was 
predicted to be a hepatotoxin based on gene expression changes indicating that, 
although not visibly damaging the cells, AAP still caused changes at the gene level 
which would lead to hepatotoxicity. Further studies are needed to better understand the 
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mechanistic processes taking place in culture and the insensitivity of primary 
hepatocytes to AAP toxicity. 
In the last few decades, a new paradigm has emerged based on the assumption that 
knowing the mechanism of action of a toxic compound would enable the development 
of predictive models which would help new, safer compounds to be brought quicker 
onto the market. The search for adaptive changes in gene expression has resulted in 
many genes being proposed as predictive biomarkers, although only a few of them 
have been shown to be really decisive. Currently, new techniques in bioinformatic 
analysis has lead to the identification of gene signatures and networks which seem to 
contain more information and therefore to be more reliable than single gene biomarkers 
(Khor et al., 2006). 
The ultimate goal of these in vitro toxicogenomic studies is the establishment of a 
predictive screening model which is easy to use and which delivers reliable, high 
quality results. The results presented here are very promising, but this study is just the 
starting point for a more thorough classification process. As mentioned before, the size 
of the database used for classification is crucial for the validity of the system. This is 
highlighted by the fact that the best results were obtained with the whole dataset (low 
and high dose together). Is it really beneficial to combine two dosing schemes, or is the 
improvement due to the increasing size of the dataset? The high dose was chosen due 
to the reduction of cell viability, but changes in gene expression resulting from low dose 
treatment were seen as well. These low-dose effects may also contain important 
information for the prediction model. 
Another important point to consider is the dosing-scheme itself. Always controversially 
discussed (Monro, 1990; Campbell & Ings, 1988) and of central importance to the 
outcome of any in vitro experiment, there are currently no specific guidelines available. 
To avoid false positive or negative results, a list of general criteria would be helpful to 
exclude unsuitable samples due to incorrect dosing or differences in the culturing 
conditions. In toxicology testing, doses greatly in excess of pharmacologically active 
doses are used to induce adverse effects, therefore there might be effects obtained 
also for (in vivo) non toxic compounds, leading to false results. On the other hand, if a 
threshold value is not achieved, even toxic compounds may be classified as non toxic. 
A potential solution would be the application of a minimum number of deregulated 
genes according to t-test statistic and/or fold-change. A minimum set of deregulated 
genes might be adequate for discrimination. Whereas for non toxic compounds the 
genes affected should either be involved in non-damaging processes or random, toxic 
compounds should generate gene profiles clearly connected to adverse cellular fate 
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and viability.  The conduction of these tests with multiple doses, which is enabled by in 
vitro experiments, is also a possibility to increase data quality.  
The compound selection allowed a proof of concept for the constructed prediction 
model, although it was too small to cover all of the various potential mechanisms of 
hepatotoxicity. The gene set of 724 genes was capable of discriminating the 
compounds used to build the model, as well as to correctly classify newly added 
compounds with a misclassification rate of 7.5%. These results need to be further 
validated and refined, by including more compounds with specific modes of action or to 
focus a certain compound classes. This will increase the robustness of the predictive 
system and facilitate improved data interpretation. 
Finally, the insecurity of extrapolating the results in between species, especially to 
men, may be overcome by the possibility to conduct these experiments with human 
hepatocytes. Also human hepatocytes can be successfully cultured in either ML- or 
SW-conformation, there is still the need to optimize the culture conditions. Because of 
the difficulties and the costs of getting high quality human hepatocytes in a sufficient 
amount, there might also be other options like the new HepaRG cell line which may be 
considered. Yet, the data obtained during this work is promising but not sufficient to  
attest  the qualification of either possibility.  
To conclude, screening tests alone do not allow for a final estimation of the hazard and 
risk of a compound, but molecular toxicology can contribute by improving the 
mechanistic understanding, refining the predictivity of toxicological outcomes and to 
significantly reduce animal usage in toxicology and, more generally, in drug discovery. 
We have now a robust, semi-validated long-term cell culture system that can be used 
in drug discovery for predicting hepatotoxicity as well as helping the toxicologist to 
understand a compounds mechanism of action. Therefore, the development of this 
predictive in vitro test system can be seen as a contribution to the efforts to implement 
the principles of 3R into the daily toxicological work. 
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Appendix 1: Results of the one sided tests comparing gene lists ranked by p Value. 
Settings  
List comparison 
Assessing similarity of                top ranks 
Length of lists                             7263 
Quantile of invariant genes         0.5 
Number of random samples      1000 
 
Affymetrix_In vivo, high dose_24h   vs.   Illumina_In vivo, high dose_24h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 3.396578 0.021 0.00E+00 0.942
0.077 150 12.872106 0 0.00E+00 0.999
0.058 200 29.560405 0 2.55E-04 1
0.038 300 87.649945 0 2.17E-02 1
0.029 400 183.980918 0 1.72E-01 1
0.023 500 324.038894 0 6.33E-01 1
0.015 750 891.757136 0 4.39E+00 1
0.012 1000 1806.952651 0 1.45E+01 1
0.008 1500 4819.958101 0 7.07E+01 1
0.006 2000 9604.577392 0 2.09E+02 1
0.005 2500 16356.67251 0 4.71E+02 1
      
Affymetrix_In vivo, high dose_6 h    vs.   Illumina_In vivo, high dose_6 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 4.496039 0.012 0.00E+00 0.95
0.077 150 16.355067 0 0.00E+00 0.998
0.058 200 36.734735 0 0.00E+00 1
0.038 300 105.510524 0 5.53E-04 1
0.029 400 215.222581 0 1.41E-02 1
0.023 500 369.287354 0 9.00E-02 1
0.015 750 966.487184 0 1.39E+00 1
0.012 1000 1895.079548 0 7.04E+00 1
0.008 1500 4853.82513 0 5.12E+01 1
0.006 2000 9419.988236 0 1.76E+02 1
0.005 2500 15740.11764 0 4.28E+02 1
      
Affymetrix_In vivo, high dose_72 h   vs.   Illumina_In vivo, high dose_72 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 0.0820066 0.394 0.00E+00 0.936
0.077 150 0.9049201 0.351 0.00E+00 0.998
0.058 200 3.5427757 0.288 1.45E-03 0.999
0.038 300 17.8166802 0.16 9.41E-02 1
0.029 400 48.203631 0.058 7.56E-01 1
0.023 500 97.9639087 0.02 2.88E+00 1
0.015 750 319.699483 0 2.12E+01 1
0.012 1000 697.2417988 0 6.92E+01 1
0.008 1500 1994.939427 0 3.06E+02 1
0.006 2000 4137.290714 0 8.25E+02 1
0.005 2500 7258.68298 0 1.75E+03 1
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Affymetrix_In vivo, low dose_24h    vs.   Illumina_In vivo, low dose_24h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 1.991168 0.057 2.09E-04 0.888
0.077 150 6.969976 0.041 1.57E-02 0.902
0.058 200 15.638143 0.018 1.37E-01 0.91
0.038 300 45.759576 0 1.43E+00 0.919
0.029 400 95.184211 0 5.27E+00 0.946
0.023 500 166.214749 0 1.24E+01 0.976
0.015 750 451.538273 0 4.61E+01 0.999
0.012 1000 913.753175 0 1.06E+02 1
0.008 1500 2469.962063 0 3.34E+02 1
0.006 2000 5014.659594 0 7.77E+02 1
0.005 2500 8703.099602 0 1.52E+03 1
      
Affymetrix_In vivo, low dose_6 h     vs.   Illumina_In vivo, low dose_6 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 7.283426 0.006 0 0.955
0.077 150 19.243393 0 0 1
0.058 200 36.969171 0 0.00001 1
0.038 300 92.427889 0 0.01222236 1
0.029 400 180.357296 0 0.12293679 1
0.023 500 306.936003 0 0.55805418 1
0.015 750 822.530248 0 5.62455642 1
0.012 1000 1662.852982 0 22.7816052 1
0.008 1500 4442.275855 0 126.114992 1
0.006 2000 8804.673908 0 371.034203 1
0.005 2500 14842.6007 0 814.456991 1
      
Affymetrix_In vivo, low dose_72 h    vs.   Illumina_In vivo, low dose_72 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 0.6533219 0.148 1.02E-04 0.931
0.077 150 2.9582573 0.134 9.83E-03 0.945
0.058 200 6.9889852 0.122 8.04E-02 0.963
0.038 300 19.9385361 0.11 7.65E-01 0.977
0.029 400 40.3567281 0.106 2.73E+00 0.993
0.023 500 70.3485953 0.118 6.51E+00 1
0.015 750 201.443388 0.15 2.79E+01 1
0.012 1000 436.0229586 0.188 7.63E+01 1
0.008 1500 1310.829829 0.305 3.15E+02 1
0.006 2000 2856.292467 0.548 8.42E+02 1
0.005 2500 5208.756318 0.818 1.77E+03 1
      
Affymetrix_Tet_in vitro, 200µM_24h     vs.   Illumina_Tet_in vitro, 200µM_24h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 5.486148 0.009 0.00E+00 0.935
0.077 150 19.204741 0 0.00E+00 0.999
0.058 200 42.889678 0 2.55E-04 1
0.038 300 125.232997 0 2.22E-02 1
0.029 400 260.821096 0 1.85E-01 1
0.023 500 454.645129 0 7.13E-01 1
0.015 750 1213.559971 0 5.37E+00 1
0.012 1000 2392.390421 0 1.81E+01 1
0.008 1500 6122.928476 0 8.29E+01 1
0.006 2000 11833.59296 0 2.21E+02 1
0.005 2500 19662.67078 0 4.58E+02 1
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Affymetrix_Tet_in vitro, 200µM_6 h      vs.   Illumina_Tet_in vitro, 200µM_6 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 1.48309 0.069 0.00E+00 0.928
0.077 150 7.153101 0.032 1.47E-03 0.981
0.058 200 18.694907 0.006 2.48E-02 0.985
0.038 300 62.205048 0 4.50E-01 0.988
0.029 400 135.584691 0 2.20E+00 0.998
0.023 500 241.308089 0 6.24E+00 0.999
0.015 750 659.85671 0 3.12E+01 1
0.012 1000 1318.54695 0 8.42E+01 1
0.008 1500 3440.196261 0 3.09E+02 1
0.006 2000 6749.990373 0 7.60E+02 1
0.005 2500 11362.82429 0 1.54E+03 1
      
Affymetrix_Tet_in vitro, 200µM_72 h     vs.   Illumina_Tet_in vitro, 200µM_72 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 0.00E+00 0.953 3.29E-04 0.899
0.077 150 1.32E-03 0.994 1.71E-02 0.922
0.058 200 2.81E-02 0.994 1.24E-01 0.944
0.038 300 6.53E-01 0.992 1.07E+00 0.974
0.029 400 3.87E+00 0.99 3.64E+00 0.991
0.023 500 1.28E+01 0.986 8.33E+00 0.999
0.015 750 8.52E+01 0.948 3.16E+01 1
0.012 1000 2.76E+02 0.856 7.53E+01 1
0.008 1500 1.21E+03 0.491 2.49E+02 1
0.006 2000 3.17E+03 0.179 5.90E+02 1
0.005 2500 6.42E+03 0.054 1.16E+03 1
      
Affymetrix_Tet_in vitro, 40µM_24h      vs.   Illumina_Tet_in vitro, 40µM_24h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 2.385667 0.054 4.10E-02 0.504
0.077 150 7.646565 0.027 3.67E-01 0.525
0.058 200 16.499255 0.008 1.20E+00 0.572
0.038 300 47.125522 0 4.46E+00 0.706
0.029 400 97.431035 0 9.62E+00 0.851
0.023 500 169.010198 0 1.66E+01 0.942
0.015 750 449.565631 0 4.36E+01 0.999
0.012 1000 897.035527 0 9.09E+01 1
0.008 1500 2417.73594 0 2.92E+02 1
0.006 2000 4950.564876 0 7.23E+02 1
0.005 2500 8652.718524 0 1.49E+03 1
      
Affymetrix_Tet_in vitro, 40µM_6 h       vs.   Illumina_Tet_in vitro, 40µM_6 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 1.54447 0.07 1.64E-02 0.588
0.077 150 5.855951 0.052 2.09E-01 0.628
0.058 200 12.736524 0.035 8.40E-01 0.665
0.038 300 32.172252 0.02 4.06E+00 0.74
0.029 400 57.293263 0.031 1.04E+01 0.822
0.023 500 87.786004 0.049 2.05E+01 0.893
0.015 750 196.205276 0.163 6.66E+01 0.982
0.012 1000 375.311426 0.415 1.53E+02 1
0.008 1500 1069.383307 0.771 5.04E+02 1
0.006 2000 2385.423526 0.939 1.18E+03 1
0.005 2500 4494.577654 0.997 2.31E+03 1
APPENDIX  
 205
Affymetrix_Tet_in vitro, 40µM_72 h      vs.   Illumina_Tet_in vitro, 40µM_72 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 0.2532672 0.257 3.25E-02 0.527
0.077 150 1.4725369 0.249 3.15E-01 0.563
0.058 200 4.2493281 0.236 1.06E+00 0.609
0.038 300 16.3431309 0.184 4.06E+00 0.745
0.029 400 40.0437893 0.134 8.79E+00 0.866
0.023 500 78.6345881 0.089 1.52E+01 0.956
0.015 750 258.6040214 0.032 4.22E+01 1
0.012 1000 584.9951258 0.01 9.56E+01 1
0.008 1500 1780.971792 0.002 3.34E+02 1
0.006 2000 3846.553298 0.003 8.34E+02 1
0.005 2500 6931.927263 0.007 1.70E+03 1
 
Appendix 2: Results of the two sided tests comparing gene lists ranked by score. 
Settings 
List comparison    
Assessing similarity of     : top and bottom ranks  
Length of lists             : 7263    
Quantile of invariant genes : 0.5   
Number of random samples    : 1000   
   
Affymetrix_In vivo, high dose_24h  vs.   Illumina_In vivo, high dose_24h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 49.55621 0 0.00E+00 0.997
0.077 150 111.19045 0 0.00E+00 1
0.058 200 197.40218 0 0.00E+00 1
0.038 300 450.91057 0 1.65E-04 1
0.029 400 823.02235 0 8.51E-03 1
0.023 500 1322.53258 0 5.84E-02 1
0.015 750 3165.93227 0 8.55E-01 1
0.012 1000 5908.00598 0 3.74E+00 1
0.008 1500 14271.93084 0 2.11E+01 1
0.006 2000 26729.61978 0 6.50E+01 1
0.005 2500 43541.83669 0 1.59E+02 1
      
Affymetrix_In vivo, high dose_6 h vs.   Illumina_In vivo, high dose_6 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 54.99712 0 0.00E+00 0.996
0.077 150 129.93003 0 0.00E+00 1
0.058 200 236.95433 0 0.00E+00 1
0.038 300 547.40588 0 3.00E-03 1
0.029 400 989.25309 0 4.92E-02 1
0.023 500 1566.37151 0 2.62E-01 1
0.015 750 3621.70696 0 2.78E+00 1
0.012 1000 6586.25333 0 1.03E+01 1
0.008 1500 15395.64479 0 4.79E+01 1
0.006 2000 28266.90455 0 1.29E+02 1
0.005 2500 45425.74841 0 2.82E+02 1
      
      
APPENDIX  
 206
Affymetrix_In vivo, high dose_72 h  vs.   Illumina_In vivo, high dose_72 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 29.60283 0 0.00E+00 0.997
0.077 150 66.67136 0 5.59E-03 1
0.058 200 116.08303 0 7.25E-02 1
0.038 300 251.04498 0 1.14E+00 1
0.029 400 436.85835 0 5.47E+00 1
0.023 500 677.59694 0 1.59E+01 1
0.015 750 1542.033 0 8.53E+01 1
0.012 1000 2816.62934 0 2.41E+02 1
0.008 1500 6748.06413 0 8.96E+02 1
0.006 2000 12749.18053 0 2.13E+03 1
0.005 2500 21071.31965 0 4.07E+03 1
      
Affymetrix_In vivo, low dose_24h vs.   Illumina_In vivo, low dose_24h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 38.01436 0 0.00E+00 0.997
0.077 150 82.74386 0 0.00E+00 1
0.058 200 145.71855 0 1.52E-03 1
0.038 300 328.20886 0 6.04E-02 1
0.029 400 588.14631 0 4.20E-01 1
0.023 500 928.80845 0 1.48E+00 1
0.015 750 2162.53377 0 9.97E+00 1
0.012 1000 3998.17757 0 3.17E+01 1
0.008 1500 9708.97803 0 1.43E+02 1
0.006 2000 18443.33018 0 4.10E+02 1
0.005 2500 30493.33326 0 9.33E+02 1
      
Affymetrix_In vivo, low dose_6 h  vs.   Illumina_In vivo, low dose_6 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 35.45322 0 0.00E+00 0.997
0.077 150 79.64536 0 0.00E+00 1
0.058 200 147.2389 0 0.00E+00 1
0.038 300 363.52957 0 2.47E-03 1
0.029 400 696.20846 0 4.67E-02 1
0.023 500 1150.19933 0 2.74E-01 1
0.015 750 2835.18092 0 3.57E+00 1
0.012 1000 5332.80084 0 1.56E+01 1
0.008 1500 12882.55084 0 9.08E+01 1
0.006 2000 24036.39917 0 2.73E+02 1
0.005 2500 39035.32004 0 6.14E+02 1
      
Affymetrix_In vivo, low dose_72 h vs.   Illumina_In vivo, low dose_72 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 2.976163 0.055 0.00E+00 0.998
0.077 150 13.061734 0.007 2.96E-03 1
0.058 200 32.230139 0.001 4.58E-02 1
0.038 300 99.511169 0 7.66E-01 1
0.029 400 205.774151 0 3.63E+00 1
0.023 500 351.213881 0 1.02E+01 1
0.015 750 891.186768 0 5.26E+01 1
0.012 1000 1705.079388 0 1.49E+02 1
0.008 1500 4329.08781 0 6.02E+02 1
0.006 2000 8608.793868 0 1.58E+03 1
0.005 2500 14905.12842 0 3.31E+03 1
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Affymetrix_Tet_in vitro, 200µM_24h  vs.   Illumina_Tet_in vitro, 200µM_24h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 22.58013 0 0.00E+00 0.996
0.077 150 60.57986 0 0.00E+00 1
0.058 200 120.59625 0 0.00E+00 1
0.038 300 314.46124 0 0.00E+00 1
0.029 400 616.46887 0 5.43E-04 1
0.023 500 1034.53955 0 1.10E-02 1
0.015 750 2619.72023 0 3.59E-01 1
0.012 1000 5028.59504 0 2.33E+00 1
0.008 1500 12577.73879 0 1.99E+01 1
0.006 2000 24149.41609 0 7.53E+01 1
0.005 2500 40096.48161 0 2.03E+02 1
      
Affymetrix_Tet_in vitro, 200µM_6 h   vs.   Illumina_Tet_in vitro, 200µM_6 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 14.55154 0 0.4838354 0.315
0.077 150 35.10029 0 2.4942963 0.306
0.058 200 66.10476 0 6.397284 0.308
0.038 300 160.92214 0 19.4572677 0.387
0.029 400 302.45276 0 38.4889048 0.579
0.023 500 495.35045 0 62.8119617 0.798
0.015 750 1237.08209 0 146.950646 0.996
0.012 1000 2412.99373 0 269.555034 1
0.008 1500 6337.90474 0 670.206743 1
0.006 2000 12724.42496 0 1363.97036 1
0.005 2500 21927.40605 0 2470.59178 1
      
Affymetrix_Tet_in vitro, 200µM_72 h  vs.   Illumina_Tet_in vitro, 200µM_72 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 16.85476 0 0.00E+00 0.998
0.077 150 46.75645 0 0.00E+00 1
0.058 200 95.6189 0 0.00E+00 1
0.038 300 253.80153 0 1.70E-03 1
0.029 400 498.04828 0 2.77E-02 1
0.023 500 835.2868 0 1.45E-01 1
0.015 750 2126.6926 0 1.47E+00 1
0.012 1000 4127.58671 0 5.50E+00 1
0.008 1500 10549.77083 0 3.23E+01 1
0.006 2000 20588.51822 0 1.22E+02 1
0.005 2500 34607.73555 0 3.43E+02 1
      
Affymetrix_Tet_in vitro, 40µM_24h   vs.   Illumina_Tet_in vitro, 40µM_24h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 1.016569 0.219 0.103141 0.617
0.077 150 5.186208 0.149 0.6876056 0.698
0.058 200 13.919643 0.085 1.983603 0.781
0.038 300 49.101183 0.021 7.0161555 0.924
0.029 400 114.181156 0.002 15.9344595 0.976
0.023 500 216.395932 0 29.8661677 0.997
0.015 750 677.855438 0 95.230228 1
0.012 1000 1506.573843 0 218.768469 1
0.008 1500 4573.798813 0 699.055785 1
0.006 2000 9930.830092 0 1584.58575 1
0.005 2500 17961.08234 0 3004.01755 1
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Affymetrix_Tet_in vitro, 40µM_6 h    vs.   Illumina_Tet_in vitro, 40µM_6 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 0.2559717 0.461 1.523661 0.148
0.077 150 1.6982916 0.443 5.871424 0.117
0.058 200 5.2381833 0.423 13.314133 0.089
0.038 300 21.1078175 0.385 36.409515 0.082
0.029 400 51.7865426 0.361 69.01333 0.118
0.023 500 100.3429219 0.357 111.300757 0.229
0.015 750 322.5465651 0.389 272.773391 0.659
0.012 1000 738.0425118 0.437 546.638554 0.934
0.008 1500 2368.086474 0.591 1589.41331 1
0.006 2000 5336.811315 0.838 3531.41974 1
0.005 2500 9905.492391 0.978 6631.43868 1
      
Affymetrix_Tet_in vitro, 40µM_72 h   vs.   Illumina_Tet_in vitro, 40µM_72 h 
  Genes Scores p.values Rev.Scores Rev.p.values 
0.115 100 8.16E-01 0.246 0.1634394 0.523
0.077 150 5.11E+00 0.132 0.9225119 0.584
0.058 200 1.56E+01 0.048 2.4006937 0.683
0.038 300 6.13E+01 0.004 7.3470961 0.881
0.029 400 1.47E+02 0 15.1555819 0.977
0.023 500 2.77E+02 0 26.5637358 0.997
0.015 750 8.23E+02 0 76.8447866 1
0.012 1000 1.73E+03 0 172.214448 1
0.008 1500 4.78E+03 0 588.618738 1
0.006 2000 9.79E+03 0 1472.45966 1
0.005 2500 1.71E+04 0 3013.93168 1
 
Appendix 3: Number of genes deregulated between different typers of primary rat 
hepatocyte culture. Shown are the results of an ANOVA concerning the effect of culture 
condition and the effect of time. Light grey means up regulated genes and the darker 
grey means down regulated genes. 
Culture condition Nr. of genes deregulated between culture conditions
Nr. of genes deregulated over time 
of culture 
336 Liver/FC 693  
2178 Liver/FaO 1405  
123 922 Liver Slices 178 610 
253 924 FC Susp. 267 1124 
1320 463 FC/ML + FCS 992 383 
864 260 FC/ML - FCS 722 204 
910 235 FC/SW + FCS 826 98 
1199 105 FC/SW - FCS 919 168 
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Appendix 4: Number of genes deregulated between time points of rat hepatocyte 
cultures were calculated with T-test statistics (<pV 0.01; >1.5fold). Light grey means up 
regulated genes and the darker grey means down regulated genes. 
Short term 
cultures 
Nr. of genes 
deregulated ML cultures 
Nr. of genes 
deregulated SW cultures 
Nr. of genes 
deregulated
742 2099 1650 Liver/FC 868 FC/ML +FCS 1 d 1681 FC/SW +FCS 1 d 1462 
2828 143 191 Liver/FaO 2023 ML +FCS 1 d/2 d 137 SW +FCS 1 d/2 d 78 
452 346 396 Liver Slices 622 ML +FCS 1 d/4 d 264 SW +FCS 1 d/4 d 260 
248 990 512 Slices 0 h/2 h 54 ML +FCS 1 d/6 d 836 SW +FCS 1 d/6 d 328 
885 1218 590 Slices 0 h/6 h 939 ML +FCS 1 d/10 d 1026 
SW +FCS 1 d/10 
d 448 
887 1612 1920 Slices 0 h/1 d 661 FC/ML -FCS 1 d 1413 FC/SW -FCS 1 d 1701 
988 157 242 Slices 0 h/2 d 794 ML -FCS 1 d/2 d 212 SW -FCS 1 d/2 d 175 
613 362 389 FC/Susp. 2 h 778 ML -FCS 1 d/4 d 371 SW -FCS 1 d/4 d 275 
738 546 532 FC/Susp. 4h 819 ML -FCS 1 d/6 d 485 SW -FCS 1 d/6 d 356 
898 590 684 FC/Susp. 6 h 1063 ML -FCS 1 d/10 d 457 
SW -FCS 1 d/10 
d 373 
1064     FC/Susp. 1 d 1385     
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Appendix 5: List of rat genes measured with TaqMan PCR for the verification of the 
microarray experiments 
Gene 
Symbol Gene name Accession Nr.
Gene 
Symbol Gene name 
Accession 
Nr. 
Acox1 acyl-Coenzyme A oxidase 1, palmitoyl NM_017340 Hnf4a 
hepatocyte nuclear factor 4, 
alpha NM_022180 
Actn1 actinin, alpha 1 NM_031005 Hspa1b heat shock 70kDa protein 1A NM_212504 
Adk adenosine kinase NM_012895 Jund jun D proto-oncogene XM_579658 
Afp alpha-fetoprotein NM_012493 Abcb1 
ATP-binding cassette, sub-
family B (MDR/TAP), 
member 1 
NM_012623 
Nr1i3 nuclear receptor subfamily 1, group I, member 3 NM_022941 Abcb4 
ATP-binding cassette, sub-
family B (MDR/TAP), 
member 4 
NM_012690 
Cdh1 cadherin 1, type 1, E-cadherin (epithelial) NM_031334 Abcc2 
ATP-binding cassette, sub-
family C (CFTR/MRP), 
member 2 
XM_577883 
Cebpa CCAAT/enhancer binding protein (C/EBP), alpha NM_012524 Abcc3 
ATP-binding cassette, sub-
family C (CFTR/MRP), 
member 3 
NM_080581 
Cebpb CCAAT/enhancer binding protein (C/EBP), beta NM_024125 Myc 
v-myc myelocytomatosis 
viral oncogene homolog 
(avian) 
NM_012603 
Cpt1a 
carnitine 
palmitoyltransferase 1A 
(liver) 
NM_031559 Oatp1 
Slco1a1 solute carrier 
organic anion transporter 
family, member 1a1 
XM_579394 
Ccnd1 cyclin D1 NM_171992 Cdkn1a cyclin-dependent kinase inhibitor 1A (p21, Cip1) NM_080782 
Ccng1 cyclin G1 NM_012923 Pck1 Phosphoenolpyruvate carboxykinase NM_198780 
Cyp1a2 cytochrome P450, family 1, subfamily A, polypeptide 2 NM_012541 Alpi 
alkaline phosphatase, 
liver/bone/kidney NM_022665 
Cyp2c cytochrome P450, family 2, subfamily C, polypeptide 8 NM_019184 Nr1i2 
nuclear receptor subfamily 
1, group I, member 2 NM_052980 
Cyp3a3 cytochrome P450, family 3, subfamily A, polypeptide 4 NM_013105 Rgn 
regucalcin (senescence 
marker protein-30) NM_031546 
Fabp2 fatty acid binding protein 1, liver NM_013068 Sod2 
superoxide dismutase 2, 
mitochondrial NM_017051 
Fbp1 fructose-1,6-bisphosphatase 1 NM_012558 Tgfa 
transforming growth factor, 
alpha NM_012671 
Gadd45a growth arrest and DNA-damage-inducible, alpha NM_024127 Tgfb1 
transforming growth factor, 
beta 1 (Camurati-
Engelmann disease) 
NM_021578 
Gsn gelsolin (amyloidosis, Finnish type) 
NM_00100408
0 Timp1 
TIMP metallopeptidase 
inhibitor 1 NM_053819 
Gsta3 glutathione S-transferase A1 NM_031509 Tnf 
tumor necrosis factor (TNF 
superfamily, member 2) NM_012675 
Gstp2 glutathione S-transferase pi NM_138974 Txn2 thioredoxin NM_053331 
Hmox1 heme oxygenase (decycling) 1 NM_012580 Ugt1a1 
UDP 
glucuronosyltransferase 1 
family, polypeptide A6 
NM_012683 
Tcf1 
transcription factor 1, 
hepatic; LF-B1, hepatic 
nuclear factor (HNF1), 
albumin proximal factor 
NM_012669    
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Appendix 6: List of rat genes measured with TaqMan PCR for the verification of the 
microarray experiments 
Gene 
Symbol Gene name Accession Nr.
Gene 
Symbol Gene name 
Accession 
Nr. 
ACTN1 actinin, alpha 1 NM_001102 TCF1 
transcription factor 1, 
hepatic; LF-B1, hepatic 
nuclear factor (HNF1), 
albumin proximal factor 
NM_000545 
ADK adenosine kinase NM_001123 HNF4A hepatocyte nuclear factor 4, alpha NM_000457 
AFP alpha-fetoprotein NM_001134 JUND jun D proto-oncogene NM_005354 
ALPI alkaline phosphatase, liver/bone/kidney NM_000478 ABCB1 
ATP-binding cassette, sub-
family B (MDR/TAP), 
member 1 
NM_000927 
CEBPA CCAAT/enhancer binding protein (C/EBP), alpha NM_004364 ABCB4 
ATP-binding cassette, sub-
family B (MDR/TAP), 
member 4 
NM_000443 
CEBPB CCAAT/enhancer binding protein (C/EBP), beta NM_005194 ABCC2 
ATP-binding cassette, sub-
family C (CFTR/MRP), 
member 2 
NM_000392 
CPT1A 
carnitine 
palmitoyltransferase 1A 
(liver) 
NM_00103184
7 ABCC3 
ATP-binding cassette, sub-
family C (CFTR/MRP), 
member 3 
NM_003786 
CCND1 cyclin D1 NM_053056 MYC 
v-myc myelocytomatosis 
viral oncogene homolog 
(avian) 
NM_002467 
CCNG1 cyclin G1 NM_004060 CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1) NM_000389 
CYP1A2 cytochrome P450, family 1, subfamily A, polypeptide 2 NM_000761 RGN 
regucalcin (senescence 
marker protein-30) NM_004683 
CDH1 cadherin 1, type 1, E-cadherin (epithelial) NM_004360 SOD2 
superoxide dismutase 2, 
mitochondrial NM_000636 
FABP2 fatty acid binding protein 1, liver NM_001443 TGFA 
transforming growth factor, 
alpha NM_003236 
GADD45A growth arrest and DNA-damage-inducible, alpha NM_001924 TGFB1 
transforming growth factor, 
beta 1 (Camurati-
Engelmann disease) 
NM_000660 
FBP1 fructose-1,6-bisphosphatase 1 NM_000507 TXN2 thioredoxin 
NM_003329, 
BC054866 
GSN gelsolin (amyloidosis, Finnish type) NM_000177 TIMP1 
TIMP metallopeptidase 
inhibitor 1 NM_003254 
GSTA3 glutathione S-transferase A1 NM_145740 TNF 
tumor necrosis factor (TNF 
superfamily, member 2) NM_000594 
HMOX1 heme oxygenase (decycling) 1 NM_002133 UGT1A1 
UDP 
glucuronosyltransferase 1 
family, polypeptide A6 
NM_001072 
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Appendix 7: Genes induced in expression after the perfusion of rat liver. Listed are only 
genes more than 2-fold deregulated and with a pV<0.01. 
Symbol Accession Fold change Symbol Accession 
Fold 
change Symbol Accession 
Fold 
change 
Acy1 XM_579142.1 2.0 LOC246266 NM_144750.1 2.0 Pmvk NM_001008352 2.0 
Adamts7_pred XM_236471.3 2.5 LOC287419 XM_213367.3 2.0 Ppp1r10 XM_579471.1 2.1 
Ankrd9_pred. XM_576103.1 2.1 LOC287452 XM_213357.3 2.1 Ppp4c XM_341929.2 2.1 
Anpep NM_031012.1 2.4 LOC288659 XM_213769.3 2.2 Prodh2_pred. XM_341825.2 2.5 
Apba3 NM_031781.1 2.1 LOC290500 XM_214256.3 2.6 Ptges2_pred. XM_231144.3 2.1 
Atf3 NM_012912.1 5.5 LOC291905 XM_214652.3 2.0 Ptov1 NM_001008304 2.2 
Bat3 NM_053609.1 2.3 LOC293689 XM_215181.3 2.1 Rab11b NM_032617.2 2.2 
Besh3 XM_346854.2 2.2 LOC296733 XM_216063.3 2.1 RGD1305860_pred XM_343183.2 2.3 
Bhlhb2 NM_053328.1 6.1 LOC297388 XM_216181.2 2.2 RGD1311324_pred XM_343028.2 2.3 
Btd_pred. XM_577477.1 2.1 LOC300043 XM_216963.3 2.0 Rgs3 NM_019340.1 2.2 
Btg2 NM_017259.1 12.0 LOC303677 XM_221119.3 2.0 Rhob NM_022542.1 2.3 
Cbara1 NM_199412.1 2.1 LOC310395 XM_227134.3 2.7 Ring1 NM_212549.1 2.0 
Ccs NM_053425.1 2.0 LOC310585 XM_227366.3 2.0 Rps6ka1 NM_031107.1 2.0 
Cd14 NM_021744.1 2.1 LOC360919 XM_341193.2 2.2 Scarb1 NM_031541.1 2.2 
Cdc20 NM_171993.1 2.0 LOC361184 XM_341467.2 2.1 Scrn2_pred. XM_573186.1 2.2 
c-fos XM_234422.3 5.0 LOC361523 XM_341808.2 2.7 Sds NM_053962.2 2.4 
Creb3l3_pred. XM_576179.1 2.2 LOC362196 XM_342497.2 4.6 Sfrs9 NM_001009255.1 2.0 
Creld1_pred. XM_232270.3 2.1 LOC362287 XM_342601.2 2.0 Slc13a3 NM_022866.1 2.1 
Cry1 NM_198750.1 2.4 LOC362840 XM_343168.2 2.4 Slc16a11_pred. XM_213334.3 2.7 
Cxxc5 NM_001007628 2.1 LOC362899 XM_343227.2 2.5 Slc16a13 
NM_00100553
0.1 2.1 
Cyp2t1 NM_134369.1 2.2 LOC362983 XM_343313.2 2.0 Slc25a25 NM_145677.1 2.8 
Cyr61 NM_031327.2 3.1 LOC497733 XM_579432.1 2.5 Slc27a1 NM_053580.2 2.2 
Ddx56 NM_001004211 2.3 LOC497875 XM_573059.1 2.4 Slc29a1 NM_031684.2 2.1 
Dgkz NM_031143.1 2.1 LOC498703 XM_573985.1 2.3 Slc39a3 NM_001008356.1 2.1 
Dhcr24_pred. XM_216452.3 2.5 LOC499072 XM_574354.1 2.2 Slc6a12 NM_017335.1 2.3 
Dom3z NM_212497.1 2.1 LOC499823 XM_575162.1 40.7 Snf1lk NM_021693.1 3.6 
Dp1l1_pred. XM_343163.2 2.4 LOC499837 XM_580023.1 2.1 Soat2 NM_153728.2 2.0 
Dusp1 NM_053769.2 3.3 LOC500019 XM_575373.1 3.3 Socs2 NM_058208.1 2.7 
Dusp5 NM_133578.1 2.1 LOC502714 XM_578213.1 2.7 Srebf1 XM_213329.3 2.2 
Egr1 NM_012551.1 11.1 LOC503325 XM_578859.1 4.1 Srm NM_053464.1 2.3 
Egr2 NM_053633.1 2.1 Mafb NM_019316.1 2.4 Srms_pred. XM_575301.1 2.0 
Fam20a_pred. XM_573215.1 2.1 Man2c1 NM_139256.1 2.1 Stard4_pred. XM_214592.3 2.2 
Fgf21 NM_130752.1 3.7 Mbd6_pred. XM_343219.2 2.0 Stub1_pred. XM_213270.3 2.1 
Gadd45a NM_024127.1 2.3 Mclc NM_133414.1 2.4 Tieg NM_031135.1 2.1 
Gadd45g_pred XM_237999.3 9.0 Minpp1 XM_342044.2 2.0 Tmem7_pred. XM_236656.3 3.1 
Gdf15 NM_019216.1 14.4 Mtch1_pred. XM_215358.3 2.3 Tomm40 NM_212520.1 2.0 
Gfra3 XM_341593.2 2.0 Myc NM_012603.2 3.2 Tst NM_012808.1 2.4 
Gpaa1 NM_001004240 2.4 Myd116 NM_133546.1 4.6 Ube2m_pred. XM_341790.2 2.4 
Grina NM_153308.1 2.0 Napa NM_080585.1 2.1 Wbscr16_pred. XM_341066.2 2.0 
Hes1 NM_024360.2 2.7 Nat8 NM_022635.1 2.9 Zfp36 NM_133290.2 4.0 
Hspbp1 NM_139261.1 2.0 Ndufv3l NM_022607.1 2.0    
Ier2 NM_001009541 4.8 Nfil3 NM_053727.2 2.2    
Igfals NM_053329.1 3.2 Okl38 NM_138504.2 2.6    
Igfbp1 NM_013144.1 5.3 Per2 NM_031678.1 2.1    
Jun NM_021835.2 5.2 Pex14 NM_172063.1 2.2    
Junb NM_021836.2 10.2 Phgdh NM_031620.1 2.0    
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Appendix 8: Genes reduced in expression after the perfusion of rat liver. Listed are only 
genes more than 2-fold deregulated and with a pV<0.01. 
 
Symbol Accession Fold change Symbol Accession Fold change Symbol Accession Fold change
 Sept7 NM_022616 -2.4 Cmkor1 NM_053352 -2.1 Fcna NM_031348 -3.9 
1200013a08rik NM_001007002 -2.1 Col14a1_pred XM_235308 -8.1 Fli1_pred XM_235979 -2.1 
Acadsb NM_013084 -2.7 Col1a2 NM_053356 -13.8 Folr2_pred XM_215013 -2.1 
Acsl4 NM_053623 -2.3 Col3a1 NM_032085 -8.4 Frg1_pred XM_341442 -2.0 
Adamts1 NM_024400 -3.4 Col4a1_pred XM_214400 -2.4 Fstl1 NM_024369 -5.3 
Adamts9_pred XM_232202 -2.1 Col5a1 NM_134452 -2.6 Gbp2 NM_133624 -3.6 
Adcy4 NM_019285 -2.1 Col5a2 XM_343564 -4.2 Ghr NM_017094 -3.7 
Adn XM_343169 -4.9 Col6a3_pred XM_346073 -2.0 Gja1 NM_012567 -6.8 
Adora2a NM_053294 -2.5 Col8a1_pred XM_221536 -2.7 Gja4 NM_021654 -3.1 
Adora3 NM_012896 -2.2 Coro1a NM_130411 -3.3 Glipr1_pred XM_576223 -2.2 
Ahr XM_579375 -2.6 Ctbp2 NM_053335 -2.1 Gmfg NM_181091 -2.4 
Aif1 NM_017196 -6.0 Ctgf NM_022266 -5.2 Gna12 NM_031034 -2.1 
Akr1b4 NM_012498 -3.7 Ctse NM_012938 -2.2 Gnai2 NM_031035 -2.0 
Alp1 NM_199097 -2.5 Ctss NM_017320 -8.5 Gng11 NM_022396 -4.0 
Anxa1 NM_012904 -5.3 Cxcl9 NM_145672 -2.0 Gpr105 NM_133577 -4.2 
Anxa2 NM_019905 -2.2 Cyba NM_024160 -4.5 Gpx3 NM_022525 -2.4 
Anxa3 NM_012823 -8.8 Cybb NM_023965 -2.6 Gstp1 XM_579338 -2.8 
Anxa5 NM_013132 -2.0 Cyp2a1 NM_012692 -2.2 Gstp2 NM_138974 -4.3 
Aox2 XM_579191 -2.3 Cyp3a3 NM_013105 -4.7 Gucy1b3 NM_012769 -3.5 
App NM_019288 -2.7 Cyp4b1 NM_016999 -3.4 Gzma NM_153468 -3.1 
Arhgdib NM_001009600 -5.2 Dab2 NM_024159 -4.4 Hba-a1 NM_013096 -120.3 
Asah3l_pred XM_233138 -2.2 Dcir3 XM_579150 -3.3 Hbb NM_033234 -106.2 
Atp6v1a1_pred XM_340987 -2.4 Dcn NM_024129 -7.8 Hla-dmb NM_198740 -2.4 
B4galt6 XM_579528 -2.0 Ddah2 XM_579741 -2.0 Hod NM_133621 -2.3 
Bak1 NM_053812 -2.7 Ddx3x XM_228701 -2.1 Ibtk_pred XM_236481 -2.6 
Bcl2a1 NM_133416 -2.6 Dnase1l3 NM_053907 -3.8 Icam2 NM_001007725 -2.7 
Bcl6_pred XM_221333 -3.4 Ecm1 NM_053882 -5.9 Ifi44_pred XM_227821 -2.2 
Bgn NM_017087 -2.0 Ednrb NM_017333 -4.5 Ifitm1_pred XM_215117 -3.5 
Bucs1_pred XM_341917 -3.2 Ehd3 NM_138890 -2.1 Igfbp3 NM_012588 -8.6 
C1qa NM_001008515 -4.7 Eif1a_pred NM_001008773 -2.9 Igfbp7_pred XM_214014 -8.8 
C1qb NM_019262 -3.5 Eif3s6_pred XM_576262 -2.0 Igj_pred XM_341195 -3.6 
C1qg NM_001008524 -3.0 Eif4g2_pred XM_341907 -3.7 Ik NM_001005537 -2.0 
C1qr1 NM_053383 -5.2 Eltd1 NM_022294 -2.5 Il1a NM_017019 -2.6 
Casp1 NM_012762 -4.4 Emcn NM_001004228 -3.9 Il1b NM_031512 -2.0 
Ccl19_pred XM_342824 -2.4 Emilin1_pred XM_238447 -2.3 Itgb2_pred XM_228072 -2.2 
Ccl5 NM_031116 -5.5 Emp1 NM_012843 -2.3 Krt1-19 NM_199498 -2.4 
Ccl6 NM_001004202 -4.4 Emp3 NM_030847 -2.4 Lamb1-1_pred XM_216679 -3.4 
Ccr5 NM_053960 -2.7 Emr1 XM_579174 -4.4 Laptm5 NM_053538 -2.5 
Cd163_pred XM_232342 -3.3 Esam NM_001004245 -2.2 Lcp1_pred XM_573816 -4.0 
Cd36 NM_031561 -2.7 Ets1 NM_012555 -2.7 Ldb2_pred XM_214054 -2.4 
Cd48 NM_139103 -4.6 Evl XM_579484 -2.3 Lgals1 NM_019904 -2.0 
Cd53 NM_012523 -4.3 F2r NM_012950 -3.2 Lgals3 NM_031832 -4.0 
Cd68_pred XM_213372 -3.1 F9 XM_346365 -6.4 Lgmn NM_022226 -2.3 
Cd74 NM_013069 -2.6 Fbln5 NM_019153 -3.1 LOC259245 NM_147213 -2.7 
Cd83_pred XM_341509 -3.4 Fcgr1_pred XM_215643 -3.0 LOC287029 XM_212651 -2.0 
Ceacam10 NM_173339 -2.2 Fcgr2b NM_175756 -4.6 LOC287167 XM_213262 -4.0 
Cklfsf6_pred XM_579183 -2.2 Fcgr3a NM_207603 -2.3 LOC287899 XM_213548 -3.9 
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LOC289384 XM_223076 -2.0 LOC362803 XM_343130 -2.0 LOC499615 XM_574941 -3.2 
LOC289930 XM_223826 -2.0 LOC362934 XM_576293 -2.5 LOC499625 XM_574949 -2.2 
LOC291936 XM_238042 -2.8 LOC363434 XM_343756 -2.1 LOC499638 XM_574960 -4.2 
LOC293860 XM_238167 -4.1 LOC363767 XM_344015 -2.3 LOC499775 XM_580014 -2.0 
LOC294337 XM_215375 -3.7 LOC365699 XM_345167 -2.5 LOC499984 XM_575338 -3.1 
LOC294410 XM_228157 -2.1 LOC365814 XM_578024 -2.1 LOC499985 XM_575339 -2.9 
LOC294744 XM_215486 -3.4 LOC366411 XM_575861 -2.2 LOC500015 XM_575369 -2.5 
LOC294762 XM_215491 -2.1 LOC366588 XM_345652 -3.3 LOC500285 XM_575635 -2.9 
LOC294942 XM_215541 -2.2 LOC367391 XM_346122 -2.2 LOC500336 XM_575687 -2.1 
LOC295382 XM_227605 -2.0 LOC367846 XM_575151 -2.0 LOC500344 XM_575696 -2.4 
LOC295660 XM_212955 -2.7 LOC497720 XM_579423 -2.1 LOC500373 XM_231625 -2.1 
LOC295975 XM_215794 -2.2 LOC497757 XM_579393 -5.1 LOC500389 XM_575748 -2.2 
LOC297504 XM_238366 -2.7 LOC497758 XM_579454 -4.8 LOC500398 XM_575757 -3.3 
LOC300783 XM_217180 -2.3 LOC497767 XM_579388 -3.4 LOC500469 XM_575833 -2.4 
LOC301276 XM_236965 -2.6 LOC497846 XM_579586 -3.3 LOC500488 XM_580072 -2.7 
LOC302363 XM_217566 -3.4 LOC497936 XM_573123 -2.3 LOC500490 XM_575855 -2.0 
LOC302671 XM_217618 -2.6 LOC497942 XM_573130 -2.1 LOC500495 XM_575859 -2.7 
LOC303666 XM_221094 -2.4 LOC497987 XM_573183 -2.2 LOC500507 XM_575869 -2.5 
LOC304138 XM_221702 -2.4 LOC498032 XM_573233 -2.5 LOC500586 XM_575955 -3.5 
LOC306805 XM_225198 -2.0 LOC498076 XM_573278 -2.5 LOC500643 XM_576018 -2.4 
LOC307907 XM_226529 -2.4 LOC498105 XM_573309 -4.2 LOC500695 XM_576077 -2.2 
LOC308350 XM_218261 -4.4 LOC498162 XM_573377 -2.3 LOC500788 XM_576174 -2.3 
LOC308654 XM_218706 -2.1 LOC498241 XM_573464 -2.6 LOC500829 XM_576219 -3.2 
LOC310760 XM_227556 -2.8 LOC498245 XM_573468 -3.6 LOC500916 XM_576325 -2.4 
LOC310926 XM_227769 -20.6 LOC498276 XM_573502 -3.7 LOC500941 XM_576351 -2.2 
LOC312102 XM_231461 -5.9 LOC498277 XM_573503 -2.7 LOC500949 XM_576360 -2.2 
LOC312924 XM_232634 -2.9 LOC498279 XM_573505 -4.6 LOC500988 XM_576400 -2.3 
LOC313304 XM_233108 -2.3 LOC498371 XM_573606 -3.2 LOC501091 XM_576506 -2.1 
LOC313308 XM_233081 -3.1 LOC498375 XM_573610 -3.2 LOC501187 XM_576615 -2.2 
LOC313391 XM_233220 -2.0 LOC498378 XM_573613 -2.8 LOC501224 XM_576647 -2.2 
LOC313445 XM_233297 -3.2 LOC498452 XM_573711 -2.1 LOC501245 XM_576664 -2.4 
LOC313974 XM_233982 -2.1 LOC498557 XM_573833 -3.1 LOC501393 XM_576805 -2.4 
LOC314075 XM_234092 -2.2 LOC498644 XM_573926 -3.1 LOC501396 XM_576808 -2.8 
LOC315352 XM_235755 -2.2 LOC498669 XM_573952 -2.8 LOC501553 XM_576955 -2.7 
LOC316186 XM_236876 -2.7 LOC498690 XM_573975 -4.3 LOC501562 XM_576967 -2.3 
LOC316406 XM_237162 -2.5 LOC498799 XM_574084 -2.8 LOC501610 XM_577009 -2.5 
LOC316481 XM_237252 -2.9 LOC498829 XM_574110 -2.4 LOC501619 XM_577018 -2.0 
LOC317218 XM_228493 -2.8 LOC498973 XM_574260 -2.4 LOC502490 XM_577971 -3.9 
LOC317312 XM_228667 -2.0 LOC498989 XM_574280 -2.8 LOC502953 XM_578458 -2.7 
LOC317599 XM_229173 -2.3 LOC499300 XM_574598 -2.8 LOC502954 XM_578459 -2.0 
LOC360602 XM_340880 -2.1 LOC499321 XM_574626 -2.9 LOC503409 XM_578948 -38.8 
LOC360627 XM_340901 -2.1 LOC499481 XM_574804 -2.6 Loxl2_pred XM_214225 -2.3 
LOC360690 XM_340961 -2.6 LOC499526 XM_579974 -2.5 Lpl NM_012598 -8.6 
LOC361117 XM_341405 -4.0 LOC499531 XM_574855 -2.6 Lrrn3 NM_030856 -2.0 
LOC361260 XM_341544 -2.5 LOC499554 XM_574879 -2.3 Ltbp1 NM_021587 -4.5 
LOC361283 XM_341568 -2.3 LOC499560 XM_574884 -2.8 Lum NM_031050 -2.0 
LOC361885 XM_342182 -2.6 LOC499564 XM_574888 -2.6 Ly86_pred XM_225636 -2.5 
Mapre1 NM_138509 -2.5 Prss23 NM_001007691 -5.7 Tagln XM_579512 -2.3 
MGC105601 NM_001009620 -2.7 Psma1 NM_017278 -2.1 Tagln2_pred XM_222906 -3.8 
MGC72614 NM_199105 -2.6 Ptgds2 NM_031644 -2.8 Tax1bp1 NM_001004199 -2.1 
MGC72973 NM_198776 -28.1 Pthr1 NM_020073 -3.9 Tcf21 XM_341737 -4.9 
APPENDIX  
 215
MGC94010 NM_001007732 -4.5 Ptprb_pred XM_235156 -5.7 Tcf4 NM_053369 -2.2 
MGC94782 NM_001004282 -2.2 Ptprc NM_138507 -2.1 Tde2 NM_182951 -2.5 
MGC95001 NM_001007619 -3.2 Ptpro NM_017336 -2.8 Tek XM_342863 -2.2 
Mgp NM_012862 -12.6 Ramp2 NM_031646 -2.4 Timp1 NM_053819 -3.0 
Mpeg1 NM_022617 -2.6 Rasa1 NM_013135 -2.1 Tnfrsf11b NM_012870 -4.7 
Mrc1_pred XM_225585 -4.4 Rasip1_pred XM_214916 -2.4 Tpbg NM_031807 -2.2 
Ms4a11_pred XM_342028 -4.4 Rbbp7 NM_031816 -2.3 Tpm4 NM_012678 -3.9 
Ms4a6b NM_001006975 -3.3 Rcn_pred XM_342481 -4.1 Tspan3 NM_001005547 -2.3 
Mthfs NM_001009349 -2.4 Rcn2 NM_017132 -2.4 Ttpa NM_013048 -2.1 
Mx1 NM_173096 -2.5 Rcn3_pred NM_001008694 -2.5 Tuba1 NM_022298 -5.6 
Napsa NM_031670 -2.7 Reck_pred XM_233371 -3.7 Txndc1_pred XM_343076 -2.0 
Nfib XM_342854 -2.6 Reln NM_080394 -9.2 Txnip NM_001008767 -2.5 
Nid2_pred XM_573694 -2.2 RGD1308143_pred XM_237468 -2.1 Tyrobp NM_212525 -2.8 
Nkg7 NM_133540 -3.0 RGD1308373_pred XM_344268 -2.6 Ube1c NM_057205 -2.1 
Nol5 NM_021754 -2.0 RGD1310191_pred XM_341102 -2.4 Ucp2 NM_019354 -4.2 
Npy NM_012614 -2.6 Rgs10 XM_341936 -2.5 Ugcg XM_579533 -2.3 
Nritp XM_341519 -2.2 Rgs18_pred XM_222692 -2.4 Vcam1 NM_012889 -3.4 
Nrp1 NM_145098 -3.9 Rgs2 NM_053453 -2.7 Vim NM_031140 -13.6 
Oasl2_pred XM_579310 -2.0 Rock1 NM_031098 -2.4 Vwf XM_342759 -2.3 
Ogn_pred XM_214441 -6.1 RT1-Ba XM_579226 -2.9 Waspip NM_057192 -3.9 
Oit3 NM_001001507 -4.6 RT1-Da XM_579241 -8.3 Wfdc1 NM_133581 -3.1 
Pam NM_013000 -4.6 RT1-Db1 XM_579272 -2.7 Xlkd1_pred XM_219001 -4.5 
Pde2a NM_031079 -2.1 S100a11 XM_215598 -5.8 Zfp354a NM_052798 -3.3 
Pdia3 NM_017319 -2.9 S100a6 NM_053485 -4.4    
Pf4 NM_001007729 -3.2 Sart2_pred XM_345110 -3.1    
Pfc XM_216784 -2.7 Scd2 NM_031841 -3.1    
Pigr NM_012723 -3.4 Sdcbp NM_031986 -2.1    
Pla2g2a NM_031598 -2.3 Sdccag1_pred XM_216724 -2.3    
Pla2g4a NM_133551 -2.6 Sema6a_pred XM_341612 -2.3    
Plac8_pred XM_341188 -4.9 Serpinb6 NM_199085 -4.0    
Plat NM_013151 -2.5 Serpine2 XM_343604 -2.1    
Plek_pred XM_344267 -3.3 Slc25a4 NM_053515 -3.7    
Plscr1 NM_057194 -2.2 Slc28a2 NM_031664 -3.4    
Pltp_pred XM_215939 -2.3 Slfn3 NM_053687 -5.1    
Plvap NM_020086 -3.6 Slpi NM_053372 -6.3    
Plxdc2_pred XM_341567 -2.2 Smoc2_pred XM_214777 -4.9    
Plxnd1_pred XM_232283 -2.5 Snx5_pred XM_215872 -2.1    
Pmp22 NM_017037 -2.4 Sod3 NM_012880 -7.3    
Pnutl2_pred XM_573172 -3.0 Sparc NM_012656 -6.6    
Ppt NM_022502 -2.1 Sparcl1 NM_012946 -4.8    
Prkcb1 NM_012713 -3.3 Ssg1 XM_573284 -5.9    
Prkch NM_031085 -2.2 Sv2b NM_057207 -3.6    
Prnp XM_579340 -3.8 Tacc1a NM_001004107 -2.9    
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Appendix 9: Summary of gene expression changes in primary rat hepatocytes culture measured with TaqMan PCR. Only genes 2-fold deregulated 
are shown. 
 
Gene Symbol Accession Nr. Susp_1 d Slices_1 d M+_1 d M+_6 d M+_10 d M-_1 d M-_6 d M-_10 d S+_1 d S+_6 d S+_10 d S-_1 d S-_6 d S-_10 d FaO 
Acox1 NM 017340 -15.8 2.8 -2.2 -2.1 -2.6  2.6 2.2  
Actn1 NM 031005 -3.7 8.7 6.8 195.4 140.3 3.8 89.9 79.4 2.1 37.4 35.6 2.3 21.1 15.7 6.4 
Adk NM 012895 -3.2 -2.2 -2.0 2.3  -2.1 2.3 -2.2 
Afp NM 012493  3.0 3.6  -2.8 -2.3 5.2 5.5 23.7 
Nr1i3 NM 022941 -5.9 -4.1 -2.6  -5.5 -11.4 -5.1 -4.0 2.5 3.6 -18.7 
Cdh1 NM 031334 -6.4 2.0 5.5 5.8 5.1 7.0 6.9 4.0 3.4 3.9 4.6 6.0  
Cebpa NM 012524 -3.3 -2.5 -3.3 -2.1  -2.3 -2.0 
Cebpb NM 024125 2.7 6.2 2.5 2.0 2.2 2.4 2.5 2.4 
Cpt1a NM 031559 -19.7 2.9 -5.1 2.9 2.3 -6.1 2.4 -5.6 2.0 2.1 
Ccnd1 NM 171992  12.6 20.7 -7.8 2.2 5.6 8.2 -13.4 -2.3 -3.4 6.4 
Ccng1 NM 012923  6.4 14.0 25.5 23.1 16.0 30.1 22.2 9.3 7.4 9.1 13.1 7.4 4.8 3.7 
Cyp1a2 NM 012541 -4.7 3.5 -2.7 -72.5 -51.5 -153.7 -57.0 -4.9 -107.2 -95.7 -2.2 -154.6 -101.0 -194.5 
Cyp2c NM 019184 -27.7 -4.7 -5.5 -869.8 -347.5 -5.1 -6.7 -13.6 -7.1 -126.0 -352.6 -5.3 -5.1 -4.4 68.3 
Cyp3a3 NM 013105 -8.4 -883.7 -2208.5  -2.3 -96.2 -498.6 8.5 7.1 -3539.8 
Fabp2 NM 013068  4.9 2.6 -2.3 -4.1 2.7 3.3 4.3 7.2 -4.7 3.3 2.1 -4.9 
Fbp1 NM 012558 -43.8 -18.1 -28.7 -3.4 -3.5 -3.6 -2.3 -2.5 -4.1 -16.2 
Gadd45a NM 024127 4.5 14.8 45.5 67.8 38.8 28.7 35.8 23.2 33.2 25.1 19.7 32.3 15.5 9.6 2.8 
Gsn NM 001004080  2.0 -6.7 8.1 18.5 -13.2 2.5 -6.7 5.1 -19.5 -2.7 -67.2 
Gsta3 NM 031509 -11.3   
Gstp2 NM 138974 13.9 13.6 16.1 53.4 37.8 2.9 15.5 28.8 10.7 54.6 54.1 10.4 10.0 58.7 
Hmox1 NM 012580 12.2 84.6 49.5 38.0 37.3 30.3 10.4 8.1 58.0 16.3 31.2 47.3 3.8 38.8 
Tcf1 NM 012669  3.9 2.2 2.6 2.2  5.2 
Hnf4a NM 022180 -43.2 4.6 2.2   
Hspa1b mapped NM 212504 472.9 43.8 10.6 16.9 13.5 8.2 7.7 9.5 17.2 3.6 3.6 7.6 5.5 4.4 72.4 
Jund XM 579658 4.4 6.5 7.9 13.0 11.3 6.6 10.6 9.7 4.7 6.2 5.2 6.8 6.5 6.2 17.3 
Abcb1 NM 012623 51.1 1187.0 343.0 1295.3 490.8 143.2 1523.4 951.8 184.4 788.8 822.4 101.2 570.6 246.1 58.9 
Abcb4 NM 012690  -2.0 -2.2 -2.2  -3.1 -2.2 2.4 2.2 -2.2 
Abcc2 XM 577883 -5.3 3.1 3.0  
Abcc3 NM 080581  25.1 12.6 24.2 16.6 4.1 31.1 34.3 11.0 20.0 21.5 2.3 31.5 37.9 21.6 
Myc NM 012603 13.5 78.3 76.6 117.7 36.0 47.9 50.9 37.5 42.8 39.5 27.4 52.8 33.1 28.2 49.9 
OATP1 XM 579394 -32.1 -2.7 -8.1 -70.9 -68.4 -5.0 -4.0 -7.0 -11.4 -4.2 -4.9 -5.0 -2.4 -3.4 -9041.6 
Cdkn1a NM 080782 2.1 6.0 8.2 26.0 18.5 14.5 17.1 14.9 4.4 5.7 5.3 11.3 9.2 7.1 4.4 
Pck1 NM 198780 -120.2 -8.8 -244.8 -119.7 -300.0 -165.7 -77.5 -31.4 -101.1 -177.3 -104.9 -79.7 -120.4 -95.4 -4.7 
Alpi NM 022665  27.6 26.2 8.1 5.1 25.2 15.9 16.6 37.4 15.3 17.3 28.6 20.0 23.0 4.1 
Nr1i2 NM 052980 -11.4 -2.3 -2.3 2.6  -2.1 2.7 -4.3 
Rgn NM 031546 -185.6 -16.6 -14.7 -37.6 -62.8 -18.2 -42.5 -57.4 -19.5 -59.5 -60.8 -14.1 -90.4 -129.4 -11.1 
Sod2 NM 017051 -10.9 11.3 14.1 5.3 2.2 14.0 3.9  14.5 4.6 3.3 8.9 4.0 -3.5 
Tgfa NM 012671  4.1 5.6 9.6 6.5 4.1 5.9 4.8 2.6 3.0 3.2 2.8 7.2 4.8 7.1 
Tgfb1 NM 021578 -14.4 3.5 -5.0 7.7 10.6 -6.0  -5.2 3.8 -9.1 -6.1 -3.3  
Timp1 NM 053819 3.3 16.3 8.9 68.0 60.5 4.0 9.7 12.0 17.1 28.8 3.2 3.1 -3.7 
Tnf NM 012675  387.4 114.7 338.0 507.1 16.3 23.3 368.1 170.4 312.1 6.3 30.8 
Txn2 NM 053331 -18.1 2.1  2.3 2.0 
Ugt1a1 NM 012683 -3.6 5.7 3.5 6.5 6.7 5.1 5.1 14.9 12.2 2.1 
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Gene Symbol Accession Nr. Susp_1 d Slices_1 d M+_1 d M+_6 d M+_10 d M-_1 d M-_6 d M-_10 d S+_1 d S+_6 d S+_10 d S-_1 d S-_6 d S-_10 d FaO 
Acox1 NM 017340  -2.7 -4.6 -4.1  -2.5 -3.3 -3.2 
Actn1 NM 031005  2.2 4.9 5.1 4.0 4.3 2.8 2.1  
Adk NM 012895  -3.2 -3.0 -4.0  -3.4 -2.0 -2.3  
Afp NM 012493  -2.6 -2.7 -4.7 -5.9 -2.0 -2.1 -2.4 -2.4 -2.7 -2.4  
Nr1i3 NM 022941  -5.2 -5.7 -13.1 -13.1 -2.5 -6.6 -4.8 -4.7 -8.2 -8.0 -4.6 -9.0 
Cdh1 NM 031334 -5.6  -7.3 
Cebpa NM 012524  -6.1 -6.0  -5.2 
Cebpb NM 024125  2.1  2.2  
Cpt1a NM 031559 -2.0 -4.0 -8.2 -2.2 -3.0 -2.2  -5.5 -5.8 -2.2 
Ccnd1 NM 171992 -3.0 2.6 5.4 -8.8 -2.3  2.6 -10.3 -4.8 -4.1 2.1 
Ccng1 NM 012923 2.5 4.4 7.1 8.5 10.9 7.8 9.8 9.9 5.5 5.1 5.6 11.0 6.1 4.9 2.3 
Cyp1a2 NM 012541  -5.4 -138.7 -100.4 -3.5 -103.5 -70.8 -8.4 -92.6 -83.9 -4.3 -64.7 -69.2 -53.9 
Cyp2c NM 019184 -4.7 -3.7 -2.6 -276.3 -188.6 -2.5 -4.7 -7.0 -2.8 -36.8 -119.5 -2.4 -3.0 -2.4 -448.8 
Cyp3a3 NM 013105 -3.7 -5.4 -2.4 -278.7 -233.4  -2.4 -47.1 -78.9 -254.1 
Fabp2 NM 013068  -4.0 -4.1 -3.7  2.2 2.5 -4.0 -4.1 
Fbp1 NM 012558 -2.7 -5.1 -3.5 -54.1 -61.8 -6.0 -8.1 -7.4 -2.4 -3.5 -4.0 -6.2 -3.2 -2.5 -17.2 
Gadd45a NM 024127 6.2 6.5 13.8 11.4 10.4 9.8 8.3 6.9 14.5 9.7 6.6 12.1 5.3 3.8 2.5 
Gsn NM 001004080  3.0   
Gsta3 NM 031509    
Gstp2 NM 138974 4.2 17.6 29.7 34.8 4.1 15.3 21.4 18.3 38.0 40.5 2.4 10.9 10.8 22.0 
Hmox1 NM 012580 8.4 4.8 11.3 4.3 7.0 7.3  22.9 4.1 7.9 17.0 3.7 
Tcf1 NM 012669  -2.1 -3.1  -2.0  
Hnf4a NM 022180  -4.3 -3.8  -2.4 -2.2  
Hspa1b mapped NM 212504    
Jund XM 579658  2.5 2.4 2.2 2.5 2.3 2.4 2.2 2.2 2.1 2.3 2.3 2.4 2.1 
Abcb1 NM 012623 73.7 25.9 49.9 98.0 61.7 17.6 97.4 95.1 29.2 91.4 81.5 8.4 54.0 38.5 12.2 
Abcb4 NM 012690  -2.5 -4.8 -4.2  -4.5 -3.9 -2.2 -2.5 
Abcc2 XM 577883  -2.2 -2.4  -2.2 -2.1 -2.1 -2.1  
Abcc3 NM 080581 3.6 3.2 3.6 2.7 5.5 6.2 4.0 4.7 4.4 6.4 7.8 6.6 
Myc NM 012603 6.3 7.7 12.9 11.8 6.0 9.8 7.0 6.8 10.6 8.6 5.7 12.2 6.1 7.4 4.9 
OATP1 XM 579394    
Cdkn1a NM 080782  2.1 2.5 3.9 2.8 2.7 5.1 2.4 2.3  
Pck1 NM 198780 -9.2 -31.9 -82.1 -126.8 -180.5 -65.4 -60.0 -25.0 -52.6 -120.7 -91.8 -41.5 -51.3 -59.8 -3.8 
Alpi NM 022665    
Nr1i2 NM 052980 -2.3 -3.8 -4.0 -5.7 -5.7  -2.9 -2.7 -2.7 -10.5 
Rgn NM 031546 -41.4 -53.9 -16.8 -69.3 -71.7 -19.2 -62.6 -69.6 -21.1 -48.3 -53.8 -11.1 -71.8 -69.9 -12.8 
Sod2 NM 017051 3.4 4.0 3.3  7.2 4.0  
Tgfa NM 012671   2.1 2.1 
Tgfb1 NM 021578 2.4 3.4 4.6   
Timp1 NM 053819 7.5 2.3 11.2 13.4 2.6 4.9 7.3 -2.4 -2.4  
Tnf NM 012675    
Txn2 NM 053331  -2.2 -2.7 -2.6 -2.0 -2.2  
Ugt1a1 NM 012683   8.5  
Appendix 10: Summary of gene expression changes in primary rat hepatocytes culture measured with Illumina BeadChips. Only genes 2-fold 
deregulated and with a pValue lower than 0.05 are shown. 
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Gene 
Symbol
Accession 
Nr.
HepaRG_
DMSO 1 d
HepaRG_
DMSO 2 d
HepaRG_
DMSO 9 d
HepaRG_
basal 1 d
HepaRG_
basal 2 d
HepaRG_
basal 9 d
Susp_24h M-_2 d M-_7 d M-_11 d S-_2 d S-_7 d S-_11 d 
ACTN1 NM_001102    3.3 3.2   2.4 3.0 3.3  2.1 2.8 
ADK NM_001123       -4.6 -2.7 -2.4 -3.0 -6.5 -3.8 -4.6 
AFP NM_001134 -2.0  -3.6    -10.2  -21.1 -15.5 -67.2   
ALPI NM_000478 -5.4 -7.2     -6.1 -3.8 -10.2 -6.7 -2.8 -5.3 -5.1 
CEBPA NM_004364        -4.1  2.3   3.6 
CEBPB NM_005194          2.1    
CPT1A NM_0010318      -2.0 -7.5 -7.7 -3.1  -13.8 -5.2 -3.2 
CCND1 NM_053056 -2.9 -2.4 -3.6    -5.0 -5.2 -2.4 -2.5 -8.8 -5.3 -4.5 
CCNG1 NM_004060     2.1 2.1     -3.7 -2.9 -3.3 
CYP1A2 NM_000761 -280.5 -357.8 -151.0 -588.5 -1009.6  -11.4 -17.7 -2.0  -14.0   
CDH1 NM_004360 -4.2 -3.3 -4.5    -9.9 -3.6 -3.4 -4.7 -5.6 -3.8 -3.4 
FABP2 NM_001443 -7.5 -5.1 -22.2 -3.6 -3.9 -4.5 -10.8 -134.2 -15.9 -15.4 -83.7 -9.1 -7.9 
GADD45A NM_001924 11.2 14.7 10.2 12.0 11.5 8.5 -2.7  4.3 3.5  6.3 6.4 
FBP1 NM_000507  -2722.9 -3427.4  -1613.6  -11.4 -16.3 -9.0 -8.5 -11.6 -3.8 -4.4 
GSN NM_000177 5.7 3.9 5.8 13.6 11.7 6.9  2.9 5.0 4.3 2.8 5.1 8.1 
GSTA3 NM_145740       -9.4 -11.3 -12.1 -9.1 -15.0 -11.6 -9.0 
HMOX1 NM_002133     -2.1  3.9  3.5 2.9 2.2 2.3 2.1 
TCF1 NM_000545              
HNF4A NM_000457       -2.0       
JUND NM_005354            2.1 2.1 
ABCB1 NM_000927           -5.5 -2.2  
ABCB4 NM_000443 -3.0 -3.1 -3.8 -3.6  -3.0 -13.4 -20.4 -35.5 -42.1 -37.7 -63.7 -55.2 
ABCC2 NM_000392      -2.1 -2.3    -4.2 -2.1  
ABCC3 NM_003786 2.8 3.0 2.9 5.3 4.9 2.8 -3.8    -2.2   
MYC NM_002467    2.1    3.7 3.1 4.4 3.0  2.2 
CDKN1A NM_000389 2.6 2.3 2.4 3.7 1.9   3.0 7.2 11.8  5.9 12.7 
RGN NM_004683 -6.7 -5.2 -8.1 -4.7 -6.7 -7.4 -13.0 -21.0 -14.4 -16.5 -21.1 -10.7 -12.5 
SOD2 NM_000636 2.3  2.1 4.4 5.4 2.2 9.7 14.1 4.8 3.5 8.9 2.6 2.4 
TGFA NM_003236 3.6 3.8 3.7 5.4 6.4     2.5   2.6 
TGFB1 NM_000660 3.7 3.3 3.9 6.5 7.0 5.6  -2.6 -2.3  -2.2 -2.2  
TXN2 NM_003329, 2.7 2.2 2.7 8.1 4.5 4.7  3.4 3.2 3.2 2.8 3.1 3.6 
TIMP1 NM_003254 6.3 5.5 5.5 8.8 7.5 5.0  -2.1   -2.2   
TNF NM_000594        -3.2  -3.9 -2.2   
UGT1A1 NM_001072  2.2 -4.2 -3.8 -6.4  
Appendix 11: Summary of gene expression changes in primary human hepatocytes culture measured with TaqMan PCR. Only genes 2-fold 
deregulated are shown. 
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Gene 
Symbol 
Accession 
Nr.
HepaRG_
DMSO_1 d 
HepaRG_
DMSO_2 d
HepaRG_
DMSO_9 d
HepaRG_
basal_1 d
HepaRG_
basal_2 d
HepaRG_
basal_9 d Susp_24h M-_2 d M-_7 d M-_11 d S-_2 d S-_7 d S-_11 d 
ACTN1 NM_001102              
ADK NM_001123              
AFP NM_001134 -4.8 -4.9 -4.6 -3.4 -4.8 -2.6 -4.5 -6.5   -5.7   
ALPI NM_000478              
CEBPA NM_004364 -3.0 -2.1 -2.9 -3.6  -2.3  -3.4      
CEBPB NM_005194              
CPT1A NM_0010318              
CCND1 NM_053056 -3.6 -2.6 -3.3    -3.4 -4.5 -3.4 -4.6 -5.3 -6.4 -5.6 
CCNG1 NM_004060           -2.8 -2.3  
CYP1A2 NM_000761 -47.5 -37.0 -39.5 -49.3 -62.8 -54.5 -8.0 -13.1 -2.4 -3.0 -7.0  -3.2 
CDH1 NM_004360              
FABP2 NM_001443              
GADD45A NM_001924        2.3      
FBP1 NM_000507 -273.0 -220.1 -234.5 -250.3 -275.3 -268.2 -5.5 -14.3 -11.1 -13.3 -7.1 -6.1 -7.6 
GSN NM_000177 7.6 6.4 8.4 11.0 10.3 7.2 2.2 4.4 5.4 4.5 4.9 6.5 3.4 
GSTA3 NM_145740              
HMOX1 NM_002133 -3.3 -3.3 -2.4 -4.0 -4.9 -5.5 2.6       
TCF1 NM_000545              
HNF4A NM_000457              
JUND NM_005354 -2.0   -2.6  -2.4        
ABCB1 NM_000927              
ABCB4 NM_000443 -2.8 -2.8 -3.1 -4.4 -2.2 -3.5 -5.9 -7.1 -7.0 -10.5 -8.3 -8.6 -8.1 
ABCC2 NM_000392     -2.2         
ABCC3 NM_003786              
MYC NM_002467       2.2 2.2   2.5   
CDKN1A NM_000389 2.6 2.6 3.1 2.6 2.5 2.6 2.6 3.9 4.4 5.2 3.2 3.7 4.3 
RGN NM_004683 -4.3 -2.9 -6.0 -4.6 -6.3 -9.0 -3.6 -14.1 -12.3 -15.0 -7.3 -8.4 -10.5 
SOD2 NM_000636 5.4 4.5 5.8 7.4 7.5 5.9 15.3 12.1 9.0 7.7 13.4 8.0 9.0 
TGFA NM_003236              
TGFB1 NM_000660              
TXN2 NM_003329,              
TIMP1 NM_003254 3.3 3.8 4.1 3.6 2.9 3.3        
TNF NM_000594              
UGT1A1 NM_001072 2.6 3.5 2.8 -2.1  3.2  
Appendix 12: Summary of gene expression changes in primary human hepatocytes culture measured with Illumina BeadChips. Only genes 2-fold 
deregulated and with a pValue lower than 0.05 are shown. 
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Appendix 13: Gene set with the 724 top ranked genes of the predictive model giving 
the best classification results of the experiments 9 d after treatment 
Gene Symbol Accession-Nr Gene Symbol Accession-Nr Gene Symbol Accession-Nr
Abca3_predict
ed XM_220219 Clic5 NM_053603 Frg1_predicted XM_341442 
Abca8a_predic
ted XM_221100 
Cnot6l_predict
ed XM_341191 
Fusip1_predict
ed XM_342948 
Abcg4_predict
ed XM_236186 
Cobll1_predict
ed XM_229988 Fxc1 NM_053371 
Abl1 XM_231137 Col18a1 XM_241632 
G2an_predicte
d XM_215144 
Acbd3 NM_182843 
Colec10_predi
cted XM_235330 Gata4 NM_144730 
Adar NM_031006 Commd5 NM_139108 Gbp2 NM_133624 
Aer61 XM_579302 
Cops5_predict
ed XM_232615 Gcipip NM_133417 
Aes NM_019220 Coq3 NM_019187 Ghitm 
NM_00100590
8 
Akna_predicte
d XM_342848 Cox7b NM_182819 Gla XM_343817 
Akt1s1_predict
ed XM_238103 Cryl1 NM_175757 Gluld1 NM_181383 
Alg5_predicted XM_215561 
Csprs_predicte
d XM_237360 
Gm83_predict
ed XM_343231 
Amid_predicte
d XM_342137 Ctla4 NM_031674 Gnb1 NM_030987 
Ankrd24_predi
cted XM_216841 Cubn NM_053332 
Gpr61_predict
ed XM_227581 
Ankrd5_predict
ed XM_215854 
Cxxc1_predict
ed XM_238016 
Gps2_predicte
d XM_220615 
Anpep NM_031012 Cycs NM_012839 
Grtp1_predicte
d XM_341463 
Ap1g1 XM_341686 Cyp11a1 NM_017286 
Gsta4_predicte
d XM_217195 
App NM_019288 Cyp17a1 NM_012753 Gtf2b NM_031041 
Aprin_predicte
d XM_221833 Cyp1a1 NM_012540 Gucy1b2 NM_012770 
Areg NM_017123 Cyp2e1 NM_031543 Hadh2 NM_031682 
Arhgap21_pre
dicted XM_225628 
Cyp2r1_predict
ed XM_341909 Hagh NM_033349 
Arhgap8_predi
cted XM_576323 
Dclre1b_predic
ted XM_227537 Hdh XM_573634 
Arsb XM_345140 Ddt NM_024131 
Herc2_predicte
d XM_218720 
Arvcf_predicte
d XM_221276 Ddx24 NM_199119 Hexa 
NM_00100444
3 
Ascc1 
NM_00100763
2 Ddx3x XM_228701 Hgd_predicted XM_573291 
Atad2_predicte
d XM_235326 Dgka NM_080787 
Hibch_predicte
d XM_217395 
Atp13a_predict
ed XM_214310 Diablo 
NM_00100829
2 Hmgb1 NM_012963 
Atp5g1 NM_017311 Dnm2 NM_013199 Hoxc4 XM_235703 
Atp5h NM_019383 Dnmt1 NM_053354 Hpd NM_017233 
Atp6ap1 NM_031785 
Drap1_predict
ed XM_215177 Hsd17b9 NM_173305 
Bap1_predicte
d XM_224614 Dscr1 NM_153724 Idh1 NM_031510 
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Gene Symbol Accession-Nr Gene Symbol Accession-Nr Gene Symbol Accession-Nr
Bat2 NM_212462 
Dzip1_predicte
d XM_344460 Igbp1 NM_031624 
Bcl2l2 NM_021850 Echs1 NM_078623 Igf2r NM_012756 
Bmp4 NM_012827 Egf NM_012842 Ikbkap NM_080899 
Bmp7 XM_342591 
Ehmt1_predict
ed XM_342379 Ikbkb NM_053355 
Brd2 NM_212495 Eif4b 
NM_00100832
4 Inppl1 NM_022944 
Btc NM_022256 
Elmo2_predict
ed XM_342579 Ipo13 NM_053778 
Bwk1 NM_198743 
Eml1_predicte
d XM_343109 Itm2b 
NM_00100696
3 
Cacnb4 XM_215742 Eno3 NM_012949 Itpa XM_230604 
Cadps NM_013219 Ensa NM_021842 Jam3 
NM_00100426
9 
Calmbp1_predi
cted XM_213891 
Entpd4_predict
ed XM_341346 JSAP1 XM_220232 
Camta2_predic
ted XM_213362 Epb4 XM_345535 Kcng1 XM_215951 
Ccr7 NM_199489 
Eps8l3_predict
ed XM_215677 
Kctd5_predicte
d XM_220224 
Cd59 XM_579359 
Exosc5_predic
ted XM_218343 Khdrbs1 NM_130405 
Cdc14a_predic
ted XM_227618 Fadd NM_152937 Kidins220 NM_053795 
Cdc26_predict
ed XM_345540 Fah NM_017181 
Kif3b_predicte
d XM_215883 
Cdk7 XM_215467 Falz_predicted XM_221050 
L3mbtl2_predi
cted XM_235769 
Cdk9 
NM_00100774
3 
Fbxo33_predic
ted XM_234205 
Lactb2_predict
ed XM_216316 
Cetn2 XM_215222 Fdx1 NM_017126 Lama5 XM_215963 
Chd4 XM_232354 Fkbp4 XM_342763 
Laptm4b_predi
cted XM_235393 
Chd7_predicte
d XM_232671 Fkbp9 
NM_00100764
6 Ldhb NM_012595 
Cipar1 NM_173114 Fkbpl 
NM_00100281
8 
Leng1_predict
ed XM_214797 
Ckap4_predict
ed XM_343189 Flrt2_predicted XM_234361 Lnk XM_579519 
Clasp2 NM_053722 Frap1 NM_019906 LOC245925 NM_139093 
Cldn10_predict
ed XM_214250 Freq NM_024366 LOC287101 XM_213222 
LOC287115 XM_213235 LOC298842 XM_216656 LOC317604 XM_229179 
LOC287250 XM_220370 LOC299179 XM_216763 LOC360531 XM_340803 
LOC287388 XM_213328 LOC299199 XM_234416 LOC360596 XM_340876 
LOC287477 XM_213394 LOC299264 XM_216764 LOC360664 XM_340940 
LOC287541 XM_213403 LOC299315 XM_238474 LOC360668 XM_340943 
LOC287962 XM_213588 LOC299713 XM_235021 LOC360681 XM_340953 
LOC288089 XM_221431 LOC299949 XM_216928 LOC360760 XM_346914 
LOC288309 XM_213675 LOC300126 XM_217016 LOC360826 XM_341099 
LOC288396 XM_221799 LOC300160 XM_235581 LOC361140 XM_341426 
LOC288455 XM_213700 LOC300361 XM_217080 LOC361174 XM_341459 
LOC288646 XM_222167 LOC300441 XM_217094 LOC361340 XM_341623 
LOC288772 XM_222316 LOC300444 XM_235926 LOC361460 XM_341739 
LOC288978 XM_213864 LOC300644 XM_217113 LOC361475 XM_341753 
LOC289182 XM_213922 LOC300783 XM_217180 LOC361543 XM_341829 
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LOC289264 XM_222923 LOC300839 XM_217189 LOC361578 XM_341861 
LOC290500 XM_214256 LOC301137 XM_236799 LOC361606 XM_341884 
LOC290706 XM_214341 LOC301711 XM_237538 LOC361646 XM_341925 
LOC290825 XM_212786 LOC302092 XM_229666 LOC361649 XM_341928 
LOC290916 XM_225053 LOC302559 XM_217599 LOC361774 XM_342068 
LOC290999 XM_214433 LOC302898 XM_579268 LOC361797 XM_347003 
LOC291000 XM_214432 LOC303100 XM_220372 LOC361871 XM_342165 
LOC291034 XM_214448 LOC303730 XM_221185 LOC361990 XM_342290 
LOC291290 XM_225531 LOC304349 XM_221990 LOC362127 XM_342428 
LOC291952 XM_226397 LOC304860 XM_222736 LOC362294 XM_347039 
LOC291974 XM_214666 LOC304863 XM_222746 LOC362295 XM_342608 
LOC292195 XM_217716 LOC305122 XM_223143 LOC362370 XM_342695 
LOC292811 XM_214901 LOC305332 XM_223397 LOC362526 XM_342844 
LOC293156 XM_215012 LOC305452 XM_223536 LOC362559 XM_342878 
LOC293509 XM_219352 LOC306007 XM_224329 LOC362662 XM_575960 
LOC293699 XM_212887 LOC306586 XM_224997 LOC362725 XM_343047 
LOC293711 XM_219546 LOC307235 XM_225730 LOC362776 XM_343103 
LOC294560 XM_215428 LOC308758 XM_218817 LOC362801 XM_343127 
LOC294722 XM_226796 LOC308765 XM_218824 LOC362938 XM_343266 
LOC294925 XM_226988 LOC309081 XM_219424 LOC363000 XM_343330 
LOC295015 XM_227132 LOC310137 XM_226853 LOC363069 XM_343397 
LOC295090 XM_215580 LOC311114 XM_230006 LOC363129 XM_343464 
LOC295161 XM_215594 LOC311218 XM_230305 LOC363162 XM_343501 
LOC295234 XM_215630 LOC311355 XM_230503 LOC363289 XM_343631 
LOC295952 XM_215788 LOC311382 XM_230560 LOC363309 XM_343649 
LOC296050 XM_215787 LOC311591 XM_230798 LOC363332 XM_343670 
LOC296300 XM_215885 LOC312728 XM_232372 LOC363476 XM_343795 
LOC296318 XM_215910 LOC312946 XM_232647 LOC363555 XM_343870 
LOC296320 XM_215906 LOC313346 XM_233144 LOC363611 XM_343905 
LOC296761 XM_216066 LOC313373 XM_233199 LOC363817 XM_344036 
LOC297388 XM_216181 LOC313842 XM_233805 LOC363937 XM_344119 
LOC297402 XM_216190 LOC313982 XM_233989 LOC363962 XM_573437 
LOC297514 XM_238368 LOC314196 XM_234264 LOC363974 XM_344134 
LOC297890 XM_216348 LOC314660 XM_234947 LOC364006 XM_577273 
LOC297971 XM_216368 LOC314927 XM_235252 LOC364060 XM_344178 
LOC298282 XM_216446 LOC315434 XM_235833 LOC364136 XM_344230 
LOC298384 XM_216480 LOC315463 XM_235924 LOC364139 XM_573586 
LOC298490 XM_216527 LOC316228 XM_236927 LOC364253 XM_344296 
LOC298496 XM_233477 LOC317346 XM_228716 LOC364258 XM_344301 
LOC298787 XM_216638 LOC317405 XM_228821 LOC364343 XM_344366 
LOC364381 XM_344404 LOC499316 XM_574620 
Lpin2_predicte
d XM_237521 
LOC364535 XM_344495 LOC499401 XM_574716 
Lrp10_predicte
d XM_224170 
LOC364577 XM_573906 LOC499411 XM_579965 
Lsm8_predicte
d XM_216102 
LOC364613 XM_573924 LOC499525 XM_574850 Man2b1 NM_199404 
LOC364823 XM_344652 LOC499561 XM_574885 
Map3k3_predi
cted XM_221034 
LOC365300 XM_574483 LOC499581 XM_574906 Mapkapk2 XM_579712 
LOC365314 XM_344924 LOC499617 XM_574942 Mark2 NM_021699 
LOC365580 XM_577905 LOC499660 XM_574984 
Mbd1_predicte
d XM_574171 
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LOC365664 XM_574847 LOC499700 XM_575029 
Mcmdc1_predi
cted XM_342146 
LOC365924 XM_345284 LOC499755 XM_575090 Mcpt1l4 XM_573784 
LOC365949 XM_345296 LOC499809 XM_575149 
Mesdc1_predic
ted XM_218853 
LOC366248 XM_575286 LOC499856 XM_575197 
Metap1_predic
ted XM_215717 
LOC366315 XM_345503 LOC499905 XM_575251 MGC94056 
NM_00100425
8 
LOC366461 XM_345576 LOC499931 XM_575276 MGC94221 
NM_00100422
4 
LOC366468 XM_345581 LOC499950 XM_575298 MGC94326 
NM_00100770
9 
LOC366565 XM_578532 LOC499956 XM_575304 MGC94413 
NM_00100774
5 
LOC367030 XM_576362 LOC500005 XM_575359 MGC95208 
NM_00100555
2 
LOC367109 XM_345951 LOC500148 XM_575500 MGC95210 
NM_00100553
2 
LOC367171 XM_576473 LOC500196 XM_575548 
Mgst2_predict
ed XM_215562 
LOC367205 XM_578768 LOC500382 XM_575740 
Mki67_predicte
d XM_225460 
LOC367761 XM_346284 LOC500506 XM_575868 Mlc3 NM_020104 
LOC367806 XM_346310 LOC500553 XM_575916 Mnt_predicted XM_220698 
LOC367944 XM_346362 LOC500606 XM_575979 
Mocs1_predict
ed XM_236911 
LOC497703 XM_579683 LOC500650 XM_576028 Mocs2 
NM_00100763
3 
LOC497706 XM_579538 LOC500662 XM_576040 
Mrpl22_predict
ed XM_213307 
LOC497717 XM_579724 LOC500814 XM_576201 
Mrpl27_predict
ed XM_213439 
LOC497754 XM_579458 LOC500819 XM_576208 
Mrpl42_predict
ed XM_216882 
LOC497832 XM_579562 LOC500869 XM_576267 
Mrpl49_predict
ed XM_219525 
LOC497886 XM_573071 LOC500981 XM_576391 
Mrps17_predic
ted XM_213762 
LOC497904 XM_573090 LOC501002 XM_576412 
Ms4a8b_predi
cted XM_342026 
LOC497974 XM_573168 LOC501058 XM_576474 Mss4 
NM_00100767
8 
LOC498002 XM_573198 LOC501064 XM_576479 Mybph NM_031813 
LOC498058 XM_573255 LOC501172 XM_576599 Myc NM_012603 
LOC498229 XM_573449 LOC501204 XM_576630 Myo1 d NM_012983 
LOC498230 XM_573451 LOC501326 XM_576737 Myr8 NM_138893 
LOC498268 XM_579805 LOC501351 XM_576762 Nap1l3 NM_133402 
LOC498374 XM_573609 LOC501363 XM_576776 Ncdn NM_053543 
LOC498411 XM_573658 LOC501370 XM_576783 
Ncor2_predicte
d XM_341072 
LOC498435 XM_573687 LOC501397 XM_576809 
Ndufa8_predict
ed XM_216044 
LOC498729 XM_574003 LOC501514 XM_576915 
Ndufb9_predict
ed XM_216929 
LOC498747 XM_574026 LOC501534 XM_576934 
Ndufs3_predict
ed XM_215776 
LOC498759 XM_574044 LOC501621 XM_577021 Ndufv2 NM_031064 
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LOC498805 XM_574089 LOC501655 XM_577050 Nedd4a XM_343427 
LOC498819 XM_574101 LOC501952 XM_577379 Negr1 NM_021682 
LOC498837 XM_574121 LOC502201 XM_577662 Neo1 XM_343402 
LOC498899 XM_574186 LOC502393 XM_577872 Neu1 NM_031522 
LOC499009 XM_574302 LOC502686 XM_578183 
Nfatc4_predict
ed XM_240184 
LOC499018 XM_574311 LOC502743 XM_578243 Nfe2l2 NM_031789 
LOC499031 XM_574321 LOC502858 XM_578358 nidd NM_213627 
LOC499071 XM_574352 LOC502935 XM_578437 
Nisch_predicte
d XM_240330 
LOC499087 XM_574374 LOC503000 XM_578512 
Nosip_predicte
d XM_214926 
LOC499255 XM_574549 LOC503197 XM_578721 Notch1 XM_342392 
LOC499262 XM_574557 LOC503351 XM_578889 Npl4 NM_080577 
LOC499288 XM_574587 Loc65027 XM_573762 Npy NM_012614 
Nr3c1 NM_012576 Prlph NM_021580 RGD1359460 
NM_00100695
9 
Nucb1 NM_053463 Psma2 NM_017279 RGD1359600 
NM_00100768
8 
Nudt6 NM_181363 Psma4 NM_017281 Rgs14 NM_053764 
Nyw1 XM_230288 Psma5 NM_017282 Rhcg NM_183053 
Ogfrl1_predict
ed XM_237000 Psma6 NM_017283 Ripk5 NM_199463 
Olr1024_predi
cted 
NM_00100006
8 Psma7 XM_579184 
Rnf111_predict
ed XM_236380 
Olr1242_predi
cted 
NM_00100045
0 Psmb1 NM_053590 
Rnf153_predict
ed XM_215286 
Olr1340_predi
cted XM_236174 Psmb3 NM_017285 
Rpl3l_predicte
d XM_213231 
Olr1592_predi
cted 
NM_00100008
4 Psmb4 NM_031629 Rpo2tc1 
NM_00100961
8 
Olr1690_predi
cted 
NM_00100027
4 Psmb6 NM_057099 Rps12 NM_031709 
Olr1751_predi
cted 
NM_00100049
2 Psmb7 NM_053532 
Rragc_predicte
d XM_216515 
Olr29_predicte
d 
NM_00100069
1 Psmc1 NM_057123 RSB-11-77 NM_182669 
Olr495_predict
ed 
NM_00100031
0 Psmc2 NM_033236 S100a1 XM_579178 
Olr535_predict
ed 
NM_00100067
2 Psmc3 NM_031595 Sdhc 
NM_00100553
4 
Olr552_predict
ed 
NM_00100105
5 Psmc5 NM_031149 Sec14l2 NM_053801 
Olr818_predict
ed 
NM_00100084
4 Psmd1 NM_031978 
Sec24b_predic
ted XM_215706 
Pabpc4_predic
ted XM_216517 
Psmd11_predi
cted XM_220754 
Sema3b_predi
cted XM_343479 
Pacs1 NM_134406 
Psmd7_predict
ed XM_226439 
Sema3f_predic
ted XM_236623 
Pafah1b3 NM_053654 Pspn NM_013014 Serpinh1 NM_017173 
Pafah2 NM_177932 Ptbp1 NM_022516 
Setdb1_predict
ed XM_227444 
Pam NM_013000 Ptgfrn NM_019243 Siahbp1 XM_343268 
Pax2_predicte
d XM_239083 Ptk2 NM_013081 Skp1a 
NM_00100760
8 
Pcdhga8_predi
cted XM_344668 Ptms NM_031975 Slc12a4 NM_019229 
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Perq1_predicte
d XM_222024 Ptpn21 NM_133545 Slc1a3 NM_019225 
Pgpep1 NM_201988 
Pus1_predicte
d XM_222267 
Slc24a4_predi
cted XM_234470 
Phb XM_579541 
Pycs_predicte
d XM_342048 Slc25a11 NM_022398 
Phr1_predicted XM_214245 Pygb XM_342542 Slc28a2 NM_031664 
Pias3 NM_031784 
Rab6b_predict
ed XM_343459 
Slc30a8_predi
cted XM_235269 
Pigh_predicted XM_343083 Rac2 
NM_00100838
4 
Slc35b4_predi
cted XM_216122 
Pigq 
NM_00100760
7 
Rarsl_predicte
d XM_216367 
Slc35e1_predi
cted XM_224707 
Pip5k2c NM_080480 
Rasip1_predict
ed XM_214916 
Slc37a1_predi
cted XM_574727 
Plcb1 XM_342524 Rassf5 NM_019365 
Slc39a6_predi
cted XM_214607 
Plec1 NM_022401 
Rce1_predicte
d XM_219685 
Slc39a8_predi
cted XM_575042 
Plekhb2_predi
cted XM_217372 Rfx1_predicted XM_222456 Slc6a8 XM_579415 
Plekhf2_predic
ted XM_342803 
RGD1305327_
predicted XM_343285 Slc7a1 NM_013111 
Plekhm2_predi
cted XM_233611 
RGD1305649_
predicted XM_575926 Slit2 XM_346464 
Plk3 XM_342888 
RGD1305679_
predicted XM_341511 Smad1 NM_013130 
Plod3 NM_178101 
RGD1305793_
predicted XM_219958 
Smndc1_predi
cted XM_213506 
Plp2_mapped NM_207601 RGD1306284 
NM_00100828
3 
Snapc1_predic
ted XM_234299 
Podxl NM_138848 RGD1307423 
NM_00100833
4 
Snx11_predict
ed XM_573185 
Poldip2_predic
ted XM_237790 RGD1307481 
NM_00100832
7 Spr XM_342714 
Pole4_predicte
d XM_342710 
RGD1307512_
predicted XM_343357 
Spred2_predict
ed XM_223647 
Polr2j_predicte
d XM_213753 
RGD1307599_
predicted XM_233692 Srd5a1 NM_017070 
Pom210 NM_053322 
RGD1307648_
predicted XM_215262 Ssr1_predicted 
NM_00100889
1 
Pomc NM_139326 
RGD1308009_
predicted XM_226233 Ssrp1 NM_031121 
Pp XM_215416 
RGD1308054_
predicted XM_214834 Stard3nl 
NM_00100829
8 
Ppie_predicted XM_216524 
RGD1308350_
predicted XM_343116 
Sulf2_predicte
d XM_230861 
Ppm1 
d_predicted XM_213418 
RGD1308600_
predicted XM_342393 
Supt4h2_predi
cted XM_213415 
Ppp5c NM_031729 
RGD1309207_
predicted XM_343064 Syngr1 NM_019166 
Pprc1_predicte
d XM_215259 
RGD1309256_
predicted XM_214087 Tacc2 
NM_00100441
5 
Prcc_predicted XM_227476 RGD1309721 
NM_00100967
0 Tacc2 
NM_00100441
8 
Prdm13_predic
ted XM_345509 RGD1309906 
NM_00100924
6 Taok2 NM_022702 
Prkaca XM_341661 
RGD1310022_
predicted XM_214983 Tcam1 NM_021673 
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Prkcdbp NM_134449 RGD1311745 
NM_00100832
9 
Tceb3bp1_pre
dicted XM_576183 
Tcerg1_predict
ed XM_225983 
Trim21_predict
ed XM_219011 
Vps13 
d_predicted XM_233792 
Tcf2 NM_013103 Trim28 XM_344861 
Vps39_predict
ed XM_575216 
Tcf8 XM_341539 Trpv6 NM_053686 Vwf XM_342759 
Tcof1_predicte
d XM_214552 Tsga10ip XM_579136 
Wdr22_predict
ed XM_234345 
Tep1 NM_022591 
Tspyl_predicte
d XM_228225 
Wfdc3_predict
ed XM_215938 
Terf1_predicte
d XM_238387 Tst NM_012808 
Xpo6_predicte
d XM_574559 
Tex27_predict
ed XM_574725 
Ttyh3_predicte
d XM_221962 Xylt1 XM_341912 
Tfdp2_predicte
d XM_217232 Tubb5 NM_173102 Zbtb7a NM_054002 
Tfpi NM_017200 
Tubgcp3_predi
cted XM_225013 
Zc3hdc5_predi
cted XM_340939 
Tfrc XM_340999 Txk_predicted XM_223365 
Zc3hdc6_predi
cted XM_230592 
Tgfb1 NM_021578 Txn2 NM_053331 Zdhhc2 NM_145096 
Tgfb2 NM_031131 Txndc9 NM_172032 
Zfp262_predict
ed XM_233529 
Timm17a NM_019351 
Txnl5_predicte
d XM_213382 
Zfp282_predict
ed XM_216140 
Timm22 XM_340856 Ua20 NM_144742 
Zfp367_predict
ed XM_573970 
Tinf2 
NM_00100696
2 
Ube2r2_predic
ted XM_216864 
Zmynd12_pred
icted XM_233458 
Tjp4_predicted XM_236932 Ufc1 
NM_00100370
9 
Zmynd15_pred
icted XM_213338 
Tlr6 NM_207604 Ufd1l NM_053418 
Znf500_predict
ed XM_343376 
Tmc4_predicte
d XM_218186 Uhrf1_mapped
NM_00100888
2   BC093384 
Tmprss7_predi
cted XM_221464 Uqcrh 
NM_00100948
0   AY724519 
Tnfrsf6 NM_139194 Urod XM_342887   AY724532 
Tnn_predicted XM_222794 Uros_predicted XM_574579   BC079376 
Tor1b_predicte
d XM_231146 
Usp12_predict
ed XM_341033   BC100083 
Tpi1 XM_579468 
Usp7_predicte
d XM_340747   CO382628 
Trim14_predict
ed XM_232992 V1rj6 
NM_00100950
7   DN935439 
Trim2_predicte
d XM_342268 Vmac XM_579064   DV728079 
      BC083830 
 
 
 
